<SEC-DOCUMENT>0001144204-16-133951.txt : 20161114
<SEC-HEADER>0001144204-16-133951.hdr.sgml : 20161111
<ACCEPTANCE-DATETIME>20161114125735
ACCESSION NUMBER:		0001144204-16-133951
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20160930
FILED AS OF DATE:		20161114
DATE AS OF CHANGE:		20161114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-26787-D
		FILM NUMBER:		161992966

	BUSINESS ADDRESS:	
		STREET 1:		9990 PARK MEADOWS DRIVE
		CITY:			LONE TREE
		STATE:			CO
		ZIP:			80124
		BUSINESS PHONE:		(303) 703-4906

	MAIL ADDRESS:	
		STREET 1:		9990 PARK MEADOWS DRIVE
		CITY:			LONE TREE
		STATE:			CO
		ZIP:			80124

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS INC
		DATE OF NAME CHANGE:	20050812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS   INC
		DATE OF NAME CHANGE:	20040120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>v452312_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 10-Q</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(Mark One) </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 33px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the quarterly period ended: September
30, 2016 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OR </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 33px; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission file number <U>33-26787-D&nbsp;</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Zynex, Inc.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 51%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>NEVADA</B></FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 48%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>90-0214497</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or other jurisdiction of</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>incorporation or organization)</B></P></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(IRS Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>9990 PARK MEADOWS DRIVE</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LONE TREE, COLORADO</B></P></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>80124</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Address of principal executive offices)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>(303) 703-4906</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Registrant&rsquo;s telephone number,
including area code)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Former name, former address and former
fiscal year, if changed since last report)&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant (1)&nbsp;has filed
all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing
requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&nbsp;See the definitions of &ldquo;large
accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller reporting company&rdquo; in Rule 12b-2 of the Exchange
Act. (Check One):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 2%; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD>
    <TD STYLE="width: 2%; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 30%; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">Accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="width: 2%; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
<TR>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;(Do not check if a smaller reporting company)</FONT></TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;<FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate the number of shares outstanding of each of the issuer&rsquo;s
classes of common stock, as of the latest practicable date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="width: 48%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Class</FONT></TD>
    <TD STYLE="width: 4%; padding-top: 0.7pt; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 48%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Shares&nbsp;Outstanding&nbsp;as&nbsp;of&nbsp;November 10, 2016</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Common Stock, par value $0.002</FONT></TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.7pt; padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt">31,271,234</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. AND SUBSIDIARIES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEX TO FORM 10-Q </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PART I&mdash;FINANCIAL INFORMATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 80%">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;1.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_001">Financial Statements</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_002">Condensed Consolidated Balance Sheets as of September 30, 2016 (unaudited) and December 31, 2015</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_003">Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2016 and 2015</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_004">Unaudited Condensed Consolidated Statement of Stockholders&rsquo; Deficit for the nine months ended September 30, 2016</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_005">Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2016 and 2015</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_006">Unaudited Notes to Condensed Consolidated Financial Statements</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;2.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_007">Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item 3.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_008">Quantitative and Qualitative Disclosures About Market Risk</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;4.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_009">Controls and Procedures</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>PART II&mdash;OTHER INFORMATION</B></FONT></TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;1.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_010">Legal Proceedings</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;1A.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_011">Risk Factors</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;2.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_012">Unregistered Sales of Equity Securities And Use of Proceeds</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;5.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><A HREF="#a_013">Other Information</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Item&nbsp;6.</FONT></TD>
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_014">Exhibits</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD COLSPAN="2" STYLE="padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_015">SIGNATURES</A></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">27</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.45pt; text-align: center; text-indent: -55.45pt"><B><U>PART
I. FINANCIAL INFORMATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.45pt; text-indent: -55.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 55.45pt; text-indent: -55.45pt"><B><A NAME="a_001"></A><U>ITEM 1. FINANCIAL STATEMENTS
</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED BALANCE SHEETS
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(AMOUNTS IN THOUSANDS, EXCEPT NUMBER
OF SHARES)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">September 30,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center">December&nbsp;31,</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><FONT STYLE="font-size: 10pt"><B>(UNAUDITED)</B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">ASSETS</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Current Assets:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font-size: 10pt; padding-left: 9pt">Cash</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">91</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">8</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Accounts receivable, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,981</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,426</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Inventory, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">96</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">305</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Prepaid expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">28</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">27</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 27pt">Total current assets</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">4,196</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,766</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Property and equipment, net</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">517</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">801</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">Deposits</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">55</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">55</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Intangible assets, net</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">44</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">74</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,812</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,696</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">LIABILITIES AND STOCKHOLDERS&rsquo; DEFICIT</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Current Liabilities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-left: 9pt">Line of credit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">3,027</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">4,002</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Current portion of capital leases</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">109</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">109</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Accounts payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,090</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,477</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Deferred revenue</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">528</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">89</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Income taxes payable</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">79</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">79</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Accrued payroll and payroll taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">760</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">484</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Deferred insurance reimbursement</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">880</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Accrued expenses</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">187</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">299</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 27pt">Total current liabilities</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">8,660</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,539</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Capitalized leases, less current portion</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">165</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">216</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Warranty liability</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">12</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 27pt">Total liabilities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8,837</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7,767</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Stockholders&rsquo; Deficit:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Preferred stock; $.001 par value, 10,000,000 shares authorized, no shares issued or outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.1in; padding-left: 16.2pt">Common stock, $.001 par value, 100,000,000 shares authorized, 31,271,234 shares issued and outstanding</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">31</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Paid-in capital</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">6,018</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,832</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Accumulated deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(9,985</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(9,845</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total Zynex, Inc. stockholders&rsquo; deficit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,936</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(3,982</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Non-controlling interest</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(89</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(89</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,025</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(4,071</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and&nbsp;stockholders&rsquo; deficit</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">4,812</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,696</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to unaudited condensed
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_003"></A><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
SHARE AND PER SHARE DATA)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Three months ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Nine months ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Net revenue:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 48%; font-size: 10pt; padding-left: 13.7pt">Rental</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,324</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">924</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,226</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,768</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; padding-left: 13.7pt">Sales</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,303</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,743</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7,164</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7,155</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; padding-left: 27.35pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">3,627</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,667</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">10,390</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8,923</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 13.7pt">Cost of revenue &ndash; rental, product &amp; supply</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">880</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">950</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,803</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,361</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-left: 13.7pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 13.7pt">Selling, general and administrative expense</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,125</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,943</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">7,465</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">6,923</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Income (loss) from operations</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">622</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(226</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">122</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,361</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Other income (expense):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 13.7pt">Interest expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(90</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(98</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(262</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(368</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; padding-left: 13.7pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 27.35pt">Total other income (expense)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(90</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(98</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(262</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(368</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Income (loss) before income taxes</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">532</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(324</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(140</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,729</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Income taxes</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Net income (loss)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">532</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(324</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(140</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(1,729</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 13.7pt">Plus: Net loss &ndash; noncontrolling interest</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">18</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) &ndash; attributable to Zynex, Inc.</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">532</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(322</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(140</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(1,711</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Net income (loss) per share &ndash; attributable to Zynex, Inc.:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 13.7pt">Basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.02</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.05</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 13.7pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.02</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.01</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.05</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">Weighted - average number of common shares outstanding:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 13.7pt">Basic</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 13.7pt">Diluted</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,440,526</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to unaudited condensed
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_004"></A><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&rsquo;
DEFICIT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Paid-in</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Retained</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Noncontrolling</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Amount</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Capital</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Deficit</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Interest</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="width: 22%; font-size: 10pt">January 1, 2016</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">31</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">5,832</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(9,845</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(89</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">(4,071</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">Employee stock-based compensation expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">171</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">171</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left">Service provider warrant expense</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Net loss</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(140</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(140</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt; padding-bottom: 2.5pt">September 30, 2016</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31,271,234</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">31</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,018</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(9,985</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(89</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(4,025</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to unaudited condensed
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONDENSED CONSOLIDATED STATEMENTS OF
CASH FLOWS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS)</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">Nine months ended</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from operating activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left; padding-left: 9pt">Net cash provided by operating activities</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,183</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">82</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from investing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Change in inventory used for rental</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(73</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">63</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net cash (used in) provided by investing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(73</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">63</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Cash flows from financing activities:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Net repayments on line of credit</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(976</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(120</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Payments on capital leases and other obligations</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(51</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(47</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 9pt">Net cash (used in) provided by financing activities</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,027</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(167</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Net increase (decrease) in cash</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">83</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(22</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Cash at the beginning of the period</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">63</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Cash at the end of the period</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">91</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">41</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Supplemental cash flow information:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Interest paid</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">262</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">368</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 9pt">Income taxes paid (including interest and penalties)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See accompanying notes to unaudited condensed
consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(1)&nbsp;<U>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Organization</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Zynex, Inc. (a Nevada corporation) has its headquarters in Lone
Tree, Colorado. The Company operates in one primary business segment, Electrotherapy and Pain Management Products. As of December
31, 2015, the Company&rsquo;s only active subsidiary is Zynex Medical, Inc. (&ldquo;ZMI,&rdquo; a wholly-owned Colorado corporation)
through which the Company conducts most of its operations. One other subsidiary, Zynex Europe, ApS (&ldquo;ZEU,&rdquo; a wholly-owned
Denmark corporation), produced minimal revenues during 2015 and 2016 from international sales and marketing. Zynex Monitoring Solutions,
Inc. (&ldquo;ZMS,&rdquo; a wholly-owned Colorado corporation) is developing a blood volume monitoring device, but it is not yet
developed or ready for market and, as a result, ZMS has achieved no revenues to date. Its inactive subsidiaries include Zynex NeuroDiagnostics,
Inc. (&ldquo;ZND,&rdquo; a wholly-owned Colorado corporation), Zynex Billing and Consulting, LLC (&ldquo;ZBC,&rdquo; an 80% owned
Colorado limited liability company) and Pharmazy, Inc. (&ldquo;Pharmazy&rdquo;), which was incorporated in June 2015 as a wholly-owned
Colorado corporation. The Company&rsquo;s compound pharmacy operated as a division of ZMI dba as Pharmazy through January 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The term &ldquo;the Company&rdquo; refers to Zynex, Inc. and
its active and inactive subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Nature of Business</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ZMI designs, manufactures and markets U.S. Food and Drug Administration
(FDA) cleared medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes
with electrical stimulation. ZEU was formed in 2012 to conduct international sales and marketing for Company products. ZEU produced
minimal revenues during 2016 and 2015. In addition, ZMI dba Pharmazy, which sold compound transdermal pain cream, began operations
in early 2014 and was closed in January 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ZMS was formed to develop and market medical devices for non-invasive
cardiac monitoring, the products of which are under development. The Company is currently developing a blood volume monitoring
device (Blood Volume Monitor). ZMS produced no revenues during 2016 or 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ZND was formed in 2011 to market electromyography (&ldquo;EMG&rdquo;),
electroencephalography (&ldquo;EEG&rdquo;), sleep pattern, auditory and nerve conductivity neurological diagnosis devices to hospitals
and clinics worldwide. In 2014, the Company decided to no longer focus on selling this product line. ZBC was formed in 2012 to
provide medical billing and consulting services. The Company stopped offering billing and consulting services in April 2015. No
significant revenue was generated from ZND or ZBC in 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2016 and 2015, the Company generated substantially all of
its revenue in North America from sales and rentals of its products to patients, dealers and health care providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Unaudited Condensed Consolidated Financial Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The unaudited condensed consolidated financial statements included
herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&ldquo;SEC&rdquo;)
and accounting principles generally accepted in the United States of America (&ldquo;U.S. GAAP&rdquo;). Certain information and
footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted
pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make
the information presented not misleading. A description of the Company&rsquo;s accounting policies and other financial information
is included in the audited consolidated financial statements as filed with the SEC in the Company&rsquo;s Annual Report on Form
10-K for the year ended December&nbsp;31, 2015. Amounts as of December&nbsp;31, 2015, are derived from those audited consolidated
financial statements. These interim condensed consolidated financial statements should be read in conjunction with the annual audited
financial statements, accounting policies and notes thereto, included in the Company&rsquo;s Annual Report on Form 10-K for the
year ended December&nbsp;31, 2015, which has previously been filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the opinion of management, the accompanying unaudited condensed
consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as
of September 30, 2016 and the results of its operations and its cash flows for the periods presented.&nbsp; The results of operations
for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be achieved for
a full fiscal year and cannot be used to indicate financial performance for the entire year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B><U>Reclassifications</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Certain reclassifications
have been made to the prior years&rsquo; condensed consolidated financial statements to conform to the current year presentation.
These reclassifications had no effect on previously reported results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Recent Accounting Pronouncements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In July 2015, the <FONT STYLE="background-color: white">Financial
Accounting Standards Board (</FONT>FASB) issued <FONT STYLE="background-color: white">Accounting Standards Update (</FONT>ASU)
No. 2015-11, &ldquo;Inventory (Topic 330) Simplifying the Measurement of Inventory&rdquo;, which changes the measurement from lower
of cost or market to lower of cost and net realizable value. The guidance requires prospective application for reporting periods
beginning after December 15, 2016 and permits adoption in an earlier period. The Company is evaluating the impact of this guidance
on the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">In August 2014, the FASB
issued ASU 2014-15 &ldquo;Presentation of Financial Statements&mdash;Going Concern (Subtopic 205-40) Disclosure of Uncertainties
about an Entity&rsquo;s Ability to continue as a Going Concern&rdquo;. The amendments in this update provide guidance in GAAP about
management&rsquo;s responsibility to evaluate whether there is substantial doubt about an entity&rsquo;s ability to continue as
a going concern and to provide related footnote disclosures. The amendments in this update are effective for the annual period
ending after December 15, 2016 and for interim periods thereafter. Early application is permitted. The Company is evaluating the
effect of this updated guidance on the disclosures in the footnotes to the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">In May 2014, the FASB
issued ASU No. 2014-09&mdash;&ldquo;Revenue from Contracts with Customers (Topic 606)&rdquo; which amended revenue recognition
guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize
revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity
expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the
nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative
and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets
recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the
first quarter of fiscal year 2018, using one of two prescribed retrospective methods. Early adoption is permitted only as of annual
reporting periods beginning after December 15, 2016. The Company is evaluating the impact of the amended revenue recognition guidance
on the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management has evaluated other recently issued accounting pronouncements
and does not believe that any of these pronouncements will have a material impact on the Company&rsquo;s consolidated financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>(2) BACKGROUND AND MANAGEMENT&rsquo;S PLANS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Background</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December&nbsp;31, 2015 and 2014, the Company
reported net losses of $2,911 and $6,199, respectively. As of September 30, 2016, the Company had no available borrowing under
its line of credit although, based on an interim agreement with the Company&rsquo;s senior secured lender, Triumph Healthcare Finance,
a division of TBK Bank, SSB, formerly known as Triumph Community Bank, (the &ldquo;Lender&rdquo;), continues to make additional
loans to the Company based on the Company&rsquo;s cash collections. The Company&rsquo;s working capital deficit at September 30,
2016 totaled ($4,464) as compared to ($4,773) at December 31, 2015. In addition, the Company remains in default of its secured
line of credit and as a result, if its lender insists upon immediate repayment, the Company will be unable to do so and may be
forced to seek protection from its creditors. The Company has not been in compliance with the financial covenants under the agreement
with its primary lender since July 2014. The Company&rsquo;s assets, both at December 31, 2015 and at September 30, 2016, are significantly
less than the Company&rsquo;s liabilities, and the Company is dependent on its banking relationship to be able to pay its obligations
as they become due.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s losses, lack of liquidity, and substantial
working capital deficit raise substantial doubt about the Company&rsquo;s ability to continue as a going concern. The accompanying
consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and
the settlement of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments
relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary
should the Company be unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although the Company&rsquo;s revenues increased during the three
months and nine months ended September 30, 2016 as compared to the same periods in the prior year, the Company has not recovered
from the significant revenue decreases in total net revenue for the years ended December 31, 2015 and 2014 (approximately $11.6
million and $11.1 million, respectively) as compared to 2013 and 2012 (approximately $21.7 million and $39.7 million, respectively).
The primary reasons for the decline in revenue from 2012-2013 to 2014-2015 were (i) the impact of Medicare and healthcare reform,
(ii) a loss of Zynex&rsquo;s independent sales force to sell transdermal compounded pain cream from competing pharmacies rather
than focusing on selling the Company&rsquo;s Electrotherapy products and (iii) in the latter part of 2012, the elimination of Medicare
reimbursement for transcutaneous electrical nerve stimulation (TENS) Electrotherapy products for low-back pain while still covering
TENS for other indications. Medicare also continued increasing the requirements for paperwork and documentation in connection with
reimbursement requests. As a result, late in 2013 Zynex began declining orders for Medicare and Medicaid patients. Commercial and
workers&rsquo; compensation insurance plans continue to reimburse at similar levels as in previous years and have not adopted Medicare&rsquo;s
limited coverage.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2015 and throughout 2014, in an effort to minimize the
impact of the challenges discussed above, the Company restructured its internal operations, including manufacturing, billing and
customer service; and made reductions in its fixed expenses by cutting its administrative costs by approximately $2.2 million and
$9.7 million, respectively, principally through reductions in headcount and facilities rent. In addition, the Company during the
second quarter of 2014 narrowed its focus to the NexWave, InWave and NeuroMove electrotherapy products and continued to build the
sales representative group for its electrotherapy solutions. The Company continued to narrow this focus by closing its billing
consulting services in April 2015 and closing its compound pain cream operations in January 2016. The Company is continuing to
address cost of revenues and overhead expenses in 2016 and as a result has improved the Company&rsquo;s operating performance for
the three and nine months ended September 30, 2016 (being net income of $532 and net loss of $(140) respectively) as compared to
the same periods of the prior year (being net losses of $(322) and $(1,711) respectively).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the fourth quarter of 2015, the electrotherapy industry
experienced a significant development when the Company&rsquo;s largest competitor (DJO/Empi) announced the closure of their Empi
electrotherapy division. Empi previously held a large share of the electrotherapy market. Management believes this presents a significant
growth opportunity for the Company. The Company has recruited many former Empi sales representatives, including those in areas
where it had no previous representation. In addition, during 2016, the Company&rsquo;s orders have been steadily increasing as
compared to 2015. To focus on growth and the potential for future positive cash flow, the Company has committed its limited resources
to the new salesforce, including the supporting product production and supporting administrative (customer service and billing)
personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is not in compliance with the financial covenants
under the terms of its line of credit with the Lender. See Note 7 to the Unaudited Condensed Consolidated Financial Statements
in this Quarterly Report for further discussion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Management&rsquo;s Plans</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s business plan for the remainder of 2016
and into 2017 focuses on the Company&rsquo;s effort to attain external financing, retaining the Lender&rsquo;s continued support,
maintaining the continued support of the Company&rsquo;s vendors on the slow payment of past due invoices, and pursuing organic
growth in our electrotherapy and pain management products with a goal of attaining positive cash flow. The accomplishment of organic
growth in revenues and cash flows is dependent on taking advantage of the Empi opportunity, increasing the number of sales representatives,
promoting the EZ Rx Prescribe program (described further below) and continuing improvements to the Company&rsquo;s billing organization
and processes. The Company&rsquo;s long-term business plan contemplates organic growth in revenues through an increase in the electrotherapy
market share and the addition of new products such as the ZMS Blood Volume Monitor, which is currently under development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is actively seeking additional financing through
the issuance of debt or sale of equity. The additional capital is to refinance or replace the line of credit and to provide the
additional working capital necessary to continue the Company&rsquo;s business operations. The Company&rsquo;s history of net losses
and negative working capital may make it difficult to raise any new capital and any such capital raised (if any) may result in
significant dilution to existing stockholders. The Company is not certain whether any such financing would be available to the
Company on acceptable terms, or at all. Any additional debt would require the approval of the Lender. A significant component of
our negative working capital at September 30, 2016 is the amount due under our line of credit and past due accounts payable, all
of which is considered a current liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition to seeking external financing, the Company has
and will continue to monitor and control its sales growth, product production needs and administrative costs going forward.
The Company&rsquo;s efforts to reduce costs and increase revenues have led to net  income (loss) from operations for the
three- and nine-month periods in 2016 ($532 and ($140), respectively) as compared to losses for the same periods in 2015
(($322) and ($1,711), respectively). If the Company continues to increase its revenue while controlling its administrative
costs and the Lender permits it to continue to operate, the Company believes that it may continue its 2016 return to
profitability in future periods. The Company believes that as a result of potential growth opportunities coupled with reduced
administrative expenses, the securing of additional capital (if available), the continued support of its Lender (which cannot
be assured), and the continued support of vendors to work with the Company on the slow payment of past due bills (which
cannot be assured); that the Company&rsquo;s cash flows from operating activities will be sufficient to fund the
Company&rsquo;s cash requirements through the next twelve months. Management believes that its cash flow projections for 2016
are achievable and that sufficient cash will be generated to meet the Company&rsquo;s currently restrained operating
requirements. Such cash is projected to be generated by securing external financing, retaining the continued support of the
Lender and vendors, and increasing cash flow from operations generated from organic growth. There is no guarantee that
the Company will be able to meet the requirements of its 2016 cash flow projections or that it will be able to address its
working capital shortages; the principal component of which is the negative working capital.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There can be no assurance that the Company will be able to secure
additional external financing, the Lender will continue to make loan advances, the vendors will continue to work with slow repayment
terms, and the sales and cash flow growth are attainable and sustainable. The Company&rsquo;s dependence on operating cash flows
means that risks involved in the Company&rsquo;s business can significantly affect the Company&rsquo;s liquidity. Contingencies
such as unanticipated shortfalls in revenues or increases in expenses could affect the Company&rsquo;s projected revenues, and
cash flows from operations and liquidity, which may force the Company to curtail its operating plan or impede the Company&rsquo;
growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(3)&nbsp;<U>PROPERTY AND EQUIPMENT </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and equipment as of September 30, 2016 and December&nbsp;31,
2015, consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30,<BR> 2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December&nbsp;31,<BR> 2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Useful<BR> lives</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>(UNAUDITED)</B></FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="width: 48%; font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Office furniture and equipment</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">913</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">911</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 15%; font-size: 10pt; text-align: right">3-7&nbsp;years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Rental inventory</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,201</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,216</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">5&nbsp;years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Vehicles</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">76</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">76</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">5&nbsp;years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left; text-indent: -12pt; padding-left: 12pt">Leasehold improvements</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">104</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">104</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">2-6&nbsp;years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Assembly equipment</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">125</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">125</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right; padding-bottom: 1pt">7&nbsp;years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,419</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,432</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Less accumulated depreciation</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,902</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1,631</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD NOWRAP STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">517</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">801</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(4) <U>EARNING (LOSS) PER SHARE </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basic earnings (loss) per share is computed by dividing net
income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed
by dividing net loss by the weighted-average number of common shares outstanding and the number of dilutive potential common share
equivalents during the period, calculated using the treasury-stock method. For the three months ended September 30, 2016 and 2015and
the nine months ended September 30, 2016 and 2015, the potential common stock equivalents totaled 2,040,958; 1,450,500 and 2,210,250;
1,450,500, respectively, and were excluded from the dilutive income (loss) per share calculation as their impacts were antidilutive.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(5)&nbsp;<U>STOCK-BASED COMPENSATION PLANS </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company previously reserved 3,000,000 shares of common stock
for issuance under its 2005 Stock Option Plan (the &ldquo;Option Plan&rdquo;). The Option Plan expired as of December 31, 2014.
Vesting provisions are determined by the Board of Directors. All stock options under the Option Plan expire no later than ten years
from the date of grant. Since the Option Plan expired, the options granted in 2015 and 2016 have not been approved by the Company&rsquo;s
shareholders and were issued as non-qualified stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the nine months ended September 30, 2016 and 2015, the Company
recorded compensation expense related to stock options of $171 and $67, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2016, the Company
granted options to purchase up to 804,000 shares of common stock to employees at a weighted average exercise of $0.27 per share.
The 2016 grants were issued as non-qualified stock options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company used the Black Scholes option pricing model to determine
the fair value of stock option grants, using the following assumptions during the nine months ended September 30, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -13.2pt; padding-left: 13.2pt">Weighted average expected term</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;6.25 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 79%; font-size: 10pt; text-indent: -13.2pt; padding-left: 13.2pt">Weighted average volatility</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 20%; font-size: 10pt; text-align: center">122.73%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -13.2pt; padding-left: 13.2pt">Weighted average risk-free interest rate</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">1.51%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -13.2pt; padding-left: 13.2pt">Dividend yield</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">0%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(5)&nbsp;<U>STOCK-BASED COMPENSATION PLANS </U>(continued)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of stock option activity under all equity compensation
plans for the nine months ended September 30, 2016, is presented below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Shares<BR> Under<BR> Option</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average<BR> Exercise<BR> Price</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average<BR> Remaining<BR> Contractual<BR> Life</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate<BR> Intrinsic<BR> Value</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Outstanding at January&nbsp;1, 2016</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,685,250</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">0.46</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 12%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Granted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">804,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.27</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Exercised</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Forfeited</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(329,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.36</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Outstanding at September 30, 2016</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,160,250</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.40</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right; padding-bottom: 2.5pt">6.91 years</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Exercisable at September 30, 2016</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,537,048</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.45</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right; padding-bottom: 2.5pt">6.23 years</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of status of the Company&rsquo;s non-vested share
awards as of and for the nine months ended September 30, 2016, is presented below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Non-vested&nbsp;Shares<BR> Under&nbsp;Option</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted&nbsp;Average<BR> Grant&nbsp;Date&nbsp;Fair&nbsp;Value</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Non-vested at January 1, 2016</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">672,155</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">0.31</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Granted</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">804,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.34</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -12pt; padding-left: 12pt">Vested</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">(523,953</TD><TD STYLE="font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">0.31</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Forfeited</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(329,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.31</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Non-vested at September 30, 2016</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">623,202</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.23</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2016, the Company had approximately $252
of unrecognized compensation expense related to stock options that will be recognized over a weighted average period of approximately
5 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(6)&nbsp;<U>INCOME TAXES </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The provision for income taxes is recorded at the end of each
interim period based on the Company&rsquo;s best estimate of its effective income tax rate expected to be applicable for the full
fiscal year.&nbsp;The Company&rsquo;s effective income tax rate was 0% for both the three and nine months ended September 30, 2016
and 2015, respectively, as the realization of any deferred tax assets is not more likely than not. The Company paid no income taxes
during the three and nine months ended September 30, 2016 and 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(7)&nbsp;<U>LINE OF CREDIT </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has an asset-backed revolving credit facility under
a Loan and Security Agreement as amended, (the &ldquo;Triumph Agreement&rdquo;) with Triumph Healthcare Finance, a division of
TBK Bank, SSB, formerly known as Triumph Community Bank, (the &ldquo;Lender&rdquo;). The Triumph Agreement contains certain customary
restrictive and financial covenants for asset-backed credit facilities. The Company has not been in compliance with the financial
covenants under the Triumph Agreement since July 2014.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On July 14, 2014, the Company received notice from the Lender
of an event of default under the Triumph Agreement. The notice relates to the Company&rsquo;s default under the minimum debt service
coverage ratio requirement for the quarter ended March 31, 2014 and certain other alleged defaults. The Lender notified the Company
that it was exercising its default remedies under the Triumph Agreement, including, among others, accelerating the repayment of
all outstanding obligations under the Triumph Agreement (outstanding principal and accrued interest) and collecting the Company&rsquo;s
bank deposits to apply towards the outstanding obligations. The Company and the Lender have been discussing the terms of an accelerated
repayment of the amounts outstanding under the Triumph Agreement and the Lender has (pursuant to a forbearance agreement which
has been extended through December 31, 2016) continued to make additional loans to the Company based on cash collections. As a
result of the Company&rsquo;s increased revenues and cash flow, the Company was able to make a $976 payment to the Lender against
the principal amount of the debt during the first nine months of 2016 as compared to only a $120 payment against principal during
the same period in 2015. This payment during 2016 resulted from increased accounts receivable collections, principally from a single
insurance carrier which (as described in Note 8 to the unaudited financial statements below) we may be obligated to refund to the
insurance carrier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the Company&rsquo;s improved performance in
2016 and expectations for the future, no assurance can be given that the Lender will continue to make such additional loans or
that the parties will agree on a repayment plan acceptable to the Company. If the Lender insists upon immediate repayment, the
Company may be forced to seek protection from creditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2016, $3,027 was outstanding under the Triumph
Agreement and zero was available for borrowing based on the default status. Borrowings under the Triumph Agreement bear interest
at the default interest rate. As of September 30, 2016, the effective interest rate under the Triumph Agreement was approximately
11.0% (6.75% interest rate plus 3% additional default interest rate and 1.25% fees). The Triumph Agreement requires monthly interest
payments in arrears on the first day of each month. The Triumph Agreement matured on December 19, 2014. Triumph has agreed to forbear
from the exercise of its rights and remedies under the terms of the Triumph Agreement through December 31, 2016, pursuant to the
terms of the September 29, 2016 forbearance agreement. The Triumph Agreement requires a lockbox arrangement whereby all receipts
are swept daily to reduce borrowings outstanding. The Company is obligated to reduce the loan balance by $85 each month. In connection
with the agreement entered into on March 28, 2016, the Lender suspended this monthly payment requirement for February, March and
April of 2016 up to an aggregate cap of $250, in exchange for the issuance of a warrant to purchase 50,000 shares of the Company&rsquo;s
common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company used the Black Scholes option pricing model to determine
the fair value of the stock warrant, using the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Contractual term</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: right">5.0 years</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; font-size: 10pt; text-indent: -13.2pt; padding-left: 13.2pt">Volatility</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">122.44</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -13.2pt; padding-left: 13.2pt">Risk-free interest rate</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.00</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -13.2pt; padding-left: 13.2pt">Dividend yield</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1.44</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2016, the Company
recorded bank fee expense related to this stock warrant of $15.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ZYNEX, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(UNAUDITED, AMOUNTS IN THOUSANDS, EXCEPT
NUMBER OF SHARES AND PER SHARE DATA) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NINE MONTHS ENDED SEPTEMBER 30, 2016
AND 2015 </B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>(8) DEFERRED INSURANCE REIMBURSEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the first quarter of 2016, the Company collected $880
from a single insurance company for accounts receivable. The accounts receivable had been previously reduced to zero by the allowance
for contractual adjustments. Subsequent to March 31, 2016, the insurance company verbally communicated to the Company that this
payment was made in error and requested it be refunded to the insurance company. The Company recorded this $880 insurance reimbursement
as a deferred insurance liability. However, the Company is disputing the refund request and has initiated an internal audit of
the reimbursement to determine that the original sales arrangement was properly executed, the products had been shipped and title
was transferred (or rental services were rendered), the price of the products or services and the reimbursement rate is fixed and
determinable, and the Company&rsquo;s ultimate claim to the reimbursement is reasonably assured. The Company will record the appropriate
amount as net revenue when such internal audit is complete and the Company&rsquo;s claim to the amount is reasonably assured.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(9) <U>CAPITAL LEASES AND OTHER OBLIGATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company had previously entered into a Lease Termination
Agreement (&ldquo;LTA&rdquo;) and new Lease Agreement (&ldquo;LA&rdquo;) with its landlord relating to the Company&rsquo;s headquarters
location in Lone Tree, Colorado, under which the Company reduced the amount of space leased at its headquarters. Subsequently,
on August 12, 2016, the Company entered into an amended Lease Agreement to extend and amend the terms and conditions of the LA.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following is a summary of the key terms of the LA, as amended:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The original term of the LA term was extended by two years and as amended is to end, unless sooner terminated, on December 31, 2018;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Fixed rental payments were decreased from $49 to $38 per month; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The Company and landlord shall each have the right to terminate the lease at any time, without liability to the other, with ninety days (originally six months) prior written notice to the Company and ninety days written notice to the Landlord.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company also leases certain equipment under capital leases
which expire on various dates through 2018. Imputed interest rates on the leases range from approximately 5% to 10%. At September
30, 2016, the total recorded cost of assets under capital leases was approximately $461. Accumulated depreciation related to these
assets totals approximately $264.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUB>&nbsp;</SUB></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(10)&nbsp;<U>CONCENTRATIONS </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company sourced approximately 35% and 40% of components
for its electrotherapy products from one vendor during the nine months ended September 30, 2016 and 2015, respectively. Management
believes that its relationships with suppliers are good; however, the Company has delayed and extended payments to many of its
vendors for cash flow reasons, which has caused many of its vendors to require pre-payment for products or services. If the relationships
were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available
and additional expenses may be incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company had receivables from a private health insurance
carrier at September 30, 2016 and December 31, 2015, that made up approximately15% and 5%, respectively, of the net accounts receivable
balance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(11)&nbsp;<U>LITIGATION </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">From time to time, the Company may become party to litigation
and other claims in the ordinary course of business. To the extent that such claims and litigation arise, management would provide
for them if losses are determined to be both probable and estimable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is currently not a party to any material pending
legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A><U>ITEM 2. MANAGEMENT&rsquo;S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF&nbsp;OPERATIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary Notice Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This quarterly report contains statements that are forward-looking,
such as statements relating to plans for future organic growth and other business development activities, as well as the impact
of reimbursement trends, other capital spending and financing sources. Such forward-looking information involves important risks
and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from
those expressed in any forward-looking statements made by or on behalf of the Company. These risks include the Company&rsquo;s
difficulty in paying its debts as they become due, the need for additional capital in order to grow our business, our ability to
avoid insolvency and engage effective sales representatives, the need to obtain U.S. Food and Drug Administration (&ldquo;FDA&rdquo;)
clearance and Certificate European (&ldquo;CE&rdquo;) marking of new products, the acceptance of new products as well as existing
products by doctors and hospitals, our dependence on the reimbursement from insurance companies for products sold or rented to
our customers, acceptance of our products by health insurance providers for reimbursement, larger competitors with greater financial
resources, the need to keep pace with technological changes, our dependence on third-party manufacturers to produce key components
of our products on time and to our specifications, implementation of our sales strategy including a strong direct sales force,
and other risks described herein and in our Annual Report on Form 10-K for the year ended December 31, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These interim financial statements and the information contained
in this Quarterly Report on Form 10-Q should be read in conjunction with the annual audited consolidated financial statements,
and notes to consolidated financial statements, included in the Company&rsquo;s 2015 Annual Report on Form 10-K and subsequently
filed reports, which have previously been filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We operate in one primary business segment, Electrotherapy and
Pain Management Products. We only have a single active subsidiary: Zynex Medical, Inc. (&ldquo;ZMI,&rdquo; a wholly-owned Colorado
corporation). Another subsidiary, Zynex Europe, ApS (&ldquo;ZEU,&rdquo; a wholly-owned Denmark corporation), produced nominal revenues
during 2015 and 2016 from international sales and marketing. Zynex Monitoring Solutions, Inc. (&ldquo;ZMS,&rdquo; a wholly-owned
Colorado corporation) is developing a blood volume monitoring device, but it is not yet developed or ready for market and, as a
result, ZMS has achieved no revenues to date. Our inactive subsidiaries include Zynex NeuroDiagnostics, Inc. (&ldquo;ZND,&rdquo;
a wholly-owned Colorado corporation), Zynex Billing and Consulting, LLC (&ldquo;ZBC,&rdquo; an 80% owned Colorado limited liability
company) and Pharmazy, Inc. (&ldquo;Pharmazy&rdquo;), which was incorporated in June 2015 as a wholly-owned Colorado corporation.
Our compound pharmacy, which operated as a division of ZMI dba as Pharmazy, was closed in January 2016. None of our inactive subsidiaries
are expected to product revenue for the Company in the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RESULTS OF OPERATIONS (<I><U>dollars in thousands, except
per share data</U></I>) </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the nine months ended September 30, 2016, net loss was $(140)
as compared to a net loss of $(1,711) for the nine months ended September 30, 2015. This reflects increased net revenue and decreased
cost of revenue offset by increased selling, general and administrative expense; all of which will be discussed below. This amount
does not reflect receipt of $880 from a single insurance company which has been classified as a deferred insurance liability on
our balance sheet. We will record the appropriate amount as revenue when an internal audit is complete and our claim to the amount
is reasonably assured.&nbsp;See Note 8 to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report for
further discussion of the classification of the $880 as a deferred insurance reimbursement.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Background</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the years ended December&nbsp;31, 2015, 2014 and 2013, we
reported net losses of $(2.9) million, $(6.2) million and $(7.3) million, respectively. As of September 30, 2016 we had a working
capital deficit of $(4,464) as compared to $(4,773) at December 31, 2015 and had no available borrowing under our line of credit
(which the Lender declared to be in default in July 2014). Based on an interim agreement with our principal lender (Triumph Healthcare
Finance, a division of TBK Bank, SSB (formerly known as Triumph Community Bank (the &ldquo;Lender&rdquo;)), the Lender continues
to make additional loans to us based on our cash collections. Our historical losses, limited liquidity and continuing working capital
deficit, and the possibility for the continuation of losses, limited liquidity, and working capital deficits through 2016 and beyond
raise substantial doubt about our ability to continue as a going concern unless we can raise and deploy to operations (not repayment
of debt) a significant amount of investment capital in the near future. The accompanying condensed consolidated financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in
the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability
and classification of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue
as a going concern.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our operating plans moving forward through 2016 emphasize revenue
growth and cash flow; focusing our attention on increasing the number of sales representatives, promoting our EZ Rx Prescribe program
(see description below), continued improvements to our billing organization and processes and reducing and controlling administrative
expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Total net revenue for the nine months ended September 30, 2016
was $10,390 compared to $8,923 for the nine months ended September 30, 2015. Although net revenues improved in the first three
quarters of 2016 as compared to the same period of 2015, this continues to be a significant decrease, when annualized as compared
to revenues in 2013 and 2012 of approximately $21.7 million and $39.7 million, respectively. The primary reasons for the decline
in revenue were (i) the impact of Medicare and healthcare reform, (ii) a loss of Zynex&rsquo;s independent sales force to sell
transdermal compounded pain cream from competing pharmacies rather than focusing on selling our Electrotherapy products and, (iii)
in the latter part of 2012, the elimination of Medicare reimbursement for transcutaneous electrical nerve stimulation (TENS) Electrotherapy
products for low-back pain while still covering TENS for other indications. Medicare also continued increasing the paperwork and
documentation requirements for reimbursement. As a result, late in 2013 Zynex began declining orders for Medicare and Medicaid
patients. Commercial and workers&rsquo; compensation insurance plans continue to reimburse at similar levels as in previous years
and have not adopted Medicare&rsquo;s limited coverage.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the years ending December 31, 2015 and 2014, in an effort
to minimize the impact of the challenges discussed above, we restructured our internal operations, including manufacturing, billing
and customer service; and made reductions in our fixed expenses by cutting our administrative costs by approximately $2.2 million
and $9.7 million, respectively, principally through reductions in headcount and facilities rent. In addition, during the second
quarter of 2014 we narrowed our focus to the NexWave, InWave and NeuroMove electrotherapy products and continued to build the sales
representative group for our electrotherapy solutions. We continued to narrow our focus by closing our billing consulting services
in April 2015 and closing our compound pain cream operations in January 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In early 2014, ZMI slowly introduced the EZ Rx Prescribe program,
a new distribution model for dispensing ZMI products to patients. The program is known to prescribers, as EZ Rx Prescribe and has
streamlined the way physicians prescribe and patients receive our products, and how ZMI utilizes inventory. Under the program prescriptions
are faxed directly to ZMI reducing the requirements on the physician or office staff to spend time filling out device paperwork
and educating patients on how to use the device. After receiving a prescription, ZMI contacts the patient directly to process the
necessary paperwork and ships the device directly to the patient. Upon the patient receiving the device, they are taught how to
use the device via instructional videos on the ZMI website. The EZ Rx Prescribe program ramped up significantly during 2015, resulting
in the fact that it represented over 75% of new orders by December 2015. The EZ Rx Prescribe program has also significantly reduced
the number of units consigned to clinics for patient dispensing, thus virtually eliminating the amount of consignment inventory.
In addition, the EZ Rx Prescribe program provides ZMI more control over the decision whether to ship a unit to a patient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During 2014 and 2015, in conjunction with the introduction and
ramp up of the EZ Rx Prescribe program, industry conditions driven by health care reforms and the ongoing evaluation of field inventory
reserves, we provided significant reserve for field inventory ($916 in 2014 and $655 during the first nine months of 2015). During
the fourth quarter of 2015, the Company wrote off the remaining non-productive field inventory. The Company wrote-off and/or provided
a reserve for field inventory during 2015 and 2014 of $1,256 and $916, respectively. During the nine months ended September 30,
2016, the Company held no inventory in the field and the Company expects to hold minimum inventory in the filed on a going forward
basis.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the fourth quarter of 2015, the electrotherapy industry
experienced a significant development when our largest competitor, Empi announced closing their business in the electrotherapy
market immediately. Empi previously held a large share of the electrotherapy market. We believe this presents us a significant
growth opportunity. Through September 30, 2016, we have recruited and retained over 70 former Empi sales representatives, including
those in geographic areas where we had no previous representation. During 2016, our electrotherapy product orders have averaged
2,337 per month as compared to an average of 996 per month in the first 9 months of 2015. To focus on growth and the potential
future positive cash flow from the electrotherapy products, we have committed our limited resources to the new salesforce and the
supporting product production and supporting administrative (customer service and billing) personnel.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We continue to make progress on the development (through ZMS)
of the Blood Volume Monitor, a noninvasive device that monitors a patient&rsquo;s fluid level during surgery and recovery. The
device is intended to alert the doctors or nurses in real time that a patient is losing fluid (blood). We filed our complete application
for clearance with the FDA during the third quarter of 2015, received and responded to comments in October 2015, received updated
comments in May 2016 and submitted our response in October 2016 to the FDA. In addition, we are continuing to collect data from
certain international test sites and hospitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As discussed herein, we are not in compliance with the financial
covenants under the terms of our line of credit with Triumph Healthcare Finance, a division of TBK Bank, SSB (formerly known as
Triumph Community Bank (the &ldquo;Lender&rdquo;) and we have not been in compliance since July 2014. In July 2014, the Lender
notified us that it would no longer make additional loans under the credit agreement and that it was exercising its default remedies
under the credit agreement. The Lender has agreed to forbear from the exercise of its rights and remedies under the terms of the
credit agreement and continues to make additional loans to us based on our cash collections. Our current forebearance agreement
with the Lender expires December 31, 2016. We are obligated to decrease the Lender&rsquo;s outstanding balance by $85 per month.
As of October 31, 2016, we had $2,921 of outstanding borrowings under the credit agreement, as compared to $3,027 at September
30, 2016 and $4,002 as of December 31, 2015. This reduction in the line of credit from December 31, 2015 primarily results from
increased accounts receivable collections, principally from a single insurance carrier which we may be obligated to refund to the
insurance carrier. Refer to Note 8 to the unaudited condensed consolidated financial statements for further information regarding
the payment received from this single insurance carrier. The Company and the Lender continue to negotiate the terms of an accelerated
repayment of the amounts outstanding under the credit agreement and continued extension of the forbearance agreement. However,
no assurance can be given that the Lender will continue to make such additional loans, or that the parties will agree on a repayment
plan acceptable to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are actively seeking additional financing through the issuance
of debt or equity, but we cannot offer any assurance that we will be able to do so, or if we are able to reach an agreement for
a debt or equity investor, that it will be accomplished on reasonable commercial terms. The additional capital is to pay-down in
part, refinance or replace the line of credit and to provide the additional working capital necessary to continue our business
operations. The net losses and negative working capital may make it difficult to raise any new capital and any such capital raised
(if any) may result in significant dilution to existing stockholders. We are not certain whether any such financing would be available
to us on acceptable terms, or at all. In addition, any additional debt would require the approval of the Lender. A significant
component of our negative working capital at September 30, 2016 is the amount due under our line of credit and past due accounts
payable, all of which is considered a current liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our business plan for the remainder of 2016 focuses on our effort
to attain external debt or equity financing, the Lender&rsquo;s continued support, maintaining vendors continued support on the
payment of past due invoices for products and services and maintaining positive cash flow from operations from organic growth.
The accomplishment of organic growth in revenues and cash flows is dependent on taking advantage of the Empi opportunity to gain
market share and the resulting increase in the number of sales representatives selling Zynex products, successfully promoting our
EZ Rx Prescribe program and continued improvements to our billing organization and processes. Our long-term business plan contemplates
organic growth in revenues through an increase in the electrotherapy market share and the addition of new products such as the
ZMS Blood Volume Monitor, which is still under development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There can be no assurance that we will be able to secure additional
external financing or, if obtained, that it will be sufficient for our needs. We can also offer no assurance that the Lender will
continue to make loan advances, the vendors will continue to work with slow repayment terms and the sales and cash flow growth
are attainable and sustainable. Our dependence on operating cash flows means that risks involved in our business can significantly
affect our liquidity. Contingencies such as unanticipated shortfalls in revenues or increases in expenses could affect our projected
revenues, cash flows from operations and liquidity, which may force us to curtail our operating plan or impede our growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Net Revenue </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net revenues are comprised of (i) sales (which includes sales
of our TENS products, consumable supplies, and transdermal pain creams, and, through the first quarter of 2015, our billing consulting
services) and (ii) rental billings of our TENS Products, reduced by estimated Third-party Payors reimbursement deductions and an
allowance for uncollectible amounts. The reserve for contractual adjustments and allowance for uncollectible accounts are adjusted
on an ongoing basis in conjunction with the processing of Third-party Payor insurance claims and other customer collection history.
During January 2016, we ceased our transdermal pain creams for sale and they will not form a significant part of our 2016 revenue
base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our electrotherapy products may be rented on a monthly basis
or purchased. Renters and purchasers are primarily patients and healthcare insurance providers on behalf of patients. Our electrotherapy
products may also be purchased by dealers and distributors. If a patient is covered by health insurance, the Third-party Payor
typically determines whether the patient will rent or purchase a unit depending on the anticipated time period for its use. Under
certain Third-party Payor contracts, a rental continues until an amount equal to the purchase price is paid then we transfer ownership
of the product to the patient and cease rental charges; while other rentals continue during the period of patient use of the equipment.
For all patients using our electrotherapy products, we also sell consumable supplies, consisting primarily of surface electrodes
and batteries. Revenue for the electrotherapy products is reported net, after adjustments for estimated insurance company reimbursement
deductions and estimated allowance for uncollectible accounts. The deductions are known throughout the health care industry as
&ldquo;contractual adjustments&rdquo; whereby the healthcare insurers unilaterally reduce the amount they reimburse for our products
as compared to the rental rates and sales prices charged by us. The deductions from gross revenue also take into account the estimated
denials, net of resubmitted billings of claims for products placed with patients which may affect collectability. See Note 2 to
the Consolidated Financial Statements included within our Annual Report on Form 10-K for the year ended December 31, 2015 for a
more complete explanation of our revenue recognition policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We continually pursue improvements to our processes of billing
insurance providers. We review all claims which are initially denied or not received and rental claims not billed for the full
period of use. As these situations are identified and resolved, the appropriate party is appropriately rebilled (resubmitted) or,
for those claims not previously billed, billed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We frequently receive, and expect to continue to receive, refund
requests from insurance providers relating to specific patients and dates of service. Billing and reimbursement disputes are very
common in our industry. These requests are sometimes related to a few patients and other times include a significant number of
refund claims in a single request. We review and evaluate these requests and determine if any refund is appropriate. We also review
claims where we are rebilling or pursuing additional reimbursement from that insurance provider. We frequently have significant
offsets against such refund requests which may result in amounts that are due to us in excess of the amounts of refunds requested
by the insurance providers. Therefore, at the time of receipt of such refund requests we are generally unable to determine if a
refund request is valid and should be accrued as a liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2016, we believe we have an adequate allowance
for contractual adjustments relating to known insurance disputes and refund requests. However, no assurances can be given with
respect to such estimates of reimbursements and offsets or the ultimate outcome of any refund requests, such as the potential obligation
to refund all or a portion of the $880 received from an insurance carrier as described in Note 8 to the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net revenue for the nine months ended September 30, 2016 and
2015 consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 95%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Product Rentals</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">3,226</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">31.0</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,768</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">19.8</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Product Sales</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,576</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">34.5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,105</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23.6</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Supplies Sales</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,555</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">34.2</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">3,906</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">43.8</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Pharmazy Sales*</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">0.2</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,106</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12.4</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">Other</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">14</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.1</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">38</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.4</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">10,390</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100.0</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8,923</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">100.0</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
in January, 2016.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net revenue for three months ended September 30, 2016 was $3,627
compared to $2,667 for three months ending September 30, 2015. Net revenue for the nine months ended September 30, 2016 increased
$1,467 (16.4%) to $10,390 as compared to $8,923 in for the nine months ended September 30, 2015. The increase reflects an increase
in patient orders (approximately 21,036 in 2016 as compared to approximately 8,972 for the same period in 2015) resulting from
our expansion into the market upon Empi exiting the market, and the related increase in the number of our sales representatives,
offset by the decrease in Pharmacy revenue ($19 for the nine months ended September 30, 2016 as compared to $1,106 for the nine
months ended September 30, 2015) and an increase in deferred revenue ($528 at September 30, 2016 as compared to $89 at December
31, 2015).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deferred revenue represents amounts paid by Third-party Payors
for consumable supplies that were not yet shipped to patients as of that date. The increase in deferred revenue is principally
due to delays in shipping supplies to patients, which resulted from a lack of available supply inventory as a result of cash constraints.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Product Rental Revenue for the nine months ended September 30, 2016 increased to $3,226 from $1,768 for the same period in 2015. The increase in Product Rental Revenue for 2016 reflects the cumulative increase in the number of patients using our Electrotherapy products, and the increase in the number of patient orders in 2016.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Product Sales Revenue for the nine months ended September 30, 2016 increased to $3,576 from $2,105 for the same period in 2015. The increase in Product Sales Revenue for 2016 reflects the increase in the number of patient orders in 2016.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Supplies Sales Revenue for the nine months ended September 30, 2016 decreased to $3,555 from $3,906 for the same period in 2015. The decrease in Supplies Revenue for 2016 reflects the cumulative increase in the number of patients using our Electrotherapy products (both sold and rented devices), offset by the deferred revenue ($528) and changes in the allowance for contractual adjustments.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pharmazy Sales Revenue for 2016 declined to $19 from $1,106
during 2015. We shut down our compound pharmacy business in January 2016 as we struggled with the constantly changing pharmacy
insurance reimbursements and to focus on our core (Electrotherapy products) and future (blood volume monitor) business.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other revenue includes billing consulting revenue totaling $0
and $32 for the nine months ended September 30, 2016 and 2015, respectively. In order to focus on our core Electrotherapy products,
we terminated the billing consulting services in the second quarter of 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Operating Expenses </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Cost of Revenue &ndash; rental, product and supply </U>for
the nine months ended September 30, 2016 and 2015 consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left">Rental depreciation</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">162</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">92</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Product and supply costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,280</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,431</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Operations labor and overhead</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">887</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">762</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Shipping costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">460</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">454</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Pharmazy costs</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">250</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt">Field inventory write-off</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">--</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">372</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,803</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,361</TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Total Cost of Revenue was $880 for three months ended September
30, 2016 compared to $950 September 30, 2015. Total Cost of Revenue was $2,803 for nine months ended September 30, 2016 compared
to $3,361 September 30, 2015.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The rental depreciation represents the net change in the depreciation
of rental assets, which are included in property and equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Product and supply costs decreased $151 (11%) for the nine months
ended September 30, 2016 as compared to the nine months ended September 30, 2015. The lower costs reflects our tightening of costs
and reduced overall per unit costs of current products and the sale (as substitute product) of previously written off (discontinued)
TruWave and TruWave Plus devices $(110). Operations labor and overhead, which includes the production department labor and associated
overhead (principally rent), increased $125 (16%). The increased costs reflect an increase in production compensation, offset by
reduced administrative overhead expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pharmazy material costs decreased as a result of closing the
Pharmacy operation in January 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Field inventory reserves decreased to $0 for the nine months
ended September 30, 2016 as compared to $372 for the nine months ended September 30, 2015. During 2014 and 2015, in conjunction
with the introduction and ramp up of the EZ Rx Prescribe program, industry conditions driven by health care reforms and the ongoing
evaluation of field inventory shrinkage, management provided significant allowances for shrinkage of field inventory ($916 in 2014
and $655 during the first nine months of 2015). During the fourth quarter of 2015 we wrote off the remaining non-productive field
inventory. In total, we wrote-off and/or provided an allowance for shrinkage of field inventory during 2015 and 2014 of $1,256
and $916, respectively.&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Selling, general and administrative </U>expense for the three
months ended September 30, 2016 was $2,125 compared to $1,943 same period 2015. For the nine months ended September 30, 2016, the
selling, general and administrative increased to $7,465 from $6,923 for the same period in 2015. The increase is principally a
result of increased sales commission (increasing to $2,216 in 2016 from $1,595 in 2015), which reflects the increase in our sales
force and resulting increase in orders, reflecting the opportunity provided by Empi withdrawing from the market in late 2015 (discussed
above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Other income (expense)</U> is comprised of interest expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Interest expense for the three month ended September 30, 2015
was $90, compared to $98 for the same period in 2015. Interest expense for the nine months ended September 30, 2016 was $262, compared
to $368 for the same period in 2015. The decrease in interest expense is the result of lower average borrowings in the 2016 periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>LIQUIDITY AND CAPITAL RESOURCES (<I><U>dollars in thousands</U></I>
)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Line of Credit </U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have an asset-backed revolving credit facility under a Loan
and Security Agreement as amended, (the &ldquo;Triumph Agreement&rdquo;) with TBK Bank, SSB, a division of Triumph Community Bank
(the &ldquo;Lender&rdquo;). The Triumph Agreement contains certain customary restrictive and financial covenants for asset-backed
credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2016 and since July 2014, we were not and
have not been in compliance with the financial covenants under the Triumph Agreement. On July 14, 2014, we received notice from
the Lender of an event of default under the Triumph Agreement. The notice relates to our default under the minimum debt service
coverage ratio requirement for the quarter ended March 31, 2014 and certain other alleged defaults. The Lender notified us that
it was exercising its default remedies under the Triumph Agreement, including, among others, accelerating the repayment of all
outstanding obligations under the Triumph Agreement (outstanding principal and accrued interest) and collecting our bank deposits
to apply towards the outstanding obligations. The Company and the Lender are negotiating the terms of an accelerated repayment
of the amounts outstanding under the Triumph Agreement and the Lender has continued to make additional loans to us based on cash
collections. However, no assurance can be given that the Lender will continue to make such additional loans or that the parties
will agree on a repayment plan acceptable to us. If the Lender insists upon immediate repayment, we may be forced to seek protection
from creditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2016, $3,027 was outstanding under the Triumph
Agreement and zero was available for borrowing based on the default status. Borrowings under the Triumph Agreement bear interest
at the default interest rate. As of September 30, 2016, the effective interest rate under the Triumph Agreement was approximately
11.0% (6.75% interest rate plus 3% additional default interest rate and 1.25% fees). The Triumph Agreement requires monthly interest
payments in arrears on the first day of each month. The Triumph Agreement matured on December 19, 2014. The Lender has agreed to
forbear from the exercise of its rights and remedies under the terms of the Triumph Agreement through December 31, 2016, pursuant
to the terms of the September 29, 2016 forbearance agreement. The Triumph Agreement requires a lockbox arrangement whereby all
receipts are swept daily to reduce borrowings outstanding. We are obligated to reduce the loan balance by $85 each month. In connection
with the agreement entered into on March 28, 2016, the Lender suspended this monthly payment requirement for February, March and
April of 2016 up to an aggregate cap of $250, in exchange for the issuance of a warrant to purchase 50,000 shares of the Company&rsquo;s
common stock.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Limited Liquidity </U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of the losses we suffered in the years ended December
31, 2015, 2014 and 2013, the default under the Triumph Agreement, and other factors, we continue to have significant working capital
deficits of $(4,464) at September 30, 2016 as compared to $(4,773) at December 31, 2015. As a result of this negative working
capital and resulting limited liquidity, our independent registered public accounting firm has included an explanatory paragraph
with respect to our ability to continue as a going concern in its report on our consolidated financial statements for the year
ended December 31, 2015. Our Lender could, in its discretion, cease making additional loans to us based on our cash collections
and, at that point we would have no remaining liquidity or ability to pay our debts.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Triumph Agreement default and resulting limited liquidity
are primarily a result of (a) significant reduction of revenue and inability to cut costs at the same pace in 2013 and 2014, (b)
the high level of outstanding accounts receivable because of deferred payment practices of Third-party Payors, (c) the previously
required high levels of inventory kept with sales representatives or held at the offices of health care providers that are standard
in the electrotherapy industry, (d) the delayed cost recovery inherent in rental transactions, and (e) expenditures required for
on-going product development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our negative working capital of $(4,464) as of September 30,
2016 and limited liquidity may restrict our ability to carry out our current business plans and curtail our future revenue growth.
In addition, we reported a net loss of $2,911 for the year ended December 31, 2015. As noted above, we are not in compliance with
the financial covenants under the terms of our line of credit. These conditions raise substantial doubt about our ability to continue
as a going concern.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are actively seeking additional financing through the issuance
of debt or sale of equity and monitoring and controlling our sales growth, product production needs and administrative costs going
forward. The additional capital is to refinance or replace the line of credit and to provide the additional working capital necessary
to continue our business operations. The net losses and negative working capital may make it difficult to raise any new capital
and any such capital raised (if any) may result in significant dilution to existing stockholders. We are not certain whether any
such financing would be available to us on acceptable terms, or at all. In addition, any additional debt would require the approval
of the Lender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We believe that as a result of identified growth opportunities
(primarily with respect to the Empi, Inc. closure discussed elsewhere herein) coupled with the reduced administrative expenses,
the securing of additional capital, the continued support of our Lender, and the continued support of our vendors to work with
us on the slow payment of past due bills; that our cash flows from operating activities will be sufficient to fund our cash requirements
through the next twelve months. There is no guarantee that we will be able to meet the requirements of its 2016 cash flow projection
or will be able to address its working capital shortages; the principal component of which is the negative working capital (importantly
the line of credit and past due accounts payable which are considered a current liability in their entirety).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our dependence on operating cash flow means that risks involved
in our business can significantly affect our liquidity. Contingencies such as unanticipated shortfalls in revenues or increases
in expenses could affect our projected revenues, cash flows from operations and liquidity, which may force us to curtail our operating
plan or impede our growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash provided by operating activities was $1,183 and $82 for
the nine months ended September 30, 2016 and 2015, respectively. The change in cash from operating activities for the nine months
ended September 30, 2016 was primarily the result of the decrease in net loss for the nine months ended September 30, 2016 compared
to 2015 plus an increase in accounts receivable, a reduction of inventory, and increases in accounts payable, deferred revenue,
and accrued payroll expenses, and the deferred insurance reimbursement of $880 received in the first quarter of 2016 (which amount
may be refunded in whole or in part to the insurance carrier, which refund would likely increase the amount due to the Lender).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash (used in) provided by investing activities was $(73) and
$63 for the nine months ended September 30, 2016 and 2015, respectively. Cash provided by investing activities primarily represents
cash flows relating to the change in inventory held for rental offset by the purchase of equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash used in financing activities was $(1,027) and $(167) for
the nine months ended September 30, 2016 and 2015, respectively.&nbsp;The primary changes in cash during these periods were net
repayments on the line of credit and payments/borrowings on the line of credit and payments on capital lease obligations.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>CRITICAL ACCOUNTING POLICIES AND ESTIMATES:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are several accounting policies that involve management&rsquo;s
judgments and estimates and are critical to understanding our historical and future performance, as these policies and estimates
affect the reported amounts of revenue and other significant areas in our reported financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please refer to the &ldquo;Management&rsquo;s Discussion and
Analysis of Financial Condition and Results of Operation&rdquo; and Note 2 to the Consolidated Financial Statements located within
our Annual Report on Form 10-K for the year ended December 31, 2015, filed with the Securities and Exchange Commission on March
31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>OFF BALANCE SHEET ARRANGEMENTS:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company had no significant off-balance sheet arrangements
that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition,
revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><A NAME="a_008"></A><U>ITEM 3.&nbsp;&nbsp;QUANTITATIVE AND
QUALITATIVE DISCLOSURES ABOUT MARKET RISK</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_009"></A><B><U>ITEM 4.&nbsp;&nbsp;CONTROLS AND PROCEDURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Disclosure Controls and Procedures </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Disclosure controls and
procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports
filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in
the SEC&rsquo;s rules and forms.&nbsp;&nbsp;Disclosure controls and procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated
to management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions
regarding required disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We, under the supervision and with the participation of our
management, including our President and Chief Executive Officer, one person who also acts as our principal executive and principal
financial officer, performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures
as of September 30, 2016. Based on that evaluation, our President and Chief Executive Officer concluded that our disclosure controls
and procedures were not effective as of September 30, 2016, due to the material weaknesses in our internal control over financial
reporting (ICFR), which are described below. A material weakness is a deficiency or a combination of deficiencies in internal control
over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial
statements will not be prevented or detected in a timely basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of our assessment of ICFR as of December 31, 2015,
management identified the following control deficiencies that represent material weaknesses that continue to exist as of September
30, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">We lack independent Board members necessary to maintain audit and other board committees consistent with best practice corporate governance standards. At the present time we have only one Board member (who is also our President and Chief Executive Officer) and we have no independent directors. As a result, oversight and monitoring responsibility pertaining to our financial reporting and related internal control is not sufficient. Considering the costs associated with procuring and providing the infrastructure to support additional qualified Board members that are independent, management has concluded that the risks associated with the lack of independent Board members are not sufficient to justify adding independent members at this time.&nbsp;&nbsp;Management will periodically reevaluate this situation as circumstances change.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">We have a material weakness due to lack of segregation of duties. In October 2015, we discontinued the employment of the person who then served as our Chief Financial Officer and our Principal Financial Officer. Since then, we have hired a permanent Vice President of Finance; however, our President and Chief Executive Officer assumed the role of Principal Financial Officer, in addition to that of Principal Executive Officer. This one person is also involved in the processing our banking transactions, has overall supervision and review of all cash disbursements and cash receipts, and has responsibility for the overall accounting and approval process. Therefore, while there are some compensating controls in place, we cannot ensure effective segregation of accounting duties</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">Notwithstanding the assessment
that our ICFR was not effective and that there were material weaknesses as identified in this report, we believe that our consolidated&nbsp;financial
statements contained in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2016, fairly present our
financial position, results of our operations and cash flows for the periods covered thereby in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are committed to improving our ICFR. As part of this control
improvement and when we have adequate funds and necessary additional available, we plan to (1) hire a Chief Financial Officer,
who will also serve as Principal Financial Officer, (2) appoint outside independent directors to our Board of Directors and utilize
an independent audit committee of the Board of Directors who will undertake oversight in the establishment and monitoring of required
internal controls and procedures (when funds and/or additional resources are available to the Company), and (3) <FONT STYLE="background-color: white">retain
and utilize an outside independent consulting firm to assist us with assessing and testing the effectiveness of our ICFR. </FONT>We
will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our ICFR on an ongoing basis,
and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds
allow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Changes in Internal Control Over Financial Reporting </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no changes in our ICFR during the quarter ended September
30, 2016 that has materially affected, or is reasonably likely to materially affect, our ICFR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II. OTHER INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U><A NAME="a_010"></A>ITEM 1. LEGAL PROCEEDINGS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not a party to any material pending legal proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><A NAME="a_011"></A><U>ITEM 1A. RISK FACTORS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You should carefully consider the factors discussed in Part
I, Item 1A. &ldquo;Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended December 31, 2015 and set forth below,
which could materially affect our business, financial condition, cash flows or future results. The risks described in our Annual
Report on Form 10-K for the year ended December 31, 2015 and noted below are not the only risks facing our company. Additional
risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially adversely affect
our business, financial condition or future results. In addition to the foregoing, you should carefully consider the additional
risk factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>We have an additional risk factor relating to the deferred insurance liability booked as of March 31, 2016. During the first
quarter of 2016, the Company collected $880 from a single insurance company for accounts receivable. The accounts receivable had
been previously reduced to zero by the allowance for contractual adjustments. Subsequent to March 31, 2016, the insurance company
verbally communicated to the Company that this payment was made in error and requested it be refunded to the insurance company.
The Company recorded this $880 insurance reimbursement as a deferred insurance liability as of March 31, 2016. However, the Company
is disputing the refund request and has initiated an internal audit of the reimbursement to determine that the original sales arrangement
was properly executed, the products had been shipped and title was transferred (or rental services were rendered), the price of
the products or services and the reimbursement rate is fixed and determinable, and the Company&rsquo;s ultimate claim to the reimbursement
is reasonably assured. The Company will record the appropriate amount as net revenue when such internal audit is complete and the
Company&rsquo;s claim to the amount is reasonably assured. To the extent that the Company has to repay any significant portion
of the $880, this will exacerbate the Company&rsquo;s liquidity issues and financial weaknesses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>As a result of the Company&rsquo;s cash flow shortages and negative working capital&nbsp;discussed above in the financial statements
and the management&rsquo;s discussion and analysis, the Company has been unable to maintain its various insurance coverages. &nbsp;As
a result of non-payment of premiums, the Company&rsquo;s director&rsquo;s and officer&rsquo;s liability insurance coverage has
been cancelled, and the Company has received notice of cancellation for its&nbsp;property, liability, auto, product liability,
professional liability and employment practices policies. &nbsp;While the Company hopes to be able to reinstate such policies and
to satisfy its numerous vendors awaiting payment&nbsp;when it&rsquo;s financial condition permit, the Company can offer no assurance
that the insurers will reinstate coverage or the other vendors will continue working with the Company when the Company becomes
able to deal with them.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U><A NAME="a_012"></A>ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE
OF PROCEEDS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the period covered by this Form 10-Q, there were no sales
of unregistered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U><A NAME="a_013"></A>ITEM 5. OTHER INFORMATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U><A NAME="a_014"></A>ITEM 6.&nbsp;&nbsp;&nbsp;EXHIBITS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 10%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="width: 2%; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="width: 88%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Current Report on Form 8-K filed on October 7, 2008)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amended and Restated Bylaws (incorporated by reference to Exhibit 10.2 of the Company&rsquo;s Current Report on Form 8-K filed on October 7, 2008)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Forbearance Agreement, effective December 17, 2014, between Zynex, Inc. and Triumph Community Bank, N.A., dba Triumph Healthcare Finance (incorporated by reference to Exhibit 10.1 of the Company&rsquo;s Current Report on Form 8-K filed on December 24, 2014)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amendment No. 1 To Forbearance Agreement dated March 27, 2015. <FONT STYLE="color: #222222; background-color: white">(incorporated by reference to Exhibit 10.12 to the Company&rsquo;s Report on Form 10-K filed on March 31, 2015)</FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amendment No. 2 To Forbearance Agreement dated June 30, 2015. (incorporated by reference to Exhibit 10.2 to the Company&rsquo;s Report on Form 10-Q filed on August 14, 2015)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amendment No. 3 To Forbearance Agreement dated September 30, 2015. (incorporated by reference to Exhibit 10.3 to the Company&rsquo;s Report on Form 10-Q filed on November 17, 2015)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amendment No. 4 To Forbearance Agreement dated December 15, 2015. (incorporated by reference to Exhibit 10.4 to the Company&rsquo;s Report on Form 8-K filed on December 31, 2015)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10.16&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amendment No.5 To Forbearance Agreement dated March
28, 2016 (incorporated by reference to Exhibit 10.16 to the Company&rsquo;s Report on Form 10K filed on March 31, 2016)&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">10.17</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Amendment No. 6 to Forbearance Agreement dated June 30, 2016
        (filed herewith)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">10.18</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Amendment No. 7 to Forbearance Agreement dated September 29,
        2016 (filed herewith)</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Amendment to Lease Agreement dated August 12, 2016 (filed herewith)</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">31.1*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of Sarbanes-Oxley Act of 2002</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">32.1*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">101.INS*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">XBRL Instance Document</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">101.SCH*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Schema Document</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">101.CAL*</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Calculation Linkbase Document</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>

<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt; width: 10%"><FONT STYLE="font-size: 10pt">101.DEF *</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt; width: 88%"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Extension Definition Linkbase Document</FONT></TD></TR>

<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt; width: 10%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 88%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">101.LAB *</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">XBRL Taxonomy Label Linkbase Document</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-top: 0.7pt; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">101.PRE *</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-top: 0.7pt; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">XBRL Presentation Linkbase Document</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Filed herewith</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.5pt; text-indent: -24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 55%">&nbsp;</TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-size: 10pt">ZYNEX, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: November 14, 2016</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/&nbsp;Thomas Sandgaard</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Thomas Sandgaard</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chairman, President, Chief Executive Officer, Principal Executive Officer, Chief Financial Officer and Principal Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>2
<FILENAME>v452312_ex10-17.htm
<DESCRIPTION>EXHIBIT 10.17
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.17</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>3
<FILENAME>v452312_ex10-18.htm
<DESCRIPTION>EXHIBIT 10.18
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.18</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_004.jpg" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_004.gif" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_005.jpg" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>4
<FILENAME>v452312_ex10-19.htm
<DESCRIPTION>EXHIBIT 10.19
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.19</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_006.jpg" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_007.jpg" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_010.jpg" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;<IMG SRC="image_009.jpg" ALT=""></B></P>

<P STYLE="margin: 0; text-align: left"><B>&nbsp;&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>v452312_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Thomas Sandgaard, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1.&nbsp;I have reviewed this quarterly report on Form 10-Q of
Zynex, Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2.&nbsp;Based on my knowledge, this report does not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.&nbsp;Based on my knowledge, the financial statements, and
other financial information included in this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.&nbsp; I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">a)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">b)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">c)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">d)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.&nbsp; I have disclosed, based on my most recent evaluation
of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s
board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">a)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">b)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated:&nbsp;November 14, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 40%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/&nbsp;THOMAS SANDGAARD</FONT></TD>
    <TD STYLE="vertical-align: top; width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Thomas Sandgaard</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Chairman, President, Chief Executive Officer, Principal <BR>
Executive
Officer, Chief Financial Officer and Principal <BR>
Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt"></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>v452312_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350, </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 906 OF
THE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SARBANES-OXLEY ACT OF 2002 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned hereby certifies, for the purposes of Section&nbsp;1350
of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002,
in his capacity as an officer of Zynex, Inc. (&ldquo;Zynex&rdquo;), that to his knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">This Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 (the &ldquo;Report&rdquo;) fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49pt; text-indent: -24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33px">&nbsp;</TD>
    <TD STYLE="width: 33px"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">The information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of Zynex for the period covered by this Report.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Certification is executed as of November 14, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: black 1pt solid; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">/s/ Thomas Sandgaard</FONT></TD>
    <TD STYLE="width: 60%; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Thomas Sandgaard</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Chairman, President, Chief Executive Officer, Principal <BR>
Executive Officer, Chief Financial Officer and Principal <BR>
Financial Officer </FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The foregoing certifications are not deemed filed with the
Securities and Exchange Commission for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (Exchange
Act), and are not to be incorporated by reference into any filing of&nbsp;<B>Zynex, Inc. </B>under the Securities Act of 1933,
as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language
in such filing.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>zyxi-20160930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 14-Nov-2016 [11:36:19] {AM} EST - www.datatracks.com -->
<!-- Based on XBRL 2.1 -->
<xbrli:xbrl xmlns:zyxi="http://www.zynexmed.com/20160930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr">
  <link:schemaRef xlink:type="simple" xlink:href="zyxi-20160930.xsd" />

<!--Context Section-->
  <xbrli:context id="P01_01_2012To12_31_2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2012-01-01</xbrli:startDate>

      <xbrli:endDate>2012-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2013To12_31_2013">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2013-01-01</xbrli:startDate>

      <xbrli:endDate>2013-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2014To12_31_2014">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2014-01-01</xbrli:startDate>

      <xbrli:endDate>2014-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To09_30_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To12_31_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To03_31_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2016To03_28_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-03-01</xbrli:startDate>

      <xbrli:endDate>2016-03-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn03_28_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-03-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2015To09_30_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-07-01</xbrli:startDate>

      <xbrli:endDate>2015-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P07_01_2016To09_30_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-07-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn11_10_2016">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-11-10</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2014">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2014-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2015">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

<!--Dimension Section-->
  <xbrli:context id="P01_01_2016To09_30_2016_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_CommonStockMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_RetainedEarningsMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_NoncontrollingInterestMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_RetainedEarningsMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_ZbcMemberdeiLegalEntityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">zyxi:ZbcMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_RentalInventoryMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zyxi:RentalInventoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_RentalInventoryMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zyxi:RentalInventoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_TwoThousandAndFiveStockOptionPlanMemberusgaapPlanNameAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">zyxi:TwoThousandAndFiveStockOptionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2016-09-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P03_01_2016To03_28_2016_MaximumMemberusgaapRangeAxis_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-03-01</xbrli:startDate>

      <xbrli:endDate>2016-03-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_WarrantMemberusgaapClassOfWarrantOrRightAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_LeaseTerminationAgreementAndNewLeaseAgreementMemberusgaapLeaseArrangementTypeAxis_MaximumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">zyxi:LeaseTerminationAgreementAndNewLeaseAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_MinimumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_MaximumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_CostOfGoodsProductLineMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To09_30_2015_CostOfGoodsProductLineMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:CostOfGoodsProductLineMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CreditConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2015To09_30_2015_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CreditConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>

      <xbrli:endDate>2015-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_RentalInventoryMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">zyxi:RentalInventoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_CommonStockMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_RetainedEarningsMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="PAsOn12_31_2015_NoncontrollingInterestMemberusgaapStatementClassOfStockAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:instant>2015-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_LeaseTerminationAgreementAndNewLeaseAgreementMemberusgaapLeaseArrangementTypeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">zyxi:LeaseTerminationAgreementAndNewLeaseAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:context id="P01_01_2016To09_30_2016_LeaseTerminationAgreementAndNewLeaseAgreementMemberusgaapLeaseArrangementTypeAxis_MinimumMemberusgaapRangeAxis">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier>

      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>

        <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">zyxi:LeaseTerminationAgreementAndNewLeaseAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>

    <xbrli:period>
      <xbrli:startDate>2016-01-01</xbrli:startDate>

      <xbrli:endDate>2016-09-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>

  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>

  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>

  <xbrli:unit id="USD_per_Share">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>

      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>

  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>

<!--Element Section-->
  <us-gaap:Cash contextRef="PAsOn09_30_2016" id="Factid_1" unitRef="USD" decimals="-3">91000</us-gaap:Cash>

  <us-gaap:Cash contextRef="PAsOn12_31_2015" id="Factid_2" unitRef="USD" decimals="-3">8000</us-gaap:Cash>

  <us-gaap:AccountsReceivableNetCurrent contextRef="PAsOn09_30_2016" id="Factid_3" unitRef="USD" decimals="-3">3981000</us-gaap:AccountsReceivableNetCurrent>

  <us-gaap:AccountsReceivableNetCurrent contextRef="PAsOn12_31_2015" id="Factid_4" unitRef="USD" decimals="-3">2426000</us-gaap:AccountsReceivableNetCurrent>

  <us-gaap:InventoryNet contextRef="PAsOn09_30_2016" id="Factid_5" unitRef="USD" decimals="-3">96000</us-gaap:InventoryNet>

  <us-gaap:InventoryNet contextRef="PAsOn12_31_2015" id="Factid_6" unitRef="USD" decimals="-3">305000</us-gaap:InventoryNet>

  <us-gaap:PrepaidExpenseCurrent contextRef="PAsOn09_30_2016" id="Factid_7" unitRef="USD" decimals="-3">28000</us-gaap:PrepaidExpenseCurrent>

  <us-gaap:PrepaidExpenseCurrent contextRef="PAsOn12_31_2015" id="Factid_8" unitRef="USD" decimals="-3">27000</us-gaap:PrepaidExpenseCurrent>

  <us-gaap:AssetsCurrent contextRef="PAsOn09_30_2016" id="Factid_9" unitRef="USD" decimals="-3">4196000</us-gaap:AssetsCurrent>

  <us-gaap:AssetsCurrent contextRef="PAsOn12_31_2015" id="Factid_10" unitRef="USD" decimals="-3">2766000</us-gaap:AssetsCurrent>

  <us-gaap:PropertyPlantAndEquipmentNet contextRef="PAsOn09_30_2016" id="Factid_11" unitRef="USD" decimals="-3">517000</us-gaap:PropertyPlantAndEquipmentNet>

  <us-gaap:PropertyPlantAndEquipmentNet contextRef="PAsOn12_31_2015" id="Factid_12" unitRef="USD" decimals="-3">801000</us-gaap:PropertyPlantAndEquipmentNet>

  <us-gaap:DepositsAssetsNoncurrent contextRef="PAsOn09_30_2016" id="Factid_13" unitRef="USD" decimals="-3">55000</us-gaap:DepositsAssetsNoncurrent>

  <us-gaap:DepositsAssetsNoncurrent contextRef="PAsOn12_31_2015" id="Factid_14" unitRef="USD" decimals="-3">55000</us-gaap:DepositsAssetsNoncurrent>

  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="PAsOn09_30_2016" id="Factid_15" unitRef="USD" decimals="-3">44000</us-gaap:FiniteLivedIntangibleAssetsNet>

  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="PAsOn12_31_2015" id="Factid_16" unitRef="USD" decimals="-3">74000</us-gaap:FiniteLivedIntangibleAssetsNet>

  <us-gaap:Assets contextRef="PAsOn09_30_2016" id="Factid_17" unitRef="USD" decimals="-3">4812000</us-gaap:Assets>

  <us-gaap:Assets contextRef="PAsOn12_31_2015" id="Factid_18" unitRef="USD" decimals="-3">3696000</us-gaap:Assets>

  <us-gaap:LinesOfCreditCurrent contextRef="PAsOn09_30_2016" id="Factid_19" unitRef="USD" decimals="-3">3027000</us-gaap:LinesOfCreditCurrent>

  <us-gaap:LinesOfCreditCurrent contextRef="PAsOn12_31_2015" id="Factid_20" unitRef="USD" decimals="-3">4002000</us-gaap:LinesOfCreditCurrent>

  <us-gaap:CapitalLeaseObligationsCurrent contextRef="PAsOn09_30_2016" id="Factid_21" unitRef="USD" decimals="-3">109000</us-gaap:CapitalLeaseObligationsCurrent>

  <us-gaap:CapitalLeaseObligationsCurrent contextRef="PAsOn12_31_2015" id="Factid_22" unitRef="USD" decimals="-3">109000</us-gaap:CapitalLeaseObligationsCurrent>

  <us-gaap:AccountsPayableCurrent contextRef="PAsOn09_30_2016" id="Factid_23" unitRef="USD" decimals="-3">3090000</us-gaap:AccountsPayableCurrent>

  <us-gaap:AccountsPayableCurrent contextRef="PAsOn12_31_2015" id="Factid_24" unitRef="USD" decimals="-3">2477000</us-gaap:AccountsPayableCurrent>

  <us-gaap:DeferredRevenueCurrent contextRef="PAsOn09_30_2016" id="Factid_25" unitRef="USD" decimals="-3">528000</us-gaap:DeferredRevenueCurrent>

  <us-gaap:DeferredRevenueCurrent contextRef="PAsOn12_31_2015" id="Factid_26" unitRef="USD" decimals="-3">89000</us-gaap:DeferredRevenueCurrent>

  <us-gaap:AccruedIncomeTaxesCurrent contextRef="PAsOn09_30_2016" id="Factid_27" unitRef="USD" decimals="-3">79000</us-gaap:AccruedIncomeTaxesCurrent>

  <us-gaap:AccruedIncomeTaxesCurrent contextRef="PAsOn12_31_2015" id="Factid_28" unitRef="USD" decimals="-3">79000</us-gaap:AccruedIncomeTaxesCurrent>

  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="PAsOn09_30_2016" id="Factid_29" unitRef="USD" decimals="-3">760000</us-gaap:EmployeeRelatedLiabilitiesCurrent>

  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="PAsOn12_31_2015" id="Factid_30" unitRef="USD" decimals="-3">484000</us-gaap:EmployeeRelatedLiabilitiesCurrent>

  <us-gaap:AccruedLiabilitiesCurrent contextRef="PAsOn09_30_2016" id="Factid_31" unitRef="USD" decimals="-3">187000</us-gaap:AccruedLiabilitiesCurrent>

  <us-gaap:AccruedLiabilitiesCurrent contextRef="PAsOn12_31_2015" id="Factid_32" unitRef="USD" decimals="-3">299000</us-gaap:AccruedLiabilitiesCurrent>

  <us-gaap:LiabilitiesCurrent contextRef="PAsOn09_30_2016" id="Factid_33" unitRef="USD" decimals="-3">8660000</us-gaap:LiabilitiesCurrent>

  <us-gaap:LiabilitiesCurrent contextRef="PAsOn12_31_2015" id="Factid_34" unitRef="USD" decimals="-3">7539000</us-gaap:LiabilitiesCurrent>

  <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="PAsOn09_30_2016" id="Factid_35" unitRef="USD" decimals="-3">165000</us-gaap:CapitalLeaseObligationsNoncurrent>

  <us-gaap:CapitalLeaseObligationsNoncurrent contextRef="PAsOn12_31_2015" id="Factid_36" unitRef="USD" decimals="-3">216000</us-gaap:CapitalLeaseObligationsNoncurrent>

  <us-gaap:StandardProductWarrantyAccrualNoncurrent contextRef="PAsOn09_30_2016" id="Factid_37" unitRef="USD" decimals="-3">12000</us-gaap:StandardProductWarrantyAccrualNoncurrent>

  <us-gaap:StandardProductWarrantyAccrualNoncurrent contextRef="PAsOn12_31_2015" id="Factid_38" unitRef="USD" decimals="-3">12000</us-gaap:StandardProductWarrantyAccrualNoncurrent>

  <us-gaap:Liabilities contextRef="PAsOn09_30_2016" id="Factid_39" unitRef="USD" decimals="-3">8837000</us-gaap:Liabilities>

  <us-gaap:Liabilities contextRef="PAsOn12_31_2015" id="Factid_40" unitRef="USD" decimals="-3">7767000</us-gaap:Liabilities>

  <us-gaap:PreferredStockValue contextRef="PAsOn12_31_2015" id="Factid_41" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>

  <us-gaap:CommonStockValue contextRef="PAsOn09_30_2016" id="Factid_42" unitRef="USD" decimals="-3">31000</us-gaap:CommonStockValue>

  <us-gaap:CommonStockValue contextRef="PAsOn12_31_2015" id="Factid_43" unitRef="USD" decimals="-3">31000</us-gaap:CommonStockValue>

  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="PAsOn09_30_2016" id="Factid_44" unitRef="USD" decimals="-3">6018000</us-gaap:AdditionalPaidInCapitalCommonStock>

  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="PAsOn12_31_2015" id="Factid_45" unitRef="USD" decimals="-3">5832000</us-gaap:AdditionalPaidInCapitalCommonStock>

  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="PAsOn09_30_2016" id="Factid_46" unitRef="USD" decimals="-3">-9985000</us-gaap:RetainedEarningsAccumulatedDeficit>

  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="PAsOn12_31_2015" id="Factid_47" unitRef="USD" decimals="-3">-9845000</us-gaap:RetainedEarningsAccumulatedDeficit>

  <us-gaap:StockholdersEquity contextRef="PAsOn09_30_2016" id="Factid_48" unitRef="USD" decimals="-3">-3936000</us-gaap:StockholdersEquity>

  <us-gaap:StockholdersEquity contextRef="PAsOn12_31_2015" id="Factid_49" unitRef="USD" decimals="-3">-3982000</us-gaap:StockholdersEquity>

  <us-gaap:MinorityInterest contextRef="PAsOn09_30_2016" id="Factid_50" unitRef="USD" decimals="-3">-89000</us-gaap:MinorityInterest>

  <us-gaap:MinorityInterest contextRef="PAsOn12_31_2015" id="Factid_51" unitRef="USD" decimals="-3">-89000</us-gaap:MinorityInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn09_30_2016" id="Factid_52" unitRef="USD" decimals="-3">-4025000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn12_31_2015" id="Factid_53" unitRef="USD" decimals="-3">-4071000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="PAsOn09_30_2016" id="Factid_54" unitRef="USD" decimals="-3">4812000</us-gaap:LiabilitiesAndStockholdersEquity>

  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="PAsOn12_31_2015" id="Factid_55" unitRef="USD" decimals="-3">3696000</us-gaap:LiabilitiesAndStockholdersEquity>

  <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="PAsOn09_30_2016" id="Factid_56" unitRef="USD" decimals="-3">880000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>

  <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="PAsOn12_31_2015" id="Factid_57" unitRef="USD" decimals="-3">0</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>

  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="P01_01_2016To09_30_2016" id="Factid_58" unitRef="USD" decimals="-3">3226000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>

  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="P01_01_2015To09_30_2015" id="Factid_59" unitRef="USD" decimals="-3">1768000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>

  <us-gaap:SalesRevenueGoodsNet contextRef="P01_01_2016To09_30_2016" id="Factid_60" unitRef="USD" decimals="-3">7164000</us-gaap:SalesRevenueGoodsNet>

  <us-gaap:SalesRevenueGoodsNet contextRef="P01_01_2015To09_30_2015" id="Factid_61" unitRef="USD" decimals="-3">7155000</us-gaap:SalesRevenueGoodsNet>

  <us-gaap:CostOfGoodsAndServicesSold contextRef="P01_01_2016To09_30_2016" id="Factid_62" unitRef="USD" decimals="-3">2803000</us-gaap:CostOfGoodsAndServicesSold>

  <us-gaap:CostOfGoodsAndServicesSold contextRef="P01_01_2015To09_30_2015" id="Factid_63" unitRef="USD" decimals="-3">3361000</us-gaap:CostOfGoodsAndServicesSold>

  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="P01_01_2016To09_30_2016" id="Factid_64" unitRef="USD" decimals="-3">7465000</us-gaap:SellingGeneralAndAdministrativeExpense>

  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="P01_01_2015To09_30_2015" id="Factid_65" unitRef="USD" decimals="-3">6923000</us-gaap:SellingGeneralAndAdministrativeExpense>

  <us-gaap:OperatingIncomeLoss contextRef="P01_01_2016To09_30_2016" id="Factid_66" unitRef="USD" decimals="-3">122000</us-gaap:OperatingIncomeLoss>

  <us-gaap:OperatingIncomeLoss contextRef="P01_01_2015To09_30_2015" id="Factid_67" unitRef="USD" decimals="-3">-1361000</us-gaap:OperatingIncomeLoss>

  <us-gaap:InterestExpense contextRef="P01_01_2016To09_30_2016" id="Factid_68" unitRef="USD" decimals="-3">262000</us-gaap:InterestExpense>

  <us-gaap:InterestExpense contextRef="P01_01_2015To09_30_2015" id="Factid_69" unitRef="USD" decimals="-3">368000</us-gaap:InterestExpense>

  <us-gaap:NetIncomeLoss contextRef="P01_01_2016To09_30_2016" id="Factid_70" unitRef="USD" decimals="-3">-140000</us-gaap:NetIncomeLoss>

  <us-gaap:NetIncomeLoss contextRef="P01_01_2015To09_30_2015" id="Factid_71" unitRef="USD" decimals="-3">-1711000</us-gaap:NetIncomeLoss>

  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="P01_01_2015To09_30_2015" id="Factid_72" unitRef="USD" decimals="-3">-18000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>

  <us-gaap:ProfitLoss contextRef="P01_01_2016To09_30_2016" id="Factid_73" unitRef="USD" decimals="-3">-140000</us-gaap:ProfitLoss>

  <us-gaap:ProfitLoss contextRef="P01_01_2015To09_30_2015" id="Factid_74" unitRef="USD" decimals="-3">-1729000</us-gaap:ProfitLoss>

  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="P01_01_2016To09_30_2016" id="Factid_75" unitRef="USD" decimals="-3">-140000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="P01_01_2015To09_30_2015" id="Factid_76" unitRef="USD" decimals="-3">-1729000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

  <us-gaap:EarningsPerShareBasic contextRef="P01_01_2016To09_30_2016" id="Factid_77" unitRef="USD_per_Share" decimals="2">0.00</us-gaap:EarningsPerShareBasic>

  <us-gaap:EarningsPerShareBasic contextRef="P01_01_2015To09_30_2015" id="Factid_78" unitRef="USD_per_Share" decimals="2">-0.05</us-gaap:EarningsPerShareBasic>

  <us-gaap:EarningsPerShareDiluted contextRef="P01_01_2016To09_30_2016" id="Factid_79" unitRef="USD_per_Share" decimals="2">0.00</us-gaap:EarningsPerShareDiluted>

  <us-gaap:EarningsPerShareDiluted contextRef="P01_01_2015To09_30_2015" id="Factid_80" unitRef="USD_per_Share" decimals="2">-0.05</us-gaap:EarningsPerShareDiluted>

  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="P01_01_2016To09_30_2016" id="Factid_81" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="P01_01_2015To09_30_2015" id="Factid_82" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="P01_01_2016To09_30_2016" id="Factid_83" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="P01_01_2015To09_30_2015" id="Factid_84" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

  <us-gaap:IncomeTaxExpenseBenefit contextRef="P01_01_2016To09_30_2016" id="Factid_85" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>

  <us-gaap:IncomeTaxExpenseBenefit contextRef="P01_01_2015To09_30_2015" id="Factid_86" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>

  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="P07_01_2016To09_30_2016" id="Factid_87" unitRef="USD" decimals="-3">1324000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>

  <us-gaap:OperatingLeasesIncomeStatementLeaseRevenue contextRef="P07_01_2015To09_30_2015" id="Factid_88" unitRef="USD" decimals="-3">924000</us-gaap:OperatingLeasesIncomeStatementLeaseRevenue>

  <us-gaap:SalesRevenueGoodsNet contextRef="P07_01_2016To09_30_2016" id="Factid_89" unitRef="USD" decimals="-3">2303000</us-gaap:SalesRevenueGoodsNet>

  <us-gaap:SalesRevenueGoodsNet contextRef="P07_01_2015To09_30_2015" id="Factid_90" unitRef="USD" decimals="-3">1743000</us-gaap:SalesRevenueGoodsNet>

  <us-gaap:CostOfGoodsAndServicesSold contextRef="P07_01_2016To09_30_2016" id="Factid_91" unitRef="USD" decimals="-3">880000</us-gaap:CostOfGoodsAndServicesSold>

  <us-gaap:CostOfGoodsAndServicesSold contextRef="P07_01_2015To09_30_2015" id="Factid_92" unitRef="USD" decimals="-3">950000</us-gaap:CostOfGoodsAndServicesSold>

  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="P07_01_2016To09_30_2016" id="Factid_93" unitRef="USD" decimals="-3">2125000</us-gaap:SellingGeneralAndAdministrativeExpense>

  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="P07_01_2015To09_30_2015" id="Factid_94" unitRef="USD" decimals="-3">1943000</us-gaap:SellingGeneralAndAdministrativeExpense>

  <us-gaap:OperatingIncomeLoss contextRef="P07_01_2016To09_30_2016" id="Factid_95" unitRef="USD" decimals="-3">622000</us-gaap:OperatingIncomeLoss>

  <us-gaap:OperatingIncomeLoss contextRef="P07_01_2015To09_30_2015" id="Factid_96" unitRef="USD" decimals="-3">-226000</us-gaap:OperatingIncomeLoss>

  <us-gaap:InterestExpense contextRef="P07_01_2016To09_30_2016" id="Factid_97" unitRef="USD" decimals="-3">90000</us-gaap:InterestExpense>

  <us-gaap:InterestExpense contextRef="P07_01_2015To09_30_2015" id="Factid_98" unitRef="USD" decimals="-3">98000</us-gaap:InterestExpense>

  <us-gaap:NetIncomeLoss contextRef="P07_01_2016To09_30_2016" id="Factid_99" unitRef="USD" decimals="-3">532000</us-gaap:NetIncomeLoss>

  <us-gaap:NetIncomeLoss contextRef="P07_01_2015To09_30_2015" id="Factid_100" unitRef="USD" decimals="-3">-322000</us-gaap:NetIncomeLoss>

  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="P07_01_2015To09_30_2015" id="Factid_101" unitRef="USD" decimals="-3">-2000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>

  <us-gaap:ProfitLoss contextRef="P07_01_2016To09_30_2016" id="Factid_102" unitRef="USD" decimals="-3">532000</us-gaap:ProfitLoss>

  <us-gaap:ProfitLoss contextRef="P07_01_2015To09_30_2015" id="Factid_103" unitRef="USD" decimals="-3">-324000</us-gaap:ProfitLoss>

  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="P07_01_2016To09_30_2016" id="Factid_104" unitRef="USD" decimals="-3">532000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="P07_01_2015To09_30_2015" id="Factid_105" unitRef="USD" decimals="-3">-324000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>

  <us-gaap:EarningsPerShareBasic contextRef="P07_01_2016To09_30_2016" id="Factid_106" unitRef="USD_per_Share" decimals="2">0.02</us-gaap:EarningsPerShareBasic>

  <us-gaap:EarningsPerShareBasic contextRef="P07_01_2015To09_30_2015" id="Factid_107" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareBasic>

  <us-gaap:EarningsPerShareDiluted contextRef="P07_01_2016To09_30_2016" id="Factid_108" unitRef="USD_per_Share" decimals="2">0.02</us-gaap:EarningsPerShareDiluted>

  <us-gaap:EarningsPerShareDiluted contextRef="P07_01_2015To09_30_2015" id="Factid_109" unitRef="USD_per_Share" decimals="2">-0.01</us-gaap:EarningsPerShareDiluted>

  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="P07_01_2016To09_30_2016" id="Factid_110" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="P07_01_2015To09_30_2015" id="Factid_111" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>

  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="P07_01_2016To09_30_2016" id="Factid_112" unitRef="shares" decimals="INF">31440526</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="P07_01_2015To09_30_2015" id="Factid_113" unitRef="shares" decimals="INF">31271234</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>

  <us-gaap:IncomeTaxExpenseBenefit contextRef="P07_01_2016To09_30_2016" id="Factid_114" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>

  <us-gaap:IncomeTaxExpenseBenefit contextRef="P07_01_2015To09_30_2015" id="Factid_115" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>

  <us-gaap:NonoperatingIncomeExpense contextRef="P07_01_2016To09_30_2016" id="Factid_116" unitRef="USD" decimals="-3">-90000</us-gaap:NonoperatingIncomeExpense>

  <us-gaap:NonoperatingIncomeExpense contextRef="P07_01_2015To09_30_2015" id="Factid_117" unitRef="USD" decimals="-3">-98000</us-gaap:NonoperatingIncomeExpense>

  <us-gaap:NonoperatingIncomeExpense contextRef="P01_01_2016To09_30_2016" id="Factid_118" unitRef="USD" decimals="-3">-262000</us-gaap:NonoperatingIncomeExpense>

  <us-gaap:NonoperatingIncomeExpense contextRef="P01_01_2015To09_30_2015" id="Factid_119" unitRef="USD" decimals="-3">-368000</us-gaap:NonoperatingIncomeExpense>

  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="P01_01_2016To09_30_2016" id="Factid_120" unitRef="USD" decimals="-3">171000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>

  <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="P01_01_2016To09_30_2016_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis" id="Factid_121" unitRef="USD" decimals="-3">171000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>

  <us-gaap:SharesOutstanding contextRef="PAsOn09_30_2016_CommonStockMemberusgaapStatementClassOfStockAxis" id="Factid_122" unitRef="shares" decimals="INF">31271234</us-gaap:SharesOutstanding>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn09_30_2016_CommonStockMemberusgaapStatementClassOfStockAxis" id="Factid_123" unitRef="USD" decimals="-3">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn09_30_2016_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis" id="Factid_124" unitRef="USD" decimals="-3">6018000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn09_30_2016_RetainedEarningsMemberusgaapStatementClassOfStockAxis" id="Factid_125" unitRef="USD" decimals="-3">-9985000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn09_30_2016_NoncontrollingInterestMemberusgaapStatementClassOfStockAxis" id="Factid_126" unitRef="USD" decimals="-3">-89000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="P01_01_2016To09_30_2016" id="Factid_127" unitRef="USD" decimals="-3">15000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>

  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="P01_01_2016To09_30_2016_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis" id="Factid_128" unitRef="USD" decimals="-3">15000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>

  <us-gaap:ProfitLoss contextRef="P01_01_2016To09_30_2016_RetainedEarningsMemberusgaapStatementClassOfStockAxis" id="Factid_129" unitRef="USD" decimals="-3">-140000</us-gaap:ProfitLoss>

  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="P01_01_2016To09_30_2016" id="Factid_130" unitRef="USD" decimals="-3">1183000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>

  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="P01_01_2015To09_30_2015" id="Factid_131" unitRef="USD" decimals="-3">82000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>

  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="P01_01_2016To09_30_2016" id="Factid_132" unitRef="USD" decimals="-3">73000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>

  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="P01_01_2015To09_30_2015" id="Factid_133" unitRef="USD" decimals="-3">-63000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>

  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="P01_01_2016To09_30_2016" id="Factid_134" unitRef="USD" decimals="-3">-73000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>

  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="P01_01_2015To09_30_2015" id="Factid_135" unitRef="USD" decimals="-3">63000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>

  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="P01_01_2016To09_30_2016" id="Factid_136" unitRef="USD" decimals="-3">-976000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>

  <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="P01_01_2015To09_30_2015" id="Factid_137" unitRef="USD" decimals="-3">-120000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>

  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="P01_01_2016To09_30_2016" id="Factid_138" unitRef="USD" decimals="-3">51000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>

  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="P01_01_2015To09_30_2015" id="Factid_139" unitRef="USD" decimals="-3">47000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>

  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="P01_01_2016To09_30_2016" id="Factid_140" unitRef="USD" decimals="-3">-1027000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>

  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="P01_01_2015To09_30_2015" id="Factid_141" unitRef="USD" decimals="-3">-167000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>

  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="P01_01_2016To09_30_2016" id="Factid_142" unitRef="USD" decimals="-3">83000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>

  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="P01_01_2015To09_30_2015" id="Factid_143" unitRef="USD" decimals="-3">-22000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>

  <us-gaap:InterestPaid contextRef="P01_01_2016To09_30_2016" id="Factid_144" unitRef="USD" decimals="-3">262000</us-gaap:InterestPaid>

  <us-gaap:InterestPaid contextRef="P01_01_2015To09_30_2015" id="Factid_145" unitRef="USD" decimals="-3">368000</us-gaap:InterestPaid>

  <us-gaap:IncomeTaxesPaid contextRef="P01_01_2016To09_30_2016" id="Factid_146" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxesPaid>

  <us-gaap:IncomeTaxesPaid contextRef="P01_01_2015To09_30_2015" id="Factid_147" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxesPaid>

  <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="PAsOn09_30_2016_ZbcMemberdeiLegalEntityAxis" id="Factid_148" unitRef="pure" decimals="1">0.8</us-gaap:MinorityInterestOwnershipPercentageByParent>

  <us-gaap:SalesRevenueNet contextRef="P01_01_2015To12_31_2015" id="Factid_149" unitRef="USD" decimals="-5">11600000</us-gaap:SalesRevenueNet>

  <us-gaap:SalesRevenueNet contextRef="P01_01_2014To12_31_2014" id="Factid_150" unitRef="USD" decimals="-5">11100000</us-gaap:SalesRevenueNet>

  <us-gaap:SalesRevenueNet contextRef="P01_01_2013To12_31_2013" id="Factid_151" unitRef="USD" decimals="-5">21700000</us-gaap:SalesRevenueNet>

  <us-gaap:SalesRevenueNet contextRef="P01_01_2012To12_31_2012" id="Factid_152" unitRef="USD" decimals="-5">39700000</us-gaap:SalesRevenueNet>

  <zyxi:EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts contextRef="P01_01_2015To12_31_2015" id="Factid_153" unitRef="USD" decimals="-5">2200000</zyxi:EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts>

  <zyxi:EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts contextRef="P01_01_2014To12_31_2014" id="Factid_154" unitRef="USD" decimals="-5">9700000</zyxi:EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn09_30_2016_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_155" unitRef="USD" decimals="-3">913000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn12_31_2015_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_156" unitRef="USD" decimals="-3">911000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn09_30_2016_RentalInventoryMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_157" unitRef="USD" decimals="-3">1201000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn09_30_2016_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_158" unitRef="USD" decimals="-3">76000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn12_31_2015_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_159" unitRef="USD" decimals="-3">76000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn09_30_2016_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_160" unitRef="USD" decimals="-3">104000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn12_31_2015_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_161" unitRef="USD" decimals="-3">104000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn09_30_2016_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_162" unitRef="USD" decimals="-3">125000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn12_31_2015_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_163" unitRef="USD" decimals="-3">125000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="PAsOn09_30_2016" id="Factid_164" unitRef="USD" decimals="-3">1902000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>

  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="PAsOn12_31_2015" id="Factid_165" unitRef="USD" decimals="-3">1631000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn12_31_2015_RentalInventoryMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_166" unitRef="USD" decimals="-3">1216000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="P07_01_2016To09_30_2016" id="Factid_167" unitRef="shares" decimals="INF">2160250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>

  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="P01_01_2015To09_30_2015" id="Factid_168" unitRef="shares" decimals="INF">1507750</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>

  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="P01_01_2016To09_30_2016" id="Factid_169" unitRef="USD" decimals="-3">171000</us-gaap:AllocatedShareBasedCompensationExpense>

  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="P01_01_2015To09_30_2015" id="Factid_170" unitRef="USD" decimals="-3">67000</us-gaap:AllocatedShareBasedCompensationExpense>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="P01_01_2016To09_30_2016" id="Factid_171" unitRef="shares" decimals="INF">804000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="PAsOn09_30_2016_TwoThousandAndFiveStockOptionPlanMemberusgaapPlanNameAxis" id="Factid_172" unitRef="shares" decimals="INF">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate contextRef="P01_01_2016To09_30_2016" id="Factid_173">2014-12-31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="PAsOn12_31_2015" id="Factid_174" unitRef="shares" decimals="INF">1685250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="P01_01_2016To09_30_2016" id="Factid_175" unitRef="shares" decimals="INF">329000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="PAsOn09_30_2016" id="Factid_176" unitRef="shares" decimals="INF">2160250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="PAsOn12_31_2015" id="Factid_177" unitRef="USD_per_Share" decimals="2">0.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="P01_01_2016To09_30_2016" id="Factid_178" unitRef="USD_per_Share" decimals="2">0.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>

  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="P01_01_2016To09_30_2016" id="Factid_179" unitRef="USD_per_Share" decimals="2">0.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="PAsOn09_30_2016" id="Factid_180" unitRef="USD_per_Share" decimals="2">0.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="P01_01_2016To09_30_2016" id="Factid_181">P6Y10M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="P01_01_2016To09_30_2016" id="Factid_182">P6Y2M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="PAsOn09_30_2016" id="Factid_183" unitRef="USD" decimals="-3">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="PAsOn09_30_2016" id="Factid_184" unitRef="USD" decimals="-3">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>

  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="P01_01_2016To09_30_2016" id="Factid_185" unitRef="shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="PAsOn09_30_2016" id="Factid_186" unitRef="USD_per_Share" decimals="2">0.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="PAsOn09_30_2016" id="Factid_187" unitRef="shares" decimals="INF">1537048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="P01_01_2016To09_30_2016" id="Factid_188" unitRef="shares" decimals="INF">523953</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="P01_01_2016To09_30_2016" id="Factid_189" unitRef="shares" decimals="INF">329000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="P01_01_2016To09_30_2016" id="Factid_190" unitRef="USD_per_Share" decimals="2">0.26</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="P01_01_2016To09_30_2016" id="Factid_191" unitRef="USD_per_Share" decimals="2">0.36</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="PAsOn12_31_2015" id="Factid_192" unitRef="shares" decimals="INF">672155</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="PAsOn12_31_2015" id="Factid_193" unitRef="USD_per_Share" decimals="2">0.31</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="PAsOn09_30_2016" id="Factid_194" unitRef="shares" decimals="INF">623202</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="PAsOn09_30_2016" id="Factid_195" unitRef="USD_per_Share" decimals="2">0.27</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="P01_01_2016To09_30_2016" id="Factid_196" unitRef="USD_per_Share" decimals="2">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="PAsOn09_30_2016" id="Factid_197" unitRef="USD" decimals="-3">252000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>

  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="P01_01_2016To09_30_2016" id="Factid_198">P5Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>

  <us-gaap:LinesOfCreditCurrent contextRef="PAsOn09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis" id="Factid_199" unitRef="USD" decimals="-3">3027000</us-gaap:LinesOfCreditCurrent>

  <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="PAsOn09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis" id="Factid_200" unitRef="pure" decimals="3">0.110</us-gaap:DebtInstrumentInterestRateEffectivePercentage>

  <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd contextRef="PAsOn09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis" id="Factid_201" unitRef="pure" decimals="4">0.0675</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>

  <zyxi:PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate contextRef="PAsOn09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis" id="Factid_202" unitRef="pure" decimals="2">0.03</zyxi:PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate>

  <us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="P01_01_2016To09_30_2016_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis" id="Factid_203" unitRef="pure" decimals="4">0.0125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>

  <us-gaap:LineOfCreditFacilityPeriodicPayment contextRef="P01_01_2016To09_30_2016" id="Factid_204" unitRef="USD" decimals="-3">85000</us-gaap:LineOfCreditFacilityPeriodicPayment>

  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="PAsOn03_28_2016" id="Factid_205" unitRef="shares" decimals="INF">50000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>

  <zyxi:LineOfCreditFacilityPeriodicInterestPaymentSuspended contextRef="P03_01_2016To03_28_2016_MaximumMemberusgaapRangeAxis_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis" id="Factid_206" unitRef="USD" decimals="-3">250000</zyxi:LineOfCreditFacilityPeriodicInterestPaymentSuspended>

  <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="P01_01_2016To09_30_2016" id="Factid_207">2014-12-19</us-gaap:LineOfCreditFacilityExpirationDate1>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P01_01_2016To09_30_2016_WarrantMemberusgaapClassOfWarrantOrRightAxis" id="Factid_208" unitRef="pure" decimals="4">1.2244</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P01_01_2016To09_30_2016_WarrantMemberusgaapClassOfWarrantOrRightAxis" id="Factid_209" unitRef="pure" decimals="2">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2016To09_30_2016_WarrantMemberusgaapClassOfWarrantOrRightAxis" id="Factid_210" unitRef="pure" decimals="4">0.0144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <zyxi:ClassOfStockWarrantsOrRightsWarrantsIssuanceCost contextRef="P01_01_2016To09_30_2016" id="Factid_211" unitRef="USD" decimals="-3">15000</zyxi:ClassOfStockWarrantsOrRightsWarrantsIssuanceCost>

  <us-gaap:ProceedsFromInsuranceSettlementOperatingActivities contextRef="P01_01_2016To03_31_2016" id="Factid_212" unitRef="USD" decimals="-3">880000</us-gaap:ProceedsFromInsuranceSettlementOperatingActivities>

  <zyxi:FixedRentalPaymentsForEachMonth contextRef="P01_01_2016To09_30_2016_LeaseTerminationAgreementAndNewLeaseAgreementMemberusgaapLeaseArrangementTypeAxis_MaximumMemberusgaapRangeAxis" id="Factid_213" unitRef="USD" decimals="-3">49000</zyxi:FixedRentalPaymentsForEachMonth>

  <zyxi:ImputedInterestRateOnCapitalLease contextRef="P01_01_2016To09_30_2016_MinimumMemberusgaapRangeAxis" id="Factid_214" unitRef="pure" decimals="2">0.05</zyxi:ImputedInterestRateOnCapitalLease>

  <zyxi:ImputedInterestRateOnCapitalLease contextRef="P01_01_2016To09_30_2016_MaximumMemberusgaapRangeAxis" id="Factid_215" unitRef="pure" decimals="1">0.1</zyxi:ImputedInterestRateOnCapitalLease>

  <us-gaap:CapitalLeasedAssetsGross contextRef="PAsOn09_30_2016_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_216" unitRef="USD" decimals="-3">461000</us-gaap:CapitalLeasedAssetsGross>

  <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation contextRef="PAsOn09_30_2016_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_217" unitRef="USD" decimals="-3">264000</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>

  <us-gaap:ConcentrationRiskPercentage1 contextRef="P01_01_2016To09_30_2016_CostOfGoodsProductLineMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" id="Factid_218" unitRef="pure" decimals="2">0.35</us-gaap:ConcentrationRiskPercentage1>

  <us-gaap:ConcentrationRiskPercentage1 contextRef="P01_01_2015To09_30_2015_CostOfGoodsProductLineMemberusgaapConcentrationRiskByBenchmarkAxis_SupplierConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" id="Factid_219" unitRef="pure" decimals="1">0.4</us-gaap:ConcentrationRiskPercentage1>

  <us-gaap:ConcentrationRiskPercentage1 contextRef="P01_01_2016To09_30_2016_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CreditConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" id="Factid_220" unitRef="pure" decimals="2">0.15</us-gaap:ConcentrationRiskPercentage1>

  <us-gaap:ConcentrationRiskPercentage1 contextRef="P01_01_2015To09_30_2015_AccountsReceivableMemberusgaapConcentrationRiskByBenchmarkAxis_CreditConcentrationRiskMemberusgaapConcentrationRiskByTypeAxis" id="Factid_221" unitRef="pure" decimals="2">0.05</us-gaap:ConcentrationRiskPercentage1>

  <dei:DocumentType contextRef="P01_01_2016To09_30_2016" id="Factid_222">10-Q</dei:DocumentType>

  <dei:AmendmentFlag contextRef="P01_01_2016To09_30_2016" id="Factid_223">false</dei:AmendmentFlag>

  <dei:DocumentPeriodEndDate contextRef="P01_01_2016To09_30_2016" id="Factid_224">2016-09-30</dei:DocumentPeriodEndDate>

  <dei:DocumentFiscalYearFocus contextRef="P01_01_2016To09_30_2016" id="Factid_225">2016</dei:DocumentFiscalYearFocus>

  <dei:DocumentFiscalPeriodFocus contextRef="P01_01_2016To09_30_2016" id="Factid_226">Q3</dei:DocumentFiscalPeriodFocus>

  <dei:EntityRegistrantName contextRef="P01_01_2016To09_30_2016" id="Factid_227">ZYNEX INC</dei:EntityRegistrantName>

  <dei:EntityCentralIndexKey contextRef="P01_01_2016To09_30_2016" id="Factid_228">0000846475</dei:EntityCentralIndexKey>

  <dei:CurrentFiscalYearEndDate contextRef="P01_01_2016To09_30_2016" id="Factid_229">--12-31</dei:CurrentFiscalYearEndDate>

  <dei:EntityFilerCategory contextRef="P01_01_2016To09_30_2016" id="Factid_230">Smaller Reporting Company</dei:EntityFilerCategory>

  <dei:TradingSymbol contextRef="P01_01_2016To09_30_2016" id="Factid_231">ZYXI</dei:TradingSymbol>

  <dei:EntityCommonStockSharesOutstanding contextRef="PAsOn11_10_2016" id="Factid_232" unitRef="shares" decimals="INF">31271234</dei:EntityCommonStockSharesOutstanding>

  <us-gaap:SalesRevenueNet contextRef="P07_01_2016To09_30_2016" id="Factid_233" unitRef="USD" decimals="-3">3627000</us-gaap:SalesRevenueNet>

  <us-gaap:SalesRevenueNet contextRef="P07_01_2015To09_30_2015" id="Factid_234" unitRef="USD" decimals="-3">2667000</us-gaap:SalesRevenueNet>

  <us-gaap:SalesRevenueNet contextRef="P01_01_2016To09_30_2016" id="Factid_235" unitRef="USD" decimals="-3">10390000</us-gaap:SalesRevenueNet>

  <us-gaap:SalesRevenueNet contextRef="P01_01_2015To09_30_2015" id="Factid_236" unitRef="USD" decimals="-3">8923000</us-gaap:SalesRevenueNet>

  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="PAsOn09_30_2016" id="Factid_237" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>

  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="PAsOn12_31_2015" id="Factid_238" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn09_30_2016" id="Factid_239" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>

  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="PAsOn12_31_2015" id="Factid_240" unitRef="USD_per_Share" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>

  <us-gaap:PreferredStockSharesAuthorized contextRef="PAsOn09_30_2016" id="Factid_241" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>

  <us-gaap:PreferredStockSharesAuthorized contextRef="PAsOn12_31_2015" id="Factid_242" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>

  <us-gaap:PreferredStockSharesIssued contextRef="PAsOn09_30_2016" id="Factid_243" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>

  <us-gaap:PreferredStockSharesIssued contextRef="PAsOn12_31_2015" id="Factid_244" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>

  <us-gaap:PreferredStockSharesOutstanding contextRef="PAsOn09_30_2016" id="Factid_245" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>

  <us-gaap:PreferredStockSharesOutstanding contextRef="PAsOn12_31_2015" id="Factid_246" unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>

  <us-gaap:CommonStockSharesAuthorized contextRef="PAsOn09_30_2016" id="Factid_247" unitRef="shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>

  <us-gaap:CommonStockSharesAuthorized contextRef="PAsOn12_31_2015" id="Factid_248" unitRef="shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn09_30_2016" id="Factid_249" unitRef="shares" decimals="INF">31271234</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockSharesIssued contextRef="PAsOn12_31_2015" id="Factid_250" unitRef="shares" decimals="INF">31271234</us-gaap:CommonStockSharesIssued>

  <us-gaap:CommonStockSharesOutstanding contextRef="PAsOn09_30_2016" id="Factid_251" unitRef="shares" decimals="INF">31271234</us-gaap:CommonStockSharesOutstanding>

  <us-gaap:CommonStockSharesOutstanding contextRef="PAsOn12_31_2015" id="Factid_252" unitRef="shares" decimals="INF">31271234</us-gaap:CommonStockSharesOutstanding>

  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_253">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(1)&amp;#160;&lt;u&gt;ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/u&gt;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;Organization&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Zynex, Inc. (a Nevada corporation) has its headquarters in Lone Tree, Colorado. The Company operates in one primary business segment, Electrotherapy and Pain Management Products. As of December 31, 2015, the Company&amp;#8217;s only active subsidiary is Zynex Medical, Inc. (&amp;#8220;ZMI,&amp;#8221; a wholly-owned Colorado corporation) through which the Company conducts most of its operations. One other subsidiary, Zynex Europe, ApS (&amp;#8220;ZEU,&amp;#8221; a wholly-owned Denmark corporation), produced minimal revenues during 2015 and 2016 from international sales and marketing. Zynex Monitoring Solutions, Inc. (&amp;#8220;ZMS,&amp;#8221; a wholly-owned Colorado corporation) is developing a blood volume monitoring device, but it is not yet developed or ready for market and, as a result, ZMS has achieved no revenues to date. Its inactive subsidiaries include Zynex NeuroDiagnostics, Inc. (&amp;#8220;ZND,&amp;#8221; a wholly-owned Colorado corporation), Zynex Billing and Consulting, LLC (&amp;#8220;ZBC,&amp;#8221; an &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 80&lt;/font&gt;% owned Colorado limited liability company) and Pharmazy, Inc. (&amp;#8220;Pharmazy&amp;#8221;), which was incorporated in June 2015 as a wholly-owned Colorado corporation. The Company&amp;#8217;s compound pharmacy operated as a division of ZMI dba as Pharmazy through January 2016.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The term &amp;#8220;the Company&amp;#8221; refers to Zynex, Inc. and its active and inactive subsidiaries.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;Nature of Business&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;ZMI designs, manufactures and markets U.S. Food and Drug Administration (FDA) cleared medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. ZEU was formed in 2012 to conduct international sales and marketing for Company products. ZEU produced minimal revenues during 2016 and 2015. In addition, ZMI dba Pharmazy, which sold compound transdermal pain cream, began operations in early 2014 and was closed in January 2016.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;ZMS was formed to develop and market medical devices for non-invasive cardiac monitoring, the products of which are under development. The Company is currently developing a blood volume monitoring device (Blood Volume Monitor). ZMS produced no revenues during 2016 or 2015.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;ZND was formed in 2011 to market electromyography (&amp;#8220;EMG&amp;#8221;), electroencephalography (&amp;#8220;EEG&amp;#8221;), sleep pattern, auditory and nerve conductivity neurological diagnosis devices to hospitals and clinics worldwide. In 2014, the Company decided to no longer focus on selling this product line. ZBC was formed in 2012 to provide medical billing and consulting services. The Company stopped offering billing and consulting services in April 2015. No significant revenue was generated from ZND or ZBC in 2015.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;In 2016 and 2015, the Company generated substantially all of its revenue in North America from sales and rentals of its products to patients, dealers and health care providers.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;Unaudited Condensed Consolidated Financial Statements&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) and accounting principles generally accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make the information presented not misleading. A description of the Company&amp;#8217;s accounting policies and other financial information is included in the audited consolidated financial statements as filed with the SEC in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December&amp;#160;31, 2015. Amounts as of December&amp;#160;31, 2015, are derived from those audited consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with the annual audited financial statements, accounting policies and notes thereto, included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December&amp;#160;31, 2015, which has previously been filed with the SEC.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as of September 30, 2016 and the results of its operations and its cash flows for the periods presented.&amp;#160; The results of operations for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be achieved for a full fiscal year and cannot be used to indicate financial performance for the entire year.&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;Reclassifications&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;Certain reclassifications have been made to the prior years&amp;#8217; condensed consolidated financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or cash flows.&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;In July 2015, the &lt;font style="BACKGROUND: transparent"&gt;Financial Accounting Standards Board (&lt;/font&gt;FASB) issued &lt;font style="BACKGROUND: transparent"&gt; Accounting Standards Update (&lt;/font&gt;ASU) No. 2015-11, &amp;#8220;Inventory (Topic 330) Simplifying the Measurement of Inventory&amp;#8221;, which changes the measurement from lower of cost or market to lower of cost and net realizable value. The guidance requires prospective application for reporting periods beginning after December 15, 2016 and permits adoption in an earlier period. The Company is evaluating the impact of this guidance on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;In August 2014, the FASB issued ASU 2014-15 &amp;#8220;Presentation of Financial Statements&amp;#151;Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to continue as a Going Concern&amp;#8221;. The amendments in this update provide guidance in GAAP about management&amp;#8217;s responsibility to evaluate whether there is substantial doubt about an entity&amp;#8217;s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are effective for the annual period ending after December 15, 2016 and for interim periods thereafter. Early application is permitted. The Company is evaluating the effect of this updated guidance on the disclosures in the footnotes to the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;In May 2014, the FASB issued ASU No. 2014-09&amp;#151;&amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221; which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018, using one of two prescribed retrospective methods. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is evaluating the impact of the amended revenue recognition guidance on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Management has evaluated other recently issued accounting pronouncements and does not believe that any of these pronouncements will have a material impact on the Company&amp;#8217;s consolidated financial statements.&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>

  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_254">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;Unaudited Condensed Consolidated Financial Statements&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) and accounting principles generally accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make the information presented not misleading. A description of the Company&amp;#8217;s accounting policies and other financial information is included in the audited consolidated financial statements as filed with the SEC in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December&amp;#160;31, 2015. Amounts as of December&amp;#160;31, 2015, are derived from those audited consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with the annual audited financial statements, accounting policies and notes thereto, included in the Company&amp;#8217;s Annual Report on Form 10-K for the year ended December&amp;#160;31, 2015, which has previously been filed with the SEC.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as of September 30, 2016 and the results of its operations and its cash flows for the periods presented.&amp;#160; The results of operations for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be achieved for a full fiscal year and cannot be used to indicate financial performance for the entire year.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>

  <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="P01_01_2016To09_30_2016" id="Factid_255">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;Reclassifications&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;Certain reclassifications have been made to the prior years&amp;#8217; condensed consolidated financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or cash flows.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>

  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_256">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;Recent Accounting Pronouncements&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;In July 2015, the &lt;font style="BACKGROUND: transparent"&gt;Financial Accounting Standards Board (&lt;/font&gt;FASB) issued &lt;font style="BACKGROUND: transparent"&gt; Accounting Standards Update (&lt;/font&gt;ASU) No. 2015-11, &amp;#8220;Inventory (Topic 330) Simplifying the Measurement of Inventory&amp;#8221;, which changes the measurement from lower of cost or market to lower of cost and net realizable value. The guidance requires prospective application for reporting periods beginning after December 15, 2016 and permits adoption in an earlier period. The Company is evaluating the impact of this guidance on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;In August 2014, the FASB issued ASU 2014-15 &amp;#8220;Presentation of Financial Statements&amp;#151;Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity&amp;#8217;s Ability to continue as a Going Concern&amp;#8221;. The amendments in this update provide guidance in GAAP about management&amp;#8217;s responsibility to evaluate whether there is substantial doubt about an entity&amp;#8217;s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are effective for the annual period ending after December 15, 2016 and for interim periods thereafter. Early application is permitted. The Company is evaluating the effect of this updated guidance on the disclosures in the footnotes to the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="BACKGROUND: transparent; FONT-SIZE: 10pt"&gt;In May 2014, the FASB issued ASU No. 2014-09&amp;#151;&amp;#8220;Revenue from Contracts with Customers (Topic 606)&amp;#8221; which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018, using one of two prescribed retrospective methods. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is evaluating the impact of the amended revenue recognition guidance on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Management has evaluated other recently issued accounting pronouncements and does not believe that any of these pronouncements will have a material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>

  <us-gaap:NumberOfOperatingSegments contextRef="P01_01_2016To09_30_2016" id="Factid_257" unitRef="pure" decimals="0">1</us-gaap:NumberOfOperatingSegments>

  <zyxi:BackGroundAndManagementPlansTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_258">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(2) &lt;u&gt;BACKGROUND AND MANAGEMENT&amp;#8217;S PLANS&lt;/u&gt;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;Background&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; For the years ended December 31, 2015 and 2014, the Company reported net losses of $2,911 and $6,199, respectively. As of September 30, 2016, the Company had no available borrowing under its line of credit although, based on an interim agreement with the Company&amp;#8217;s senior secured lender, Triumph Healthcare Finance, a division of TBK Bank, SSB, formerly known as Triumph Community Bank, (the &amp;#8220;Lender&amp;#8221;), continues to make additional loans to the Company based on the Company&amp;#8217;s cash collections. The Company&amp;#8217;s working capital deficit at September 30, 2016 totaled ($4,464) as compared to ($4,773) at December 31, 2015. In addition, the Company remains in default of its secured line of credit and as a result, if its lender insists upon immediate repayment, the Company will be unable to do so and may be forced to seek protection from its creditors. The Company has not been in compliance with the financial covenants under the agreement with its primary lender since July 2014. The Company&amp;#8217;s assets, both at December 31, 2015 and at September 30, 2016, are significantly less than the Company&amp;#8217;s liabilities, and the Company is dependent on its banking relationship to be able to pay its obligations as they become due.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company&amp;#8217;s losses, lack of liquidity, and substantial working capital deficit raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Although the Company&amp;#8217;s revenues increased during the three months and nine months ended September 30, 2016 as compared to the same periods in the prior year, the Company has not recovered from the significant revenue decreases in total net revenue for the years ended December 31, 2015 and 2014 (approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;11.6&lt;/font&gt; million and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;11.1&lt;/font&gt; million, respectively) as compared to 2013 and 2012 (approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;21.7&lt;/font&gt; million and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;39.7&lt;/font&gt; million, respectively). The primary reasons for the decline in revenue from 2012-2013 to 2014-2015&amp;#160;were (i) the impact of Medicare and healthcare reform, (ii) a loss of Zynex&amp;#8217;s independent sales force to sell transdermal compounded pain cream from competing pharmacies rather than focusing on selling the Company&amp;#8217;s Electrotherapy products and (iii) in the latter part of 2012, the elimination of Medicare reimbursement for transcutaneous electrical nerve stimulation (TENS) Electrotherapy products for low-back pain while still covering TENS for other indications. Medicare also continued increasing the requirements for paperwork and documentation in connection with reimbursement requests. As a result, late in 2013 Zynex began declining orders for Medicare and Medicaid patients. Commercial and workers&amp;#8217; compensation insurance plans continue to reimburse at similar levels as in previous years and have not adopted Medicare&amp;#8217;s limited coverage.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;During 2015 and throughout 2014, in an effort to minimize the impact of the challenges discussed above, the Company restructured its internal operations, including manufacturing, billing and customer service; and made reductions in its fixed expenses by cutting its administrative costs by approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;2.2&lt;/font&gt; million and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;9.7&lt;/font&gt; million, respectively, principally through reductions in headcount and facilities rent. In addition, the Company during the second quarter of 2014 narrowed its focus to the NexWave, InWave and NeuroMove electrotherapy products and continued to build the sales representative group for its electrotherapy solutions. The Company continued to narrow this focus by closing its billing consulting services in April 2015 and closing its compound pain cream operations in January 2016. The Company is continuing to address cost of revenues and overhead expenses in 2016 and as a result has improved the Company&amp;#8217;s operating performance for the three and nine months ended September 30, 2016 (being net income of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;532&lt;/font&gt; and net loss of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;(140)&lt;/font&gt; respectively) as compared to the same periods of the prior year (being net losses of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;(322)&lt;/font&gt; and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;(1,711)&lt;/font&gt; respectively).&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;During the fourth quarter of 2015, the electrotherapy industry experienced a significant development when the Company&amp;#8217;s largest competitor (DJO/Empi) announced the closure of their Empi electrotherapy division. Empi previously held a large share of the electrotherapy market. Management believes this presents a significant growth opportunity for the Company. The Company has recruited many former Empi sales representatives, including those in areas where it had no previous representation. In addition, during 2016,&amp;#160;the Company&amp;#8217;s orders have been steadily increasing as compared to 2015. To focus on growth and the potential for future positive cash flow, the Company has committed its limited resources to the new salesforce, including the supporting product production and supporting administrative (customer service and billing) personnel.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The Company is not in compliance with the financial covenants under the terms of its line of credit with the Lender. See Note 7 to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report for further discussion.&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;u&gt;&lt;font style="FONT-SIZE: 10pt"&gt;Management&amp;#8217;s Plans&lt;/font&gt;&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company&amp;#8217;s business plan for the remainder of 2016 and into 2017 focuses on the Company&amp;#8217;s effort to attain external financing, retaining the Lender&amp;#8217;s continued support, maintaining the continued support of the Company&amp;#8217;s vendors on the slow payment of past due invoices, and pursuing organic growth in our electrotherapy and pain management products with a goal of attaining positive cash flow. The accomplishment of organic growth in revenues and cash flows is dependent on taking advantage of the Empi opportunity, increasing the number of sales representatives, promoting the EZ Rx Prescribe program (described further below) and continuing improvements to the Company&amp;#8217;s billing organization and processes. The Company&amp;#8217;s long-term business plan contemplates organic growth in revenues through an increase in the electrotherapy market share and the addition of new products such as the ZMS Blood Volume Monitor, which is currently under development.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company is actively seeking additional financing through the issuance of debt or sale of equity. The additional capital is to refinance or replace the line of credit and to provide the additional working capital necessary to continue the Company&amp;#8217;s business operations. The Company&amp;#8217;s history of net losses and negative working capital may make it difficult to raise any new capital and any such capital raised (if any) may result in significant dilution to existing stockholders. The Company is not certain whether any such financing would be available to the Company on acceptable terms, or at all. Any additional debt would require the approval of the Lender. A significant component of our negative working capital at September 30, 2016 is the amount due under our line of credit and past due accounts payable, all of which is considered a current liability.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; In addition to seeking external financing, the Company has and will continue to monitor and control its sales growth, product production needs and administrative costs going forward. The Company&amp;#8217;s efforts to reduce costs and increase revenues have led to net income (loss) from operations for the three- and nine-month periods in 2016 ($532 and ($140), respectively) as compared to losses for the same periods in 2015 (($322)and ($1,711), respectively). If the Company continues to increase its revenue while controlling its administrative costs and the Lender permits it to continue to operate, the Company believes that it may continue its 2016 return to profitability in future periods. The Company believes that as a result of potential growth opportunities coupled with reduced administrative expenses, the securing of additional capital (if available), the continued support of its Lender (which cannot be assured), and the continued support of vendors to work with the Company on the slow payment of past due bills (which cannot be assured); that the Company&amp;#8217;s cash flows from operating activities will be sufficient to fund the Company&amp;#8217;s cash requirements through the next twelve months. Management believes that its cash flow projections for 2016 are achievable and that sufficient cash will be generated to meet the Company&amp;#8217;s currently restrained operating requirements. Such cash is projected to be generated by securing external financing, retaining the continued support of the Lender and vendors, and increasing cash flow from operations generated from organic growth. There is no guarantee that the Company will be able to meet the requirements of its 2016 cash flow projections or that it will be able to address its working capital shortages; the principal component of which is the negative working capital.&lt;/div&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;There can be no assurance that the Company will be able to secure additional external financing, the Lender will continue to make loan advances, the vendors will continue to work with slow repayment terms, and the sales and cash flow growth are attainable and sustainable. The Company&amp;#8217;s dependence on operating cash flows means that risks involved in the Company&amp;#8217;s business can significantly affect the Company&amp;#8217;s liquidity. Contingencies such as unanticipated shortfalls in revenues or increases in expenses could affect the Company&amp;#8217;s projected revenues, and cash flows from operations and liquidity, which may force the Company to curtail its operating plan or impede the Company&amp;#8217; growth.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</zyxi:BackGroundAndManagementPlansTextBlock>

  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_259">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;strong&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(3)&amp;#160;&lt;u&gt;PROPERTY AND EQUIPMENT&lt;/u&gt;&lt;/font&gt;&lt;/strong&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;Property and equipment as of September 30, 2016 and December&amp;#160;31, 2015, consist of the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"&gt; &lt;table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;September&amp;#160;30,&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;December&amp;#160;31,&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Useful&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;2015&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;lives&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;(UNAUDITED)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;913&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;911&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;3-7&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Rental inventory&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,201&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,216&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;5&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;76&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;76&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;5&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;104&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;104&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2-6&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Assembly equipment&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;125&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;125&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;7&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2,419&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2,432&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Less accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(1,902)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(1,631)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;517&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;801&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>

  <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_260">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Property and equipment as of September 30, 2016 and December&amp;#160;31, 2015, consist of the following:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"&gt; &lt;table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;September&amp;#160;30,&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;December&amp;#160;31,&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Useful&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;2015&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;lives&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;(UNAUDITED)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;913&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;911&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;3-7&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Rental inventory&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,201&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,216&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;5&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;76&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;76&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;5&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;104&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;104&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2-6&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Assembly equipment&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;125&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;125&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;7&amp;#160;years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2,419&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2,432&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;Less accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(1,902)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(1,631)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;517&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;801&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn09_30_2016" id="Factid_261" unitRef="USD" decimals="-3">2419000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentGross contextRef="PAsOn12_31_2015" id="Factid_262" unitRef="USD" decimals="-3">2432000</us-gaap:PropertyPlantAndEquipmentGross>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMemberusgaapRangeAxis" id="Factid_263">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_FurnitureAndFixturesMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMemberusgaapRangeAxis" id="Factid_264">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_RentalInventoryMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_265">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_VehiclesMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_266">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMemberusgaapRangeAxis" id="Factid_267">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_LeaseholdImprovementsMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MaximumMemberusgaapRangeAxis" id="Factid_268">P6Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="P01_01_2016To09_30_2016_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis" id="Factid_269">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>

  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_270">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;strong&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(5)&amp;#160;&lt;u&gt;STOCK-BASED COMPENSATION PLANS&lt;/u&gt;&lt;/font&gt;&lt;/strong&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company previously reserved &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 3,000,000&lt;/font&gt; shares of common stock for issuance under its 2005 Stock Option Plan (the &amp;#8220;Option Plan&amp;#8221;). The Option Plan expired as of &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;December 31, 2014&lt;/font&gt;. Vesting provisions are determined by the Board of Directors. All stock options under the Option Plan expire no later than ten years from the date of grant. Since the Option Plan expired, the options granted in 2015 and 2016 have not been approved by the Company&amp;#8217;s shareholders and were issued as non-qualified stock options.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;In the nine months ended September 30, 2016 and 2015, the Company recorded compensation expense related to stock options of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;171&lt;/font&gt; and $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;67&lt;/font&gt;, respectively.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;During the nine months ended September 30, 2016, the Company granted options to purchase up to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 804,000&lt;/font&gt; shares of common stock to employees at a weighted average exercise of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0.27&lt;/font&gt; per &lt;font style="BACKGROUND-COLOR: transparent"&gt;share&lt;font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"&gt; . The 2016 grants were issued as non-qualified&lt;/font&gt; stock&lt;/font&gt; options.&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions during the&amp;#160;nine months ended September 30, 2016:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"&gt; &lt;table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"&gt; &lt;div&gt;2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Weighted average expected term&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;6.25 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Weighted average volatility&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;122.73%&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Weighted average risk-free interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;1.51%&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Dividend yield&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;0%&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;A summary of stock option activity under all equity compensation plans for the nine months ended September 30, 2016, is presented below:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Weighted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Weighted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Average&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Shares&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Average&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Remaining&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Aggregate&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Under&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Exercise&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Contractual&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Intrinsic&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Option&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Price&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Life&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Value&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Outstanding at January&amp;#160;1, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,685,250&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.46&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Granted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;804,000&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.27&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Exercised&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(329,000)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.36&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Outstanding at September 30, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2,160,250&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.40&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;6.91 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;-&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Exercisable at September 30, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,537,048&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.45&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;6.23 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;-&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;A summary of status of the Company&amp;#8217;s non-vested share awards as of and for the nine months ended September 30, 2016, is presented below:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Non-vested&amp;#160;Shares&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Weighted&amp;#160;Average&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Under&amp;#160;Option&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Grant&amp;#160;Date&amp;#160;Fair&amp;#160;Value&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Non-vested at January 1, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;672,155&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.31&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Granted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;804,000&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.27&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Vested&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(523,953)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.26&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(329,000)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.36&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Non-vested at September 30, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;623,202&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.27&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;As of September 30, 2016, the Company had approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;252&lt;/font&gt; of unrecognized compensation expense related to stock options that will be recognized over a weighted average period of approximately &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5&lt;/font&gt; years.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>

  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_271">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions during the&amp;#160;nine months ended September 30, 2016:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"&gt; &lt;table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"&gt; &lt;div&gt;2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Weighted average expected term&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;6.25 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Weighted average volatility&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;122.73%&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Weighted average risk-free interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;1.51%&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"&gt; &lt;div&gt;Dividend yield&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"&gt; &lt;div&gt;0%&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>

  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_272">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;A summary of stock option activity under all equity compensation plans for the nine months ended September 30, 2016, is presented below:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Weighted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Weighted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Average&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Shares&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Average&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Remaining&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Aggregate&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Under&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Exercise&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Contractual&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Intrinsic&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Option&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Price&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"&gt; &lt;div&gt;Life&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Value&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Outstanding at January&amp;#160;1, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,685,250&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.46&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Granted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;804,000&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.27&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Exercised&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(329,000)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.36&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Outstanding at September 30, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;2,160,250&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.40&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;6.91 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;-&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"&gt; &lt;div&gt;Exercisable at September 30, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1,537,048&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.45&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;6.23 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;-&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>

  <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_273">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;A summary of status of the Company&amp;#8217;s non-vested share awards as of and for the nine months ended September 30, 2016, is presented below:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Non-vested&amp;#160;Shares&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Weighted&amp;#160;Average&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Under&amp;#160;Option&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"&gt; &lt;div&gt;Grant&amp;#160;Date&amp;#160;Fair&amp;#160;Value&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Non-vested at January 1, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;672,155&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.31&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Granted&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;804,000&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.27&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Vested&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(523,953)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.26&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;(329,000)&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.36&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"&gt; &lt;div&gt;Non-vested at September 30, 2016&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;623,202&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;$&lt;/div&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;0.27&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2016To09_30_2016" id="Factid_274">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="P01_01_2016To09_30_2016" id="Factid_275" unitRef="pure" decimals="4">1.2273</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="P01_01_2016To09_30_2016" id="Factid_276" unitRef="pure" decimals="4">0.0151</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>

  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="P01_01_2016To09_30_2016" id="Factid_277" unitRef="pure" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>

  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_278">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(6)&amp;#160;&lt;u&gt;INCOME TAXES&lt;/u&gt;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The provision for income taxes is recorded at the end of each interim period based on the Company&amp;#8217;s best estimate of its effective income tax rate expected to be applicable for the full fiscal year.&amp;#160;The Company&amp;#8217;s effective income tax rate was &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;0&lt;/font&gt;% for both the three and nine months ended September 30, 2016 and 2015, respectively, as the realization of any deferred tax assets is not more likely than not. The Company paid no income taxes during the three and nine months ended September 30, 2016 and 2015.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IncomeTaxDisclosureTextBlock>

  <zyxi:LineOfCreditFacilityExtendedExpirationMaturityDate contextRef="P03_01_2016To03_28_2016" id="Factid_279">2016-09-29</zyxi:LineOfCreditFacilityExtendedExpirationMaturityDate>

  <us-gaap:InsuranceDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_280">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;8)&amp;#160;&lt;u&gt;DEFERRED INSURANCE REIMBURSEMENT&lt;/u&gt;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;During the first quarter of 2016, the Company collected $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;880&lt;/font&gt; from a single insurance company for accounts receivable. The accounts receivable had been previously reduced to zero by the allowance for contractual adjustments. Subsequent to March 31, 2016, the insurance company verbally communicated to the Company that this payment was made in error and requested it be refunded to the insurance company. The Company recorded this $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;880&lt;/font&gt; insurance reimbursement as a deferred insurance liability. However, the Company is disputing the refund request and has initiated an internal audit of the reimbursement to determine that the original sales arrangement was properly executed, the products had been shipped and title was transferred (or rental services were rendered), the price of the products or services and the reimbursement rate is fixed and determinable, and the Company&amp;#8217;s ultimate claim to the reimbursement is reasonably assured. The Company will record the appropriate amount as net revenue when such internal audit is complete and the Company&amp;#8217;s claim to the amount is reasonably assured.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InsuranceDisclosureTextBlock>

  <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_281">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(10)&amp;#160; &lt;u&gt; CONCENTRATIONS&lt;/u&gt;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company sourced approximately &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 35&lt;/font&gt;% and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 40&lt;/font&gt;% of components for its electrotherapy products from one vendor during the nine months ended September 30, 2016 and 2015, respectively. Management believes that its relationships with suppliers are good; however, the Company has delayed and extended payments to many of its vendors for cash flow reasons, which has caused many of its vendors to require pre-payment for products or services. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company had receivables from a private health insurance carrier at September 30, 2016 and December 31, 2015, that made up approximately&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15&lt;/font&gt;% and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 5&lt;/font&gt;%, respectively, of the net accounts receivable balance.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>

  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_282">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(11)&amp;#160; &lt;u&gt; LITIGATION&lt;/u&gt;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;From time to time, the Company may become party to litigation and other claims in the ordinary course of business. To the extent that such claims and litigation arise, management would provide for them if losses are determined to be both probable and estimable.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company is currently not a party to any material pending legal proceedings.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>

  <us-gaap:ShortTermDebtTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_283">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;strong&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(7)&amp;#160;&lt;u&gt;LINE OF CREDIT&lt;/u&gt;&lt;/font&gt;&lt;/strong&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;strong&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/strong&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company has an asset-backed revolving credit facility under a Loan and Security Agreement as amended, (the &amp;#8220;Triumph Agreement&amp;#8221;) with Triumph Healthcare Finance, a division of TBK Bank, SSB, formerly known as Triumph Community Bank, (the &amp;#8220;Lender&amp;#8221;). The Triumph Agreement contains certain customary restrictive and financial covenants for asset-backed credit facilities. The Company has not been in compliance with the financial covenants under the Triumph Agreement since July 2014.&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; On July 14, 2014, the Company received notice from the Lender of an event of default under the Triumph Agreement. The notice relates to the Company&amp;#8217;s default under the minimum debt service coverage ratio requirement for the quarter ended March 31, 2014 and certain other alleged defaults. The Lender notified the Company that it was exercising its default remedies under the Triumph Agreement, including, among others, accelerating the repayment of all outstanding obligations under the Triumph Agreement (outstanding principal and accrued interest) and collecting the Company&amp;#8217;s bank deposits to apply towards the outstanding obligations. The Company and the Lender have been discussing the terms of an accelerated repayment of the amounts outstanding under the Triumph Agreement and the Lender has (pursuant to a forbearance agreement which has been extended through December 31, 2016) continued to make additional loans to the Company based on cash collections. As a result of the Company&amp;#8217;s increased revenues and cash flow, the Company was able to make a $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;976&lt;/font&gt; payment to the Lender against the principal amount of the debt during the first nine months of 2016 as compared to only a $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;120&lt;/font&gt; payment against principal during the same period in 2015. This payment during 2016 resulted from increased accounts receivable collections, principally from a single insurance carrier which (as described in Note 8 to the unaudited financial statements below) we may be obligated to refund to the insurance carrier.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; Notwithstanding the Company&amp;#8217;s improved performance in 2016 and expectations for the future, no assurance can be given that the Lender will continue to make such additional loans or that the parties will agree on a repayment plan acceptable to the Company. If the Lender insists upon immediate repayment, the Company may be forced to seek protection from creditors.&lt;/div&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;As of September 30, 2016, $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;3,027&lt;/font&gt; was outstanding under the Triumph Agreement and zero was available for borrowing based on the default status. Borrowings under the Triumph Agreement bear interest at the default interest rate. As of September 30, 2016, the effective interest rate under the Triumph Agreement was approximately &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 11.0&lt;/font&gt;% (&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;6.75&lt;/font&gt;% interest rate plus &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;3&lt;/font&gt;% additional default interest rate and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 1.25&lt;/font&gt;% fees). The Triumph Agreement requires monthly interest payments in arrears on the first day of each month. The Triumph Agreement matured on &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;December 19, 2014&lt;/font&gt;. Triumph has agreed to forbear from the exercise of its rights and remedies under the terms of the Triumph Agreement through December 31, 2016, pursuant to the terms of the &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; September 29, 2016&lt;/font&gt; forbearance agreement. The Triumph Agreement requires a lockbox arrangement whereby all receipts are swept daily to reduce borrowings outstanding. The Company is obligated to reduce the loan balance by $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;85&lt;/font&gt; each month. In connection with the agreement entered into on March 28, 2016, the Lender suspended this monthly payment requirement for February, March and April of 2016 up to an aggregate cap of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;250&lt;/font&gt;, in exchange for the issuance of a warrant to purchase &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 50,000&lt;/font&gt; shares of the Company&amp;#8217;s common stock.&lt;/font&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;The Company used the Black Scholes option pricing model to determine the fair value of the stock warrant, using the following assumptions:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Contractual term&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;5.0 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Volatility&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;122.44&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Risk-free interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1.00&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Dividend yield&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1.44&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;During the nine months ended September 30, 2016, the Company recorded bank fee expense related to this stock warrant of $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;15&lt;/font&gt;.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShortTermDebtTextBlock>

  <zyxi:ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_284">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; &lt;/font&gt;The Company used the Black Scholes option pricing model to determine the fair value of the stock warrant, using the following assumptions:&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"&gt; &lt;table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Contractual term&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;5.0 years&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Volatility&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;122.44&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Risk-free interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1.00&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr style="HEIGHT: 12px"&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"&gt; &lt;div&gt;Dividend yield&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;&amp;#160;&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"&gt; &lt;div&gt;1.44&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"&gt; &lt;div&gt;%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</zyxi:ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn12_31_2015_CommonStockMemberusgaapStatementClassOfStockAxis" id="Factid_285" unitRef="USD" decimals="-3">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn12_31_2015_AdditionalPaidInCapitalMemberusgaapStatementClassOfStockAxis" id="Factid_286" unitRef="USD" decimals="-3">5832000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn12_31_2015_RetainedEarningsMemberusgaapStatementClassOfStockAxis" id="Factid_287" unitRef="USD" decimals="-3">-9845000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="PAsOn12_31_2015_NoncontrollingInterestMemberusgaapStatementClassOfStockAxis" id="Factid_288" unitRef="USD" decimals="-3">-89000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>

  <us-gaap:SharesOutstanding contextRef="PAsOn12_31_2015_CommonStockMemberusgaapStatementClassOfStockAxis" id="Factid_289" unitRef="shares" decimals="INF">31271234</us-gaap:SharesOutstanding>

  <us-gaap:Cash contextRef="PAsOn12_31_2014" id="Factid_290" unitRef="USD" decimals="-3">63000</us-gaap:Cash>

  <us-gaap:Cash contextRef="PAsOn09_30_2015" id="Factid_291" unitRef="USD" decimals="-3">41000</us-gaap:Cash>

  <us-gaap:IncomeTaxesPaid contextRef="P07_01_2016To09_30_2016" id="Factid_292" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxesPaid>

  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="P01_01_2016To09_30_2016_WarrantMemberusgaapClassOfWarrantOrRightAxis" id="Factid_293">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>

  <us-gaap:LeaseExpirationDate1 contextRef="P01_01_2016To09_30_2016_LeaseTerminationAgreementAndNewLeaseAgreementMemberusgaapLeaseArrangementTypeAxis" id="Factid_294">2018-12-31</us-gaap:LeaseExpirationDate1>

  <zyxi:IncreaseDecreaseInWorkingCapital contextRef="P01_01_2016To09_30_2016" id="Factid_295" unitRef="USD" decimals="-3">-4465000</zyxi:IncreaseDecreaseInWorkingCapital>

  <zyxi:IncreaseDecreaseInWorkingCapital contextRef="P01_01_2015To12_31_2015" id="Factid_296" unitRef="USD" decimals="-3">-4773000</zyxi:IncreaseDecreaseInWorkingCapital>

  <us-gaap:NetIncomeLoss contextRef="P01_01_2015To12_31_2015" id="Factid_297" unitRef="USD" decimals="-3">-2911000</us-gaap:NetIncomeLoss>

  <us-gaap:NetIncomeLoss contextRef="P01_01_2014To12_31_2014" id="Factid_298" unitRef="USD" decimals="-3">-6199000</us-gaap:NetIncomeLoss>

  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="P07_01_2016To09_30_2016" id="Factid_299" unitRef="pure" decimals="0">0</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>

  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="P01_01_2015To09_30_2015" id="Factid_300" unitRef="pure" decimals="0">0</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>

  <zyxi:FixedRentalPaymentsForEachMonth contextRef="P01_01_2016To09_30_2016_LeaseTerminationAgreementAndNewLeaseAgreementMemberusgaapLeaseArrangementTypeAxis_MinimumMemberusgaapRangeAxis" id="Factid_301" unitRef="USD" decimals="-3">38000</zyxi:FixedRentalPaymentsForEachMonth>

  <us-gaap:RepaymentsOfLinesOfCredit contextRef="P01_01_2016To09_30_2016" id="Factid_302" unitRef="USD" decimals="-3">976000</us-gaap:RepaymentsOfLinesOfCredit>

  <us-gaap:RepaymentsOfLinesOfCredit contextRef="P01_01_2015To09_30_2015" id="Factid_303" unitRef="USD" decimals="-3">120000</us-gaap:RepaymentsOfLinesOfCredit>

  <us-gaap:CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_304">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; &lt;b&gt;(9) &lt;u&gt;CAPITAL LEASES AND OTHER OBLIGATIONS&lt;/u&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; The Company had previously entered into a Lease Termination Agreement (&amp;#8220;LTA&amp;#8221;) and new Lease Agreement (&amp;#8220;LA&amp;#8221;) with its landlord relating to the Company&amp;#8217;s headquarters location in Lone Tree, Colorado, under which the Company reduced the amount of space leased at its headquarters. Subsequently, on August 12, 2016, the Company entered into an amended Lease Agreement to extend and amend the terms and conditions of the LA.&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"&gt; &amp;#160;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"&gt; The following is a summary of the key terms of the LA, as amended:&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt; &lt;table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt"&gt; &amp;#183;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The&amp;#160;original term of the LA term was extended by two years and as amended is to end, unless sooner terminated, on December 31, 2018;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -24.5pt; MARGIN: 0in 0in 0pt 49pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt"&gt; &amp;#183;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Fixed rental payments were decreased from $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;49&lt;/font&gt; to $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;38&lt;/font&gt; per month; and&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -24.5pt; MARGIN: 0in 0in 0pt 49pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt"&gt; &amp;#183;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"&gt; &lt;div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company and landlord shall each have the right to terminate the lease at any time, without liability to the other, with ninety days (originally six months) prior written notice to the Company and ninety days written notice to the Landlord.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;The Company also leases certain equipment under capital leases which expire on various dates through 2018. Imputed interest rates on the leases range from approximately &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;5&lt;/font&gt;% to &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 10&lt;/font&gt;%. At September 30, 2016, the total recorded cost of assets under capital leases was approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;461&lt;/font&gt;. Accumulated depreciation related to these assets totals approximately $&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;264&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock>

  <us-gaap:EarningsPerShareTextBlock contextRef="P01_01_2016To09_30_2016" id="Factid_305">&lt;div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;(4) &lt;u&gt;EARNING (LOSS) PER SHARE&amp;#160;&lt;/u&gt; &amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;b&gt;&lt;font style="FONT-SIZE: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/b&gt;&lt;/div&gt; &lt;font style="FONT-SIZE: 10pt"&gt;&lt;/font&gt; &lt;div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"&gt; &lt;font style="FONT-SIZE: 10pt"&gt;Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of common shares outstanding and the number of dilutive potential common share equivalents during the period, calculated using the treasury-stock method. For the nine months ended September 30, 2016 and 2015, the potential common stock equivalents&amp;#160;&lt;font style="BACKGROUND-COLOR: transparent"&gt;&lt;font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"&gt; totaled &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 2,160,250&lt;/font&gt; and &lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt; 1,507,750&lt;/font&gt;, respectively&lt;/font&gt;, and were&lt;/font&gt; excluded from the dilutive loss per share calculation as their impacts were antidilutive&lt;font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"&gt;&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>

<!--FootNote Section Ref-->

  <link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
  </link:footnoteLink>
</xbrli:xbrl>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>zyxi-20160930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 14-Nov-2016 [11:36:19] {AM} EST - www.datatracks.com -->
<schema targetNamespace="http://www.zynexmed.com/20160930" elementFormDefault="qualified" xmlns:zyxi="http://www.zynexmed.com/20160930" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:country="http://xbrl.sec.gov/country/2016-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2016-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2016-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.zynexmed.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>101 - Document - Document And Entity Information</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
        <link:definition>102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
        <link:definition>104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementOfStockholdersDeficit" id="CondensedConsolidatedStatementOfStockholdersDeficit">
        <link:definition>105 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#39; DEFICIT</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatements" id="OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatements">
        <link:definition>107 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/BackgroundAndManagementsPlans" id="BackgroundAndManagementsPlans">
        <link:definition>108 - Disclosure - BACKGROUND AND MANAGEMENT&#39;S PLANS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
        <link:definition>109 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/EarningLossPerShare" id="EarningLossPerShare">
        <link:definition>110 - Disclosure - EARNING (LOSS) PER SHARE</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlans" id="StockbasedCompensationPlans">
        <link:definition>111 - Disclosure - STOCK-BASED COMPENSATION PLANS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>112 - Disclosure - INCOME TAXES</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/LineOfCredit" id="LineOfCredit">
        <link:definition>113 - Disclosure - LINE OF CREDIT</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/DeferredInsuranceReimbursement" id="DeferredInsuranceReimbursement">
        <link:definition>114 - Disclosure - DEFERRED INSURANCE REIMBURSEMENT</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligations" id="CapitalLeasesAndOtherObligations">
        <link:definition>115 - Disclosure - CAPITAL LEASES AND OTHER OBLIGATIONS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/Concentrations" id="Concentrations">
        <link:definition>116 - Disclosure - CONCENTRATIONS</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/Litigation" id="Litigation">
        <link:definition>117 - Disclosure - LITIGATION</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies" id="OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies">
        <link:definition>118 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Policies)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
        <link:definition>119 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansTables" id="StockbasedCompensationPlansTables">
        <link:definition>120 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/LineOfCreditTables" id="LineOfCreditTables">
        <link:definition>121 - Disclosure - LINE OF CREDIT (Tables)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual" id="OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual">
        <link:definition>122 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/BackgroundAndManagementsPlansDetailsTextual" id="BackgroundAndManagementsPlansDetailsTextual">
        <link:definition>123 - Disclosure - BACKGROUND AND MANAGEMENT&#39;S PLANS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
        <link:definition>124 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/EarningLossPerShareDetailsTextual" id="EarningLossPerShareDetailsTextual">
        <link:definition>125 - Disclosure - EARNING (LOSS) PER SHARE (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails" id="StockbasedCompensationPlansDetails">
        <link:definition>126 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails1" id="StockbasedCompensationPlansDetails1">
        <link:definition>127 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details 1)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails2" id="StockbasedCompensationPlansDetails2">
        <link:definition>128 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details 2)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetailsTextual" id="StockbasedCompensationPlansDetailsTextual">
        <link:definition>129 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/IncomeTaxesDetailsTextual" id="IncomeTaxesDetailsTextual">
        <link:definition>130 - Disclosure - INCOME TAXES (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/LineOfCreditDetails" id="LineOfCreditDetails">
        <link:definition>131 - Disclosure - LINE OF CREDIT (Details)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/LineOfCreditDetailsTextual" id="LineOfCreditDetailsTextual">
        <link:definition>132 - Disclosure - LINE OF CREDIT (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/DeferredInsuranceReimbursementDetailsTextual" id="DeferredInsuranceReimbursementDetailsTextual">
        <link:definition>133 - Disclosure - DEFERRED INSURANCE REIMBURSEMENT (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligationsDetailsTextual" id="CapitalLeasesAndOtherObligationsDetailsTextual">
        <link:definition>134 - Disclosure - CAPITAL LEASES AND OTHER OBLIGATIONS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:roleType roleURI="http://www.zynexmed.com/role/ConcentrationsDetailsTextual" id="ConcentrationsDetailsTextual">
        <link:definition>135 - Disclosure - CONCENTRATIONS (Details Textual)</link:definition>

        <link:usedOn>link:presentationLink</link:usedOn>

        <link:usedOn>link:definitionLink</link:usedOn>

        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>

      <link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20160930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20160930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20160930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />

      <link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20160930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>

  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />

  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />

  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />

  <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />

  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />

  <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />

  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />

  <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />

  <element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_DocumentAndEntityInformationAbstract" />

  <element name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />

  <element name="IncreaseDecreaseInWorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="zyxi_IncreaseDecreaseInWorkingCapital" />

  <element name="EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" />

  <element name="ImputedInterestRateOnCapitalLease" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_ImputedInterestRateOnCapitalLease" />

  <element name="FixedRentalPaymentsForEachMonth" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="credit" substitutionGroup="xbrli:item" id="zyxi_FixedRentalPaymentsForEachMonth" />

  <element name="LeaseTerminationAgreementAndNewLeaseAgreementMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" />

  <element name="PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" type="num:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" />

  <element name="LineOfCreditFacilityPeriodicInterestPaymentSuspended" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" />

  <element name="LineOfCreditFacilityExtendedExpirationMaturityDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" />

  <element name="IncomeTaxesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="zyxi_IncomeTaxesTable" />

  <element name="IncomeTaxesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_IncomeTaxesLineItems" />

  <element name="TwoThousandAndFiveStockOptionPlanMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_TwoThousandAndFiveStockOptionPlanMember" />

  <element name="RentalInventoryMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_RentalInventoryMember" />

  <element name="ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" />

  <element name="ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" xbrli:balance="debit" substitutionGroup="xbrli:item" id="zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" />

  <element name="BackGroundAndManagementsPlansAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_BackGroundAndManagementsPlansAbstract" />

  <element name="BackGroundAndManagementPlansTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_BackGroundAndManagementPlansTextBlock" />

  <element name="OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" />

  <element name="ZbcMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="zyxi_ZbcMember" />
</schema>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>zyxi-20160930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 14-Nov-2016 [11:36:19] {AM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#PropertyAndEquipment" roleURI="http://www.zynexmed.com/role/PropertyAndEquipment" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#IncomeTaxes" roleURI="http://www.zynexmed.com/role/IncomeTaxes" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#PropertyAndEquipmentDetails" roleURI="http://www.zynexmed.com/role/PropertyAndEquipmentDetails" />

  <calculationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_Cash" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_InventoryNet" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseCurrent" use="optional" order="40" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet" use="optional" order="40" weight="1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="40" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaap_MinorityInterest" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_LinesOfCreditCurrent" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DeferredRevenueCurrent" use="optional" order="40" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent" use="optional" order="50" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" use="optional" order="60" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" use="optional" order="70" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" use="optional" order="80" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" use="optional" order="30" weight="1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_OperatingIncomeLoss" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold" use="optional" order="10" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense" use="optional" order="20" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="loc_us-gaap_SalesRevenueNet" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesRevenueNet" xlink:to="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesRevenueNet" xlink:to="loc_us-gaap_SalesRevenueGoodsNet" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaap_NonoperatingIncomeExpense" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="loc_us-gaap_InterestExpense" use="optional" order="10" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit" use="optional" order="20" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" use="optional" order="20" weight="-1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" use="optional" order="20" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" use="optional" order="10" weight="-1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" use="optional" order="30" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" use="optional" order="20" weight="-1" />
  </calculationLink>

  <calculationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/PropertyAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross" use="optional" order="10" weight="1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />

    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" use="optional" order="20" weight="-1" />
  </calculationLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>zyxi-20160930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 14-Nov-2016 [11:36:19] {AM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#DocumentAndEntityInformation" roleURI="http://www.zynexmed.com/role/DocumentAndEntityInformation" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementOfStockholdersDeficit" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementOfStockholdersDeficit" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#BackgroundAndManagementsPlansDetailsTextual" roleURI="http://www.zynexmed.com/role/BackgroundAndManagementsPlansDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#ConcentrationsDetailsTextual" roleURI="http://www.zynexmed.com/role/ConcentrationsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CapitalLeasesAndOtherObligationsDetailsTextual" roleURI="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligationsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#LineOfCreditDetailsTextual" roleURI="http://www.zynexmed.com/role/LineOfCreditDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#PropertyAndEquipmentDetails" roleURI="http://www.zynexmed.com/role/PropertyAndEquipmentDetails" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetails" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetails1" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails1" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetails2" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails2" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetailsTextual" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#IncomeTaxesDetailsTextual" roleURI="http://www.zynexmed.com/role/IncomeTaxesDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#EarningLossPerShareDetailsTextual" roleURI="http://www.zynexmed.com/role/EarningLossPerShareDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#LineOfCreditDetails" roleURI="http://www.zynexmed.com/role/LineOfCreditDetails" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#DeferredInsuranceReimbursementDetailsTextual" roleURI="http://www.zynexmed.com/role/DeferredInsuranceReimbursementDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual" roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />

  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_3" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentInformationTable_3" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_549" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_549" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_550" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_549" xlink:to="loc_us-gaap_ClassOfStockDomain_550" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_550_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_549" xlink:to="loc_us-gaap_ClassOfStockDomain_550_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_538" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentType_538" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_539" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AmendmentFlag_539" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_540" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_540" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_541" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_541" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_542" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_542" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_543" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityRegistrantName_543" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_544" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_544" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_545" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_545" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_546" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityFilerCategory_546" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_547" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_TradingSymbol_547" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_548" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_548" use="optional" order="15" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_18" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_StatementTable_18" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_19" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_18" xlink:to="loc_us-gaap_StatementClassOfStockAxis_19" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_20" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_19" xlink:to="loc_us-gaap_ClassOfStockDomain_20" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_20_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_19" xlink:to="loc_us-gaap_ClassOfStockDomain_20_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_22" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_AssetsAbstract_22" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_23" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_22" xlink:to="loc_us-gaap_AssetsCurrentAbstract_23" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_24" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_Cash_24" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_25" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_25" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_26" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_InventoryNet_26" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_27" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_27" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_28" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_AssetsCurrent_28" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_29" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_29" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_30" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_30" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_31" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_31" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_32" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_Assets_32" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_34" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_34" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_35" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_LinesOfCreditCurrent_35" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_36" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_36" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_37" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_AccountsPayableCurrent_37" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_38" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_DeferredRevenueCurrent_38" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_39" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_39" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_40" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_40" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_505" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_505" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_41" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_41" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_42" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_LiabilitiesCurrent_42" use="optional" order="26" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_43" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_43" use="optional" order="27" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_44" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_44" use="optional" order="28" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_45" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_Liabilities_45" use="optional" order="29" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" use="optional" order="30" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_47" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_PreferredStockValue_47" use="optional" order="31" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_48" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_CommonStockValue_48" use="optional" order="32" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_49" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_49" use="optional" order="33" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50" use="optional" order="34" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_51" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_StockholdersEquity_51" use="optional" order="35" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_52" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_MinorityInterest_52" use="optional" order="36" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53" use="optional" order="37" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_54" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_54" use="optional" order="38" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_60" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_57" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_StatementTable_57" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_58" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_57" xlink:to="loc_us-gaap_StatementClassOfStockAxis_58" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_59" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_58" xlink:to="loc_us-gaap_ClassOfStockDomain_59" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_59_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_58" xlink:to="loc_us-gaap_ClassOfStockDomain_59_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_61" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_61" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_62" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_62" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_63" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockSharesIssued_63" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_64" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_64" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_65" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_65" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_66" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_66" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_67" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockSharesIssued_67" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_68" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_68" use="optional" order="12" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_74" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_71" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_StatementTable_71" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_72" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_71" xlink:to="loc_us-gaap_StatementClassOfStockAxis_72" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_73" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_72" xlink:to="loc_us-gaap_ClassOfStockDomain_73" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_73_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_72" xlink:to="loc_us-gaap_ClassOfStockDomain_73_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetAbstract" xlink:label="loc_us-gaap_SalesRevenueNetAbstract_75" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_SalesRevenueNetAbstract_75" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue_76" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_75" xlink:to="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue_76" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_77" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_75" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_77" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_111" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_75" xlink:to="loc_us-gaap_SalesRevenueNet_111" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_79" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_OperatingExpensesAbstract_79" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_80" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_79" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_80" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_81" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_79" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_81" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_82" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_79" xlink:to="loc_us-gaap_OperatingIncomeLoss_82" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_84" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" xlink:to="loc_us-gaap_InterestExpense_84" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_86" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_86" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_110" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_110" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_88" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_ProfitLoss_88" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_90" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_NetIncomeLoss_90" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_92" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" xlink:to="loc_us-gaap_EarningsPerShareBasic_92" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_93" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" xlink:to="loc_us-gaap_EarningsPerShareDiluted_93" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96" use="optional" order="26" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementOfStockholdersDeficit">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_106" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_99" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_StatementTable_99" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_100" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_99" xlink:to="loc_us-gaap_StatementClassOfStockAxis_100" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_101" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_100" xlink:to="loc_us-gaap_ClassOfStockDomain_101" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_101_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_100" xlink:to="loc_us-gaap_ClassOfStockDomain_101_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_102" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_CommonStockMember_102" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_103" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_103" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_104" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_RetainedEarningsMember_104" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_105" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_NoncontrollingInterestMember_105" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_107" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_107" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_108" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_SharesOutstanding_108" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_109" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_109" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_114" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_114" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_115" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_ProfitLoss_115" use="optional" order="13" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_121" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_118" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_StatementTable_118" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_119" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_118" xlink:to="loc_us-gaap_StatementClassOfStockAxis_119" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_120" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_119" xlink:to="loc_us-gaap_ClassOfStockDomain_120" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_120_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_119" xlink:to="loc_us-gaap_ClassOfStockDomain_120_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_122" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_122" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_123" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_122" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_123" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_126" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_126" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_127" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_127" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_129" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_129" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_130" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_130" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_131" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_131" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_132" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_132" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_133" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_Cash_133" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_136" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" xlink:to="loc_us-gaap_InterestPaid_136" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_137" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" xlink:to="loc_us-gaap_IncomeTaxesPaid_137" use="optional" order="18" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/BackgroundAndManagementsPlansDetailsTextual">
    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_184" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_us-gaap_StatementTable_184" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_185" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_185" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_186" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_185" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_186" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_186_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_185" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_186_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_188" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_dei_LegalEntityAxis_188" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_189" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_188" xlink:to="loc_dei_EntityDomain_189" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_189_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_188" xlink:to="loc_dei_EntityDomain_189_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_194" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_us-gaap_NetIncomeLoss_194" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_196" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_us-gaap_SalesRevenueNet_196" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncreaseDecreaseInWorkingCapital" xlink:label="loc_zyxi_IncreaseDecreaseInWorkingCapital_197" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_zyxi_IncreaseDecreaseInWorkingCapital_197" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xlink:label="loc_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts_200" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts_200" use="optional" order="11" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/ConcentrationsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_254" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_204" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_254" xlink:to="loc_us-gaap_StatementTable_204" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_205" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_StatementClassOfStockAxis_205" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_206" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_205" xlink:to="loc_us-gaap_ClassOfStockDomain_206" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_206_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_205" xlink:to="loc_us-gaap_ClassOfStockDomain_206_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsProductLineMember" xlink:label="loc_us-gaap_CostOfGoodsProductLineMember_211" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" xlink:to="loc_us-gaap_CostOfGoodsProductLineMember_211" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_212" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" xlink:to="loc_us-gaap_AccountsReceivableMember_212" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_209" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_209" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_255" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_209" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_255" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_255_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_209" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_255_default" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_264" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_255" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_264" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_265" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_255" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_265" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_208" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_254" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_208" use="optional" order="15" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligationsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_234" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_216" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_StatementTable_216" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_217" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_StatementClassOfStockAxis_217" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_218" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_217" xlink:to="loc_us-gaap_ClassOfStockDomain_218" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_218_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_217" xlink:to="loc_us-gaap_ClassOfStockDomain_218_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_229" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228" xlink:to="loc_us-gaap_EquipmentMember_229" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_227" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_RangeAxis_227" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_231" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_227" xlink:to="loc_us-gaap_RangeMember_231" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_231_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_227" xlink:to="loc_us-gaap_RangeMember_231_default" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_232" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_231" xlink:to="loc_us-gaap_MaximumMember_232" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_233" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_231" xlink:to="loc_us-gaap_MinimumMember_233" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis_230" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_LeaseArrangementTypeAxis_230" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_235" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_230" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_235" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_235_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_230" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_235_default" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" xlink:label="loc_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember_236" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_235" xlink:to="loc_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember_236" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross_220" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_CapitalLeasedAssetsGross_220" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:label="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_221" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_221" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ImputedInterestRateOnCapitalLease" xlink:label="loc_zyxi_ImputedInterestRateOnCapitalLease_222" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_zyxi_ImputedInterestRateOnCapitalLease_222" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_FixedRentalPaymentsForEachMonth" xlink:label="loc_zyxi_FixedRentalPaymentsForEachMonth_225" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_zyxi_FixedRentalPaymentsForEachMonth_225" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_226" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_LeaseExpirationDate1_226" use="optional" order="22" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/LineOfCreditDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_274" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_239" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_274" xlink:to="loc_us-gaap_StatementTable_239" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_240" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_StatementClassOfStockAxis_240" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_241" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_240" xlink:to="loc_us-gaap_ClassOfStockDomain_241" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_241_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_240" xlink:to="loc_us-gaap_ClassOfStockDomain_241_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_242" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_CreditFacilityAxis_242" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_252" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_242" xlink:to="loc_us-gaap_CreditFacilityDomain_252" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_252_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_242" xlink:to="loc_us-gaap_CreditFacilityDomain_252_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_253" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_252" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_253" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_251" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_251" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_271" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_251" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_271" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_271_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_251" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_271_default" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_270" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_RangeAxis_270" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_275" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_270" xlink:to="loc_us-gaap_RangeMember_275" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_275_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_270" xlink:to="loc_us-gaap_RangeMember_275_default" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_276" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_275" xlink:to="loc_us-gaap_MaximumMember_276" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract" xlink:label="loc_us-gaap_LineOfCreditFacilityAbstract_243" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_274" xlink:to="loc_us-gaap_LineOfCreditFacilityAbstract_243" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_244" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LinesOfCreditCurrent_244" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_245" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_245" use="optional" order="18" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_247" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_247" use="optional" order="19" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_248" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_248" use="optional" order="20" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xlink:label="loc_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate_249" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate_249" use="optional" order="21" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_250" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_250" use="optional" order="22" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_266" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_266" use="optional" order="23" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPayment" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_267" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_267" use="optional" order="24" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xlink:label="loc_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended_268" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended_268" use="optional" order="25" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xlink:label="loc_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate_269" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate_269" use="optional" order="26" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" xlink:label="loc_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost_493" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost_493" use="optional" order="27" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_554" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_554" use="optional" order="28" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/PropertyAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_358" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_358" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_RentalInventoryMember" xlink:label="loc_zyxi_RentalInventoryMember_359" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_zyxi_RentalInventoryMember_359" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_360" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_VehiclesMember_360" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_361" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_361" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_362" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_EquipmentMember_362" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_363" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" xlink:to="loc_us-gaap_RangeAxis_363" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_364" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_363" xlink:to="loc_us-gaap_RangeMember_364" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_364_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_363" xlink:to="loc_us-gaap_RangeMember_364_default" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_366" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_364" xlink:to="loc_us-gaap_MaximumMember_366" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_365" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_364" xlink:to="loc_us-gaap_MinimumMember_365" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_368" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_368" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_369" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_369" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_371" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_371" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_376" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_376" use="optional" order="18" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_348" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_345" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_348" xlink:to="loc_us-gaap_StatementTable_345" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_346" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_345" xlink:to="loc_us-gaap_StatementClassOfStockAxis_346" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_347" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_346" xlink:to="loc_us-gaap_ClassOfStockDomain_347" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_347_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_346" xlink:to="loc_us-gaap_ClassOfStockDomain_347_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_348" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_350" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_350" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_351" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_351" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_352" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_352" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_354" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_354" use="optional" order="9" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_392" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_389" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_392" xlink:to="loc_us-gaap_StatementTable_389" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_390" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_389" xlink:to="loc_us-gaap_StatementClassOfStockAxis_390" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_391" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_390" xlink:to="loc_us-gaap_ClassOfStockDomain_391" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_391_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_390" xlink:to="loc_us-gaap_ClassOfStockDomain_391_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_392" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_394" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_394" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_395" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_395" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_396" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_396" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_397" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_397" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_399" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_399" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_400" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_400" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_402" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_402" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_404" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_404" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_410" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_410" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_412" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_412" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_426" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_426" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_429" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_429" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_430" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_430" use="optional" order="18" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_375" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_372" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_375" xlink:to="loc_us-gaap_StatementTable_372" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_373" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_372" xlink:to="loc_us-gaap_StatementClassOfStockAxis_373" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_374" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_373" xlink:to="loc_us-gaap_ClassOfStockDomain_374" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_374_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_373" xlink:to="loc_us-gaap_ClassOfStockDomain_374_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_375" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_379" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_379" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_380" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_380" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_381" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_381" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_382" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_382" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_384" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_384" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_385" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_385" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_386" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_386" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_387" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_387" use="optional" order="13" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_292" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_PlanNameAxis_292" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_293" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_292" xlink:to="loc_us-gaap_PlanNameDomain_293" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_293_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_292" xlink:to="loc_us-gaap_PlanNameDomain_293_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_TwoThousandAndFiveStockOptionPlanMember" xlink:label="loc_zyxi_TwoThousandAndFiveStockOptionPlanMember_294" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_293" xlink:to="loc_zyxi_TwoThousandAndFiveStockOptionPlanMember_294" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_295" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_295" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_296" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_295" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_296" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_296_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_295" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_296_default" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_299" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_RangeAxis_299" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_300" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_299" xlink:to="loc_us-gaap_RangeMember_300" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_300_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_299" xlink:to="loc_us-gaap_RangeMember_300_default" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_304" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_304" use="optional" order="12" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_305" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_305" use="optional" order="13" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_306" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_306" use="optional" order="14" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_307" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_307" use="optional" order="15" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_308" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_308" use="optional" order="16" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_310" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_310" use="optional" order="17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_456" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_456" use="optional" order="18" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/IncomeTaxesDetailsTextual">
    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncomeTaxesLineItems" xlink:label="loc_zyxi_IncomeTaxesLineItems_287" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncomeTaxesTable" xlink:label="loc_zyxi_IncomeTaxesTable_278" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zyxi_IncomeTaxesLineItems_287" xlink:to="loc_zyxi_IncomeTaxesTable_278" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_279" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zyxi_IncomeTaxesTable_278" xlink:to="loc_us-gaap_RangeAxis_279" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_280" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_279" xlink:to="loc_us-gaap_RangeMember_280" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_280_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_279" xlink:to="loc_us-gaap_RangeMember_280_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_283" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zyxi_IncomeTaxesTable_278" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_283" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_284" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_283" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_284" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_284_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_283" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_284_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_288" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_IncomeTaxesLineItems_287" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_288" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_289" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_IncomeTaxesLineItems_287" xlink:to="loc_us-gaap_IncomeTaxesPaid_289" use="optional" order="9" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/EarningLossPerShareDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_332" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_329" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_332" xlink:to="loc_us-gaap_StatementTable_329" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_330" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_329" xlink:to="loc_us-gaap_StatementClassOfStockAxis_330" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_331" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_330" xlink:to="loc_us-gaap_ClassOfStockDomain_331" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_331_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_330" xlink:to="loc_us-gaap_ClassOfStockDomain_331_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_333" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_332" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_333" use="optional" order="5" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/LineOfCreditDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_482" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_477" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_StatementTable_477" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_478" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_477" xlink:to="loc_us-gaap_StatementClassOfStockAxis_478" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_479" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_478" xlink:to="loc_us-gaap_ClassOfStockDomain_479" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_479_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_478" xlink:to="loc_us-gaap_ClassOfStockDomain_479_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_480" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_477" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_480" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_483" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_480" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_483" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_483_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_480" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_483_default" use="optional" order="7" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_484" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_483" xlink:to="loc_us-gaap_WarrantMember_484" use="optional" order="8" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_481" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_481" use="optional" order="9" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_485" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_485" use="optional" order="10" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_486" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_486" use="optional" order="11" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_487" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_487" use="optional" order="12" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/DeferredInsuranceReimbursementDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_502" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_499" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_502" xlink:to="loc_us-gaap_StatementTable_499" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_500" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_499" xlink:to="loc_dei_LegalEntityAxis_500" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_501" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_500" xlink:to="loc_dei_EntityDomain_501" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_501_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_500" xlink:to="loc_dei_EntityDomain_501_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_503" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_502" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_503" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_504" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_502" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_504" use="optional" order="6" />
  </definitionLink>

  <definitionLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual">
    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" xlink:label="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" xlink:to="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" use="optional" order="1" xbrldt:contextElement="segment" xbrldt:closed="true" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_513" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" xlink:to="loc_dei_LegalEntityAxis_513" use="optional" order="2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_519" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_513" xlink:to="loc_dei_EntityDomain_519" use="optional" order="3" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_519_default" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_513" xlink:to="loc_dei_EntityDomain_519_default" use="optional" order="4" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ZbcMember" xlink:label="loc_zyxi_ZbcMember_520" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_519" xlink:to="loc_zyxi_ZbcMember_520" use="optional" order="5" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_514" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_514" use="optional" order="6" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_515" />

    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" xlink:to="loc_us-gaap_NumberOfOperatingSegments_515" use="optional" order="7" />
  </definitionLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>zyxi-20160930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 14-Nov-2016 [11:36:19] {AM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />

  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />

  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_DocumentAndEntityInformationAbstract" xlink:label="loc_zyxi_DocumentAndEntityInformationAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document And Entity Information [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_DocumentAndEntityInformationAbstract" xlink:to="lab_zyxi_DocumentAndEntityInformationAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current Assets:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash at the beginning of the period</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_Cash" xml:lang="en-US">Cash at the end of the period</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts Receivable, Net, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xml:lang="en-US">Accounts receivable, net</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InventoryNet" xml:lang="en-US">Inventory, Net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InventoryNet" xml:lang="en-US">Inventory, net</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid Expense, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid expenses</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property, Plant and Equipment, Net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and equipment, net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US">Property and Equipment, Net</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xml:lang="en-US">Deposits Assets, Noncurrent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xml:lang="en-US">Deposits</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Intangible assets, net</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xml:lang="en-US">Total intangible assets, net</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Total assets</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; DEFICIT</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current Liabilities:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xml:lang="en-US">Line of Credit, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xml:lang="en-US">Line of credit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xml:lang="en-US">Capital Lease Obligations, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xml:lang="en-US">Current portion of capital leases</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts payable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred Revenue, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xml:lang="en-US">Deferred revenue</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xml:lang="en-US">Accrued Income Taxes, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xml:lang="en-US">Income taxes payable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US">Employee-related Liabilities, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xml:lang="en-US">Accrued payroll and payroll taxes</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xml:lang="en-US">Deferred insurance reimbursement</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Liabilities, Current</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xml:lang="en-US">Capital Lease Obligations, Noncurrent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xml:lang="en-US">Capitalized leases, less current portion</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsNoncurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xml:lang="en-US">Standard Product Warranty Accrual, Noncurrent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" xml:lang="en-US">Warranty liability</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualNoncurrent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US">Stockholders&#39; Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US">Stockholders&#8217; Deficit:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred stock; $.001 par value, 10,000,000 shares authorized, no shares issued or outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common stock, $.001 par value, 100,000,000 shares authorized, 31,271,234 shares issued and outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Paid-in capital</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit), Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders&#39; Equity Attributable to Parent, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Total Zynex, Inc. stockholders&#8217; deficit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinorityInterest" xml:lang="en-US">Stockholders&#39; Equity Attributable to Noncontrolling Interest</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MinorityInterest" xml:lang="en-US">Non-controlling interest</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Stockholders&#39; Equity, Including Portion Attributable to Noncontrolling Interest, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Total stockholders&#8217; deficit</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US">Balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total liabilities and stockholders&#8217; deficit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetAbstract" xlink:label="loc_us-gaap_SalesRevenueNetAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueNetAbstract" xml:lang="en-US">Revenue, Net [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SalesRevenueNetAbstract" xml:lang="en-US">Net revenue:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetAbstract" xlink:to="lab_us-gaap_SalesRevenueNetAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xml:lang="en-US">Operating Leases, Income Statement, Lease Revenue, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xml:lang="en-US">Rental</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xlink:to="lab_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueGoodsNet" xml:lang="en-US">Sales Revenue, Goods, Net, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SalesRevenueGoodsNet" xml:lang="en-US">Sales</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueGoodsNet" xlink:to="lab_us-gaap_SalesRevenueGoodsNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating expenses:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xml:lang="en-US">Cost of Goods and Services Sold, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xml:lang="en-US">Cost of revenue - rental, product &amp; supply</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, General and Administrative Expense, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, general and administrative expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Operating Income (Loss), Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss" xml:lang="en-US">Income (loss) from operations</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Other income (expense):</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest Expense, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InterestExpense" xml:lang="en-US">Interest expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Nonoperating Income (Expense), Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xml:lang="en-US">Total other income (expense)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US">Income (loss) before income taxes</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income Tax Expense (Benefit)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US">Income taxes</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net income (loss)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net loss</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xml:lang="en-US">Plus: Net loss - noncontrolling interest</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net income (loss) - attributable to Zynex, Inc.</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (loss)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss applicable to common stockholders</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net loss applicable to common stockholders</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Earnings Per Share, Basic, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Basic</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Net loss per share - basic</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Earnings Per Share, Diluted, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Diluted</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xml:lang="en-US">Net loss per share - diluted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xml:lang="en-US">Net income (loss) per share - attributable to Zynex, Inc.:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Basic</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted average shares outstanding - basic</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted average shares outstanding - basic</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Diluted</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xml:lang="en-US">Weighted average shares outstanding - diluted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders&#39; Equity [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Paid-in Capital</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Deficit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xml:lang="en-US">Noncontrolling Interest [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xml:lang="en-US">Noncontrolling Interest</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Shares, Outstanding</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Balance, shares</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesOutstanding" xml:lang="en-US">Balance, shares</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US">Employee stock-based compensation expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted - average number of common shares outstanding:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SalesRevenueNet" xml:lang="en-US">Revenue, Net, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_SalesRevenueNet" xml:lang="en-US">Net revenue</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SalesRevenueNet" xml:lang="en-US">Total net revenue</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNet" xlink:to="lab_us-gaap_SalesRevenueNet" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US">Service provider warrant expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Cash flows from operating activities:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Net cash provided by operating activities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Cash flows from investing activities:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xml:lang="en-US">Change in inventory used for rental</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xml:lang="en-US">Net cash (used in) provided by investing activities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xml:lang="en-US">Cash flows from financing activities:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xml:lang="en-US">Net repayments on line of credit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xml:lang="en-US">Payments on capital leases and other obligations</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">Net cash (used in) provided by financing activities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease), Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US">Net increase (decrease) in cash</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Supplemental cash flow information:</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InterestPaid" xml:lang="en-US">Interest Paid, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_InterestPaid" xml:lang="en-US">Interest paid</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income Taxes Paid</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income taxes paid (including interest and penalties)</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_IncomeTaxesPaid" xml:lang="en-US">Income taxes paid (including interest and penalties)</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xml:lang="en-US">ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property, Plant and Equipment [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US">PROPERTY AND EQUIPMENT</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">Earnings Per Share [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xml:lang="en-US">EARNING (LOSS) PER SHARE</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US">Summary of status of the Company&#39;s non-vested share awards</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US">STOCK-BASED COMPENSATION PLANS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US">INCOME TAXES</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xml:lang="en-US">Debt Disclosure [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaap_ShortTermDebtTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xml:lang="en-US">Short-term Debt [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xml:lang="en-US">LINE OF CREDIT</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTextBlock" xlink:to="lab_us-gaap_ShortTermDebtTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesCapitalAbstract" xlink:label="loc_us-gaap_LeasesCapitalAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeasesCapitalAbstract" xml:lang="en-US">Leases, Capital [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesCapitalAbstract" xlink:to="lab_us-gaap_LeasesCapitalAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" xml:lang="en-US">Capital Leases in Financial Statements of Lessee Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" xml:lang="en-US">CAPITAL LEASES AND OTHER OBLIGATIONS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" xlink:to="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xml:lang="en-US">Risks and Uncertainties [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xml:lang="en-US">CONCENTRATIONS</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">LITIGATION</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US">PROPERTY AND EQUIPMENT</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US">Fair Value of Stock Options Grants</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US">Summary of Stock Option Activity Under the Option Plan</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xml:lang="en-US">BACKGROUND AND MANAGEMENT&#8217;S PLANS [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="lab_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncreaseDecreaseInWorkingCapital" xlink:label="loc_zyxi_IncreaseDecreaseInWorkingCapital" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_IncreaseDecreaseInWorkingCapital" xml:lang="en-US">Increase Decrease In Working Capital</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_zyxi_IncreaseDecreaseInWorkingCapital" xml:lang="en-US">Increase (decrease) in working capital</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_IncreaseDecreaseInWorkingCapital" xml:lang="en-US">Increase (decrease) in working capital.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_IncreaseDecreaseInWorkingCapital" xlink:to="lab_zyxi_IncreaseDecreaseInWorkingCapital" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xlink:label="loc_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xml:lang="en-US">Effect Of Headcount Reductions And Facilities Rent On Administrative Costs</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xml:lang="en-US">Fixed expenses reduced by cutting administrative costs through cutting headcount and facilities rent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xml:lang="en-US">Effect of headcount reductions and facilities rent on administrative costs.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xlink:to="lab_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Concentration Risk, Percentage</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xml:lang="en-US">Percentage of sales</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xml:lang="en-US">Concentration Risk Type [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsProductLineMember" xlink:label="loc_us-gaap_CostOfGoodsProductLineMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostOfGoodsProductLineMember" xml:lang="en-US">Cost of Goods, Product Line [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CostOfGoodsProductLineMember" xml:lang="en-US">Raw materials</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsProductLineMember" xlink:to="lab_us-gaap_CostOfGoodsProductLineMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableMember" xml:lang="en-US">Accounts Receivable [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccountsReceivableMember" xml:lang="en-US">Net Accounts Receivable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalLeasedAssetsGross" xml:lang="en-US">Capital Leased Assets, Gross</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CapitalLeasedAssetsGross" xml:lang="en-US">Cost of assets under capital lease</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasedAssetsGross" xlink:to="lab_us-gaap_CapitalLeasedAssetsGross" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:label="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xml:lang="en-US">Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xml:lang="en-US">Accumulated depreciation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:to="lab_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ImputedInterestRateOnCapitalLease" xlink:label="loc_zyxi_ImputedInterestRateOnCapitalLease" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_ImputedInterestRateOnCapitalLease" xml:lang="en-US">Imputed Interest Rate On Capital Lease</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_ImputedInterestRateOnCapitalLease" xml:lang="en-US">Imputed interest rate on lease</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_ImputedInterestRateOnCapitalLease" xml:lang="en-US">Imputed interest rate on capital lease.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_ImputedInterestRateOnCapitalLease" xlink:to="lab_zyxi_ImputedInterestRateOnCapitalLease" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_FixedRentalPaymentsForEachMonth" xlink:label="loc_zyxi_FixedRentalPaymentsForEachMonth" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_FixedRentalPaymentsForEachMonth" xml:lang="en-US">Fixed Rental Payments For Each Month</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_FixedRentalPaymentsForEachMonth" xml:lang="en-US">Fixed rental payments for each month</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_FixedRentalPaymentsForEachMonth" xml:lang="en-US">Fixed rental payments for each month.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_FixedRentalPaymentsForEachMonth" xlink:to="lab_zyxi_FixedRentalPaymentsForEachMonth" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseExpirationDate1" xml:lang="en-US">Lease Expiration Date</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LeaseExpirationDate1" xml:lang="en-US">Lease termination date</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseExpirationDate1" xlink:to="lab_us-gaap_LeaseExpirationDate1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RangeAxis" xml:lang="en-US">Range [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeAxis" xlink:to="lab_us-gaap_RangeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquipmentMember" xml:lang="en-US">Equipment [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EquipmentMember" xml:lang="en-US">Assembly Equipment</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EquipmentMember" xml:lang="en-US">Assembly equipment</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseArrangementTypeAxis" xml:lang="en-US">Lease Arrangement, Type [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis" xlink:to="lab_us-gaap_LeaseArrangementTypeAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RangeMember" xml:lang="en-US">Range [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeMember" xlink:to="lab_us-gaap_RangeMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MaximumMember" xml:lang="en-US">Maximum [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MaximumMember" xml:lang="en-US">Maximum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumMember" xlink:to="lab_us-gaap_MaximumMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinimumMember" xml:lang="en-US">Minimum [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MinimumMember" xml:lang="en-US">Minimum</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinimumMember" xlink:to="lab_us-gaap_MinimumMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xml:lang="en-US">Debt Instrument [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseArrangementTypeDomain" xml:lang="en-US">Lease Arrangement, Type [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain" xlink:to="lab_us-gaap_LeaseArrangementTypeDomain" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" xlink:label="loc_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" xml:lang="en-US">Lease Termination Agreement And New Lease Agreement [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" xml:lang="en-US">Lease Termination Agreement And New Lease Agreement</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" xlink:to="lab_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityAxis" xml:lang="en-US">Credit Facility [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract" xlink:label="loc_us-gaap_LineOfCreditFacilityAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityAbstract" xml:lang="en-US">Line of Credit Facility [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract" xlink:to="lab_us-gaap_LineOfCreditFacilityAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xml:lang="en-US">Line of Credit Facility, Expiration Date</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xml:lang="en-US">Date of Maturity</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xml:lang="en-US">Effective interest rate under the Credit Agreement</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xml:lang="en-US">Interest Rate</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xlink:label="loc_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xml:lang="en-US">Portion Of Additional Default Interest Rate In Effective Interest Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xml:lang="en-US">Additional default interest rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xml:lang="en-US">Portion of additional default interest rate in effective interest rate.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xlink:to="lab_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xml:lang="en-US">Fees include in effective interest rate under the credit agreement</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityDomain" xml:lang="en-US">Credit Facility [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xml:lang="en-US">Revolving Credit Facility [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xml:lang="en-US">Revolving Credit Facility</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xml:lang="en-US">Concentration Risk [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xml:lang="en-US">Concentration Risk Type [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xml:lang="en-US">Credit Concentration Risk [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xml:lang="en-US">Credit Concentration Risk</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xml:lang="en-US">Supplier Concentration Risk [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xml:lang="en-US">Electrotherapy products</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPayment" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPayment" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LineOfCreditFacilityPeriodicPayment" xml:lang="en-US">Line of Credit Facility, Periodic Payment</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LineOfCreditFacilityPeriodicPayment" xml:lang="en-US">Obligation to reduce loan balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityPeriodicPayment" xlink:to="lab_us-gaap_LineOfCreditFacilityPeriodicPayment" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xlink:label="loc_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xml:lang="en-US">Line Of Credit Facility Periodic Interest Payment Suspended</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xml:lang="en-US">Aggregate periodic cap payment suspended</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xml:lang="en-US">Line of credit facility periodic interest payment, suspended.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xlink:to="lab_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xlink:label="loc_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xml:lang="en-US">Line Of Credit Facility Extended Expiration Maturity Date</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xml:lang="en-US">Extended date of forbearance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xml:lang="en-US">Line of credit facility extended expiration maturity date.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xlink:to="lab_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncomeTaxesTable" xlink:label="loc_zyxi_IncomeTaxesTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_IncomeTaxesTable" xml:lang="en-US">Income Taxes [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_IncomeTaxesTable" xlink:to="lab_zyxi_IncomeTaxesTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xml:lang="en-US">Income Tax Authority [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xml:lang="en-US">Income Tax Authority [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncomeTaxesLineItems" xlink:label="loc_zyxi_IncomeTaxesLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_IncomeTaxesLineItems" xml:lang="en-US">Income Taxes [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_IncomeTaxesLineItems" xlink:to="lab_zyxi_IncomeTaxesLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US">Statutory rate</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameAxis" xml:lang="en-US">Plan Name [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PlanNameDomain" xml:lang="en-US">Plan Name [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_TwoThousandAndFiveStockOptionPlanMember" xlink:label="loc_zyxi_TwoThousandAndFiveStockOptionPlanMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_TwoThousandAndFiveStockOptionPlanMember" xml:lang="en-US">Two Thousand And Five Stock Option Plan [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_TwoThousandAndFiveStockOptionPlanMember" xml:lang="en-US">Two Thousand And Five Stock Option Plan</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_TwoThousandAndFiveStockOptionPlanMember" xlink:to="lab_zyxi_TwoThousandAndFiveStockOptionPlanMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xml:lang="en-US">Income Statement Location [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xml:lang="en-US">Income Statement Location [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Allocated Share-based Compensation Expense</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US">Employee stock-based compensation expense</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Shares under option, granted</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Non-vested Shares Under Option, granted</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/presentationGuidance" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US">Shares under option, granted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Weighted average exercise price, granted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xml:lang="en-US">Unrecognized compensation expense related to stock options</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US">Weighted-average period of unrecognized compensation expense related to stock options</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive securities excluded from</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xml:lang="en-US">Fair value of stock option grants</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Weighted average expected term</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US">Contractual term</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Weighted average volatility</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US">Volatility</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Weighted average risk-free interest rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US">Risk-free interest rate</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US">Dividend yield</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Property, Plant and Equipment [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Furniture and Fixtures [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xml:lang="en-US">Office furniture and equipment</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_RentalInventoryMember" xlink:label="loc_zyxi_RentalInventoryMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_RentalInventoryMember" xml:lang="en-US">Rental Inventory [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_RentalInventoryMember" xml:lang="en-US">Rental inventory</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_RentalInventoryMember" xlink:to="lab_zyxi_RentalInventoryMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_VehiclesMember" xml:lang="en-US">Vehicles [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_VehiclesMember" xml:lang="en-US">Vehicles</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold Improvements [Member]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US">Leasehold improvements</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property, Plant and Equipment, Gross, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US">Property and Equipment, Gross</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US">Less accumulated depreciation</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsAbstract" xlink:label="loc_us-gaap_CompensationRelatedCostsAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CompensationRelatedCostsAbstract" xml:lang="en-US">Compensation Related Costs [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsAbstract" xlink:to="lab_us-gaap_CompensationRelatedCostsAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xml:lang="en-US">Property and Equipment, Useful Life</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Non-vested Shares Under Option at January 1, 2016</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xml:lang="en-US">Non-vested Under Option at September 30, 2016</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US">Non-vested Shares Under Option, Vested</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xml:lang="en-US">Non-vested Shares Under Option, Forfeited</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Exercise Price, Beginning Balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted Average Grant Date Fair Value at January 1, 2016</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted Average Grant Date Fair Value at September 30, 2016</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted Average Grant Date Fair Value, Granted</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted Average Grant Date Fair Value, Vested</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xml:lang="en-US">Weighted Average Grant Date Fair Value, Forfeited</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xml:lang="en-US">Summary of stock option activity under the option Plan</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Shares Under Option, Outstanding beginning balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US">Shares Under Option, Outstanding ending balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US">Shares under option, Exercised</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US">Shares Under Option, Forfeited</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US">Shares Under Option, Exercisable ending balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Outstanding beginning balance</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Outstanding ending balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US">Weighted Average Exercise Price, Exercisable ending balance</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xml:lang="en-US">Weighted Average Remaining Contractual Life, Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Unaudited Condensed Consolidated Financial Statements</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xml:lang="en-US">Reclassifications</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xml:lang="en-US">Summary of Status of the Company&#39;s Non-Vested Shares Under Option</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" xlink:label="loc_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" xml:lang="en-US">Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" xml:lang="en-US">LINE OF CREDIT</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of warrants, including, but not limited to: (a) expected term, (b) expected volatility of the entity&#39;s shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" xlink:to="lab_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" xlink:label="loc_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" xml:lang="en-US">Class Of Stock Warrants Or Rights Warrants Issuance Cost</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" xml:lang="en-US">Represents the amount of cost incurred in issuance of warrants</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" xlink:to="lab_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceAbstract" xlink:label="loc_us-gaap_InsuranceAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InsuranceAbstract" xml:lang="en-US">Insurance [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceDisclosureTextBlock" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xml:lang="en-US">Insurance Disclosure [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xml:lang="en-US">DEFERRED INSURANCE REIMBURSEMENT</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:to="lab_us-gaap_InsuranceDisclosureTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xml:lang="en-US">Proceeds from Insurance Settlement, Operating Activities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities, Total</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_BackGroundAndManagementsPlansAbstract" xlink:label="loc_zyxi_BackGroundAndManagementsPlansAbstract" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_BackGroundAndManagementsPlansAbstract" xml:lang="en-US">Back Ground And Managements Plans [Abstract]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_BackGroundAndManagementsPlansAbstract" xlink:to="lab_zyxi_BackGroundAndManagementsPlansAbstract" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_BackGroundAndManagementPlansTextBlock" xlink:label="loc_zyxi_BackGroundAndManagementPlansTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_BackGroundAndManagementPlansTextBlock" xml:lang="en-US">Back Ground And Management Plans [Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_zyxi_BackGroundAndManagementPlansTextBlock" xml:lang="en-US">BACKGROUND AND MANAGEMENT&#8217;S PLANS</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_zyxi_BackGroundAndManagementPlansTextBlock" xml:lang="en-US">The entire disclosure related to back ground and management plans of the entity.</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_BackGroundAndManagementPlansTextBlock" xlink:to="lab_zyxi_BackGroundAndManagementPlansTextBlock" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" xlink:label="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" xml:lang="en-US">ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS [Table]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" xlink:to="lab_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xml:lang="en-US">Number of Operating Segments</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ZbcMember" xlink:label="loc_zyxi_ZbcMember" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_zyxi_ZbcMember" xml:lang="en-US">ZBC [Member]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_zyxi_ZbcMember" xlink:to="lab_zyxi_ZbcMember" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recent Accounting Pronouncements</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" />

    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xml:lang="en-US">Repayments of Lines of Credit</label>

    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" />
  </labelLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>zyxi-20160930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8" ?>
<!-- Generated by DataTracks version 1.1.9 on 14-Nov-2016 [11:36:19] {AM} EST - www.datatracks.com -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#DocumentAndEntityInformation" roleURI="http://www.zynexmed.com/role/DocumentAndEntityInformation" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#PropertyAndEquipment" roleURI="http://www.zynexmed.com/role/PropertyAndEquipment" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#EarningLossPerShare" roleURI="http://www.zynexmed.com/role/EarningLossPerShare" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlans" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlans" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#IncomeTaxes" roleURI="http://www.zynexmed.com/role/IncomeTaxes" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#LineOfCredit" roleURI="http://www.zynexmed.com/role/LineOfCredit" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#DeferredInsuranceReimbursement" roleURI="http://www.zynexmed.com/role/DeferredInsuranceReimbursement" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CapitalLeasesAndOtherObligations" roleURI="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligations" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#Concentrations" roleURI="http://www.zynexmed.com/role/Concentrations" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#Litigation" roleURI="http://www.zynexmed.com/role/Litigation" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies" roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#PropertyAndEquipmentTables" roleURI="http://www.zynexmed.com/role/PropertyAndEquipmentTables" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansTables" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansTables" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#LineOfCreditTables" roleURI="http://www.zynexmed.com/role/LineOfCreditTables" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual" roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#BackgroundAndManagementsPlansDetailsTextual" roleURI="http://www.zynexmed.com/role/BackgroundAndManagementsPlansDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#PropertyAndEquipmentDetails" roleURI="http://www.zynexmed.com/role/PropertyAndEquipmentDetails" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#EarningLossPerShareDetailsTextual" roleURI="http://www.zynexmed.com/role/EarningLossPerShareDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetails" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetails1" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails1" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetails2" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails2" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#StockbasedCompensationPlansDetailsTextual" roleURI="http://www.zynexmed.com/role/StockbasedCompensationPlansDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#IncomeTaxesDetailsTextual" roleURI="http://www.zynexmed.com/role/IncomeTaxesDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#LineOfCreditDetails" roleURI="http://www.zynexmed.com/role/LineOfCreditDetails" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#LineOfCreditDetailsTextual" roleURI="http://www.zynexmed.com/role/LineOfCreditDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#DeferredInsuranceReimbursementDetailsTextual" roleURI="http://www.zynexmed.com/role/DeferredInsuranceReimbursementDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CapitalLeasesAndOtherObligationsDetailsTextual" roleURI="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligationsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#ConcentrationsDetailsTextual" roleURI="http://www.zynexmed.com/role/ConcentrationsDetailsTextual" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementOfStockholdersDeficit" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementOfStockholdersDeficit" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatements" roleURI="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatements" />

  <roleRef xlink:type="simple" xlink:href="zyxi-20160930.xsd#BackgroundAndManagementsPlans" roleURI="http://www.zynexmed.com/role/BackgroundAndManagementsPlans" />

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_DocumentAndEntityInformationAbstract" xlink:label="loc_zyxi_DocumentAndEntityInformationAbstract_2" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_3" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_DocumentAndEntityInformationAbstract_2" xlink:to="loc_dei_DocumentInformationTable_3" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_549" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_549" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_550" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_549" xlink:to="loc_us-gaap_ClassOfStockDomain_550" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_4" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_3" xlink:to="loc_dei_DocumentInformationLineItems_4" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_538" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentType_538" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_539" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_AmendmentFlag_539" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_540" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentPeriodEndDate_540" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_541" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalYearFocus_541" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_542" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_542" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_543" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityRegistrantName_543" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_544" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCentralIndexKey_544" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_545" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_CurrentFiscalYearEndDate_545" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_546" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityFilerCategory_546" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_547" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_TradingSymbol_547" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_548" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_548" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/PropertyAndEquipment">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_142" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_143" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_142" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_143" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/EarningLossPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_148" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_149" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_148" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_149" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlans">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_151" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_152" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_151" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_152" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_154" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_155" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_154" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_155" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/LineOfCredit">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_157" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaap_ShortTermDebtTextBlock_158" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_157" xlink:to="loc_us-gaap_ShortTermDebtTextBlock_158" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/DeferredInsuranceReimbursement">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceAbstract" xlink:label="loc_us-gaap_InsuranceAbstract_496" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceDisclosureTextBlock" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock_497" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_496" xlink:to="loc_us-gaap_InsuranceDisclosureTextBlock_497" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesCapitalAbstract" xlink:label="loc_us-gaap_LeasesCapitalAbstract_160" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock_161" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_160" xlink:to="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock_161" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/Concentrations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_164" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_165" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_164" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_165" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_17" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_18" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_17" xlink:to="loc_us-gaap_StatementTable_18" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_19" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_18" xlink:to="loc_us-gaap_StatementClassOfStockAxis_19" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_20" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_19" xlink:to="loc_us-gaap_ClassOfStockDomain_20" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_21" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_18" xlink:to="loc_us-gaap_StatementLineItems_21" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_22" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_AssetsAbstract_22" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_23" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_22" xlink:to="loc_us-gaap_AssetsCurrentAbstract_23" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_24" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_Cash_24" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_25" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_25" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_26" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_InventoryNet_26" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_27" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_27" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_28" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_AssetsCurrent_28" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_29" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_29" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_30" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_30" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_31" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_31" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_32" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23" xlink:to="loc_us-gaap_Assets_32" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_34" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_34" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_35" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_LinesOfCreditCurrent_35" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_36" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_36" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_37" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_AccountsPayableCurrent_37" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_38" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_DeferredRevenueCurrent_38" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_39" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_39" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_40" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_40" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_505" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_505" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_41" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_41" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_42" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_LiabilitiesCurrent_42" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_43" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_43" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StandardProductWarrantyAccrualNoncurrent" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_44" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualNoncurrent_44" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_45" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_34" xlink:to="loc_us-gaap_Liabilities_45" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_21" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_47" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_PreferredStockValue_47" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_48" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_CommonStockValue_48" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_49" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_49" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_50" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_51" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_StockholdersEquity_51" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_52" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_MinorityInterest_52" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_54" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_46" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_54" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/Litigation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_166" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_167" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_166" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_167" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_409" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_521" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_409" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_521" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_422" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_409" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_422" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_423" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_409" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_423" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/PropertyAndEquipmentTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_169" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_170" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_169" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_170" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_178" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_179" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_178" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_179" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_180" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_178" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_180" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_465" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_178" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_465" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/LineOfCreditTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_490" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock" xlink:label="loc_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock_491" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_490" xlink:to="loc_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock_491" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_511" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable" xlink:label="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_511" xlink:to="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_513" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" xlink:to="loc_dei_LegalEntityAxis_513" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_519" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_513" xlink:to="loc_dei_EntityDomain_519" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ZbcMember" xlink:label="loc_zyxi_ZbcMember_520" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_519" xlink:to="loc_zyxi_ZbcMember_520" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsTable_512" xlink:to="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_514" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_514" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_515" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_518" xlink:to="loc_us-gaap_NumberOfOperatingSegments_515" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/BackgroundAndManagementsPlansDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_183" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_184" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_183" xlink:to="loc_us-gaap_StatementTable_184" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_185" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_185" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_186" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_185" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_186" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_188" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_dei_LegalEntityAxis_188" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_189" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_188" xlink:to="loc_dei_EntityDomain_189" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:label="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_194" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_us-gaap_NetIncomeLoss_194" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_196" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_us-gaap_SalesRevenueNet_196" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncreaseDecreaseInWorkingCapital" xlink:label="loc_zyxi_IncreaseDecreaseInWorkingCapital_197" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_zyxi_IncreaseDecreaseInWorkingCapital_197" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts" xlink:label="loc_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts_200" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_191" xlink:to="loc_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts_200" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_56" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_57" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_56" xlink:to="loc_us-gaap_StatementTable_57" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_58" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_57" xlink:to="loc_us-gaap_StatementClassOfStockAxis_58" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_59" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_58" xlink:to="loc_us-gaap_ClassOfStockDomain_59" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_60" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_57" xlink:to="loc_us-gaap_StatementLineItems_60" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_61" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_61" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_62" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_62" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_63" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockSharesIssued_63" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_64" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_64" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_65" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_65" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_66" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_66" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_67" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockSharesIssued_67" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_68" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_60" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_68" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/PropertyAndEquipmentDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_353" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_353" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_356" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_358" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_358" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_RentalInventoryMember" xlink:label="loc_zyxi_RentalInventoryMember_359" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_zyxi_RentalInventoryMember_359" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaap_VehiclesMember_360" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_VehiclesMember_360" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_361" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_361" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_362" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357" xlink:to="loc_us-gaap_EquipmentMember_362" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_363" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" xlink:to="loc_us-gaap_RangeAxis_363" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_364" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_363" xlink:to="loc_us-gaap_RangeMember_364" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_366" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_364" xlink:to="loc_us-gaap_MaximumMember_366" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_365" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_364" xlink:to="loc_us-gaap_MinimumMember_365" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_368" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_368" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_369" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_369" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_371" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_371" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_376" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_367" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_376" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/EarningLossPerShareDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_328" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_329" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_328" xlink:to="loc_us-gaap_StatementTable_329" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_330" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_329" xlink:to="loc_us-gaap_StatementClassOfStockAxis_330" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_331" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_330" xlink:to="loc_us-gaap_ClassOfStockDomain_331" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_332" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_329" xlink:to="loc_us-gaap_StatementLineItems_332" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_333" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_332" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_333" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_344" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_345" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_344" xlink:to="loc_us-gaap_StatementTable_345" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_346" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_345" xlink:to="loc_us-gaap_StatementClassOfStockAxis_346" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_347" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_346" xlink:to="loc_us-gaap_ClassOfStockDomain_347" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_348" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_345" xlink:to="loc_us-gaap_StatementLineItems_348" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_348" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_350" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_350" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_351" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_351" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_352" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_352" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_354" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_349" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_354" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails1">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_388" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_389" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_388" xlink:to="loc_us-gaap_StatementTable_389" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_390" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_389" xlink:to="loc_us-gaap_StatementClassOfStockAxis_390" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_391" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_390" xlink:to="loc_us-gaap_ClassOfStockDomain_391" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_392" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_389" xlink:to="loc_us-gaap_StatementLineItems_392" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_392" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_394" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_394" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_395" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_395" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/presentationGuidance" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_396" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_396" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_397" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_397" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_398" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_398" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_399" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_399" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_400" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_400" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_402" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_402" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_404" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_404" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_407" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_407" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_410" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_410" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_412" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_412" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_426" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_426" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_429" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_429" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_430" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_393" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_430" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetails2">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CompensationRelatedCostsAbstract" xlink:label="loc_us-gaap_CompensationRelatedCostsAbstract_370" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_372" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationRelatedCostsAbstract_370" xlink:to="loc_us-gaap_StatementTable_372" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_373" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_372" xlink:to="loc_us-gaap_StatementClassOfStockAxis_373" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_374" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_373" xlink:to="loc_us-gaap_ClassOfStockDomain_374" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_375" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_372" xlink:to="loc_us-gaap_StatementLineItems_375" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_375" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_379" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_379" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_380" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_380" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_381" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_381" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_382" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_382" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_383" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_383" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_384" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_384" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_385" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_385" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_386" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_386" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_387" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_387" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_435" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_378" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_435" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/StockbasedCompensationPlansDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_290" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_290" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_292" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_PlanNameAxis_292" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_293" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_292" xlink:to="loc_us-gaap_PlanNameDomain_293" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_TwoThousandAndFiveStockOptionPlanMember" xlink:label="loc_zyxi_TwoThousandAndFiveStockOptionPlanMember_294" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_293" xlink:to="loc_zyxi_TwoThousandAndFiveStockOptionPlanMember_294" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_295" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_295" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_296" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_295" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_296" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_299" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_RangeAxis_299" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_300" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_299" xlink:to="loc_us-gaap_RangeMember_300" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_291" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_304" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_304" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_305" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_305" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_306" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_306" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_307" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_307" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_308" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_308" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_310" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_310" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_456" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_303" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_456" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/IncomeTaxesDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_277" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncomeTaxesTable" xlink:label="loc_zyxi_IncomeTaxesTable_278" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_277" xlink:to="loc_zyxi_IncomeTaxesTable_278" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_279" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_IncomeTaxesTable_278" xlink:to="loc_us-gaap_RangeAxis_279" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_280" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_279" xlink:to="loc_us-gaap_RangeMember_280" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_283" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_IncomeTaxesTable_278" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_283" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_284" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_283" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_284" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_IncomeTaxesLineItems" xlink:label="loc_zyxi_IncomeTaxesLineItems_287" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_IncomeTaxesTable_278" xlink:to="loc_zyxi_IncomeTaxesLineItems_287" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_288" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_IncomeTaxesLineItems_287" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_288" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_289" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_IncomeTaxesLineItems_287" xlink:to="loc_us-gaap_IncomeTaxesPaid_289" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/LineOfCreditDetails">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_476" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_477" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_476" xlink:to="loc_us-gaap_StatementTable_477" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_478" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_477" xlink:to="loc_us-gaap_StatementClassOfStockAxis_478" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_479" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_478" xlink:to="loc_us-gaap_ClassOfStockDomain_479" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_480" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_477" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_480" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_483" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_480" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_483" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_484" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_483" xlink:to="loc_us-gaap_WarrantMember_484" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_482" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_477" xlink:to="loc_us-gaap_StatementLineItems_482" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_481" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_481" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_485" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_485" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_486" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_486" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_487" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_482" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_487" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_70" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_71" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_70" xlink:to="loc_us-gaap_StatementTable_71" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_72" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_71" xlink:to="loc_us-gaap_StatementClassOfStockAxis_72" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_73" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_72" xlink:to="loc_us-gaap_ClassOfStockDomain_73" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_74" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_71" xlink:to="loc_us-gaap_StatementLineItems_74" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetAbstract" xlink:label="loc_us-gaap_SalesRevenueNetAbstract_75" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_SalesRevenueNetAbstract_75" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue_76" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_75" xlink:to="loc_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue_76" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_77" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_75" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_77" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaap_SalesRevenueNet_111" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_75" xlink:to="loc_us-gaap_SalesRevenueNet_111" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_79" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_OperatingExpensesAbstract_79" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_80" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_79" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_80" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_81" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_79" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_81" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_82" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_79" xlink:to="loc_us-gaap_OperatingIncomeLoss_82" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_84" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" xlink:to="loc_us-gaap_InterestExpense_84" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_86" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_83" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_86" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_87" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_110" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_110" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_88" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_ProfitLoss_88" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_89" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_90" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_NetIncomeLoss_90" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_92" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" xlink:to="loc_us-gaap_EarningsPerShareBasic_92" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_93" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91" xlink:to="loc_us-gaap_EarningsPerShareDiluted_93" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_74" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_94" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/LineOfCreditDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_238" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_239" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_238" xlink:to="loc_us-gaap_StatementTable_239" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_240" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_StatementClassOfStockAxis_240" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_241" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_240" xlink:to="loc_us-gaap_ClassOfStockDomain_241" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_242" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_CreditFacilityAxis_242" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_252" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_242" xlink:to="loc_us-gaap_CreditFacilityDomain_252" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_253" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_252" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_253" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_251" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_251" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_271" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_251" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_271" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_270" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_RangeAxis_270" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_275" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_270" xlink:to="loc_us-gaap_RangeMember_275" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_276" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_275" xlink:to="loc_us-gaap_MaximumMember_276" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_274" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_239" xlink:to="loc_us-gaap_StatementLineItems_274" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityAbstract" xlink:label="loc_us-gaap_LineOfCreditFacilityAbstract_243" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_274" xlink:to="loc_us-gaap_LineOfCreditFacilityAbstract_243" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_244" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LinesOfCreditCurrent_244" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_245" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_245" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_247" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_247" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_248" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_248" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate" xlink:label="loc_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate_249" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate_249" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_250" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_250" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_266" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_266" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPayment" xlink:label="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_267" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_LineOfCreditFacilityPeriodicPayment_267" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended" xlink:label="loc_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended_268" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended_268" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate" xlink:label="loc_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate_269" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate_269" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost" xlink:label="loc_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost_493" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost_493" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_554" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAbstract_243" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_554" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/DeferredInsuranceReimbursementDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InsuranceAbstract" xlink:label="loc_us-gaap_InsuranceAbstract_498" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_499" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_498" xlink:to="loc_us-gaap_StatementTable_499" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_500" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_499" xlink:to="loc_dei_LegalEntityAxis_500" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_501" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_500" xlink:to="loc_dei_EntityDomain_501" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_502" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_499" xlink:to="loc_us-gaap_StatementLineItems_502" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_503" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_502" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_503" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_504" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_502" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_504" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CapitalLeasesAndOtherObligationsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeasesCapitalAbstract" xlink:label="loc_us-gaap_LeasesCapitalAbstract_215" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_216" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesCapitalAbstract_215" xlink:to="loc_us-gaap_StatementTable_216" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_217" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_StatementClassOfStockAxis_217" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_218" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_217" xlink:to="loc_us-gaap_ClassOfStockDomain_218" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_219" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaap_EquipmentMember_229" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_228" xlink:to="loc_us-gaap_EquipmentMember_229" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_227" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_RangeAxis_227" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_231" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_227" xlink:to="loc_us-gaap_RangeMember_231" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_232" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_231" xlink:to="loc_us-gaap_MaximumMember_232" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_233" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_231" xlink:to="loc_us-gaap_MinimumMember_233" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaap_LeaseArrangementTypeAxis_230" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_LeaseArrangementTypeAxis_230" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaap_LeaseArrangementTypeDomain_235" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseArrangementTypeAxis_230" xlink:to="loc_us-gaap_LeaseArrangementTypeDomain_235" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember" xlink:label="loc_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember_236" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseArrangementTypeDomain_235" xlink:to="loc_zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember_236" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_234" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_216" xlink:to="loc_us-gaap_DebtInstrumentLineItems_234" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasedAssetsGross" xlink:label="loc_us-gaap_CapitalLeasedAssetsGross_220" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_CapitalLeasedAssetsGross_220" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation" xlink:label="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_221" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_221" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_ImputedInterestRateOnCapitalLease" xlink:label="loc_zyxi_ImputedInterestRateOnCapitalLease_222" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_zyxi_ImputedInterestRateOnCapitalLease_222" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_FixedRentalPaymentsForEachMonth" xlink:label="loc_zyxi_FixedRentalPaymentsForEachMonth_225" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_zyxi_FixedRentalPaymentsForEachMonth_225" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="loc_us-gaap_LeaseExpirationDate1_226" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_234" xlink:to="loc_us-gaap_LeaseExpirationDate1_226" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/ConcentrationsDetailsTextual">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_203" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_204" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_203" xlink:to="loc_us-gaap_StatementTable_204" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_205" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_StatementClassOfStockAxis_205" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_206" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_205" xlink:to="loc_us-gaap_ClassOfStockDomain_206" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_207" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsProductLineMember" xlink:label="loc_us-gaap_CostOfGoodsProductLineMember_211" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" xlink:to="loc_us-gaap_CostOfGoodsProductLineMember_211" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaap_AccountsReceivableMember_212" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_210" xlink:to="loc_us-gaap_AccountsReceivableMember_212" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_209" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_209" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_255" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_209" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_255" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CreditConcentrationRiskMember" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_264" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_255" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_264" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_265" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_255" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_265" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_254" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_204" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_254" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_208" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_254" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_208" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementOfStockholdersDeficit">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_98" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_99" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_98" xlink:to="loc_us-gaap_StatementTable_99" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_100" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_99" xlink:to="loc_us-gaap_StatementClassOfStockAxis_100" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_101" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_100" xlink:to="loc_us-gaap_ClassOfStockDomain_101" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_102" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_CommonStockMember_102" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_103" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_103" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_104" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_RetainedEarningsMember_104" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_105" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_101" xlink:to="loc_us-gaap_NoncontrollingInterestMember_105" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_106" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_99" xlink:to="loc_us-gaap_StatementLineItems_106" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_107" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_107" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_108" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_SharesOutstanding_108" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_109" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_109" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_114" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_114" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_115" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_ProfitLoss_115" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_112" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_112" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_113" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_106" xlink:to="loc_us-gaap_SharesOutstanding_113" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_117" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_118" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_117" xlink:to="loc_us-gaap_StatementTable_118" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_119" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_118" xlink:to="loc_us-gaap_StatementClassOfStockAxis_119" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_120" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_119" xlink:to="loc_us-gaap_ClassOfStockDomain_120" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_121" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_118" xlink:to="loc_us-gaap_StatementLineItems_121" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_122" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_122" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_123" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_122" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_123" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_126" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_126" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_127" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_124" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_127" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_129" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_129" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_130" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_130" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_131" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_128" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_131" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_132" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_132" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_133" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_Cash_133" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_134" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_Cash_134" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_121" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_136" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" xlink:to="loc_us-gaap_InterestPaid_136" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaap_IncomeTaxesPaid_137" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_135" xlink:to="loc_us-gaap_IncomeTaxesPaid_137" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatements">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_139" />

    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_140" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_139" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_140" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>

  <presentationLink xlink:type="extended" xlink:role="http://www.zynexmed.com/role/BackgroundAndManagementsPlans">
    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_BackGroundAndManagementsPlansAbstract" xlink:label="loc_zyxi_BackGroundAndManagementsPlansAbstract_507" />

    <loc xlink:type="locator" xlink:href="zyxi-20160930.xsd#zyxi_BackGroundAndManagementPlansTextBlock" xlink:label="loc_zyxi_BackGroundAndManagementPlansTextBlock_508" />

    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_zyxi_BackGroundAndManagementsPlansAbstract_507" xlink:to="loc_zyxi_BackGroundAndManagementPlansTextBlock_508" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
</linkbase>

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ." K8# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!7M3DSG_IH?Z58JM:?\MO\ KH:LT %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% %6R.?/_ZZM5JJUG_RW_ZZM_.K- !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %(:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K6G_+;_ *Z-_.K-
M5[3[LO\ UU;^=6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"M9'*2_]=6_G5FJMC_JI#_TU?\ F:M4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 444&@ HI%8,H*D$'H12T %%-
M=TC4L[!5'<G H#HV[# [3@X/0T .HI 00"#D&EH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX<T<:-!I$FFVT^GP8\NWGB$B+C.#AL\\FD3PUH4<,<*:+IR11G*(MJ@"G(/
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MAD8;OO@ $X(R&!P,5)<^*O$,>O:GI*ZIH,<]M/%;P+-I\_[YY$1ER5E(4;I
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M-;6DD@:.$D,"1QN/#,!ECC-6;?0H;:;5IH[B?=J;^9(3M^0[ @VX'H!USTH
MY;P_XIUCQ+-:6$$UK;7:Z9;W]W<-;LRDS E$1-XQCNV>?;M2M_B3?%H[FZLH
MOL=I<7=OJ8@5G9?)>)!*G?;F4$KU SZ5TUIX)M;#[))IVHWMI<V]G'8F>,HQ
MFBC^Z'5E*Y'." #R:DTSP?8:3-"UH\GE+',DL<H#><TK*SNY(R22HZ8'M0!@
MWWC/4[&&*Z>6R&GRWLR?VA]EE>*&( &/>%;@MN.7)  %=OI<MS<Z/:37@A%S
M)"K2>0VY-Q'.TGJ/2N=@\$QZ?;-;:9J=Q;6S^:K6[*LL15VW$;6';D#VX.<"
MKNAZ+>Z/=+:)>^9HUO9PV]M ZC>'4$,Q8 =1CVH Y<^/]7ANM39K&VN;>QUA
M[$QP@B5HTA:5F7+8+ +T[X([U:N?B _VH)IT%O?QWLMO#IKAF0.9%=F+L<X
M"=AGFM.R\%-9Z@US_:CR(^IR:D8FA7[[HR%<_P!W:WY\TP_#W3X0YT^XFLF6
M]6^M_* (MY NTA001L()RO\ M'% &GIEQKQU.>WU2VLS;K$'CN;5FP6+'*%6
MYX&.:TM1U&UTFS-U=R;(0RKG!))8@  #DDD@ #UJC!I^LJJF?6HWD\Q"^RS5
M4*#JH!)()_O9..PJM)I>K:GX:CLKW48XM0#HTEQ A"MMDW;=H8'!4 '!'4T
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MOH+A[611;3&5'B89 !!&>">1D=Q0!UW_  C/@.TMKEMMC#%;S)Y\GVUE\F1
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M0F+(DVJ>.< \] V>>!6O;^$X(;^2[:[N9"]^^H,DFPJ9&B\H#[O0+T[U5NO
MUM=#44^W7<<-_>17DL*>7M#1[<+ROW3L7([X]S0!C0:SXN'A,:_-+"8$G$S0
MFTVS/99&7(W?*^W+X]#BNH\/7]]JLEY?RC;IDK+_ &>KQ[9&0#F1O9CRHZX
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MEJ?,+)=EGB4HS(TJ[,*IP.03C<._% '745YR/B?=/X03Q+'X:E:Q,3RNQN@
MH67R@ =O+$Y...!6W/XS.F>%=0US6=-DL1:,%2(2;_/RBLI1L#()?;TX(.>A
MH ZNBL#7/$Z:*-)9+*6\CU.X6VA>%U #L,KG<1P0&.?;WI=>\3P:'?:=8FVE
MN;S4#)Y$2.B9V*"W+D#/( '4YH WJ*HZ1J!U72X+TVL]J9028)P Z$$C!Q]*
MO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>Q_X](_I5BJU@<V
M<1'3:*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &5XDTVXUGP
MUJ6F6LT<,MW;O ))%W*H88/ ]B:XW2/AS?Z$)$L+ZTC@O-*%E?6XB*K),J%5
MF7'0G.3D<Y;UX]'HH \[TCX=W%GH)T2=[".UGM&M[Z6W1O,NB PC8YX7;NSQ
MR2HYQQ6QHNE^)M,TBSTB632VM;*V,"SH\GF7 5-L>5VXCQQDY?..@KK** /-
MH_ NN1_!P^#A+IWV_)7S3*_E;3,9,YV9SSC&/?-;OB'0=2\22V=G.PM-.2W=
MYC;3@L9RNS9\T9RFUGYP#ST&.>LHH \KB\,^,H?#_A/3[BWL[EM&U#SY2ESC
M?'&,1@$@=F8?\!'K5W7]!UWQ4CKK?A^SEM\.+6**]"S6K;4PXDV\Y(;CZ<&O
M1Z* ,OPWI]YI7AO3["_NC=7<$"I+-DG<P'J>3Z9-:E%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!4TTYTZ ^J#^56ZJ:8,:;;>\:_RJW0 444
M4 %%%% !1110 4444 %%%% !1110 5S/C;Q8/".EP7WV<W :X194&<I$2 [^
MV,J,GC+ =ZZ:N7\0>#8?$E[=2:A<;X'LC:V\0# 0LQ)=SA@'R0AP>A04 =.I
M#*"""#R".]+7-Z'H6MZ5_9D%QX@^V6=G;- \9M0C3'(V,S9)RJC'OU/6NDH
M;(Q2-F52Q )"CO[5QH\7ZXEQJ$<WA^S_ .)=%'-=B+4RS1JZ,W0Q*"0%YY[C
M&:[2N7_X1N\;4_%$[7$'DZQ;I%$ I#1E8RGS>O7M0!<TWQ9I&H:-'J)O[2(>
M5&\R>>#Y+,F[:3ZXS]<&M%]4T^/3TU"2^MDLG"E;AI5$9#=,,3CG(Q7!S_#O
M49;B&X6_L]UO'9(D3(^R3R89(VW$$'DRD@CICI5OQ/I\FF>%?#MC!;VYD@U:
MRVQ0(RQ#$FX_WB%&#D\^OM0!U8U[1R;<#5K'-R<0#[0G[T[@OR\_-\Q X[G%
M1/XGT*.^BL6UBR-U++Y*0K.I;?\ -P0#QRK#GN,=>*Y#_A"]>MLFT?2B9KD7
MLJNSJ(Y?M:W&Q2$RR84+SCUQS@30^"M2MY="NH5T];FRU2XN[D>:^'CE9_NM
MLR6 ?H0!G/- '5V6N6L]C:SW4UM:O<NT<<;7*/N8,1A6!PQXZ#..E7XKF"9Y
M$BFCD>,X=48$J<D<^G(/Y&O,K/X<:M:1V4,JZ9>P)"8Y8Y;J>-8V^TRS*ZA
M Y D'!QRO!YKJ=!T'4-/_M:)Y%M[:Y4"W5)3*T+DR%V5B P0EE95).#NZ9H
MWQJ-D=^+RW.Q]C_O5^5NF#SP>.E-35;"2ZAMH[VW>>9&DC19 2ZJ<$CUP?\
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MVB8,N[Y<$9 X '2J6J>!-(U._P!0O\S6]W?0Q1220D##1N)$DQCE@RKUR"%
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M-W^L1F.\D.1U4# ( -74\$ZBNH6,YUZ,P6LD,OV9;$(FZ/?G:%<! ?,/ !/
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M,.MZH]W)=R1I-9_8KB%5!$D6_>0#V)Z9]#1H6CR)K^KZY=6LEK-=N(XX&E#
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M(CVT\2S0DICY6&0<'ID&@#S@_$;5H[^&4)93V<MY;P^3&AWA9+43'#[L9W'
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M)MI8W,,!3!V-)D,X8G;V&#V-1V?C[7Y=-M;J?3[+&IO MD8W0E"Z.[;U,O(
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M&\QV"ASE@H)(4$\X  II\'Z$;/4+4V/[K4)1-<_OI-SN&#+AMVY0",@*0!V
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M.]2H(;/7([T[8N -HP.G'2@#D_#?BJ>^U66PU"[TZ4-;6\]M/:@QK(T@<M&
MSL21LSQVZBLCQ)KFIMXRT>T>RU"WL8=5CC22.$E;G,;$G</X1D#'LQ)XQ7<I
MI>G1;?*LK:/;(95V1*,.1@L..N._6I;A;=(O/N A6',F]P#LP#D^W!- '&>*
M?%E[X>UN]\M%EMK71FO!#M^])YH0$D<[0.OMFMC1]8N[^76+.\\B1[)D42VZ
M,B2*\0<=2<'GU]*O61T?7[.#5K9;>ZBGA98I]@.Z-OO#D9P<<BK-MIUA96S6
MUM:P0P-DM'&@53GKD#B@#S'07O=,\,:+KHM4W2VT"?:I=0EEWO++'&F^,@#
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MUYQR =515#2I-2DCN?[3AAC=;F18#%T>$'Y&(R<$CW]^,XJ_0 4444 %%%%
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M HHHH **** "BBB@ JG=Z1INH7$%Q>:?:7,UN<PR30J[1GK\I(R.@Z>E7**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 5=._Y!UMGKY*?RJU5
M:PXL;?\ ZY+_ "JQF@!:*3-&: %HI,FC)H 6BDR:,F@!:*3-&: %HIN3GI02
M?3- #J*3)I 3W&* '5Y/:^.]<?QD=-%W:RP_V])I_ERP[%\E1ECO_OCH!W..
M*]7S7$CX9:2=0>ZEN[Z17U0ZJ8BR!?/)/<+G:,],T =N**H:582Z;:O%+J%U
M?,\K2>9<E2P!/W1@ 8':KI8C^'- "22+%&\DC!40%F8] !U-<UHGC&&]T._U
M'5(O[/\ L<Y22-@2P1@K1' R261TX R6) ':M36]/DU?3'L5G:W24@2XC#^9
M'_$A![,.#[$USM[\.[*6ZNI--E72;>XC@#VUK;HL9EAE\Q)"!C)[$=Q0 RV^
M(MK+8:M-,C1SP7EQ;6<(M9B\HBC1]SQA2ZXW@-D#'M4FD>/K::PCN-3>")WA
ML6,-NDCLCW*Y4'*XQZ8)Z'/.,PCX>21W=Q?6^L>7>W,MS),YMMR$3K&KA5W9
M&/+!!R>O.:=%\/3%% JZKEK=-.6(FWX!M,E<C=R&+'/IZT ;,/BFQ@AG?4M0
ML8RMY/;Q"%F)(C;G((SN4?>QE1ZU./%F@->Q6:ZM:M<RF,1QJ^2V\93'U!R*
MQ)?!M_%?G4;+5($O!<W3IYUIYD?E3E2RE=X)9=@(((!Z$56L_ ,NGR$6MY&(
MA-8.N^ [MEL.A(8#)//3 Y&#V -/5_'6G6>ES7FG2PZ@\%U#;S1K)M*[Y F[
MH<CK@C@X//%6->\2S:1KFE:7#9PS2:BD[+)-<^2J>4%)!^5NNZN4A^'.K 2O
M=:Q#<S3&V,CM;-SY,QD'5SG(.#^G2M_Q-H&HZKK^D:G9I8R+8).A@O58J_F!
M1GC/3:.U &K8^(K*>P6XO;FRM)?(-R\?VQ'"P[B!+N&/D.,[O?'6K+ZYI4;W
M"2:G9HUL,SAIU'E#./FYXYXY[U@'PK->KH\M^\$$UB\@DALHML+P%@RP@'L"
MD6?7:1QFN?D^&MW_ &#J&G(VGO*\$MO:W<D<GF[9)O,._G (!(R 2>.0!R =
MPOBC1)+BR@AU2UG>]E>& PR"16=%W,NY<@$#U]1ZUH6U[:W@<VUS#/L(#>4X
M;:2,\XZ<'-<4/".I)K\>I+]C*#5)[QH?F4;)+80XR!R01GWSU%6O#?AG4=-\
M/ZCI%[.J6]PGE6T<,S3?9D,84@.X5B <[0<X  S0!K:EXLTG3]&GU..\@NXH
M72,B"96^=V"J"<X')[]LU#J?BA]+@TDS:7.]SJ4WD1P12QG:^TL,L2 00#S7
M*2>!=:N[=99?L<%S!;V-JL:3,4F6WEWF1CLX8C  YQSDUT7BVQUFZO="O=)L
M8+HV%VT\D4MQY.X&-D&#M/\ >)_#\@#3T[Q)8WT5R92UC-:2"*YAN\(T3$9&
M3G!!'(()!H7Q##+XE?1+>"2:6*-7N)590L(8$KD$[CG Z _>%<=JO@_6;VYD
MU6>UANKNYN"UQ8P7\MO&(Q$8T"RJ%8GN<@ AB,<<R_\ ")ZK:B_$5E:3HTFF
M^4C29RD 3S,%\G.5&-V<XR: /0$GBD&4E1AM#Y5@?E/0_3@\U1T_6K347F2,
MM&\5U):[9< N\?WBHSR*\[M_"'B&TTN.T_LRWES:"WP+H;8V2[,RMDCGY2,8
M'4=JV;3P[JL7BBPU26R1HXK^_9E$BG;',4V2?DAX'/- '60ZS;3ZY=Z2HD%S
M:Q1RN67"D/NQ@]S\IK1KA-9\-7EYXNDU6/3%E9;BP,-QYJJRI&SF7'.1PV/4
MUB:;X(UG[-J5M-916(ET^W,1CF#!KR)V<-G);'(!).2._H >K45YE?\ A#4'
MO;<R:?>77F)%.T]I=10^1=&9Y9F)?+!3F,#8#PN/2MKQ;H5UJNJK(UC->V8T
MZ:*-(IPABN"5*O@LO. 0&&2/;K0!V=%>:_V/XC6#44:RO6UV."3[)JB7B^2^
M8 JC&X'=N!P"N ?FSS5>YTG4"FG7-AH.L6]JKW*7EH]POF.7MC&&4"0@+N Y
MW#GGWH ]2HKQQ?#'B8Z%=SSMK2:G;6%BEF(+Z1?FQB8 *W)ZYS6LNCZS8>(M
M0@LVUX?9D)TQQ.9+:5/).%D+M@D2,W7GIC@< 'HD>H6LFHS:>DZF[AC262+N
MJL2%/YJ:LUY_X*T^>'Q5J%[]EU:.WDTVUB\S4BY=I5+[@"Y)].G&3QUKGTN?
M%T\+6R6_B"V@E:W?=(':5";AO-&_ X$9'  ' Q[@'K-Y>VVGVDEW>7$=O;Q#
M+RR,%51[DTJ74#W#6ZS1M,J+(8PPW!&) ;'H2IY]C7B]Z/$-SX8O-/U)/$$@
M-E<PV4<4,KF:;SY %E(4DCRPF-QQ@GO71JNIK=QZG)'?6>G:G?2BZ:")Q-%;
MQ1E+=2 -R@LI8\=6P>O(!Z717 ^#[GQ)>Z[C6KB]1(+"&3RGA6-9'<N#N^7[
MVT(2!C!SQVK#\1>,?$5G?ZLNFR7>Q%O%3S+/(B>+R]A7*X.<N>2V00>.  #U
MJBO-[35-;/C.UL+C6;ORH6B,<3V6XWL3Q LY9$"@!R1G(QLZ$GFUK7BZ>Q\<
M6^EI?"*/[7:0O#)""'25)2Q4C+'YA&-W !..><@'?4Q94D+A'5BAVL <[3C.
M#Z'!'YUXXGB[Q#=^%]][J;HT]C;7KS1Q+&]OB\$<F,#&W8"3D'OVXK8E\7BR
MOM1MWU6VT^TDU2:,ZB+=#MVV\3H&XP2QW_,>2$('., 'I@=69E# LO4 \BG5
MY;>^+=1L-6O(;>XTX3/>Z9;273V?EG9-$2SN"P/8D*QRHR*D'Q OH)-/BN[R
MP1Y;B)>8]HN('NC$)4);H44L ,XQDG!% 'IU%>4KXVUV.*&RMKW3I[U_M$IF
MO9$B3Y;G9Y?!'1 >F3R.PY+7Q,=9\::!J%]=6D"0W&HQK;$;'MTC0J2[%NX7
M)X&* /5J*YKQ'=Q,WAR:,6TZ3:I$(W9B>&CD(9"I )QZY&">.A''VGQ'UO["
MES<#39Q=P)+;O#!)''$&NA!N?<Q)7!W?P\X'O0!ZK17E>L:WJ^GZI;:JUW87
M=U8:5J$L@MY&$,XCD15RH8X;D$C/'//%:[>.+Z;Q NB6T=F+F>_%O%*P9D2/
M[.LS,P##+?-M R,X/I0!WM%>)>%O%6H:=HMG-%%]LO$T)9]UQ<R$.6O'CP5S
MC/OC/;.*ZUO'FJPZ?/OTRWFO;?4+FRE\IG\K=%$95"X4L2PP.G7- 'H%%<7X
MQN]0?X?1SOY]CJ$TMHICM+EHW#/-&&17^4YP6'./TK,T'Q-J5M'<Z0D$DVJ'
M57M+:WU&[W&&,0>;^\F56W<*^.IY )X)H ]'HKA)/']\-/:\A\/F1+>P:]O
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M4'% &G13 Q/\)_&EW'^[F@!U%-+$?PD_2DWG^Z1^% #Z*9O/]QORI0Q_NXH
M=129-)N/]W- #J*9O/\ <:C>?[C?E0 ^BFAB3]TCZT4 168Q:0C_ *9K_*IZ
MAM?^/6'_ *YK_*IJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*K*(D9$(8-G.UV'OGGFKMYH6F:QI%O8.9'M()$>,Q3MD-&?ERV<D@CN>HYH
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MABS$E0';Y<XSSBM:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/)]J .LNO UC>"X2:\NS%/>37;J"HYEC\LJ#C( ZC^M2?\(I)(;9[G6+J>:
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MSK>G?:# MQOD69H&$:,P614+E20, A1W^G4XJW;W,-W;QW%O*DL,JATD0Y#
M]"#0!+15'5=8T_1+076I74=M"6V!GSRV"<#'L"?P-27NHVFG64E[>7$<-M&N
M]Y7/ 'K^HH M449JEJ>L:=HMLMSJ=[!:0L^Q9)W"@M@G&3WP#^5 %VBJ>FZM
MI^L6S7&FWL%W"KE#)#(' 8=1D=^1^=6)KB&W56FECC#N$4NP&6)P ,]R> *
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M&7;&EO&[;65.A+KC(ZMS753>#]"N !+8!E"3(%\Q@ )7#R=^"6&<]CG%0?\
M"">'M@ M+A7$AE\Y;V<2[B@0GS ^[E0 1G!Q0!G/XJNM8O+)=+MKB"UCU**V
MNWD(5P_E[WB9",@ ,N2#G((QCFM'5O%B:/JUY:SVK-;VMC#<F57&6>65HDC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:#=7FG> M5\47+FXOW@N;O#32-&0C2.B[2<+C.WY>P% '>T5Y[:^)]4M=?\
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M)%R8(T(EZ] 2<8[XK/\ ^$6\36U]"(-&B%O%*DB/%=*OEJ+Z29E )Z>7L
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MY&23BKMSX9L+KPG'X;=IQ8I!';JRN!(%CV[3G'7Y1VK@=&\1ZE9^&-.BM+V
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M@[L8XR/3WJ_X/\,W/AZ*5;HZ>SF*.!7M865I%C& SEB221V' ]Z -#PWKO\
M;^AKJ;VWV1#)*FQI W$;LA.<#NIJ8^(=$%L+DZQI_P!G+,HE^U)M)4989SC(
M')]*X^U\+>*T\,R^&7?1XK";[4)+I)99)2LK2.,)M4#YG /S= :EM?!%VUWI
MUS/::19F"YFFGBM&D=7WVYB!RX&3G!Q@  =2: .DU;Q)8Z5;6T@DCN9+F2%(
M(8IDWRB1PBLH)&1EASZ5?.HV.)LWEOB$XE_>K\ASC#<\<\<UP<'@O7;**SMH
M4TR=1'IIEN)975HGM2FY4 0[@VSC)7J<TO\ PA>H?V7J,$FEZ7)/))"B2&X=
MS<Q+<"0[PPPG&3@9Y)_$ [B35-,CV>;?VB^9&TB;IE&Y%&68<\@#J>U17&JV
MD<END;I-YK+DQRI\BD$ASEAD':<8R3^!(R/$_A&+6+6QCLH[>V:U<QC$8P()
M%:.5% Z91CCMD"L>S\%7]I9:2'>"YO(;V-IYS\NV"*%XH]HQR<$$^[-]* -]
MM<T+6Q]@\^.XM+VV?]ZK@1R*6\ID# YSDXXJ2WM;+P_<V\-M!>327SE&N)9F
ME90H+ ,SMG;U  Z9Z5Y^WP[UH^$8](:VLI;FTT]K:"8R9S)]H#[AE?E)49SU
M!KL/%.@7^KZIX>N+:&,K8RS/,S/@J&A9 !QSR10!LZIK&G:5IKW<\@:-72,+
M&02S.P55 ]R14^GRP76FQ$VCVR,O-M.H#(/1@.*\VM? .HV45C$NEVSQK:Z9
M%<HK+AY(9P\K'/7Y0>3R<UJ3>&M1_MN>5]-+JMU+<F[B9%:> VYC6W'(8?,1
M_L_+GO0!WGD6A99/+BW(,*V!E1['L*HZIHMEJ=BUH<P9((DAP&4A@_&01C(&
M000>]>>IX#NTTN&)=( =?#KP.F]<F^VQJ#G=UPGWL_C5>Z\(Z]:2:FEII5Q-
M;W0C\E%N4'ER"T>-I-I<#)<C)/<!L$XP =W:Z3H^C0M"P:\EDG196>)9'#M@
M+N5% 4 8YP/4UO10V\19HXXT:0Y8@ %CC&3ZG %>>2:+JG]HW-R-(NDDGO=-
MN&D$B9:- @D0X;DJ5)/;GBL_4/#GB65[HV]K=).T6IB[E28 7@DR;<)\_!&5
MQG&T C/- 'IYTZP( -I!CS/,'[L??_O?7WJNNA:(DJ.NEV*R1A0A$"@J%.5Q
MQQ@\BN<\)Z7J.E:SJT3PWB6#OYD!GDW@DQQ%L98G[_F?K7+3>&M>.CP3.=;2
MXN)[O[8T4[/(A#2"!E0N %VGMWV>G !ZA::5I=@5>SLK:WVQ^4#%&%PF2=O'
M;))QZU#-X?T*:WE@DTJQ:*;!D0P+AL$D$\>I)_$^M<!=7-TWC*6Y%QJD@MV,
M,4<#-MEE%MDP'&4#;CNR3U![<U5CT_Q+<7EC9/\ V_;6$FHQ^;()I#(L9M!N
M^?J%\U3SQ@GMD4 >BW=QH6E26D-Q]FMS!%)-;KLP(T1<.RXZ85L<=C38?#/A
MZ-#Y.E62K)(LQVQ 98-O!_[ZY^M>:7EEXE/^EI!K3:G%8ZFKEED9(YF \H1Y
MR""N -O7'K71%=?3QA#=.VH?8DNX(S&V1!Y1M7,C,,8_U@7YCT- '82Z%I<^
ME7>F_9$6UNMYEC3*[F;EF^N3G/KS4UKIXB:*XG;SKU(?),YR-PR">.@R0#^%
M<;\/=3N-2NKN6YU>>[=XHV$$J,F""P:1591A6^7 !..G6O0* *&D:7'I-H\2
M$/)+,]Q/)MV^9([%F./QP!S@ #M5^BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \E
M\0Z1K^H6/B6RBL;VYBGF62!Y=P<8NT.Q?G*LFQ2RD $* #S6E'9ZY8S7-L&U
M&"Q$VHE)C,S+'&8U\IBQ;)^;<03SGTKL-!U:YU1]46XMXH?L=\]JGER%MX4
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M=:U/JMM>6<=K/I]U]G81R%PV8U<'E1CA\?A4TGA+0Y7N';3+8O<*RRG9@,&
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M&*X=N!C 0' SAB35;5/ %_>Z(EC%>(+J>SNQ>7A<@O<3>6<@ ?<RA&.RX H
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M(8#KN('(X%5;'P3>6MQ?SRZ*LD+:Z\YM]R$SV17"J,MC <JVTX^[7K.!1@4
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M.4B:1F1?._U@"DX (XQC R?6@#)E\>2VMW%976C,M[.;8PQ1W*N)$F+J&W8
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M7P\MM>&TTV\$OVF_>$%DVQAD'S# +'C!&3T S0!W4FHV45VEI)=P)<ORD+2
M.WT7J:C;5].6Z-JVH6HN <&(S*'SZ8SFO(O!$LFO?%&YN-=CC&I+I=K-);L@
M^64*I& 1E2,D\=,D&F:CX?C\<>._&.E6FH6\,3BU,TX4NX,8Y"<CG=P3VH ]
MIEGB@C:2618XU&6=S@ >I/I3@ZD9##'7K7D>K^(-1E\+>-9;B\M)M/TN::QC
MMIK7/F?<V[B".F67]<TX>/\ 5(M<N;>"[L)K>WU&"RCLUAVNZO"SXW9X.Y=H
M^G.,T >LM+&F-SJ,G R>].W+ZBO'SXN?6K'P]<W>HZ5>I<:G8I);!"LEI,Q<
ML#\W!&U=N>>#1:?$?6%N+E;JXL2D:Z@"&A;_ $?R"!$[[2202VTC'/YF@#U]
MG12H9@"QP,GJ:7->)CQ4_BK5?#;7<MK(+?Q (XGB 'F(80_(!(RI;'!ZXK4^
M*]J+CQ9X0 TE-5<+>.UD7"&<(B-MS@^AP,<GCO0!ZS17COA[Q?JFG>%?#&EZ
M/);:E=75K-.9+IL9*R<P@O(N"NXC))X484BIM2\0:CJWC/1[MDMX;:QUJ\L8
MHPK>8?+BY+-NP02.@ Z#DT >N45X_:_&#43I7V^ZTZU*C17O]D6X$R_:S;J,
MDGY>A/?KS70ZAK/BNV\0:-97)T^&.7[;-*(=Q6:.)!L))Y7[X/U7TXH [^BO
M&=)^)=WI'A"QDCL'N8;.Q2[O)+JZ,DK*]SY053@9;J>>.W;GHM/^(M]>>,(M
M(?3+=;2349K)9EF8O\D8<';C'<9Y[^W(!Z)17F'C:+6[_P <-IFD7VI)(=%>
MYA@M;PPKYXDV*S<@8&1D=_UJW9^/-0T[5]/\/:M8PSWA,-I/=1W:[FN&AWD^
M6JX5=W&21UR!B@#T2BO.H?BA)+HSW_\ 8>'MIDM[RW%U\T$K3F(("4 8X&X]
M,9 [YJ>W^)T1NI(;[2)K58C?+(XF63#6HW2 8Z\$<\<^O6@#OJ*X(?$B46NG
MR/X=O%EO[J.WMT+[5D\R,.K*S  CG![ CJ:@A^)<EU=:7=1Z?LTJXTFXU&?+
M9E3RB00!T/W?QW=L<@'HE%9'ASQ!;>)M*&HVBX@9MJ'S%;/ /\)..N,'!&.1
M5'Q=JMWI2Z1]EEEC%U?"WE\F#SGV^5(_RK@Y.4';IF@#I:*XNU\;6]G;.;U[
MVY$8\^XE>V6!K.$LR*9%+ GYD;[HSCD@5NZ3X@@UFZOH;:UNPEG,\#S2( CN
MC%6"G.3@CN!0!KT5YN?B8\5QI-_=V<D&E7>F27LL:+YLB8D55;(/W<'.,9YK
MJK+QAHVH:X=(M;@R78\T$*A*@QMM<$]CGUZ_ED WJ*P;CQ=IMMJ%Q92K=":&
M.60?N&Q+Y2JSA/[Q =?KGC-,D\9:5&+< 74DERD;0QQ6[.TF^-I  !W"*2?3
MCUH Z&BN3@\<Z1<74EQ'JD$FG?9(YXU2WD\UB[E!R>N2-H0+NS573/B+8-9Z
MA<ZPQM%@O[J")5MY2WE0E07< $J?G7.<8) H [:BL >-/#YU*>P.HJD\#2I*
M9(W1%:-=SKO("DA>< ] ?2GOXOT.*TEN9+QD2%F616@D#H54.V4V[@ I!)Q@
M#F@#<HJE>:M96-K%<SS_ +N9@L7EJ9#(2"0%502W )X'0$]!6&?%IOM?TS3]
M$BM[NWNK?[9+<M(P"P[]GR@*?FS_ 'B.F.M '4T5S6N>+[/2=7TO2XGAN+R[
MOH[62$28>)64MO(Y_P!GC_:%7X/$VAW3,MOJUG*5=(R$F#?,[;%''JW ]Z -
M:BN;U#QKI6FZM96D]U:QVUQ]H5[N6Y2-(GA*JR'=U;<P&!Z'T-:MEK.GZC>7
MMI:74<MQ9.J3HIY0LH8?4$'J..".QH OT5AZOXJT[2'NH7E62[MH4N);=6 8
M1,X3=SV'4_AZBM%=4L'@2=+ZV:%R0L@E4JV.N#G!H MT5#-=06VWSYXHMW3>
MX7/YU7O=4@LX2P*S2D!EA210S@G&1DCCO^% %ZBHQ/$9!&)$+D$A0PR<$ \>
MQ(S]14<MR8[NW@%O,XF#$RHH*1X ^\<Y&<\8!Z4 6**3-4;75[:[UF_TN,2?
M:+%(GEW+A<2!BN#W^Z: +]%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 8HHHH *9+*D,322,%102S$X
M'K3Z@O(FGLYXD(#/&R@GIDC% &6GBW09+=+B/5K)X7?8KK,"&;CC/_ E_P"^
MAZU4O?&>G6>O6VFM<6V"DSW4AF ^S"-0WS?4'\*YZ/X?7L5OHZ>;I]Q]GTN/
M3;I+J$R(0K!@Z#UR.AX/&>E59OAIJ<L%S8-?VGV)EO\ R9-C>;FY(/S]C@CK
MZ4 =\=?TI(6F?4K-(U<1L[3J K%=P&<]2I!QZ<U5'BC2Y[FXM;2\MIKBW> 2
MH90H"RE=K!NAR&XQU/'>N-7P'XAM+Z#5;:YTR2]AG1Q#*K^4R"W6$\X)#?+D
M$=B1WJW<^$=:F>[B!TS[-+=V%TK(6C(,'E!U"[2%&(S@>_:@#LUUG2VEN(A?
MV?F6PW3IYRYB'JPSQ^-6+>[MKN-Y+:>*548HS1N& (Z@GUKSNZ\!ZK<:2NG?
MZ"HMH+J*&<2,&G\U\CS!LXXY/7Y@*Z?2](ETJX\1W+K"D%Y/YT*Q=E$"(<C'
M7*&@#9%_9/')(+RW:./&]A*,+GIGT_'UIWVJUXQ<1'*!Q\XY4]#]*\J\+^$]
M1F\.Z/JUG:VJL;&P@-I*0%E6-R[R/\I^?D <9'/.:N6.@XU#PQHTYB-_I]F8
MM4B12RO;JRO'\Y4?\M$3 ]&:@#TLRP#.Z5 !][+ 8^OI0[0R'8[(Q W88@G'
MK_\ 7KSRX\$WEWK!N9M-M60MJ3R%BK%_-*^3GCD\$_[/UJAIW@C6(+9%NM,B
MFOH+;;#<M?$#)MDC,90??^=,<D#'.2: /3Y)[. B226&/>RQ!F<#<3]U<^I[
M"IDAC5F=456;J0N,UY/IW@/5K"_:4Z;";7=I4@A61#N:!<2G!X!R<YZFNG\6
M:-=W^LVLAT@:KI[VDELT)G6/R9&=2),DCLI&1R.W6@#L&M('21&AC*2'<ZE
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MV_[*IF'!P2^W@X!QDY(%8'ARQO[;Q'IMQ<C6[F!K:ZCCGOAAHR9%8"0!C\N
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M@O;JUU?2XH)IXTECN2ZQ1;]Q6+*]CR#R!W/'-9W@J]U*:\DAO]0O+S?I=C=
MW$ 39(XD\P A1Z(<')'YT :L,/AJZ\627T$]G+KL,1@D\NYS(B#JK(&]^XIM
MWX.T6XU.75DL8EU5G$R7+%CME5=JN5W ''IWKSZUU5["*]DT#?J"K9W%W;>;
M;8N=+=G!DC? ^<$DD=3E#U'-6(/&.HM:V;7'B.Y^P7,MP@U*UTLLWF 1>7%L
M:+/5I#G:,X SP: .QL_"6GQ:,UCJY@N);N_-].T8,*R7!;<"!NS_  CC)S@F
MI8O WA^*>.5;-RR/<R8>9V#-< ++NR><@#K7('7M2M[VX6.[DN;C_A)S;_9Y
MHU8I%Y#LH7(R,[>H/KC'-9T7C+Q-+;VIAU7S6GMK;[4QMH\V5P]RL;1XVC'R
MEN&R1MSWH [NT\ :%9BP5$NY!83BXMQ+=R.$<# ZGH.PZ=?6H8?A_P"'Q;:<
M+1[R);"*2&WDM[QU(5GW$%@><-T_^M5?0=435_!6H-XHN+>6W@NY[6:>X C2
M1$DVJ7 P!V!Z"N<\.K-;W]EIA2WBLYM=GG>2P)6WN66)'01CL@/8'&8SSGB@
M#O\ 2/#5EH>#:37(!DEED#2_++)(5)9E  )&T 8 QD^M6-2T:#4[W3KJ::=&
ML)C/$D; *S[2N6&.>"P_X$:\WM_&TVN:?X@_TVVO8+?3&U&T>*,1O#(DL@08
MR2,;(V&>>1GKBNMU36]2MVT"V\^UT][^*1KBXN4#K&ZQA@@&Y>22?P4]* +V
ML>$[#6KMYYY;B(31+#=1PE0MS&K;E5\J3@$GE2IY()Q5W1M&M]$@N8;>2:07
M%U+=.TK G?(VYL8 XR:X[PTS^)O%PU/58X&FM-*LYH8@AQ%+)YNYT).0.#ZY
MRO/RBJOBSQ->6'B!-;AANVT;1+E+:ZEBDC\IO, $NY<[RREHL84CAN1F@#5N
MOACIUSIZ6C:IJ96+3FTZ(LT9V1%PW]P9(P%^@]>:W-'\._V-=2M#JE[):,TD
MB6<GE^7&\CEW((4,>2< DXR?PQ-7\3:W%J5Q!IHTQH4U"VLD:8.Q/FQJVX[6
M X+#ZBJVE^-]7U66RBBLK)&1HA?,\H52K2R1LT>6!&/+R!ALYV]1D@&Q;^#E
M@\2C66U:]E(FGE6VD"&,>:J@KG;NP-JXY[#WS#'X#M;*UTU=,NY+>[TZXDG@
MN)$$A.]2A5AQD!-JCD8"+Z8KFHOB;JT,9DO+"R?[1:>?:K"77:WVH6^)"<Y'
MS!N .A'?A-,\5:U8WM_9QK;7-U>>(;NU0W,SK%"$@1ACJ0N03CW/3K0!LM\,
MK)/+>VU.ZBGBA@6*9@KE98I3*)#G@Y9CD=/I5:Z^&,US8W5O_P )#*IO)+F2
MZ_T8%&:=E9BJ[OE(V #)/4U7M/B3J\[6D#Z/;?:=2M;>XL5BF9POF>8/WA('
M3RR<#UQDU?;QUJR2112Z+;0R106L]XKWFYD\V8Q%%"J1D$$\MTQD9Z "3_#&
MVN;:>&34I?WUU=7+$1 8,]OY) Y[?>'Y5=U/PCJFJ+87%QJUG-?VSR9:;3PT
M+)(JJP\O=U&W@DGJ>U6;34=2U#PIK-S>-%%+'+>PPO:LRD+$[Q@\]&RF<@_E
MTKE=*\1ZM"V@:9K5U<-=)_IAN(OE6]M/LTC\\\LKA58?0]Z .UU#0I[C^QI[
M>[C6\TN3>C2Q?)+F-HVRJD8R&)&. <<$<53\-^#QH%Y%<_:TF9;-K=AY14[V
MF>9F!W'"DOC;CL.:/#WBZ36=2CL;O3A92W%@FHVH$YD+P,<?/\HV,,KD9/7K
MQ5/X@>+#H=@]E:7L%I?O 9_-F=1LC! ^4'[S,3@#MR3T (!%?>"-1O-7!_M"
MV33/[6_M0@1L)P_E["@8'&.2<]:CC\"ZDMM9*U[9&?3+6WM;-UB8"18KB*7,
MO/4B%!@=,L><C&WK7BA=/N= CLTANH]5N1&)1)\HBV%BX(X/ &/6F:-XPBU>
M]LH38S6\.H027%E,\B$3(A4'@'*G#J0#V^E &+/X-UN6%B\VES3SB_CEW*ZK
M&MRT;;DX8EEV'KC.>HK1TK2-9\-2R06<=K=VMUJ$3R2.["18?)5'9NQ8&-<<
M\Y-83Z_K'_"5ZU#+K&K165IJ$4,7V?3X9((T*JS"5RFX#YO[P('J:W7\>V\2
M(9=)U //';RVL:^63.DSA%(._"X9E!!(QN'44 -\1>$;K6=1U.:.2W,%]9VT
M!68G*M%.9#Q@C!4_F/?C&O? &HR7MP?*L+ZRN+FY<VL]U-"D:2LC X0?-C:<
MKP.1S5RS^('V&[U-=<MKR*V2^:*&X*1^7#_HZR^2Y5L[Q\^3@CWJ_'\0;&72
MY+Z/2M4812%)(A''N4"+S2Q._;C;_M9SQC- &9XWLS?>,?"EC]FAN@T%\/*G
M_P!66\M I.0>1\Q'4\5FR_#.Y_LC5;5K73;J[\NQBL;V5 ) (DC5SG:2OW#C
M!Y&!772>-+47DUO;Z5JMT(EB+2P6X,>9 A49+#G#@\\#G/2HE^(&BM]FVK=D
M3H')$.1$/.\D[SG Q(".X[].: ,#4? 6IW7]I-9K:6EW=SWS"\5L2%)0NQ20
MN<'D'GC''M3\3>&;U-,&IV^C66DPP:?JDEU!;3@JCR6RHIZ*,G9V&!C/<UV4
MOCC188I9I9)DMT^Y<-&1%,?,\O"/T/S\<D<<].:T](U6R\0Z2M[:;GMY2\96
M1-I!5BK*0?<$4 >::5X;OGT"WN]-\/6K6UY:V8>W:9,2E89,S@9V[B60<YSR
M2,BNG\"Z'JVE75U/JD'E,^G6%L"90Y=X4=7/!]2#^-=HJA5"J % P .U+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4C< TM0W4236TL4C%8W0JS!MI (YY[?6@#@?#WBRY
MNO',\%U,S:;JL1DTT/&Z!&B^5E!(P=ZCS!@]/S+[3XF)=P--#HTTD9DBCC$<
MZ;MTDK1*K@XVON0Y7G (KH[CP[IMS:Z84R%TO#V;B4X0JI4$D'YAC(.>H)K!
M\/\ @::VLX+?4[QIK6#RI(8H+J5E\Q"&$@+'*Y.3M&1S0!97QT$6Y>YT34(H
MK9)3<3(N^-'C4%EW X/.5!&<E>G2I6\9LL5N'T34$N[BYDMH[=P$+%8C)D%B
M!M(&,_6K<O@O2)KN[FDBG*W?F&6'[2XBW.I5W"9VAB#UQ^M.B\(Z?&;5S)=R
M2VTKRI++<-(Y9HC%DD_[).,8H RH_B':O'$YTK4@;J&*>TC549YUD5V& K'!
MQ&QP><42_$BPMVA6?2M5B:1+=V$D*HT7G2&)0RE@V=RG/'3!YJV? 6F*EH(;
MB^@:SMXK>W>.?#1*@8+@XZX9AGT8TE[X#T_4-QN+S4F+);JS-<98^3(TB<D$
MY+,23GTZ4 :GA[5WUO3YKM[-[94NIH%5V5MXC<IN&.Q*G_\ 5@FM<>+]-M-3
MEL)8;I9(RPW"+(;;$93MYR?E!YQC/%,M_#,UC>6C66IW26L5S<7$L#L&$GFY
M)7IPH9B1W%5Y? MH^LSZI#?ZA;W,\YN&,<B$"0Q&+(W*3PIX&<9[4 :.F>);
M#5-!?68$F%FL9DR5!+*%W' 4G/'&.N015)?'.EM"\A@NAML9;_ 5&+0H1DC:
MQ!SN&.?7TJUI_AF'3+"_MK:>59+Z1IIIE"*1(R*I90!M'W0<8QDFL>/X<6=O
M:F"TO[FU62*XAE%O'$@:.8J64+L(0?(,;0.I]: -&X\;Z+;_ &TL\KI8QF6Y
M>--WE#:KC(!SR&&,#UID_CS0[2.4W+7-O)&V##+ R2'Y=^0IZC'^'6L?Q+X
M^V:?>W%M)-<ZDUE):19$:%T=53:S!1D  D9Z$_05?/@N9[P:HFJ21ZH7.9C!
M&5\HJ%\HIC&, <]<\].* +:>.M"DN;>!99R+B2*-)# WE[I(Q(@+8P"5(ZUD
MP?$2S;Q//:R%8])%A%=0W#QL'D:20J !Z$#(XZ5;N? -O=2*TM[,P%[;W9RJ
MY/E1"/;QV(7M6=!\,I(+I+H:W(;F&VAMH'-LA")$Q*Y7^+@X/KUH U+_ ,<V
M#:;;7.C.MZT[VQ4F-P@CFF$09CCY3][ ./NUH:AKUOI>IP17,L<<!LY[I\JY
M?;'MR5"KC #'/.>F >:S;CP5<SS>9_;,G[T6IN=UNA,C02F52,8"Y)P<#L/?
M-O7?"AUJ[2X^V&!EL+FR&(PW^N" MU'39T]Z -/2=;T_6HYI+&5G$+A'#QM&
M5) 8<, <$$$'N#5(^)X%\9+X>,+ O SK<?PF50&,7U",K_0U+HFA/I$U[(]U
MY_VEXFQLV[-D21XZG/W,_C60_@F:1M.U WT:ZY;WPNI[T(Y$JG*L@4O\H*$)
MUZ** -*7QKX;@>9)=8ME: N) 2?E*'#CIU!ZCTYZ5;?Q'HL<LD;ZI:!XT:1Q
MYHX55#,?P4@GT!S7,7_P]>\614OXX]_]J$GR3R;S.,_-_#G\<#I5>#X;S06E
M]:"YTYDN+2:&.X-F?M"-)%Y9^??C;DDXQG&!F@#K(O%&@SV;W<.KV4ENDHA:
M1)E(#GHO'?VJCI?C;2+O1K"_U"[M--DO$\Q()[E=VW>5!YQD$XY]ZS)/!NIV
MNJ0ZG87=L\]O-%)'%.66-PML8#NQG!^;(/..1WJD? >K/X<?3))]/:1M'>P\
MS#X$C2[\@8^[C\<@<4 =I_;^C?9?M/\ :MB+?>8_--P@7<.JYSC-.DUC2DNF
MLI=2LUN,',+3J'P%W'C.>%.?IS7&ZGX'U.?5KZ]@>SN(KJXFW6=Q/+'&T4D,
M*$ML&2P,1^7H0W45%-\.[NYUN6ZEDLTAFOWF=HRWF"%K7R=HRO4,2<$XQW[4
M 7K[2O!MKX;7Q!;Z##>VC1)(GV>/YWC8C! )![YQU[=:2TL/"5S<V%MINC1R
M:?=V[W4=Y;R!(E$94$,-P8$%E&,=^>AQH)H^K6OP_P!/TB**TEU&U@MH2#.P
MB;RRH)#;,\A<_=K,U3P)=O=ZL^FWB"SO;>0I9SCY(YWDC=\8'W'$8!'8Y.#D
MT :L7@_PO>V^8(/-BR!OBO93R/</_GO63>:?X5M?$,.AQZ1?75W(J,_V>=RL
M*.Q 9R9 <?*2< D#ZUKZ%I>H:9?WES]DMX(=1NQ++;1S96W41;=X^4;F9E7/
M3 QZ&JVL>'I-7\46ETFD6EJ]E=P7 U8%3+,BAMT> -WHO)QALCD8H ?+X-\*
M2W2V3)*MR(R_E1ZC.CE">I"N"1GUJ.^\#: 8#<SSZMY5J&E4?VK<,(R =Q7+
MG!ZU3\5>%[[4]<U&\M;&"87&E1VR.SA2629G>,]\.I5?3KGWO:-H5U9Z3K\2
M6<=C!?.S6>GHR[8!Y2H1\ORKN8,V!P,^N: .?T/PUX4UN".2VLO$<-O>Q!ED
MGN9PDB?ZSE@Y'4GKWSZY/>WD&GQZ(POHENK*VB\QOM \[*H,[CNR6.!UZFN%
M@\$ZA!X'TN(1WAOX$@BO;!KYGCFB256D1<L57<%[8&#@U63P5K$^HLLEM(NE
MBUO19V[W "VK.R^2FT-Z+GC(&<=J /2-/FL[^U@U2T1"EW!'(DNS#/&1N7/?
MHW3MFI'L;22"2![6!H93NDC:,%7/J1T->4CPAK]O:6L5M8ZC!I:6]I%?6*7,
M+S7+HCAY$W,R #,?!QNV]!@&KAT;Q-;:OHYAL-5-G9RVBAWO4ED:-1()!(?,
M R=ZY 4@[1SP!0!Z*NDZ:K!ET^T!#HX(A7AD&U#TZJ. >PZ5'_86CBY@N?[*
ML?/MR3#+]G3=&22QVG&1DDGCN37EMQI?C&V\&6:1V^ORZM)%<M)*NJR%XY#*
M!$"IDQ]P \9'!X)-6GL/%@OIY[%=96YDN;\#S9V$:JUK^ZX+;<>=R#C@\>E
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M578;V?[QR#D9]L4^'1M/@@L(4MQLT]=EMN8L8UV%,9)R?E..<UYE;WOB4:1
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MK);.P>W#2Q(48YY8>9U&.01BO0=/M6LK&*W:1Y'4$L[R.Y+$Y."Y+8R3@$G
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M>&X+]+*2_D\U_)*E;65D(EQY9WA=N&SP<^OH: .EHK+TSQ#INL7,]O8RR2O
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M.K,,\#W- %NBLQ]=L3]F>"YMYX9MY,D<Z$*J*26 SEL8 .,XS5#P_P"+(?$
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MA0QQH(@ JEMQ''OS]<^IJ:U\*Z'9:I_:=KI=O#> L1*BX(W?>P.@SSG%;%%
M&1>>&-&OY+J6YL(GENFC>:0$JS,@PC9!!# < C!KG[[P%)+KL5YI]]%9VJ0Q
MP)&D<BR0HK,QV,LB@DEB275N<<'OV]% &''X/T&%;A8M/5%G^^J2. /G#_*
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MT1Y7B36=/:2.+SW072$K'@-O(SPN"#GI@T :=%5[.^M-0MQ/974-S"20)(9
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MJ%N]V,_N5D!;@ G'KP0?H: .;\)0:I;:!JC1RZO+.^6M5UI2&5]F,?,[-MR
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MB\'[]L"01^5TSTV?+CTH JZKXOM]*O9X397,\%JT2WEQ&4"P&4@)D%@6Z@G
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M4<\TWG7$EPS3%<AG8L0, #&3Q0!>HHHH **** "BBB@ HHHH **** "BBB@
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M^:V"N\9"OB! =K=&P01QZ5TU% 'A^L-XGNO!VI6[?VO,?[-"ZE'/#(<79F3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 !HI#THH 6BBB@ HHH
MH **** "BBB@ HHHH ***0D"@!:*3>I8J",CJ/2ES0 449HS0 449HS0 449
MHS0 449HS0 4444 %%&:* "BBC- !11FB@ HHHS0 449HS0 449HS0 449HH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"%Y!OD"IG'12< <<FG:=X1T72;V*[L;62&:(2*F+F4J!(VYQM+8Y.#T[#T%
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M'GC&9(]OL&)%0:18>(-%ETNY.@M.;;1S:/%%=1 B3S,@9) QA0<_[7M7H-%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !
MHH-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 URP4[0"<<9-.&<<]:** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH #10:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ -%!HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ." K8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** *]G_JG_ .NC_P#H1JQ5>S_U3_\ 71__ $,U8H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** *UE_JG_ZZO\ ^AFK-5K+_5-_
MUT?_ -#:K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!7LQB-Q_TT<_^/&K%06G^K?_ *Z-_P"A&IZ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@"O:?ZM_P#KH_\ Z$:L57M/]4W_ %T?_P!"-6*
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M^VX5O+9+J[UV<V]K&0)I5=E"87KCG/TR:@FN["VUG6[*.7QJW]ED-<M;WP8
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M3QJ"F-N1O8+T/:G:CX9UC6[F]GEM_#JW5Y9_9+B6WNYE=H<@D'Y".V,XX'%
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M 0>#@]>F16(_B+58M#TN^ACT6\BU/5(K*UG-FT8\IP1N*%SR&5N_(QTH ?\
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M1M=,_GP;I-Y96)'R[1@X&.F:NFQTK3[]5_X2:U@E#R0I,GAR +O4'S$#A,9
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M8=0",9'.[O[4 9MMHGB*QDT^YTSP==6E[9O,R2KJEO\ .)6W.K+L"XST QC
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MT<LL.UDMX%0QIEMW.[.\GOGV%7=*>6V?4]!EMY%N)O$8U!+H)F$PB:.3?YG
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M49+^*X7$<5PSN8]^> 0>%)Z'\*Z/POXIT;3)-8N;JRM-(MY-3%HLMNQ>*ZE
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MA)?6LT=HG[LL2<,#)SP2"!P0:AU*UUG4-7\0SPZ+K,5IK4,-LZ_8$9HHD7!
MS+@DY/)Z9KVFC /:@#Q./37T_5Q+;Z!JTEM%I<6G);W6FO(0$8,&+H2"<^GY
MU2U32+[7-7O+_4;+7)7GT]+9)%T:0/#,A5UD4= -ZG@'HQYSU]XQ1@9SB@#@
MK#QIJ,6CQ1WWA[7)]26/#21Z7(D;L.AP3D#IGBN*73+7_A6D7A2^BUB.\MIS
M=Q3)I,Y57WEAN&WI\Q!P?QKW/ ]*3% 'B]U+/KGC73/$>K1:I!:V&PI8VNEW
M,@9U+%6+LB_Q-G&.@ SWJMXN1O$?BB]U%=)NFMIM*:PC$^F7.^)RV[S>(CR"
M3CFO<<48H \$OY],NM=L[W4[QKM8-(BL<7%M<PS-+'('\S_4,%^8%>IX^M>Q
M>%=3EUGP[:7\TD3O*&+&*-T7.XC #@-@=,D<]:V< = * ,4 +1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#;_=;_ 'F_]"-35!:G
M,1/^VW_H1J>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9+%'-&T<L
M:NC@JRL,@CT(I]% %#^Q-*SG^R[+_P !T_PJ*3PUH,KEY-$TUW/)9K1"3^E:
ME% &3_PC&@ G&AZ9S_TZ1_X4[_A&M"_Z FG?^ J?X5J44 8TWA'PW<.'F\/Z
M7(P& 7LXSC]*:/!OA@#'_".:1_X!1_\ Q-;=% &&?!GA<]?#FDG_ +<H_P#"
M@>#/"XZ>'-)'_;E'_A6Y10!SC> O";LS'PYIF6))_P!'7^6*3_A /"0(/_"-
MZ7D>MLG^%=)10!SG_"!>$\Y_X1K2L_\ 7JG^%6-.\):%I%[]LT[2K:UG(*[H
MD"X!Z@ <#\*VZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @L_P#CW_X$
MW_H1J>JUB<VH/^TW_H1JS0 4444 %%%% !1110 4444 %%%% !1110 4444
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M -"-6JJZ=_QY)^/_ *$:M4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% %:Q_X]%^K?\ H1JS5:Q_X]1_O-_Z$:LT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% %6P_X]5^K?^A&K55=._P"/-/J?
M_0C5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J::/
M] B^A_F:MU4TW_D'Q?0_S-6Z "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"IIO\ QX1?3^IJW573QBS0>F?YFK5 !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!6L#FU7ZG^9JS5331BQ0>A8?^/&
MK= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5T__CS3
MZM_Z$:M54TS_ )!\)_V?ZU;H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** *>E<Z; ?5?ZFKE4='.=(MO]P5>H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *:J;79MQ.XYP3TX[?E3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHWM_<;\J 'T4S>?[C?E1O;^X: 'T4S>W]QORHWM_<;\J 'T4S>?[C?E1O/\
M<;\J 'T4S>?[C?E1O/\ <;\J 'T4S>?[C?E1O/\ <;\J 'T4S>?[C?E2@GN,
M4 .HI,T4 5M.&VQB'HM6JKV7_'JOX_S-6* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"O9?\>J58JO9<VJ&K% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!6L/^/./Z59JM8?\><7^Z*LT %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %33#G3X#V* _I5
MNJ>E#&F6X_Z9K_*KE !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!1T=M^DVK^L2G]*O50T3C1K0>D2_R%7Z "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@"AHA#:-:$# ,2_RJ_5'1O\ D$6F/^>2
M_P JO4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %+20
M!IEN!T""KM5--_Y!\/\ NBK= !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!5TW_CPA_W:M51TA_,TJV?^]&K?F*O4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% &?H8QHED!T$"?^@BM"L_1/^0+
M9_\ 7%/Y5H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M %'1U"Z/9@=/)3^0J]5/2O\ D%6G_7%/Y5<H **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** *FE_\ (*M/^N*_RJW533.--MAZ1)_*K= !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!4T[_D'V_P#U
MR3^56ZJ:8<Z=;'UA3^56Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **0G':EH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** *>E'.EVI]8(__ $$5<JEI'_((L_\ KBG\JNT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% %+2/^0/9?\ 7!/_ $$5
M=JGI(QI%F/\ IBG_ *"*N4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% %32_^07: _\ /%/Y"K=5=-_Y!MK_ -<4_E5J@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JZ=_R#;;_ *Y+_*K55M/_
M .0?;_\ 7)?Y59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** *NG<Z=;'UB4_I5JJNF_\@RU_P"N*?\ H(JU0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 5=-_Y!EK_ -<4_P#015JJNF_\@RU_
MZXI_Z"*M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %
M73?^09:_]<4_]!%6JJZ;_P @RU_ZXI_Z"*M4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% %73O\ D&VO_7%/Y"K55=._Y!MM_P!<E_D*
MM4 %%%% !1110 4444 %%%% !1110 4444 %)2T4 %%%% !1110 E&*6B@!,
M48I:* $Q1BEHH 3%&*6B@!,44M% "8I:** $Q12T4 )BC%+10 F*6BB@!,48
MI:* "BBB@ I*6B@ HHHH .U)2T4 %%%% ""CO2T4 %%%% "4M%% "4M%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% "4M%% !1110 4444 5=._Y!MM_UR3^0JU573?^09:_]<4_]!%6J "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"II?_ ""K3_KBG_H(
MJW532CG2;,^L"?\ H(JW0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 4]*_Y!-F?^F"?^@BKE4])_P"019C_ *81_P#H(JY0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %'>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6D_\@BSSU\B/_P!!
M%7:IZ3_R"+/_ *X1_P#H(JY0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 4M).=)LS_TPC_]!%7:IZ4 -)LP!QY"?RJY0 4444 %%!Z4
M@&.] "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/2?^019C_IA'_Z"
M*N53TO\ Y!5I_P!<$_\ 015R@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*,T4 %%%% !1110!3THYTJT/_3!/_015RJ>D_P#()L_^N$?_ *"*N4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %(>E+10!#;PF!-GF/(,ELN<D9.<9_&IJ** "B
MBB@ HHHH J:7_P @JT_ZX)_Z"*MU3TGC2;/_ *X1_P#H(JY0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 5-+_Y!=I_UQ3_T$5;JGI?_
M ""K3_KBG_H(JY0 4444 %%%% !1110 4444 %%%% !11FC- !11FC- !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!4TSG3+4_\ 3%/Y"K=5--_Y!MK_ -<4_E5N@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JZ;_R#;7_ *XI
M_*K55=-_Y!UM_P!<4_E5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3O0 M%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!5TW_D&6O\ UQ3_ -!%6JJ:9_R"[0_],4_]!%6Z "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M8(T5A;Q.,.D2JP]"
M *LT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ." K8# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WBW_UD_\
MO_\ LHJ>H+;[T_\ UT/\A4] !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!6LSGS_ /KJ?Y"K-5K/_EO_ -=6JS0 4444 %%%% !1110
M4444 %%%% "!@V<$$CK[4M1QQ[))&&,,0>G>I* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"K9$
MG[1G_GLU6JJV7_+Q_P!=FJU0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 5K+I-_UV;^=6:K6?W9?^NK?SJS0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFB1][%\C).0.?853NOASHDYL# ]W9_8+F6ZMA;2*H221MQ(!4C (X'85UU%
M'*3?#[1I=-MK-9+R(V][_: N$FS*]SDGS'8@[FY/6FW?@&TOO)>YU?5I)H=1
M34DE,L>1*HPHQLV[1R<8[FNMHH Y6W\ Z;933-97VIVD,NH)J!M[>XV1B1>J
M@ ?<;C*D]AC%=5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O8_\
M'JO^\W_H1JQ5:P)-J,C'S-_Z$:LT %%%% !1110 4444 %%%% !1110 44C$
MA20"Q Z#O7-:)XYTW7+FT@BM;^V-XDCVK7$("S!#AP"">1Z'% '344FX'U_*
MEH **** "BBB@#F_']F+[P%K=O@EC:.ZA>I91O'ZK2^%2L7P[T9@2573(2""
M"?\ 5CIBM?58VFTF[B7[SPNHXSR5(K!\*S[_ (8Z4T (==+C4*V3AECQ@Y]Q
M0!!)?#PW\+X+BV'EM#8QB('DAF4 =?<YK8\*2WTOA;3I-3E\V]:%6E?'WCZU
MS.KDW_A+PK:!%E^WSVJ/GHH$9<G'?[AJ_P"-;JXM-+L-'TQQ#=:E<I:1E3@H
MF"68>X5: .P'-%01F.W2*%I"6*X7=U; YJ>@ K'\4V1U+PSJ%F)T@>6(A)7.
M K9RI/XXK8K,U*&[NKJRABP+82^;<,2,[4Y"@>[8Y] : ,M?$%Y9:?NU'0]1
M66-?WK6\:2J6YRR[7SC@GD=^:Y+1]3N=&\1Z.E]IU[)>ZHTS3S2A(][RO'A@
M@8G:B( 1UP >]>BZI/:6VDW4EXY2W$3"0J"3@C!QCG//;FN$LIKJW\7Z1J'B
M(QP1M:W,=FLQ56@5?+.Z0YQO9<\= %QU- 'I. >HI:YZ7QQX:AD,9U:&1AU$
M(:3'_?(-/D\4V:6TLY@OQ!$I9IGM)%0 =3DKTH H:%YL'COQ$D_E!+I89[8I
MU=%&QL_1L"NMP#VK@O#T%WI\_AJ2ZF4W%U:W*S9')+NLRC)].1S793ZA!;W=
MM;2,?-N2PB4*3G:,GZ<4 6L#T%+@>E(#D9I: "BBB@ HHHH **** "BBB@!#
M@5GZIJUOIZ(A5YKF4D0V\6"\A'IZ#U)P!5F]G-M9RSA&D,:,^Q1DM@$X%<_X
M4L ]O_;MS.;F_P!2C6623=E(U(R(XQV49_$\FJBE;F>Q,I:V6Y/;:1<ZG+]J
MUX1R+NS%8J=T,0[%O[[^YX'8#J=X1JJ@!0 .U*,=J4D 4I2;&HI>HAP!TKE-
M,=/$GB%]63+:=8!H+/(PLDIXDD'J ,(I_P!['6H/B+X@.DZ#]CMANO\ 4<P0
M*#@X. 3[?> ^K"ETOQ5H&AZ19:=>ZU827<$*QNMHN1D#LB9P*WC1G[/G2O?1
M?J_T^\SE-<W*^AU\445O$$BB2-!GY44 <\G@>]/R*Y^/Q5%<X-CIFK72$9#K
M:%%/XR;:M1:CJ,I&=#NXE]9)8?Z.:R=.:W5ON_S+4DS6R*-PSBL*'77N->U'
M1HK:03V<,<GFOS&Q<$@''3I_/TK"NO$OB33Y"NI:?IMBG %Q)-(\+?\  E3Y
M?^!8IPHSD[(4JD8[G=;@*Y?QQ>2G1H]*LI"M]JLHLXB!RJMS(_X(&/Y4Y(O%
M-S&)#JNE0JPRODV;R#'8@EQG\JXF2/4]=UF\N9=7N6^PSG3+"2%%A\R9_P#6
MD8_A4+]?E:M:-%<]Y25EZOTZ=R)U-+);EGQ#8366CK?:+')'9>')85MHHV^\
MJ-BX/O\ +\OU5O6O1CJEC%"DTMW!'&RA@SR!1@]#S7-+\.M%6Q^S2/J$\>PH
MOFWCX&1Z @?IWJ/P%I.EOX<MMVF6BWUJ6M;E_*!8RQ$H3D\\[<_C55)4YPNV
MW9]N_J^Z?WBBI1>UKG0CQ-HK$"+48)CZ0-YA_)<U>M;R*\0O$)0 <?O(F0_D
MP%2+"BKM50![4JH%Z"N6371&ROU'T444AA1110 4444 %%%% !1110 4444
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M*** "BBB@ HHHH **** "BBB@"O9_P#'O_P)O_0C5BJ]E_Q[?\";_P!"-6*
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M_;IGDD60HNX?.21R.G;FMQ45$"JH55&  , "EH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *UAS:(?4G^9J
MS573N;&(^HS5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHR/6B@ HHS1D
M4 %%%% !1110 4449 [T %%&:* "BBC(SC- !1110 449%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!5T[_CPA_W!5JJFFG.GP'U05;H **** "BBB@ HHHH
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M/T&YAUZ$#M6I;:=XJM=:LY[C58KN"6=VO(HX/+B2(1X0("S,#OY)SSN.>@H
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M4 %%%% !1110!4TS_D&V_P#US7^56ZIZ7_R#;?\ ZYK_ "JY0 4444 %%%%
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MV$TS#'1G944_B _Y59L0TWC/5I\?)#!!;KSGYOG=N.W#I0!O8&.E&!Z"EHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"GI?\ R#;?_KF*N51T@8TFV'I&.M7J "BBB@ HHHH
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MI%/GQ[-A!P57Y1E1V/.?4U7\0:/:^(=(NK&4@-+"\:2J?FC+*1D'J.#@^H-
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MECN(1(LBI&5SYF<X!&,9Z_G5_37M%^(A&BO;M:36#-?K;$&,2AQL;CC<06_
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MW&_*@!]%,WG^XWY4;S_<;\J 'T4S>?[C?E1O/]QORH ?12 D]1BC- "T444
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M]_TI<TM #=OOQ]*1HE<88 CW%/HH A^RPYSY2?\ ?-+]GB_YYK^52TA.!DT
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MT@!VC. "%/'3)SBK=WX$C&BS6UE=7KW?V,V5M-/=L#!&6!P&7!ZJI[YV@=*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8:9>:C<>*-3W00O*=OE1KP"1QMQ4?PQN[Z_\*R76IH5O9+R4R@J%.00.1^%
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M.] &3<^%-;U"_DN[^TT6X:4@R1FYN!&Q"[02F,$XP/PK:"^+HHU2&#0551M
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M!Y&G^)-6LXRZR-Y"PHS,OW=S!,D#)X)Q39/A1YMY'>2>+==>ZB</'.SQF1"
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MDFM>HHC''&J(0 !P/:I-RCO0 M%-+J!DGCUIU !1110 4444 %%%% !1110
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M9=BY#[>#@*N2!DXR#<T>UU^WU:[_ +3U%;NQ$$"0$PI&QE"XE?Y>S'G!Z$D
M8 )W:* ./\(^#K[P[>:E<WVJ1W[7L4,;?N"AS'OY)+'.0_H!Z8 K._X1C4_#
M8FN=+GCGMU&V: 1'S9X-X.T\[2ZJ7"MC., YKT&B@#Q'Q-X4NI]$\/)_:5E+
M#(;;2[66"(@R0LP<.YR<\1(<#'\7K6IXF\):G9:3XBD\ZWDTU?MFHPOEO/\
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MGV/PEI4/&1;(6QW)&3^IH VJ*** "BBB@ HHHH **** "BBB@ HHHH ****
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MRC^V;S_H7]1_[[A_^.4 6/[$TOJ=.M,^OD+_ (53U3PCH&LV+V5]I5K) W)
MC"$'U#+@@^X-/;6KQ49O^$?U$X!X#0\_^1*JQ>*+E_\ 6>&-:BZ8RD1_E(:
M- :!I MU@_LVT,2J%"M"IP ,#J/05&/#&A+TT>P_\!D_PJ'_ (2*7_H :O\
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M1110 4444 %&.<T44 %%%9VJZYINBQJ^H7<<!?.Q#RSX_NJ.3^% &C17(?\
M"=-*2;3PYKMQ&/\ EI]C9 <],9ZT^7QE=6L7GWOAO5X8,9+I$)2OU522* .L
MHJGINJ66KV4=W874=Q#(H8.C9_/T/M5R@ HHHH **** "C%%% !111TH **3
M.:K76IV-B\275U%"\S!(U=L%V/8#O0!:I#C'(S2U3U2\^PZ?+.!EEP$7^\Q.
M /S(H +35+*^N+JWM;A)9;63RYE7^!O0U<KF/"^GKINH:I;JI.QH5:5@-TC^
M7N9CCK]X5T] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#%I]XCP%X4 =27'H14OC[Q+)IM_I.A16"W$^K,1#(;@Q")T*L"?E/ .#QZ4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M /4@>M &=XY\%ZQXNEU"1;C[.+>%$TR-77#ON#N[$KE#E4'!Z+[FK%YX9O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\9C1T*JNW+@$,NT<<=0170^%?!MS<6%W-XJMHCJ,MS*[-&?O%LCS X.>5.T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW0-9BUS2UNDC>&0.T4T,GWHI%8JRGUP0>:U:X[P]X6N-.TI/[.\2ZBUO<$W
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MRE"OO5BL:$,#@=0PKKJY'P':,D.L:B0HCU'4YIH@HZ1KB)?Q(CS774 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>/K6G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUH TJ*!10 4444 &!Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 444A!(X.#0 M%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ." K8# 2(  A$! Q$!_\0
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MT9I** %S1FDHH 7-&:2B@!<T4E% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%'>@ HHHH **** "BBCO0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 *.M)WI1UI.] !1110 4444 %-V+YF_'S8QGVIU%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM8[T23-:"WN(9,0I&KGSDE7<,C:21D9)/!%=Q0 4444 %%%% !1110 4444
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MSPQR$[!, &9>S  G@]1[5F:GXJATV35$-A=SG38HIIO*"?,LA/W<L,XVM^5
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MT:HPVD,5((?UH /$?@U?$TNHO>R#YK06]CLD=1&?O%G .&^<(<<CY1WK/O/
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M9U?86YX.0#UIL!EBETE;>5?/>UU5=*,A/F&/<OD#G!SMSCOC\: .N'A_PO\
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M4 %%%% !_*BBB@ HHHH **** "BBB@ IO>G4WO0 4X=*;1B@!U%%% !1110
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M^,'T">%8\VZS17'FY#D[OD(Q\IPC'J<@53TSPWJ&E:M;7T%["WG0!-4#J?\
M29<Y\U?0Y)'IC [##]7\)C6-1O)I+@0Q7$5NJM$I$L;QL^2&S@921EZ=#^8!
M3L_&-]JD-TUA80[WU'[!8B:0@-B/S#))QPNP%@!SVJ'5_$_B'2H;NU>VTXZE
M!&ES&5WF*YB+["H!(*,&9>22.?>M"#PC+;BZ,-_'"[7ZWUJ8K<J('"",J1O.
MY2@P1QU.,<82\\)W>HI?SW>J1-J-S%'!%-':E8X(T</@(7))+<DEO3L,4 9V
MJ>+-4FM/MFCRV,<2Z;=74T-Q"SR1RP% \9(< 'YP.1VSR",$NH^*H]4T:S?4
M]/']J),4:.R)5"D8=0<OSGD^V*U]2\'VE_>7]['.]O<WUA)93%%!0A]N7V_W
ML*!G/0#TJP_A[S+O1+@WTH_LI2$4(N)24V$M_P !ST]: ,N#5-=U.QU2[M+J
MUA;3Y'MA";<L)9(@-Y)+ @,V0/0 $YS@8W_"7ZU=ZQ&UC(/+N'LC;6+V^0\<
MT6]]TG&"H#GKV[UU5WX9\^>X^S:I=V5K=L6NK:!8]LK$88[F4LI(QG:1Z]<F
MHI?!>G2_:U^T7:1SB'RDC95%J8AB-HB%RI7W)H Q]4U;7EUK7;>PU%$-G)8K
M;12P*R,9VVE7(&[&<<@Y SUJ*[\8W\TJ_9G6VF\N*VGMWVM]FN'G$;%N^ #E
M>@((.#6VW@V-KBZN?[:U47%R8#+(&A!)AY0_ZO'7D^M:-WX=TJ^N;FXN;-'D
MNH5AG/3>JG*DX[@@8/48'H* *MB);#Q$FFOJM]>![-IRES&A (=1NWJHY.3\
MO\JWJRK+1[73+LW;W=S/.\:P(]U-N(7.=H^IY[DUJT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !3>].IO>@ IPZ4VG#I0 4444 %%%% !1110!QE_9
MZO+XEO\ ;;:AERK6%W%<!8(E\G:P<;L_?+'&TY..1VS+70]2,"FWTS4K:/\
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M[)M.WYN "3G(JZVH7C7]W!/<ZE#IHU-UEN+>%EE4&!#$#M3.W=OR<9!"YX-
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MMUA+Y-Q8R.JNC>9Y?WAD$9SR,CBG7D>O:HUE))ID%NMO?Q2B)K@%O+"MN8D
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M+4YY]1@*[9'FD8/(-VX D'.!P.O04 0^*I9X+#3U@NYHG;4;6)WC8!F1Y C
M\=P3^-1^(KF6?6='T9+J6VM[V27[1)!(4D^1-RH&'*ECSQC(4C-6I?"NDSI*
MLT=U+YCQR,TE[.S90DIAB^0 6) &!DT]O"^CO9RVLMJTZ2R+([3S222%U^ZV
M]F+ CH#GB@!^BZ?'I45S:QZC<7:^?E1<3F5X?D7]WDDG_:P>S5F-XGN/^$O3
M24CMFM#<_9GD#-O5O(,H[8ZC&!G'?KBK5KI>B P3V/EJ-,NI79D;<?,,;(X=
MCDDX;G// ]*GBT?0[V\BUR.PM)+F0++'=B,;R-ORG/7I0!D2PV.K>+]4LM7F
M+K;P0O;6SR,BJA#%I  1DYR">V.U4;;Q%/8S):Z?-#=Z9:7%K:#>&DGG6901
M('W8P-W]TYVMSZ=/=:9HWB***:[L;>]2-V"&:+.""0>HZ9'T-+<MHUOJ5G//
M%;?;6D^R6\WDAG1BI;8& ^7C/!(Z^] '!V'B.[TC09(K:>UMX[6"\O(S<*6%
MR5NI1Y:G(Z #ID_.OXWKKQ=JL5OJ%T]W9VT<5^MG'"\&&3<BOEW9P!C)!R/X
M3WXKM/[&TLI$ATVSVQ2&6-?(7".>2PXX)]:L?9X,L?)CRS!R=HY8=#]>.M '
MF4'B\Z\--FOKNUAV26$T=JJ*3,[2[)'4D$C:V1A3D $'K6[X9U^]U'4K*-K\
MWC2V\S:A;F-%^PRJR!4^49'5Q\Q.[:2/2NJO[RWT?2KB]E1A;VT;2NL:C(4<
MG JS'(LL22(<JZAA]#0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ IG
M<T^F]Z "G#I3:<.E !1110 4444 %%%% ',>(/#E]K=TT;363V+-&Z^="3+;
M,I!9HVSU('M^/0LN?#&HLNI6%KJ-O%I.I/(\Z/;EID\S_6!&W!><G&5.,U#X
M@OKBRUG42;FZ^RC38I!%#*$*-YQ!93@X.",]<XQ4ESXOO4U*2TMM%$JB^:P6
M1[L)NE\KS!QM. 1GGM[T /'AW6;:[OSIVJV=K;72QQJIM'>2)$3:-K>8!NZ=
M1[^U+<>$IY)[Z*+5 FEZA*);NUDM@[N<*K;9-PP&"CJ#W]:RI?%MU.LMU86L
MD=W)86DR1S3,\2[YS&P* <$?-\PZ@#.,5;OO&>HVMS?O'HL<FGVLSVPN'NU0
MF4 8!7DX)/8< 9H WWTC=XFBUK[0P*6C6OD[1@@L&)SUSE1^54(_"4,+74T-
M]<1W4U\]_'.%0F%V7:0 1RI7@@]?8\U%HYN6TKQ EXV95NYP0'8A044@+GD#
MGCZUSND:]+9:;ILXCM$N'T>RC2>9I&9LR;,$#W)(Z<GD@"@#K%\,0,3-/>7,
MMX]S#<R7'R*7:,85<!<!>O&,\GG/--O/!^DW=_=WP26"[NC$SS0O@AHV#*P!
M! .0.W:N1_X2>_7SO$$7V-;L:<_GP,&*R&&X=,)AOE+9SDEL<#GK6DFHI-JM
MO<+9QP-%XB$;K]QV\RS*[F!)^;YP,#^[0!T<&AS6D\4L6J73,;HW%VTH3-S^
MZ\L*0J@#&U.@_A]3FB_\.6FH:E+?RS7*S2V3V+!' 'EL<G QUSW]JY'P]JNI
M7EJMMI<]C:O)8W+VUO%'B+SUN7&[DDX88SSQDFNDT;6[[4M)OM3%NQB1!]FA
M9"K.ZQ@OG(_OY7_@/O0!I+HMD&TQV1GETT$6TC-\R@H4.3WR#^@JG9^$M*L'
MC,"W BB+F&!KAVCA+<$HI.%[X],G'6N:_P"$LN+BSMS#XAM'6ZD@$\\-KC^S
MU97+;BQ*@[U50'Y&><\&J%SXF\1R1[HM2$*Q:?)-YD=JK+,4N?+63D'ATYP,
M=,C@B@#OM.T=--NYY8IY6BDAAA2)W9@@C! .6)Y((R>,[1WR3'I7AK1]$N))
M].LA#+("&;>S'!;<1R3@9YQ[FN,_M_61K*:7+KKQP?;YH3>B"++1B 2+@;=O
M# C..<^U-37/$1US1C<2WB1,+>.Y46YV,)$?+X"$#D(2<_*3C &: .VD\-Z/
M+K"ZM)81-?*P829/+ 8#%<X+ ="1D=J>OA_2%N[FZ&G6WG7*LLS% 1(& #9'
M3G SZXYKB=(D\07^E/$-3OQJ,FG07<9N$,:K*CNKQD[0,,-@/?O74:!J<LL%
ML^H-*MUJQDNX(64D0Q +M3(& 0I4D'N6H TAHNE+-;S+IED);90D#B!=T2CH
M%./E')Z41:+I4%NEO%IEE'"CETC2!0JL1@D#& 2"1GT-<7J9UQ_%6I2P)JRV
MRI-$J+YAB8?9@49 #M^^K#@$[CR>0*K10:FKL!;:W)ITWV*>[BD:;S.5E\T*
M2V[.[RBRJ>@/':@#M)+S15TE=:>*,VEO'N686K,T:*>RA=P Y[<=:@C\1^'[
M>>4(YAN&GBBE3[)(DADDSLW+M#<\X)&/>LNULKT?"Z^T\V-PERUM=0PP/R[!
MBXCZDG)!7K6=>>&C#X?MKWRM8N]3N+FR>9OD\Z)8F!(     WXQSN*Y)H [:
M"^LI]4O+"+FY@5&N/W9 PP.W+8P3@=,U5'B#3(]!N=4MRTEE9ET<0IDJ(R5;
M ]!C/TKF;?3=8T?4?$<5K;ZG<Q7<-LEK<S3K*0V&1F)+@Y&X'Z+SCC+1X:U7
M2K76](L[<WEIJ6G;$F01PQQ3B,Q8V[LX*A"2!U^IP :6DZWIND>'[\6UIJ;+
MIT?VN>&95$I20LY<9(4CAVP#V(QGBK]WXMTVVTK2[]/,N%U.6**UCBV[W9^G
M4@#'?)XK B\/:MI^C:UIL=FUV-3L2%N&G5I(Y3%L\IBQ!,8/W2,X!(I]QX1U
M!+MY8!!+%%J,5Q91,=GDQ>:LTRYP<9<8 '8#\ #J;O6K*QU>PTR9R+B^WB(
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ME;G=NVD*>27)QP.V>:N#P?HIA@B>WD=(HA"0T[_O5#[QYF#\_P V3SG[Q]:
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MC6[.SU5)5C^T:4ICN)3%MC<R2KY4B\GA8MS$9/)&:[@VMN7WF"(MO#[B@SN
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M@YRO/'.*]+LD>.PMDE79(L2AESG!P,C-3T4 %%%% !1110 4444 %)GFEHH
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M-I%9V\=U&K^4B @D''5LC)X^Z/2DTGPLFFM9-->RWGV6Q>Q F1<-&S*W/T"
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M4 %%%)F@!:*** "BBB@ HHHH 4=::>M.'6FGK0  4M(.E*.M !1110 4444
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MZUSLD^JR.ERUMJ[Z@EIJ$5ZL"RYC8LC1K$S*54D*N"HY&#@F@#TRD)VJ2<X
MSP,UYM86^M27EM=NNHN\;W\=NTB3J%+K&T60_P VS(89;CH#V ;I*:VG]G2W
M+^))K43I]N2=75U/E.HV[6WLH?!;'!R.#T !W5QK^FVNAQ:S+,XL)42195A=
M_E< J2J@D=1VI;#7=/U*ZEM;>61;F)0[03P20R!3_%M=02/<#%<M=VFH2_!P
M:>;*<WWV%+<6ZQ'?E<*,CZ#)J+Q/I^L^(;NXN])@NK9(+![='DQ%)<%Y$+*@
M;E?D1AE@.2/J #OZ*\V.B79MK<RZ!J.HVSB4+;W=Q"DL$Q92),KA4'! *]!V
M^;%0ZMX1U6[GUZ4:3++?W F,%X+N-497V[4QPQ(QCYL !<Y]0#TN29(USG<V
M#M0'EB.H [FJ^GZG;:EIL%]"VV.:!)]KD!D5E##=@\<&N.;PQ)%XBDO+/0(X
M$6_M)89(S$FV/;B; #<8/W@/O=LUEP^!;^;38X8M+ATV6WL8[:8+*BB_D66-
MRQ9,D B,\G#9<<8!H ]+-W; 1DW$6)#A#O'S'.,#UYXJO<ZI';:M9:>\,Q>\
M#F.50-@*#)!YR#CIQ7.6'A;R]7TV\DTBRB@A:YD>*24W#QR.8F5PS?Q;D8Y'
M3=ZDFMZ_L+BYUO2;N/RO)M3*9=S$-\R;1M&,'GKDC\: *L6OW)\0QZ7/H\\"
M3&8Q3M*A#+'@%]H.0IR,9]15_5+R\L[=#8Z<]].[;1&)5C"C!.68]!QCOR15
M>:UNX=0U'552.>5;016<.2.1N8@G'&YBHXSPHIFIIK&H:'"M@8+2ZF"&<3%O
MD4C+J"!P>V>W)ZXH R7\=I]CBOHM-=[)+:.ZO9&E"M;H[L@PN#O.4<G!' XS
MD"MFWUOSO$M_H[6_EBU@BG$Q<$.'SVQQC'K6!>>$-0N[26U1M.MH;VTCL[M(
M$8"-(W8H8Q_$=C%><<@'MBM>X\.K>ZOJTUT4-IJ%C':,L999, ONYZ<A\?A^
M8!+H?B*WUVZU&*WC94M)$4.Q_P!:K(&#@=@0>/4>E7;K5;&RN8;:XN4CFF("
M(<DG+!1TZ99@.>YK!70[[0;NZNM':2X^U3VR>5<W$DOEQ XD.7;T)(Z],8[4
M[Q1X9OM>NX)(-1A@AC5?DDA9BK+(K[E(88)V <@X XZF@#:T_6++57G2SD=S
M VURT+H,Y9?E+ !AE6&1D<5GQ>,M$E1W6XGVJ8@,VLN7$A*H5&W+ L"N1W'T
MIGA[P_=://J,L]U ?M94A;:(QJK L2Y4DC>VX9P /E'%94'@;4(F1V\0>;(/
M(#/)9Y+"*<S GY^I8G).<\T :EOXXT.X=P)KB()'([-/:R1*#']]<LHRR]P*
MKR_$'08UDV/<3-&9@ZPPE\>4H9SD<8 8'.<<U"_@9[C$=UJA> SW<[(D 0DS
MYZ'<<%2<@]_2I9?!UU<R0S77B&]GN(XKB+S'BC'$J!>   ,;5/N<^M !J?BT
M+?Z;%IY+6[WZ6]U.4!0!HC)M!SG=C:>F/?/%6+'QGI^I!3:6M]())4C@S"%$
MVY68%2Q P%1B<X(QTY%58_ -FEQ;M_:-\((9H;G[,GEA'F1!&6;Y<_,H (!'
M4_A:A\'6UO9Q6L6J:H$MY5DM6,X)M@H90J97[NUV7G)QCG@8 *B:SJ;>!M+U
M0RN;MKBV68)&FZ56G6-EQT!(/;OW%6&\:6R2;)-/O(2K3QRB78#'+%&)-APQ
M!+*<C!/3ZXO_ /".6:^'ET9);E($8.DHD_>(P<.K D=0P!'&.*I3^& XLK-5
MCFM%NA>7<]PY,\LJXVG  ') !.1@# &* .AB9GA1WC,;LH+(2"5/ID<4^BB@
M HHHH **** #%(32T4 )C-+129YH 6BBB@ HHHH **** %'6FGK2BD- "44H
MZ4M !1110 4444 %%%% !1110 UV98V94+L 2%!QD^G-<3:Z#K6GZ]HNKP1*
M\\\$D>LKYB*NYFW@CCG:[, >3M4#Z]Q10!!9/=/8P->Q1Q710&5(GW*K=P#@
M9J>BB@#&\66%WJGA?4+"Q2-[BYB,2B1]@&>"<X/0<XK,U;0M5U233)@EHABT
M^YMYUEF9B'EC4#!V\@%>2<'!/%;NMZB-)T6ZO=T2O&F(_-.$+D[4#'L"Q _&
ML73_ !:H\,P7MVOVN[2Z%A.EB5;,^_9QD@8)(/T84 5-+\*ZM9:K8S3RZ;-
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MLDFLRM>VZ20QW2VT2;874+Y810%P,*1U.1Z<4 6=/UR;4=0TEHUC6QU#3'O
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MEN_LS>;*69P97V;F7:S!,[0Q'!(&: )M8M)+[3)8(Y;J-CR/LLWE.V.=H?\
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M_0Y9WU&XD1?.*QR/]J9(Y2.BNH8*WT(-:+ZA91S20R7=NDL:;W1I &5?4C/
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MF3YC)L8+PO)7<5) KCTL-;@M-)CMM+U*,V_ENOSGY<71+*PWXY3DDYSQTYR
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M4=EI6GZ<S-9V4$!8DDQH!U.2!Z D9P.,\T <1;:/GQKJ\XAO)TM+])?/^WR
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MOKCIQ0!MS^=]GE^S[/.V'R]_W=V.,^V:YOP;->?8]0M;^2\DU*VGVSK=SK(
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M".RIQ*>K'JG'S<=7%H>E0W%S/'I]N);G=YS>6#OW'+ ^Q/)]3S3/^$<T,P)
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MMMN%&X[=Y7) /7/O3+_3=5EMIX)-/U_48I;1&LVNYD9XI!,Q;> 0 2I0C/(
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M@GBMI6TC5((;F9(8I98X]I9I!'R5<XPQZ'!QR,T =/14<D\4)02RHA=MJ!F
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M]BS [2P 9< 8*Y'O4^KZ_8Z'Y/VTS 2Y(,<+.% *@DX' RZ_G6-;^'-;TNT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'I24IZ4E
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MYU.U\N5BJ-Y@Y(8*?P!(!/09'K5B/5K"747T^.[B:[0$M$#SQC/XC<N1VR*
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M%%% !1110 M4].4K:-GKY\W_ *,:K=9^E2B2UF .=EU.I]OWC4 7Z*2G#I0
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M\L#S!@C)^@!VVF:-;Z;H%MI#9N;>&$0GS@&W@#N.F/:J5M%X:TZ2ZT^ULK2
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M6\4<VE2Z>5DB+$>8P);((]!^M %RZ\7Z'9+*T]W(/)EDAD"VTK%6C +Y 4G
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M+8W^9LP#C!'T)R3^="3P??GS%CN;%$\^RE010-$H$!R0%4_+DXQ@\#\Z;;>
M[B"T2U.L*T5O;K#:D6@W)MF69&?+$/@J!C !H VT\6Z'*UNL5^LK7#E(UCC=
MSN! (( RN"PSG&,YZ4RR\0A+:QCU>,VNHW1(^SQ122!?WFP,<+E5)*\M@<U#
MI_AFZM-3L;Z?4HYFMEF5D2T$2GS @^4!OE \L'G.23STQ-KGAPZUJ-A=&\\C
M[(<KMB!=3N4DH^05)"[3G((/2@";5-?TK3;ZWLKUG\^7$D:BW=P!N WE@,*
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MZ;)?64DOEE9HP,>8/F/3<K%3S@CCG%;VDZ,-*GOI5NYYS>2+*XDVX#A%0L,
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M)I^HWT7PCCN[.Y%O=0JR>:Z^9]V8H3R>^#USC-16&KW>E>(=1$#13:=<:I<
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M**)$C7HBJ !SGI]: .%.KW6D:C>6^H:E:Q,)[1+R_BMT4QAH7)+<="Z!06'
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M'E;-ZENF5D.,8/'48IMGH>L7FG-'(M_:3C3-L_G7!/FWH965P0QR,JV<8R&
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M/$?*#_@/;\/2K<$$-M$(H(DBC!)"1J% R<G@>Y)J2B@ HHHH **** "BBB@
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M&Z*1C[V0 >J5E)XCTJ6Y:W2Y9G2X^RL1"^T3?W"V-N?QK0MKA+JW6:,.%;.
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MXB"Q';(Q<80^A]*1KVU26&)KF%9)AF)#( 7_ -T=_P *X;_A$-2MIX+JTLK
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M8P#MYY]1WK4H ***#TH **0"EH ***3'- "T444 %%%% !1110 577G4)O\
MKDG\WJQ5<$"_DYY,2\?0M_C0!8'%%)GFE% !1110 4444 %%%% !10.!BB@
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M VA=V0XP/QSS7HC2QHA=I%5!G+$X QU_+!J*"^M;FZN;:&='FMBJS(IY0D9
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M#TVJ>O34\,:5K&BF>2>RADGNEL_-D$P!&V)(Y,X')&UF'8[L>M=A10 4444
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M'BR%1855B-A7:SCEEY)P>^/2L7P]J>I:IXHBO+C$-E>Z0EQ#;).TBKE_O$$
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MJMC:KK&HO:&2Z>&8J$,RH8S&)3LX!;S1QC( Q0!WL5G;0>5Y5O#'Y,?E1;$
MV)Q\J^@^4<#C@>E1VFFV-@TK6=E;6S3'=(88E0N?4X'/4UYV-0U9;(S'4-72
M/9:?;?,B*O%<-<(DBQY7GY2_RC(^[CK3[K^WS!'_ *3KG]E">X\B6UB=KIL;
M/+W@C=MR)0,C&,9'0T =Z-,TJWG6<6-G%-O^601*K;CZ''6F65MI4\+O;6,*
MH)CNS;;/WB,1G! R00<'\JXXZ=J$LXU*[&L7,UKK2!87:38(^/G5!A2 6/S8
M(QGMFH)K?Q#/&%EEU]+);Z^1C:-MN-I;]RV6.2F-V.W3V( ._?3;&2-8WLK9
MD4DJK1*0,]<#'?O4Q@A+[S$A;;MSM&<>GTKD?#5GJ5OXADDNX[UT:"3?+='Y
ME?=& N5.Q\A200HQ@CH138M/U Z_OD@O!<KJ,LKW6[]U+:%6VQ]<="BXP"",
M^IH N:EJ.FZWX7OIY5U"'3;<K,)X$"F5$(</&>?E!4'/!X].NKI^O6FHW1M5
MCN(+CRA,(IX2A:,X^8'H1D@=<CO6';:1-'\,[O3+32Y+>ZFM)H5M6**Q=@5!
M)W8].<]*SX_#^L21S&*WN[>8Z*;5FN[M9-\V5(5,,Q0'#@G(ZK@<4 =Z[K&C
M.[!4499F. !ZFF2W$$(<RS1QA "Q=@-H)P"?3)%</#X1$U["'T-;?2C>),UB
M\B%8Q]G=&.T,1R[)TZ[2?K!;>"3:A+C^P[255U*XEFLV*$3PMO$77Y24WC /
MOWQ0!WSW=M']^XB7@-\S@<'@'\:@FUG2[?'G:E9QYE,(WSJ,R#JG)^][=:XJ
M3P)?7&DV%J98H&-M)!<@$.8P)/.A"$C!V-\O3&TG&.*DU#P=J4]O:-Y%A>32
MQRB^BFFDBC$LKJ[.-G+*",8/.%6@#MH;^SN9W@@NX)9D&7CCD#,O..0#QR,5
M5N=:M;+4);>ZEA@BBMA</-),HV@L5Y7.0,CKT[5B:/I-YX96X,6GVEQ/?:L[
M&2#(9;=V+;G)7JHSP21VSDTOB?PU>ZS<7[VILU6YTMK,-*6#;_,##.%/R@9]
M\]J -8^*-!%FMY_:]F;9G,8E$H*E@,D9]AS^-$7BC09[J2VBU>R>:)79T68$
MJ%SN_+!K!U+PQK%TU\;9K*![B\,T4D<TB/"/)CCR,*0>4Y0@A@>H/-9=IX6N
M/$J:@MR[6=K%?ZAY#FW997,VY22& RH#=LYQCC% '82>*]"ALQ=/J4(A+%<\
MD@A0QR,9& 03Z BC2-0TR[NM5:QM1&\,X6>58<&<^6K!L@?-PV/7CT(K%L_"
M6HZ=#;/8SZ3;7,0EC=([(B&1)!&&)4,#NS$IZ^WO6QHNC7.EW^HSS7:7"7?D
MMGRMC;DB6-B<<<[0< #&: *=OXQM);JWDE)AT^[LX[BW:2%Q("S[3O&,!<E,
M'H<]2"#6I%K^F3:K_9B7/^F'?A#&P#;?O;6(P<=\&L%O!EY)HQTUM6A"#31I
MZ.+0[@%?*O\ ?Z[0!CUYSVK0TWPRVFZQ->K>JT4DLDYA%LBG>_+9?[Q&2Q ]
MQR0* .@HHHH **** "BBB@ I#2T4  Z4444 %%%% !1110 4444  IC]1['^
ME/ICYRN.I/\ 0T /[44W)IPZ4 %%%% !1110 4444 %%%% !1110 4444 %<
M;XE\/:AJ/B6TU"UM+>1(%MV61I K;H[@.RG*D@;<],<]<X KLJP=0UB[;Q+!
MH&FM;17+6C7DLUQ&TBJ@<( %5ER22><C&.] '-VGA#5;33(8&LM-FN;+:/.,
MK#[>JS>8%8$$+U)).[Y\'IS5J;PGJ$EK=PQV6DP1WMBUIY*.VVS)=W#H2GS'
M+[CPO*KZ9K5;Q))I$31:Y%NN8E:69[*,F-(=VU9&!)*@^G)&#V&:@_MK44O)
M(FF@=!K:6JLL?!@>!9 .O7YNM $8\.:F-:CF9;&2RBOY[M=TC;G66)D*,NW
MP6ZY.1VJM%X.U&WGTVXCGM#)8V=G;A6+;7:%FW-P.ZL0.M7QXSBN?DL=/NGF
M5K<M',%C/ERR;-W)ZC!X.#TIL_CW3HIKA$LM1GC@+J9XHE,;,C!6 8L.^>N
M<'&: *-_X0UJ]_M$G4+8/<V[1+(=V5;S_,0@8PH X(&>1G)K470+]=<GU$75
MN%EF=VBV,0RM#%'@\\\Q TK^*"NJVVF7&G75G)=-Y2N\L+,C%68':K-QA3ST
MSQS2:9K%S!X&MM2N3]KN1& 3)(D6]M^T$L< =LG^= $.F^$)(_"E]H6HWGF0
MW651("VVW4J!M3>2<9!;!.!G&/6,^$M0EO8+Z;4+4W,36J_);,%,<)8]-_WF
M+]>V,<]:;+XZ9+59DTEY2MI-=3A9U 189?+E"DCYB.2.!NXZ=F2:_/J7B[1T
ML\KIJ7UQ;/(LY'GND+D@IC!4,."3U&<=#0!M:SHMSJ%]8WUCJ'V*ZM!(@<PB
M4,DFW<,$CGY5(/MT-4)/!WF3NKZBYLC</=K#Y0WK,Z,C'=G&T[V;;M')ZXXJ
MCXKU;43_ &C;VK>2MA-8LCQ3,CR-)*%*M@?=(/\ ^OM)-XLUD(MO;:-;W&HI
M)<+-"MV%0+$4R59PN<B1>W8T 7;CPBLT$$?V]_W=G%9N'A1UE1#D[E(QSW%0
M6W@6WM$A2'4[R-$BM4D"B,^8;=]T;'<IQSV'M5_6-9O8+W3['3(K9[B]BEF5
M[AR$"QA3CY>I.\<YP,'K7'7?B"\\0Z?K$WF^1 D&FW5G#G#1L[Y;+#KDC'TQ
MT/4 ZM_!EBZ%1=WB$_:PS(R D7)S(/N\8(!&,8QWI;/P=8V;6S"ZNY#;W*W2
MERG+K$(AG"CC:!P,<BN?N_'6JQL+:*'3X[A'NP\D[;8G\F4(%!9UP3G)Y)'H
M:Z7P_JU[J\]_)+]D%K#.T,:Q;O,!!ZL2<<@CL* ([/P?9V _T6]U")C''&S)
M, 6".77.!S]X@]B"0:GF\+Z=/H,6D-YRP0N)8GCDV21N&W!E8="":Y.'QWJ=
MY!=?9Y--9U-NT)"[=Z/)(LF TG)&P8W;"<]!D5&OC?60IG@:"]46(DCCBB \
MR3R!(2XW;T.3D  @KT(- '3_ /"$:,;6XMW2YD6Y@\B=I+AV:0;S)EB3RVYB
M<^]9P\':A-K-])=7^=/O)I7FBCGE'F1N"NPQYV9Q@;NO'Y8]GXDU.75=&EO-
M9L9K=IKA?,LV+QL?(W*CML4$@]E&>0#S6WX2UW4=3T/4;B6X6^O(OGC6-4\K
M)3<J(R\D=.& 9<X.>"0"+6_!4<=LDVG7SV_E2">9[R]G.66,HK^9ORA )SCJ
M,#C Q-!9^%XK+2]5U75+&ZG2-8X[^6\PD[(21U?#E3G&[<01US6!>:EJ%]X<
MO$N-6DN[:6SMIWD\E$>VF,PW185<= ?E()X]ZW_%S1V6EZ']FDBXU*%Q(8MX
M(^8LY5 ,]23C')[4 :.A>'O#=G+_ &KHEO 3*C(D\,QD3:6R0G) &1T7 '-3
M?\(U8VT]Y>Z;&EIJ5P'(N6!D"._+,$)QR0"0,9KC+&[O[=;M2T]MI,VKR/<:
MC;PF([##\FQ"#M7>JJ6YS^)J.>?Q/<Z??7#7^K175OIEO/!!!" )G.\-D;#\
MV-I(&""W08P #T2RTV&STM+#+2QA2KL_5RV2Q./4D_G5*P\)Z#IDYFL]*MHI
M/+,6X+GY3U'/8USD]OJ=GK8MS>ZO+<17%L+$EW:*:#(\XR[0$SS)G< 0%3';
M-2#2?$JZFMA)/J#6GG&T:Z:[D8F-91.LN#QS'^Z+==W';D [<:#HZPI"-)L1
M$BNB(+9-JJ_W@!C@'OZT]='TQ)HIDTVS66%52-Q H9%7[H!QP!V':O-KVPU_
M;J;JWB--1,P$I@9A#(K7"E3&0V>(R1\H  !!KT/29[>-[C2+<71_LT1QM).2
MV_<H8$,22W'7_#% %T6MN&9A;Q!F8.QV#EAT)]_>H=5U.WT?2[C4;K?Y$"[G
M\M2Q SZ5YO9Z'K LECGTW4E2:>Q>9//.25ED$Q)\PDY3;D\9.#@<4EQX>UR?
M3-1LUTBZN+5X;J"QC>9 ;<F=F4D.XX*;0",D;2.AH ]0NKA;2TFN61W6*-I"
MJ#+$ 9P!W-5M,U6+58(YX(9UAD@BG221,*RR#( .>H'7TR*R/$]GJ-U=6$EM
M8R7EH(;B.>W654(=T 1_F(!Q\XZY&XXS7-KX6U06D4+:;(,Z;802F.2%LS0E
M@Q*L=K@ KD' (Z'(% 'I--$B'HZG@'@]CT_.N*M="U)+JT2[T+3YT/V9_/$V
MS[)LC5)(P/O,HP^!D@[R#QFJ-IX=\1#1V@N+4(\>GV=K&(;I Y>"8L'&4(&
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MVDUI!+;Y$DJR$9+@C"XP#@$Y//&,5-;>!@IO&N]1EE>\LGAF*\ SR+MDF Z
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M-# DZ_9U;S7BE,JOG/'S,V1]* -&_P#$]D+02VEZL2K<Q1M/-:RF-@9-C*K
M8).&&0< ]?6I6\7:*C3![IU6'SO,=H'55,1PXR1R1Z#-9UQX'2Y%WNOA&;F2
M)W\FW5 Y23S S*#@N>!N ' [U)-X'M;I)(KF[F>&2>[E**JKQ<#YES[$Y!_
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M457O+VVL(5ENIEBC9UC#-T+,< ?B30!8HHHH *0&EHQ0 &DS0>E H 44444
M%%%% !1110 4444  ZTTG]XOU_H:=3#PP/\ M?T- "TX=*3H!2T %%%% !11
M10 4444 %%%% !1110 4444 %8VKZ VH7T&H6>H3Z?J$,;0B>%$?=&Q!*LK
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MLLQR 1G.!CI@]\57D\5ZAHVE6\<$%FBV^E"^DB?S)"V)0CJK%LC@\$YKM/\
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MU:ZA+/(\MS&]NL;/(<[ YR^U^,#KG)]>L7Q=H3PF5-01P'9&548NI7&[*@9
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M:XU>;5;>"VDOT)@DN% +*P&"I/J!QZXXJY'8VD4HECM8$D!<AUC (+D%^?\
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MPZR^4Z+YJM(T@##;_"SL01@_,>W%=910  8 'IZT444 %%%% !1110 4444
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MV;(?F^5?O YW8[D8..M6;7PU)'-IDLEM:A[;5+N[<JV?DD\XICCD@O']-O%
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M4W\&@QWVV2- A=@YW\=_EY'3BM&'6Y=/OKFQG-]>71FABB29H0"SQL^%*JO
M"MG=S\O'6IQX.L!#<1&ZO62>P&G-NE!(B!8C!QU^<CGM4L_A33[EII)I;MII
M?*/FB=E=&C4A64C&&P3D]\F@"M+XL>#4K&RETN2%KHQHWFS)NB=P^T,J[N,H
M1N]^,X.,[3O&$S:7::C?02>=+I\4OEQ,!$SR2^6N 1D')7)R< ]#6O'X.T:"
M[6[6.<2*R2$_:7 9T9F#L,_,<NQ.<]32Q>'_  \FFP1JBM9"$6\6ZY=DV%PR
M@$MC.X+M;J,#!H IW7BZZMY9+8:0'NXI)HY$^T@(/+B27<&VY(*R#'&<_G71
MV5RM[86]VJE5GB60*>H# ''ZU1'AS2Q(LA@=W#N^]YY&+,Z!&));GY0%YS@#
MBIK:TT[1EACB*VZNL=K$CS'!V*0BJ&/7&>G)QSG% %^BF&6,3+"9%$K*65">
M2!@$@>@R/S'K3Z "BBB@!,8.:6@\4 YH **** "BBB@ HHHH **** "D;[II
M:1NAH 4=**0=!2T %%%% !1110 4444 %%%% !1110 4444 %9>OZ.VMV,5L
MMV]JT=Q'.)$4,<H=PZ^X'Y5J52U?4!I>DW-Z4:1HD)2-029'/"J .<EB /K0
M!5UC0SJ<JS07LMG/Y3V\CQHK;XFQE<,#SD @]N?6J2^#[?R=2@:\N!#>R6\B
MJ@4&$PA FTD'/^K3.<]*YU+^YB\+:OI%_<W+WMG-#,)IU:-I(I)%;=SS@-O7
MZ*/6NCT)737O%,4;L<7<;()&+ %H(V/4],GH/PH ?)X1M6(ECO[^&\\Z29KN
M)T61BX4,#\NW!")V_A%12>"=/EN99VN[_P#>><"GFC $J!''W<G(53R3R,UA
M:?XQU+^Q-,7S+)[I].2\EN+Z411RYDVLH;/RD*&).#@E>*T(/$&N7#V[>;I,
M45SJ4UA&3&[[=GG?,?G&<^4 !QG=VXH V;SPW:7UVMS-<7F\"#(68A6,+ET)
M'^\2?3\:AC\':4EL+=OM,D825 'G;I))YC'CON (/48%<]IWC/5[S2([MGTD
M37-HES!$<Q[3YPC926?GKP?E&2 ?6M.Y\3S+X(L]7CE ,\L<,MT\.Q8 9-CR
M%,D?+SWP>#R* +3^"]"NXHA(+F;R_,C>0WDA:4,?G61MV7&5'!],5H7,>F-K
M5D\UTB7T"/Y$'G[<AL G9GGL,XXS7GMMXAO=,L5T^WUBQMDBDOI$O;A5\N[D
M$Y8+\H( *N3A0#G 7I6H;N&+7;ZZ:ZM7G.M6D122.,LB/#$/ER-PR21_P$]\
MT :VO>#$U!&.GR1PO+=_:[@3O,RR/L* C9(I7@]B,X'88J6P\,Z7HNC3G5)A
M<;[8PWEQ<ROL:(%B%(9CA5W$#G..]<[<^)M;MC+)#J277G1ZB(H1"F8S!-M1
MEP,L=A)P<@XZ57O-1O;C1I+*76[R>SFBO/*NX[7<TK[4*0ME.>'<\!<XP#\I
MH ZP^&O",&D6ULVGV L))E:$. 0\C8"X)Y)/ Z\UJ?V%I7V@7'V"#SA.+@/L
MY\P+M#?@.*R=4N;F'0M!DM/.1GN[-618B28R0'##' VYSZ8K/\/2:A%K=H\U
MYJ=U%=?;8W6Y4A$$<P$3@;0 2H/'?=[4 ;\NF^'[&33P^G6$+))Y=G_HRC8Y
MRV$./E)()XQS5B+0])@0)%I=E&BHT85+=  C'++TZ$\D=ZXRXT]WN[JV:WU7
M=)X@CD=T$Q41LIPRMT51R"5QCC..*K0IJLD6FK<PZ\X\I$MI(HW#I(D[D^9O
M*[0R+$,N.5S0!VNI7.C036UE?01R2!3+!"+5I=JJ-I90%.,!L?C[U;LS87D,
M5]:QQ.DO[Q)1'@DD8STSG%<YXCM;N^\7Z)%:S:C:H+:Z66[M8<A-^S:"S*5&
M2A]Q@=*KRZ?K!\2>85NGN$OX7ANM_P"Y-IL42(0#@$D.<8Y8J?< '4F\LK34
M;?3@ICGGC9H@L1"E4QQN QP#TJ[7FD/AHG3M'>ZTG4IR_P!H%U'Y[;PY&U#R
M_P HP/8#@FGVWASQ$ES:O?I>7DZ16ICGCNXHUA9%Q(C,09""2Q.WALX..M '
MI%%>;V?AJ_FBM;6^\.LEL9K229%N4"JRQ-'(<!R2.0>22V23S40\)ZINU98]
M$CMUN+.[MT6*5%1V>16B;(8N> <[CQG  '% 'I4DT44;222(D:]69@ /QI#/
M")Q 98Q,PW",L-Q'KCK7G\GAK5(=3O)K70K2736N1(FF2S(D3!H0C,, A2&!
M/3D-5_3_  Q>V_BI=0N+*W=?,$J7*WLH^SCR0AC6$84XY 8]CT[4 =%JFO66
MD7FG6MR7\V_F\F(*,XZ#<?0;F1?JXJ:[UC3+"XCM[S4;.VGD *1S3JC-SC@$
MY/-<[K_AJ_UZ75I6FEMG%L(; 0W&U789<,_&0=^WH>@'>N:U0:E+XIB^WZ8D
MLVRRDFBCD?$DL3.05/E-N7YQD#&.A..: /07\2:'' 9WUG3UA#^69#<IM#XS
MMSGKCG'I4LVM:7;M*LNHVJ-%&99%,JY5  22,],%3^(]17('P;J#Z7I*M;:8
M\]L+E+BVED?RI%E;(.Y5R2 !U'<].M23>"KMAJ%O'%HPANHY=ER;<^=$9(3&
M47^ZH/.<YQQCO0!T5OXIT"\NDM;;6K":>1MB1QW"L6.,\8/-.?Q-HB;]VIVX
MV$*1O[EBHQZY((X[BL=_"EX\AD-Q;!S+82G:A )MSEA^..*JV'@F[L(+6W27
M3"EG+"89Q:$32(C[OWC;N3C@ <9)/I@ Z&U\1:??:E;6=H[3?:+9[E)D7Y-J
M.$()[-D].V.:I:_XLM]+T_46M!YU]9Q-)Y4D;JC;<;@'Q@D!AD GJ/6F:-X:
MN]/U5+^XO8'93=KY<<+ %9I1+U+<$,/3&#Z\FOJO@F34I]2D34(K8WT,D3^5
M;$;@VW!<;\.0 <' //7C% &O)XGTB*W,S73[1(\9"P2%@RKN;*A<C"\YQ68_
MB6]_M.Y@C6U:&/4[:U5P"=T4L2OG.<;LMP>F/6EO/"=Y=RWK'58D6[E>1T6U
M.WYX!">-_)PN0?4GKFDB\'RHTK'4^6NK2Z7;!MPT"*F#\W(;8/3'/6@"]JNN
MG1]9@CN%+6,EG-.WE0/)(K1M&"3MS\NV3T[=>0*=)XHL([M[8)=2.(7F0I 2
MLH4*6V'^(@.O3^=.U71)-3O3.+SRD^PSV8019QYNW+9SVV+Q['UK.T/P9_8M
M_#<_VM=77E9P)D4ELQHA!;&['R @ B@":^\::;8Q!VANY=ZQ-$L<8S*75GVK
MD@9"KDYQU'7-6[KQ!'#9:9=V]K-<QW]PD*@8C9 P)W$-CICIUYJK)X0MA9V\
M-G>WEK/;737,%PK*S1E@5VX(P5"G:!C@ 5;GT!)]*LK)KZ[\RTECF2Z+AI6=
M3R22"#G)SQCF@#'T_P 8K:P7@UGS,P27A6Y2(!'2&4J5 !SN P>F#ZDYK7LO
M$"WEA?W3Z;J%H;(L)(;F-5=L*&^7#$'@^M4F\%6$J>7<75W/$TET\B,4 D\_
M[X.%!&#R,$<^O2KMEX?6STR[LCJ>I7#72E6N9[C=,H*[1M8 !<=1QUYYH Q[
MCX@VEKI$>I36,H@=W4,)XF4A0IRI#88_,>!S\K<<5:N?%[6^HM9C1;V3%Y]A
M6021 -*8Q(HY<'!4YS_7BH9/A]I,UDUO+<Z@[.93+-YP5Y?,"!MVT 'B-.W;
MG))J\/#FFB] -W<O/]K74=CW&6+JNP''7;@!<=.!0!3M_&?VZ6V6QTFZN-XC
M-P%!S!N<K@\%3C:2>1QTS5O7/$<FCRW*1V'V@6]DUZY\X)E%;# <'D#GMFHX
MO".C:>;.Z,ERGV $^8]TP#@,7'F<@-@L2,^O-7+O1M*U:]N)9V::22T-G-&E
MPP'E,=V"%/&?7J1[4 4)?%%Y'<26/]E+_:(G,21&=O+=?+$F[>J$]#C&WKWQ
MS44WC&X@NH(9=)$;31N=CW'SHZP>=M<!2%_N\G/?;BK0\+^'-3LG(B^UP3LC
M&47<CDLB[ 0^[(( *G!YYSFK#^$]">5I#IT0<KLRI88&SR^,'@[>,CG&/2@#
M"F\737>DQ27-@]OYT5C=I]GO"&,<TP7[VP="!D=PV,BK+>++]-4,#:5&\/VB
MXM46&<M*[Q1&0$ J!\P&,9ZGK6B/!^@CR_\ 0<^7!';INF<XCC;<@Y;L1G/6
MK%YX?T^ZL[N%+>**2X,DGG! 6CE=-AD7/1L4 5]#U;4-6\]Y;1(8#;P2V\N&
MP[/'N8<@ @$XX_G6%9>+M8N=1CTYX+)+IE6%L)(56Y67$R9S@XCS(!G.,'D5
MH^$]%T[2_MEU9W<4P)$#^5&8T1H^&R"3EL]2>F.,5T?V:#>K^3'O5BX;:,AB
M,$_4CC- 'G5EXBO_  [926\:VMS9H-3>)<-YBO#.?O-G&W#YX' &<U83Q5XC
MDN(+%+C0S<3"Y82H"ZXC2-U! DPI(<_Q'C!^O<QZ=91,&CL[=""Q!6)1@L<M
MV[GKZU2OET32;&2:XM;6.*UADFV+"I*ICYRJ@9QT!QZC- &;>^)I+?2/#>J;
M[>&VU&:$7+2C"HDD3-G)/R\@=?6LJQ\87]U>:5F:VD@NDY^SA6,C^9*H&"X*
MAA&,,,@$'/:NV2&UFLXD6&)K?:I1"@V@=L#M3Q;PB17$,8=1A6"C(^GYF@#S
MBV\7ZC-]F2]UG2XK6ZE07$T?S-9920F-]RA5RR!1NR?O9SQBU9WT=K\)])G#
M6LBPR6\69%61'VSJA(S]"0>HQ[5WPAB"LHC0!CN8;1R?4^]*41DV%5*C'!''
M'2@#B-%\1W]UXAM[>;4HIXI;Z_M#"$5<"$@H00,EL<GG&#[<PWHFEU[4K9KV
MY#1:U920%DW^4KQ $J,8 ^^,G(&.??O0Z,[(&4LN-P!Y&:8US J.[31A$.UF
M+#"GT- '%-KNIBRC7[9.)/LVI1_:C9;SOBE012,JKW3)P!@YZ'%:?@[4[[48
M[P745X(HV'E33X*2Y+;MC;%) ([@8&*Z<$$ @Y!Z$44 %%%% !1110 4444
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MG &.F><581%C1410J*,*JC  ]!7G-SX>N[G7(IY;'49%.KW G!E.Q[9ERO\
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M$H\O,?DDE&&4(S\S YR"#TJ_'X:M4\.3:)]HN6@E:1C*2OF NY<D87'WB>U
M&7:>+%M-5U*TU4S>4E_)#!<B(".-5A638Q'.<;ST/3GM6GH?B&#Q):W#6D-W
M:F/ #31KSN7(92"RGZ=1W%12>$;"=I?M$US,LMX;QT<KAG,7E$<*/EVY&/>K
M>EZ'%I4,L<5Y>S%T6,/<3ERBJ"%"YX&,GG&3WS0!QOAGQ-J1T>WU?4-0OK[S
M+>-#:&TBC62>64I&(W 7^Z0<Y'S Y].AC\6&ZDMK1-*OTN[B:6W= T68&CV[
MB26P0 V1C.<8QS5F'PGIT7AJ/0=UPUG$0T3&3$D9#;P588((;D&G6WAFRM;R
MTNTENFGMGED#-,3YC2 !B_\ >X ^F.* .9T#QZ8/#>GR:O;7KSS6OF1W!5"+
MEA(L94!3D'+IU X_7=;Q5)'/'#-I4\!:81-YSJI(,T<09!U9<R YP.!Z\4Y/
M!6AI;R6YMI'A:)H4C>5BL*,X<A!GY?F"D$<C:,=*D'@_1R4:6*XF=5P7ENI6
M9\.'!8[LMAE!&>F* *,OC*1+*[N5TPD07,ULJ&X&Z5HA(7VJ 2>$'&/XL\ $
MT^+Q@T^I-;IIQ$"7%O TK3?-F9 ZD*!SC//(_&KS>$]%>'R3:/L\^2XXGD!W
MR ASG=G!R<CI[4EKX1T2R;=;V;*=\,G,\C?-$,1GENP'X]\T 9K^,;U+*RNO
M[$W)J @-D%O$S)YG9@0"I4$9X(Y S6O'K,J>&SJM]82VTR1L9+0,)7#@D; 5
MZDD8'U' J./PCX?BAGB72K;9.<R!ESWSQG[HR,X&!FKITC3VL8;(VD1MH75X
MXL?*&4Y!]SGGZT <MHOB&]T_1M9BU+S[K4-/C:]421-$98F!88#<X5@Z?11C
M/ J]-K^MG5!80Z9;1-)<RPPRW$C@.J(K[P-O(.6''<5IZOX?L=7BN2\:Q74]
MLUJ;I4!D$9ZKD]CSD>YJIH'A6TT4>;(MM/=ABRR1VJPI%P1^[09V9!(.#S0!
MA?\ ":ZN;%[O['8+#<2B*T)G!9"91&3(NX9 [G*\X''6DF\7ZY#!N(T<O!:_
M:+C8S.&Q,8V"D-@<;3WVG/6NR72=-1KAET^T5KG_ %Y$*@R_[W'S?C3?[%TK
M:%_LRSP(_* \A>$SNV].F><>O- '*ZCXHUNSN'T\3:-'>+=R1"XN5>.%D$"2
MJ,;\AB7QG./E/TIC>*=8DU%U6?3Q EY%:"..,[F,L(=3O9L9#''W1GVKL#I6
MG,'!L+4AR&;,*_,1T)XYQDXIXL+-93*+2 2%PY81C)8 @'/K@GGWH Y;1=7N
MO^%76^I'4(9;T6F3<7,@"[^@#,3C(R!D]^M<S)K5U<7RZS:WRI?P:'=R/));
M(#((K@'R\!B,?*R[@3_$1@]/4U@A6'R5B01<_(%&WGKQ2K#$F-L2#"[1A1P/
M3Z4 >:ZGXANKW5-:TV34E?3+FSOH5#1Q@0F.)3N7!W,-KYRQYYP !6WX/='U
M[4""OF'2].+XP"3LDZ_@1^E=@$4,6"@,>IQR?\X'Y4Z@#RRQOM=TJTN+'1KB
M2YN;=+\SZ=Y2L;9_-9HG!"@DL#D*2=V>!CINV>HZBW@?7+Q-6EO9UCEDM;A+
M8H5/EY" $?-AO;@DCMQVU% 'G,TFOI-I<::YJ212VL=PLYTXSF>9B2T9V;0@
M"@8#< $\C&::E[K[RWDB?VT8)/\ 6!XGWHBW05C'A  WE;L*O.!GD\#TBB@#
MAK2TN;KP7XKM(;74%:2:[%J+D2++,&0%2-V&(R=HSU Y[U&[:M)K$\D/]KKN
MN+,Z:KB81>1\OG"4= <>9GS/FSC'.*[VB@#R5+K7;M&GM;[5%GGMF2&,/*?M
M.)]SRQ;QY:MY(X'^UQTJW-HM_)'(T-AK%PL^DW]K"]\Z&4.^TJ' P%!^< ?3
M\/0+/1-*TZXDN++3;2VFD^_)#"JL?Q J_0!YM<Z/K$0-O#9:HVF)<033017"
MF24-#API=CG$@4D$X]/47;&.70%U+6K^PU-DL[2#R!<W2R.^$VOC#;=W3/ R
M>F<UWE% '%>/M(U#7M.M4L---PWE2L&+(KPN5&SAV '.<D9(QQC)-2^%]&U&
MQ\1:A?W5KY2729E>41%VEXY5D.2AY.&Q@XQQ7844 >;W7@_5'L;U!:127CQ7
MZ2W 90UZ),F$$DYRI*_>X&W@U++X.NH9S]ETJ V*O [6,=SY"RGR61VRO1@2
M.OWN?K7H=% %+1[06&CVEH+=+<0QA!"DK2B,#HH9N6QTR:NT44 %%%% !2&E
MHH !THHHH **** "BCMBCH* "BBB@ %(3@TM%  *!R:** "BBB@ HHHH ***
M* "BBB@ HHHH **** "F3316\+S3R)%$@W,[L%51ZDGI3ZR/$FEW&K:4L%JT
M(FCGBG59\^7(8W#[6QS@X]#]* (--\6Z9>V4]W<7%O9PQWDEHCS7"!964\%6
MS@Y'.!6C<ZQIEG<-;W.H6L,ZQF4Q/,H<( 26VYS@ $Y]C7+R>%=4\Z[N$CTY
MVNS<J\$DK%$$OED,#LY8%#D8&[(Y&*FL/"E]IT]Q D]G/93D.TD\1:=&\D1$
M*>F#C\ 2.>M &[/X@T:V\SS]6L8_*V>9ON%&W>,KGGC(Y'MS3+;Q+H=Y)LMM
M6LYF\DSD1S*<(.K'Z=ZYB/P3JK:C'?7%]9F1'LCLBC91B!@3R2>HS5B?P3<7
MEL]O-=P(CW%]*2D9) GR5X/'!.2#P<8H W)/%>@Q []5M@074INRV4 +#;UR
M 0<8J>PUJTU+4+NTMB[-;)$[/M(5A(NY2#WXK#MO"VI0ZO8ZHUUIB3P&X,B6
MUEY2/YB(H_BR3E 22>^!C%3Z-X9O]'B(AU=-S6]K"P-MD P@*Q'S9^91CV)S
M[4 =-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %!HHH 3-&:6B@!,T9I:* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M444=Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%%  .M(>M+10 @I:** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*0TM% !3:=10 VBG44 -IU%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.gif
M1TE&.#EAM@*" _<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
M,\P  )G__YG_S)G_F9G_9IG_,YG_ )G,_YG,S)G,F9G,9IG,,YG, )F9_YF9
MS)F9F9F99IF9,YF9 )EF_YEFS)EFF9EF9IEF,YEF )DS_YDSS)DSF9DS9IDS
M,YDS )D _YD S)D F9D 9ID ,YD  &;__V;_S&;_F6;_9F;_,V;_ &;,_V;,
MS&;,F6;,9F;,,V;, &:9_V:9S&:9F6:99F:9,V:9 &9F_V9FS&9FF69F9F9F
M,V9F &8S_V8SS&8SF68S9F8S,V8S &8 _V8 S&8 F68 9F8 ,V8  #/__S/_
MS#/_F3/_9C/_,S/_ #/,_S/,S#/,F3/,9C/,,S/, #.9_S.9S#.9F3.99C.9
M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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5I$F>)$JFI$JN)$NVI$N^Y 4%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ." K8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W[-&:2B@!
M<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH
M 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I*
M* %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:
M2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1
MFDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<T9I** %S1FDHH 7-&:2B@!<
MT4E% "T9I** %S1FDHH 7-%)10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %'7-%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 444#O0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!D:[J]UI;:>EK9Q7,E[<_9E$D
MYB"DHS DA&XPA_\ KU5B\764"7::SY>FW5I*D4L1D\P'>I9"K ?," W8$;3D
M#%6M>TR[U%M-ELY(5DLKL7.V8'#X1UQD=/OUCW/A*_NTN+B6^MOM]Y<*]RRQ
M.L?E+$\:Q@!@QQO+=1GD'@XH W(_$&G2R7BK,Q^R&)96",03( 4"X'S$[EZ>
MHK,UGQE8V6FQW5C/#<LTD0*_-A4:3RR6('RD'=]['*D=16;;> KF/3Y;:748
M'+K9NI>W,B++ BH<J6PRLJ#T//; IUSX&O;BWNHEU2RB6\CB6X1-.P@,<K2+
MY8$@VXW8YR3C.<T =%K'B/2= "'4[P0;P6 ",YP" 3A02!DCGIS7.W_B[4$O
M+W[*L"VT5[#81>;:3,S22>61)D$!EP[':.3A2#\PK4\0^&)-:O(+J"^6UECA
M>!O,MEG5D8J> W1@5!!Y^E.E\.7#)=B+4MCSWL5XKM;ABIC5%"GGD$1KR,'K
MZT 5[7QQHX1K>[U&&2_@0F=;>*38S*VPA,CD[B !DDYXS3Y?%UO,98;6&ZC<
M64UQYTEJQ$31L4*L@Y)# Y ]!@\\5G\#N]K=67]MW:V,DSW$,*(@\J0R"0$M
MCY@&&0#Z_3%J7PQ=S,TSZW.;J6VEMY93"A!#G(VKT4+QQWQZY- $B^++&.(I
M*99+A$M20D6WSC.0J% 3TSGOQ@^E2:+XJT_7KN6"Q2X943S%G:/]W(NXKE6!
M//'0X..U*GABS6^TF]9G:?3;?R$/ $@P "P]N2/3<:9H/A=- E'EZE?7$$<9
MAM[>=P4A0L#@8 R> ,G) &* (9?&MC!)J*3V=_#]AB:9C+&J^8@;;E06R,GI
MN"Y!STJW<^(X+71(-2DM;G-Q*D,-L-GF/([[54?-M]\[L8YK+3P)#$UT8=:U
M.+SQ)@1M&NS?*)#@[,G)&#G.0<5?_P"$3L?^$<@T43W"QP2B>.="JR)()#)N
M7"[1\Q/&, <8H R[[Q%?:G+I5II@NM.DNKN>UN&DCC:2!TB9@,$E2,@-QG(&
M.":F\2ZYJ-C#J-M:!EDL[*"Z-T@4[F:5EV;&_O!&Y[>O2KT/A6UAN;&Y^V7K
MS6EQ+=%V=?WTD@*L7 7'0X 7: *EU7PW::O<R37$]VGFP"WD2&8JC*&W D=R
M"3SZ$T 9L_C=8;>(KHVHRWCRSQFTB59'7RA\Q^0D=U''=A6O=ZL8HK"..VE-
MU?G;'"Q",GR%F+$Y V@>_.!5.Y\&Z9<O)(9+R*9[EKI98;ED>-V&&VD= 0!D
M5<O?#^GWUE:6C)+#'9LIMVMY6B>/"[<*RG(&TD=>E '.:%XTFDL=&AOHA-<7
M<< DGWJ"7D#8.Q1P,KC)Q[ X-%IX\NI]-L)5T=[NZFM$NYHK5F^1&<J,97&?
ME8X8@?*>3QG6MO!6AVDMN\4$X%OY1C0W4FT-&25;;NP2,]\\<="<J/!.@_9[
M>&2S:1;<MY>Z9_NL^\J<$;ES_"<CVZT 3:[=ZA#?:-;615$N[IHII-P!P(9'
MP,JW]W.?]G'?-8&D^-;^]TJTDM-'N+UWLI;E_.G59"8W9"N%0 L2HQ@#KTKK
M+W2;/4+JTN;E96EM',D)6=T"L1C.%(!XR.<\$^IJA;^#]!M;4VT5CB$V[VQ1
MII&!C9R[+RQZL2<]: ,[3O%-UJFN:9;Q+:);S"Z%PD<C.R-%Y> <JI4_/RI
M(_FS6O&%UHNM265Q:0+")8'24NQ+6S%A+)@#@H0"?8BMNV\-Z1:/;/%9+YEM
M(\L<CNSN'888EF)+$@#J3T'H*O3V-I=,6N+:&8F)H3YB!LHV-RG/8X&1[4 <
MFOB76KN_6SCL;!%;3Q?OYDSAO+9G4  +][ 4G\?7C*@U_7YM-22UN;6UM]FE
M+&OD[_*6;:'))//+8^F.AYKO&TG3WO7O&LX&N'@^SM(4!)BSG9]/:H_[!T<Q
M>4=*LFC\D0;6MU(,8.0G(^Z#SCUH XN[\>:PAU2:"UTY;>V:2.)99"95:.54
M)=%;=@@GH...N>>BTK6[V6VUR/4!:K=:9*R&2,,L3+Y8=21R1P>>O2M271-*
MG:9IM,LI&G4)*7MU)D4$$!LCD @=?05+!IUC:B<6]E;Q"<YF\N)5\P_[6!S^
M- 'G$>N:AK=]I2//8_VG;7V8;@QE8MCVDCG<H<G@\#D9QR!S6D?&&KW%K'=0
M_8X6@M[>>:VDC9C="1RA,;9&T#:<<-R<'W[$:/I:PM"--LQ$Q#,@@7:2.A(Q
M[FI7L;226*5[6!I(?]4[1@E/H>WX4 <5>^)]=LSJ\!$3W.D^=<RD0$))!Y8,
M0ZGDEB2?^F;"M?PKK_V^!H;[5],O+MYW$!LG.UT"JV!D#+ ,,@9QD9KI"BDD
ME1EA@G'4>GZFFI!#'MV1(NW.W:H&,]<4 24444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%9.OZR^BVUM,ELMP9[F.V"F79AG.T'.#QGK6.GCN%]/>06#F\_M0Z5';
MK("))ACD/C[F#G.* .NHKDKGQG-96VN)<Z6JZAI,23O MSF.:-OXE?8#QSU7
MKBHT\<3-#J9;2T$UEIRZCM6YW(R%=VTMLRK8SQ@YH [&BN+LOB!&\B&_LXK>
M!]+&I^9!<^=L3^XP*KAO3KD\4^U\7Z@(]$O=0T^WAL-9E2&#RY6:2)G!,>[*
M@'(';&,]Z .QHKSNX^(6H6>GZA/<V-K'/I^IBSGB+-_JSTD'KG!/T&:L:YXL
MURPD6:!=-BL)M733H9KB-S\I7YI#AP" P8=ONGZT =Y17"ZMXFUW3=(T:]^T
M:0R:A?1V_P!H,$GE^5*NY),>8"N &R"3GCD5>T7Q=+-H^H7^I0B2&UO3:QSV
M,#LER-P4.B\DC<<<$CC@F@#K**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BN!TF[MK'XG^+&NG@BA6""1'=P-@V#?@>YY/T%<]J"
MZ3J7CK5I[F'3WTZ6"UDN'N-BND3(2S)GD-R,X.[TR: /7F944LQ 4#))/ %+
M7D>L6DTLOB;Q+H960-B.]L'P!);O:Q-N*]G4LY_ ^X,OB*#18?&VNPW<=FL*
MZ !'&@42+(" BIZ-@+@=?N]J /3Y[ZTMG"7%U!$Y&0LD@4X]>::^I6$9 DO;
M92RAANE49!Z'KTKQ[4X[J'7?"\5]<V%OJ']BXFDU C:OWOO%OXL9&3GG/6KF
ML&UN-71_#EE:.CZ%,EO'- 6$@$G&WT8HI*Y[<8YH ]?!! (.0>A%%<;X5OK;
MRO#UI9ZE=&$Z:Q-I+!DLRE02SX^4J<C'0_EGLJ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH !UI#UIPZTT]: $IPZ4@XI: "BBB@ HHHH
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MO##JNG6$S0BXG$%J6D5"64;=[D'D<\'''/.*ZW_A'K/^U+757W?VA!;&V,Z
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M<#/I7+PZAXYN5 .@Z5:,5SF>^9@I]"$4_I0!T>HZA;:78RWEW)LAC'/&22>
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M T2,68G][(N .">O?ZXR+/5-6U:R.IRZOJ#>)'N[9+%/-"Q%'+ 81.#]Q]W
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M#Y?G60CUV^E5? >L:[J@MY+Z>6[LY[$3O<2VRQ;)M^WRT*@!A@$GJ1QR,XH
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M*DMD  <#&* -VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IO>G44 %%%% !1110 4444 *.M)WI1UIK=: %HIO-'- #J*** "BBB
M@ HHHH H:Q;QSZ7<LT*R21PR-$2N2K%&7*^AP2..Q-<ZDAMM+\*26Y>V>Y2.
MWEQ%@E3;/LW<9&URN/3<?6NQHH \EM4U&TL[*;38[Y[U?#,D(+6[^8DWFH6
MR!DC+8'^R*Z[POYF8_M>J:G=R&69K<S6DL$;1D1GE7))"DX4N03EL9ZGK**
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M11FFT=Z '4444 %%%% !1110 #K32>:=3>] !112@<4 +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!A6WAYAXKNM>OKG[3)L$-E&4 %M'CYL?[1.
M>?3\ANT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 48HHH 3%&*6B@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@H ZC5H@OP]\#:7&3MOKJR#EO1AN(_-A^5>J5Y_=VX_M3X=V)S&41WVCMY<
M.,?I7H% !1110 4444 %</XS:3Q!KFF^#H'=8;@?:M19",B!3P,]LL,?7'O7
M7:EJ%OI.F7.H73%8+>,R.0,G '0>]</\-/M>KWFN>)]1B,=S>3K#'&V<QQJH
M( R.F&7Z[<T 6T6&X^*5G8VD:K:Z)IC?*G"Q/(0 H';Y,?A7;UQG@D&YU_Q?
MJ3$DR:F;7)ZXA7 _]"KLZ "O%KF2.W^'_CVSBCPEOKA906.,&:, >O\ !Z]Z
M]IKQZZ^4>/K"18]AU2RD ;D-YDP)!'?@=/K0![#1110 4444 %%%% !1110
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MY5)_9]F.EK /^V2_X4 >6:=:Z=X=\:'4K/Q5IVHPZA;2075S/J,*R0,<$/\
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M0 4444 %%%% "CK3!R>:<.M)CF@ /%)2FDH =112'=_#CWS0 M%%% !1110
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M2+(?:JA@3NX7L.3DB@#UB]U6QT[36U&ZN42T 5O-&6!!P!C&2<Y&,=<UD?\
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MV@LHCYMND@'F\AE!;@C SZC(S5/0/#FH:9J\5W<S6[(EM+"WE,W[PM*'5MN
MJX&1@>I/<T =51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444A-
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MO\WZUZ?\479/AQJQ4D$B(<>AE0&N(L[61OA_JL4C\S>)@/,QU_>1KG'U!XH
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MVFR6,.0CR.#U'?[WM]S\^CTKQ3::QXAU72+:*0MII59)^-C,<@J.^001^!H
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MUJ<EY"BX +=/7G_#-3ZUX1\'>%XI=?U&6]202EU=;AM[3-D@H!CYNI]._04
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MAG@C$C0G.\@]-H_B/L*Q/!OQ%L?$EI=->O!8SP28Q)(%5U.=I&X]>.1VX]:
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M.HY.01R>M=[X9O[C0_#.G:9/HVJR36\"J[1VXVYZD#+ \9Q7944 88\1N?\
MF!:S_P" Z_\ Q5/&N7C'Y/#>KL,9!S;KGIZRCUK9HH Q_P"VK_\ Z%C5O^_E
MK_\ 'J/[:O\ _H6-6_[^6O\ \>K8HH R#JNHGE?#M\!@</- #G//20]!S41U
M76]QV^&Y",\$WD0_K6Y10!A_VKKG_0M2?^!L7^-.34];<\^'BG(^]>1_TK:H
MH Y\ZCXIR<>';$CMG5#_ /&JU=.FOI[7?J%G%:S[B/+BG\T8['=M7\L5;HH
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M*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:0]:**
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MXBZY>R6%PMI<6\*13X7:Q0<]\]^..U<3J_AG7;OPOXDGC6_T\C4KF_\ LS2
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M02:7J-J+_/V>2>- K80OSAB5.%/# &B\\46]KJ\VFQV5Y=S6Z1O.;<(1$KG
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MM1LC9EC/3YB"3[L3S0!Z?163H3:L4OQJS*S"\D%LRQA,P\;> 3WW=3G&*UJ
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M *+6LSXER+%\/-79LX,:+QZF10/YU?\ !DHF\$Z&P&,6,*_D@']* -RBBB@
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M HHHH **** "BBB@ HHHH .*;1WIQZ4 (*7BFT4 *>M+0.E% !1110 4444
M%%%% !2&E%(: #&:2C-% #J*** "BBB@ HHHH *Y^VT.[CN_$<\TELPU0CRE
M"DA (_+&[/7@ G'O7044 <6/!5ZNC2:>+ZV^>ULHLM"QP\!'/##@[1^?YV+#
MPE<:7JM_>VDNFJTK32V\C6(,P>0DX>3.2BD\ 8)'4\5UE% &9JNMQZ3+ DEC
MJ-P)0QW6EH\P3&/O;0<9SQ51/% E!:/1-;90<9:S*9_!B#^E;U% &'_PDC_]
M '6?_ =?_BJ/^$D?_H ZS_X#K_\ %5N44 8$GB>1$W+X>UN0_P!U;=,_JXK)
M\36-SXACM7&AZW:7UF_F6MW#):[HF(&1@S<@X&?IUKM:* /,UT/Q1<1F+5+W
MQ1<PL"KI!]BA# ]0?WQ[507P+?6EY(=)M-9L;-W+BW,-E+M)[;FGR0/?->MT
M4 >?:IH>O7FAZ<D U#^V--=I;:]F%L,GD!642$8QQGGH.#S5#1=%\9Q^*5\0
M:[9K>7,4;1Q1P20QJ W')')P..>>G->H44 8?]JZY_T+4G_@;%_C41U/Q.S-
ML\-VH0'"^9J8!(]<",C]:Z&B@#G_ .T?%/\ T+EC_P"#4_\ QJC^T?%/_0N6
M/_@U/_QJN@HH Y\:AXJ;C_A']/0G^)M4) _**@7'B]HU_P");HJOSNW7TI^G
M B_K7044 <_YWC'_ )\-"_\  V;_ .-4>=XQ_P"?#0O_  -F_P#C5=!10!SZ
M/XP>0[X=#A3;P5FFD.?IM7BM+3AJH$G]IM9L>/+^S!AZYSN/TJ]10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F*4T44 )BE Q11
M0 4444 %%%% !1110 4444 *.M-/6E'6D/6@!*4#BDH7K0 ZBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***S]=UBV\/Z)=:I=AC#;IN(7JQ)  'U) _&@#0HJII=]_:>E6E]Y$D N(
MEE$<F-RAAD XJW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 AI,TIH% "CI1110 4444 %%%% !1110 #K32.:>.M-/6@!*4#G-)
M3ATH **** "BBB@ HHHH *YR'QQHT][;VB?;?-N698,V4H$NWJ5.W!'O71UY
MO8-J::]?Z_>:+?RZM*_V.PMS ?+M;<$8+/\ =YR2<9Q@^M '56OC#2;S2WU"
M W+PQW0M'46S[UE.!M*XS_$/SJ,>-]$>SO[A)9G-A+Y5S"L+&6-LXY3KC/&>
ME9FFZ1-;?$?4KC[#<IILP$\3\>5]IV[6?&<Y()YQCD^U9.H>#;Z]TV2_LX);
M;5?MDZW,8*I]LMWN6D ZD# (()YXQSQ0!T=QX\TJW>^0VVH.U@1]K$=L3Y(.
M2"WM@$\9X%2MXTTY+O4K1K>]%S8,BR1&'YI"[!5V#/S9)&/8US,VE:I9>.-8
MUI/#][<K+/&]DD4T0CD98)(F\P%_E!+Y#;21STR<RZUI&OZEK$'BBRTOR=2T
MR<0P6DC1#[3#C#L7SQRS 9Z 9ZG@ ZS7?$5MX>L(;V\MKIH9&"$Q(&*,>@89
M[]/3],Y\_CS2K;2KS4)(+T1V-Q]FND\H;X7S@;AGH20,C/6F>.-,U/7?#D%C
M8V9:>6:.24-,JB(*=Q!/<YXX^M<U=>#?$$WASQ/8PVT*+JMY'-;P/<!FCPV]
MW=R,L3A1C)_Q .VL_$D%[XCN]#6SNX[FUB661Y FS#8Q@AB3G/IVI;+Q'#?>
M([_18K&\$UAM\^9@GEC<-RX.[)R/;ZXK GL?$.G>,=9UNRTA+R.ZM8XH46Z1
M&WJ!UW<8SGOV]Z98:?XHT;Q'J^HKIMMJ/]H0VH9S="$[XX@K'&T\$EOR% &W
M>>++>SUB]TS^S[Z:6SMOM<CQ^5M\OU&YP?48QVJE;?$+2+JRM+U0\%K+.]O,
M]TZ1&V=5+ ,"W.0.,9_/BN"UUO'UC<WFK7.C0QB>Q6QN;A664;0?FD"J<J#S
MU' K5M_ EC;Z;;^*;FZ^W$:=)+>"9Q(K9A.TQD ?=Z#V^E &U;?$R'5;BZ70
M]#O]1@MB@DF4I&/F.%X8YP3_ "). *U1XVL8]*U:[O+:YLI]* ^U6LX7>&8?
M*%()!#'@'/->5_#+2-9U.RO!I5X+&/[9 ;JX$[*S1JKY155><[LY+#H*[[5M
M"DU7XF*H?RK)M-CDN=C%7<AY N."#U&1QT% &QX@\8VN@Z58:H+:6\LKM@ ]
MN0652I?=CN-JL?PJCJ_CF73M*U+5(--AN[&T$#QRI>8\Y)>,XV'&"0,<T:1X
M4U/3;?2+26>TN+?3+MY(BV[?Y+I(I0]B1O&/I5:^^'2KX>UK2-*NTA@U*>.5
M4E4D6ZJP8JN#R,CCI@'OUH WM(\127NKW.CZA8_8=2@B6?RQ,)4DC)QN5L G
M!X.0,&JY\2W][J&HVVB:1'>II[>5-+-=^2'E R8T^5LD<<G:,U/IV@31>)+C
M7]0NDFO9;9;5(X4*QQ1@[B!DDL2W.>/I5>#P_J>DZIJ-QHUY:+;:C/\ :)8;
MJ%F\J0C#,NUAG=U(..G7T *R^*M6U.<66C:5#]N@M8KB^2]F9%MVD7<L/"Y+
M]>H &/RS)/B<H@TC4X]/+Z3=HYNF!)EM"CJKD@#!4&1,=SGMTK<;PS>6WB";
M6M.U"&.ZN[9(+LSVY<.R@ 2* PP>!\O2LE] L/!.AP7%S<0S:586-Q#<0RP9
M>Z:5D) ^; R44 $'CCOD %36OB+>:?:O%'%8?:Y]0>TM9&D/E>4%4B9B>V77
MIQP>>*S?"VKZI'\15TU[DW,\]FDE\\UP9$#D;R8@OR@;2H ' _2GZ)X)'A[P
MM=:].MK#=R02S7%K<PF:(0$!A"06'(V@Y['CG'+_  !X)FA\/:-K=I=1V>ID
MRS,9+?S5DCD 55;#*2 %##D8+&@#2/B;Q6FI:;%)_8BV]]J$]F"(92R>4[*3
M][!SL./J/PS/C5J-Y;Z3;6(:!;.Y<'!!\QF7)..<;1\G;JPYKJ[CP>\B:28=
M2*2Z=<370>2'>)99&+$D;A@99N,]Z\_\8>';G4_'6B:!?:I+=SW8DN)9E0)Y
M8(QA$R0J@19QGKF@#KKC6/$NDC0;9GTDI?72VJL+:3Y4* JV/,Z_>!&>PK/;
MQYK41N]/O4L[:_%WY=E<+"WE7,:W'DR8!?A@06QGI^9Z^^\.+?RZ+))>2*=+
MD$JA47$K  <@YQQGIZ^U0R^$;6[TU+.]G>;RM0:_AE50C(S2&0CN#RS#Z'VH
M S#K>MZO=:W-IE_I^GZ?ID[6BO=PEC+,H&[<=P"+N( /-=3I4T]SH]E/=&(W
M,D"--Y+ IO*C=M()!&<]ZP=1\#V]Y)J8M[Z:SMM4P;VWCC1ED;^^N1E6/<_4
MXSS6EIFCS:9J3^5=RMIJVD,$%L[ K&R9!(&!CY0OU)/3B@#8HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 3-+28I: "BBB@ HHHH **** "BBB@ H
MHHH 4=::>M.'6FGK0  4M-IPZ4 %%%% !1110 4444 %<_X4UN\UZQO9KJ&&
M%X+N2V41Y.=AP2<^_:N@KEK'PMJ.GQW<-OK:I%>7[7L[+:8E)9E8J&#X (7&
M<$\_A0!=\,ZM>ZO#?O>QVT;6UY+:@0%CGRSM).>F3V]*S+'7?$.NV3ZKH\&G
M_8/->.&"</YLJJQ7=OW!1D@\8/3KZ3V'A6]TT7<=OK 6&\U$W\^+<B0DLI9
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M_.%.W)XRHSG 8CT(GG\&VESJW]HS7]^\ID@E="R;':(84D;.,C.0,#YCC&:
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MDC<QV3I) !*XVL@PI.#\V/\ :S6:_@CP^_WK*3[NPXNI1D>89>?FY^<EN>]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4'I2'-+0 F30*6B@ HHHH **** "BBB@
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M#9]IG#EMB;1@.RCCZ 5=LO$6EZCK5[I-K<B2\LL><@4X'8\]#@\&@#4HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN_?2L1N\ILJ!@,0.V/?  .U\/^)[#P]\);.],T+3P6QV6[2C<TA8@#'7!)_
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MI1* F^".51'(R1B,,1MSG:J\9QP.*Z"B@#,G?4=-TZVCMK:759UPDCO*D3$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN2.#0!T]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MII%OK?A6TU&\A1-*%U&Q>97A$K,65]WW=IW#!]5'I5GQQX@T76=<N_[(N;;
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ME^)/'&H:DE]X;O?"\&J2VTJBX>SFF:+*G)&%4,.01UZ@]:[#X?VOAF736O\
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M.RY!QV Y Z =*Z.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI.].- "4'I110 @YI:**
M"BD/6EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#U#2+R[\
M5:3JD<EN+>QCE5D8-O8R  D8XXVC\S6Y10!REOX5O8M8BOVOX<0ZI/>HGE,<
MQRQ["GWN#R>>G?':J=MX#GMWMY?M=A)+]G2"X:?3Q+C:Y<-%N;Y3SCG(X!QQ
MBNWHH HRW,^G:9+<7227DD99BMI"2S*6.T!,DD@8'7G&:H_\)(__ $ =9_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** $)HS2T4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)FEHH 3-&:6B@!
M,TM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%(
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ML5D%PTI(XX."./<]:[.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 44AH% !BEI">:6@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *0TM% #:*=10 VBG44 -HIU% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .' JH# 2(  A$! Q$!_\0
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M .]6E5&6RFDE=EN% 8Y"F/./QS0!#BC.!3A8W(/^OB_[Y/\ C2FSNCTDA'_
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M_P#GS;_OXO\ C1LN_P#GS?\ [[7_ !H 6CL:39=XS]D?_OM?\:15NF!Q:/\
MBP']: -8?=%+2#H.,>QI: "BBB@!"!BD4GI3J,#TH *0@=>]+10 45%</+'
MS0P^<XZ)NVY_&I!T'7\: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1BBB@ HHHH **
M** "BBB@ HHHH !QTHHHH **** "BBB@ HHHH **** "BBB@ HHHH *BN8$N
MK:2"3.R12K8.#@U+29^8#VH @M+.&R@2&%2%48&3GOG^9JQ110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1C%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445"+NV:*65;B(QPEEE<.,(5^\">V.^>E $U%5(=5TZXL'
MOH;^UDLT!+7"3*8U ZY8' Q55_$V@1Q1ROKFFK'*"8W:[C ?!P<'/.#Q0!JT
M5G#7]&-O%<#5[ PS/Y<<GVE-KM_=!S@GV%/GUK2K62XCN-3LHI+8*TZR3JIB
M!Q@L"?ESD8SZCUH O453M-7TW4(99K+4+2YBB_UCPS*ZIQGD@\5)!?6ES:FZ
MM[J"6W R98Y R8QG.1QTYH L455;4K%$1VO;94?.QC*H#8X..>:5=0LGC21;
MRW9';:C"52&/H#GDT 6:*@>]M(FD62ZA1HP"X:0 J#TSZ=1^=-AU"RN)!'#>
M6\KGHJ2JQ_(&@"S15=KZT2X^SO=0+-D#RS( V3T&.M/^TV_V?[1Y\7D8SYF\
M;<?7I0!+12*RNH92"I&00>"*6@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** ,W7M631='FNR8S-C9;QR.%$LK<(
MN2>Y_(9/:O/_  W=3>'-9UO0]55K47]H=2B^T31D^85VRY*DCE@2.>B5WVN:
M(FNVT,#W]_9B*42[K*?RF8C/!.#QS6+)X A=U<>(_$BNHQN_M L2/3Y@>* .
M&^QSZ=I>MZ3:X_L&[TK^U5D5_E!\H@HIZ?-(%/L%Q@YJLKM_9GPV,-Q;0S+]
MJ*27&3&C;EP6P1W'K7HZ^"W6(1#Q/K_EA=NPSQ8Q]/+II\#*RJI\1:V57[H+
MPX'T_=4",G4;/1_$>CZ-I8E@:.?4&2X>V?Y1/]EE8LAZ'#E3QQGCUKGY+K4!
MH'C6UU]%-[8:?;6;3GGS_FE*29/KN7GKP.]=N/!&T*%\2:X IW*!)#P?4?NN
MM.?P8\@8/XGUY@P .Z6$Y Z?\LZ .2AD@;Q5H3:6T9(T-_[3:$C&WRODWXXS
MNQUYZ5EZ);7EII%UH=N7_LV_T>+5'D#?<'DXD3_@3A01Z9KOU\$[(WC3Q)KB
MHXPRB2$!A[CRN:A;P(X@-O#XEU=+<QE/*/DE><]@@&,]J .!!+Z#\-X(8+62
M22>;89_NYW@;3WP2>?H*[&^T32=9T"PTAQ%&\U[B[-N5'E77V5V+  X!SM.%
MX.?<U9'@6]%M%;GQ"6BB!$:OIEJVW/7&4[U+'X.U*)8UC\2,BQOYB!=+M0%;
M^\/DX/O0!C>$+.36-<UJT\3Z=!+?6$=I#)(Z@_:"K2LLAXYRNSUSM&?0-^%&
MF:=-9:CJ(LH5N8=5G6&4(%9$*+\N1_#\QXZ5T7_"-ZZ)'D_X2ZXWN KM_9]M
ME@,X!.SGJ?SJ.U\*:O9*RVGBB6!6.6$6FVR@GWPE &%\0-"TM-8\.S_88&EO
MM;A%R[H&,BG *DG^' Z=*2]TRT7XFZ-H$]I;_P!AI9RSVUFPS$TI+ECL/!(R
M<#G YK9O_!VL:CY)N/%'GM"VZ,W&DVTNP^JY7@\4VX\*>)+P*MWXJM;I%.56
MXT6)\'/7[W6@"'P"TD>L^*;*W&W2+:^"6BI]Q'.XR*OH =IP.!GWK.\%26>G
M>,/'UW-Y<,-O.CM)MQL7,I;I],_A6W:^&O$]E;K!:^*;.&)>B1:-&JC\ ^*H
M2_#[4+B626;5-%DDE8O([^'H278]226Y/)Y]Z ,NXTVTU7XGWQ71[._M;BVM
MGF:9>45NKJ,=< <Y!'O6IXNGEE\/V^D:!<W(,5DMXDMO"\I94QY*$J.-Y4G/
M3Y#ZU)-X%U6XG>>?6=(EFD4(\CZ!"S,H  !);D8 'X5/!X3\06KLUOXCT^%F
MC6(F/1(U)11A5X?H!P!VH Q]<O+GQ;I?AS5=+ALKV=8I+F71[DADN!PK8SP2
MC9 SZ_@<'53;:VO@J>VTIIC(M\/L5U+DLR<^67(.5#9 ]N..W5'X>ZB8T1=8
MTJ,1L60Q:%$A0G&2I5P03@=/2H;[P%K]RUJ1J^E.;4$0'^S!%Y0)Z+M/ [T
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBC/.*
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M_I5,:Q&VOP:8D>]9K-[I9U<%2%=5Q_X^#F@"CX6MHHK:6=-,N]/>58Q+%.V
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M0/3D4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6-/,(.#)]J3;G .,YQT(/XT 9OC&TO=8\&RV]G9R/=3- _D[E#+B1'())QP
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M+F)BN;>9BFY-H *XP!@^GU->D[5+!L#<!@''('^0*:L4:-N6-5/)R!CKU_/
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MGEB-B0R^O!/''(!S78T4 <+J>D_V?8:E9-<-_:.J:HU]II@A=]DH\O;N(&%
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M,+\O (S\QK)N_#.M7/B-+N6TLY+.*ZNY-D<_E^:DL)09^7(;H"<GGI@5WU%
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MU'IBS7\$SR[8WPKH'(P=_P!T[5[9'- '<T5Y^OB#QB_B6YT",Z(U[#IPO/\
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MB@"AHFEKHNAV6F+,\PM8EC\Q^"V!Z=OIVJ_110 4444 %%%% !1110 4444
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ML+%+J148")EY(<_PE2<\X(-<E?6]Y8>)KW0K2-_L6OC[0'7&(","Y/XJ5/\
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M 4444 %%%% !4-U<QV=G/=2AC'#&TC;%+' &3@#J>.E353U8,VC7P56=C;R
M*BEB3M/  Y)]J )K2ZCO;*"[AW>5/&LB;E(.UAD9!Z=:FKS:"QU"35K"*Z36
M[<I'9&TEMHLQ(JH!(LA_@^8MN!ZCL>E16T>I7$>HJL6KV7VBV4OY]M/(?-^T
MGAB -P*$ [,?*3@G&0 >G53O-3M;"XLX)W*R7DOE0@*3EMI;\. :\Y\G6KNY
MLX;S^WM.MC;J(!9I-,%D$KY+$\KD;"-_13@]#5WRM2O/%.FO>66H"[@U>9I'
M*2M MOL<1E6QLQ@@=CG.1S0!Z+17!>,[K5H]4;^SH=75X1;,KVZS/$Z^8WF
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M !X&,[B02WM45MXAFN=2T_S->:>&'5Y(E=9H?WJ&U#HC%%"-ER5&!U.!R :
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MRJSH=F.3N YZ]O:NE\"W,]V+R:36KG4%*Q9CFLY(1 ^T[@"[-N)P,@' /UH
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M#Q0&=BJ1694%CA<H^<#MT'Y4I\3W;WDLL-G ^FP:BFG2OYW[T,Q10X&,8W2
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M68<L,AO,5AD=>B]:JBPU+5KJ^^V:7)827ELUL;P722-#'V5% /4DDGCZ\#
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M3.OF-&>[>7OVE3TZ=L;O@2)8[OQ 8DNQ;27BO URDJLT9C7',@#'&,?@.V*
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MBC'.: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9XK%9KJ"*[NXHW6 R#=EEW 8_/'KBN=B\,Z[:VZF%[%Y3'>P-'+<2%52>3S
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M"MCHU['=03WDC0VQM8EGFWK'$2IVCCH-HQ0!#/XL2V\21Z1)IUP!*[QQS%E
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ML6FT:33%,<;*JDO(P;!)XPX_*I-0TDZ=%K[:GON;'670)%9VSR3+*8PI/'
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MV07 BR/WYP3R#G@<$9% '3Z1KZ7^FZCJ%P\,=I:W,R"5"<>5'_$<]^N:SO\
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MZC=R*NV>4E/FW G=DJYSZ$?AZ!0 4444 %%%% !1110 4444 %%%% !1110
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M/XC3Z3O0  >U+110 4444 %%%% !1110 4444 %%,EEC@B>65UCC12SNYP%
MY))["HQ?6AMH;D7,/D3[/*DWC:^_&W![YR,>N: )Z*** ,CQ1I+:YX:O]/C8
MK-+$3$P."''*\_4"N&L=6:]O;B:*/">);-((AA@?M$>$FRI VX$C'W\L]:]0
MK/DM-)TV"*>6*TMH;1F>.1PJ+$SDAB"> 3N.?7/O0!F6D4=MXPU"*UA4K'8V
M:[5;'EC=../P5./0"N2T]/,_X0B$6J7,<EM?,UO*V5<_*1G(.>?6O24L[>.Z
MGN4B59[@*LL@^\P7.T9]LG\ZJ+X?TJ.*VCBLUB6U5E@,3,AB#?>"E2",]\4
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M-4]7T77-8A*376G+Y+Q36\?DLR-(K$D2 G)4C X]SZ4 7#XNT'R[9_[00K<
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M6BW.G0-ITPO-+M[*4S32#R7B!^9,(=RDL3@[<<>G(!WUY?V>G1"6]NX+:,G
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M$+S32)'$@+.[L % ZDD]!0 ^BJUEJ%IJ,+36=PD\:N8V9#D!AU%6: "BBB@
MHJ$7ELUJ]TMQ";= Q:4.-B[20V3T&,'/I@U(CI)&LD;*R, 593D$'N* '444
M4 %%%1R3Q1-&LDJ(TC;4#, 6/H/4T 244PS1+,L)D02L"RH6&X@=2!^(I] !
M113?,3S/+WKOQNVYYQZXH =1110 444U'5UW(P9?4'(H =12!@V<$'!P<4M
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M,<X':M*_TZTU2U^S7L*S0[E?:21\RG(/'H10!P>B:U>Z-?7H:WA>PN=7U($
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M,^?+%-)^\?YGB "'KV"CZXYS5,>"M#\F:(PW#)-#) P:[E(\MVW%1EN!D=J
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MMO4*<X4< +QC'4DYJA9^![;3%/\ 9^IW]NWV-+0,#&QPC%E8Y3D\D$="">*
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MQ@X&>*[ZB@#QN#6+V\UR#5Y-7%I=GPY(!<J(R)I([AAL^9=I)P,@ 'TQ6O\
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M(D&PY('8;NC?E39;W5;32T#3ZLTDFBW\,;?OG)G63]V3CH^T'#'!]^E>FT4
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M &RH  !R3R,6]*UB=O&EWI\]\;E7\TPI;R1O'&J%1AP 'C=>1SD-D]Q76T4
M<#J\MZFM^*6LDDDF2'3_ +B[V1-TA8J,'D#)X^HYJY)++(+N.*6XN+#^T; V
MSR%G.?.0R $C)48!R2>]=E10!P'VVYM-9N//,EKI,VLS"[GW%, 01B/+C[JE
MAUR.F/6I+FZ\0PZ1:W-E-<33327%G"Q3<2"S>1*ZD8'W%!)'W7)ZUW=% ' 7
M?B'5;G1TUF"]>SL[I_,2 "$7$421?/M$@PY\S)(_N@8(S76Z=<_:KF:1=1CG
M0PPLML$"O#D$[FYS\V1P0,;?K5Z:WAN HFACDVG<N]0<'U&:<$179PJAFQN(
M')QTS0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@#!7=_P )_)D#;_9:
M8.><^:V?Z5O5BK%)_P )L\WEOY7]G*N_:=N[S&.,^M;5 !1110 4444 %%%%
M !1110 4444 %%%% !29YQ2TT?>- #J*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BL?Q7JMSHGA>_P!2LTB>>VCWJLP)4\C.<$'IGO6Q0 4444 %%%<Y
MXMUO4-%_L;[ MJWV[48K*3ST9L!\\C!'3!H Z.BN5TCQ>LB:P-7:VA72YEB>
MZMRQAEW#C;GG=G@J,X) YK3G\4:+;64=Y/J$<<$A95+JP.5;:V5QD8/!R..]
M &O17*R>,8;![Z34)+9[9-0CLK<VA9WRP'WQZCD\=N,9Z[<6MZ9-J)L([V)K
MH,R>6#U90"R@]"1D9 Y'>@"_17+>&_&EGJ^A:9>7SQ6EW?$A8 2W/FF-><=R
M!U[FIO%'B6?0+S1+>"UCF_M*]2V9G<KL!(&1@>_Z=Z .CHK._P"$@T?^T%L!
MJEFUX9#%Y"S*7#@$[2 <@\'K0-?T=IYX1JMD9;=6>9?/7,84X8MSQ@CGT[T
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M-0VFI>#[]+A[6;29EMX?/F**AV)C)8\=!W].] SG-)\?VW]G6^F7-S86TD4
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MZC.$D:VGA$>Z$A5/F,SL-W&YB>K#.,UN^(DG/B_29;42M<0V%XT:J2%+XCV
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MU5;>6&YVI9RQ#-U;B+.\?*#DMN.X-@;<;:A\4>);K3=<FMX-32#R!9M]G94
M=9)BCG)!9L+CIMQD<FNNU+4[32;3[5>R&.'>D>X*6^9F"CH/4BK#0Q.VYHT9
ML8R5!.,YQ0!P4GB34;>TNKVXU(I:KK4NGNVQ%6VC5WVN3L/7"+R#U!KK?#T\
M]SH5K-<WL=[(X8_:8TV+(-QVD# [8Y P>HX-:+HLB,CJ&1AAE89!'H:<
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M)9V\EII,ELK*KD33"89 0="P]._J* -C7;34CK.CZE80+=):&59;=I?+SO4
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ML8U9%$(<\Y *]P<DG</6KR>.M+DFM8TANV^T& ?<4%#+G;N4MNXXR0".1UH
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MNO"5S<6=];BZA N$L@IVGY3 P+9^N!BMS2]6CU>&X\N&>UN()#%-!<*!)$V
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MG)S7H+7MJETMJUS"MRPRL)D <CV'7L:8NIZ>T<TBWUL4A.)6$JX3_>.>/QH
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MQG(Y[>PKI** ,"R\)VMC<6LT5[?,]O/<3@NZG>TWWMWR\@'D>_7-2#PO8_\
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MVF42,LCALXP"ORX)SGJ*L6GA*_@F:62]M][37<N8T<?ZY% ZL3D$$]377T4
M<)+X&OFT#^S$O+?G24L-Y5OO"3<6^F,_C4?C#3I[8S7K>27N+^UFMI#'(PMG
MBC/S,5!(!(V@X/WN1W'?T4 >?V^EZSK.C6KVD=M87,,\QCODN)@WSLLC2*I0
M;U9M^4< ' P>E=7J6G3W>LZ5=Q^28K0S&02$Y.Y"HP,>IYY''K6K10!YU8>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^(9U\422WL5ZFCP7D=A T$BJGGG!+2 ,&*Y( [8'(.: .XHJ&[@-U:2P+-+
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M#$YSWH ZJ73K&:Z6ZELK>2X7&V9XE+C!R,'&>#3[>TMK3S?LUO%#YLAED\M
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M19:5X>E741IUI=P*DVH)&&'$1,:ENRDL2.?YF@#6?PI:RZV)9+> Z8E@+58
M6!)WECD="I&.N<GK5ZY\-Z/>->&XL8Y/M@03@DX;8,*0,X!  Y&#P.>!7#W6
MMZQ MW*FORS"R336B98$C2Y\YRKEE()Y7G (J23Q7/'KUY'!K)E#+J*&"4(O
MD-"JE,+U!'S\G[P&<#L".P'A711 819#8;1K(_O'R86.67.<\GG/7WIE[H7A
M^,2_;$CB-\T$)9[AD9WC_P!4%.X$,.VW!/O7*R:E=Q6%Q'=>(9G54TJY>Y)C
MC,/FS;9.0 -NT!N0>O.:Z#Q<D<\.@@S*J_VO:N'.,-@D@?C@#\:!ENX\(Z)=
M6L=O-:.RQR-*LGVB02;V&&)D#;CD8SDGH/05?M-*LK"ZN+FVB*2W"QK(=[$$
M(NU< G P/0#/>N"T_P 57USHUQJ5YXAAMV$(%Q:1Q1F6SE,X0<,!M&#M_>$X
M//0',%UXMU%-.,PUU&BM;BZ2XDM'MWFV!D$;A60!U&[!"A2<B@#O8] L8]6?
M4C]HDF9MZI+.[QQMC!9$)VJ2.,@=,@8R:IQ>']'%UJ,=O*?M4L91T\\DVR2$
ML=@!!C#')XQG'M7.MXMU#SM8N8[^TWV0O -+DQYI$8_=N%VA@#@$DD@ACC&!
M5[PBP?Q5KSC5/[3#6MDPNOD^?(E_N #].F.O6@#=NM @OM"@TJYN;LI$D:^=
M',R2,5&,E@<G/7FJQ\(:>;".V-QJ!>.5YEN3=N9@S+M;Y\YP1QC^M<];Z]KW
MVEKDZA#/"NJ76G_9!;@'8@<A]PYRH4>@QUYYJO>>.+Y-!%]:7=K+.FB0WDL8
M4,%F+JK9P<CJPQVQ0!V_]AV2KIB1*\,>FG-M'&Y"CY"G([_*2.?4U6F\+:=<
M:J;^3SSF9+DVXE(A,R@!9"HZM@#VX'%9Z:GJ=GXC@L+Z\26W9E030P+M:1@[
M>7(-Q:-L;"IY! YZ\8UCXUU"[TJ"=KJQC=M%>[D9E)"S"14!*@YQR<CUQ0!V
M.A:9)I&E1VDMS-<.K.Q>:4R,-S$A=QY(&<<^E00>&-/AAU>%_-GCU:5Y;E96
M!'S#!"X P,=._O7.IXCUJ6]BTQ)X%G_M:6Q:9X@S>6(/,#%0V,Y/_CH]\V_#
MVK:AJFMV,ES=@(VDF1[=%PKR>;M+@9S_  CUQD^M %ZT\'VUK%9H^J:K=/:W
M:W22W5SYC$A64*<CA<,W QUZU5OOA_I^H6YADU'4T5TE20QS(#())3*=WR_W
MF/X8SFF7FMWUGK6KQBZ0Q_:;.VA61,K;^8!ES@C.23U[XYK2T'4;V^_M6SNG
M1I["Y-NMRD>T2?(K [<GD;N1G\LT ,C\,V,<T2/?74LR:@=442.F[?M*8X4?
M(-WUZ<U8L/#\>F>'O[&M;^]6-5*Q3%U,D0[!3C'';(KAQJ.IV\VGZXLUM+J"
M^%'NY9)H2?, :-]I"L.><9SW)QVKH=.\3:KJ^JE+2VLUM8+E(KA)'^<(T2ON
M!W#G+8 V8(4\YZ %BS\$6EE,)X[RY\[=<LQ"HJEIE0-\H7  \M2!ZYSFHK?P
M);VUU:31ZG>JML+4>4!'MD,"[5W97/(SD CDY]*EU$1M\1="RJETLKI@>XYC
M'^/YFB\\1W[Z[<Z?I-K!=FU6!W4R*"X>1T<!BXV[=OHW/! XH E3PA:QWEM<
MBYF+6^H3WZCC!>7.5/L,U+JWAI-8U"&XN+N3RH98I4A$:?*R-N^5\;ESP#@]
M!VK%N/&.IKJTME96=O>L\-VUNL8=<O"V%&X\/GN%Z'(SQ2?\)CJ=S)'9:7;1
MWU\8)I67R#"0R.J^6R22*4/S')RV." : + \ 0BR:R_M:\-I]GGM8H2D6(HY
M65B 0H)P5'))Z?7.K)X9M9[\74TLCYTUM-="!AHV()/UXI^JZG>6L.FI MO%
M=7DPB9)B7V?(S' 4@L05 X['/:N9O?'.IPV<5W!9V9B71H-4G#LV[]XQ!1<?
M3J: -6+P?.MG:VT^O7EU':W5O/")T0[5A8D+P 3G(RQYX%(/!C07ZW]AJ\]I
M=?:+F5G6-6#),P=D(/'! P?T-8WB?5KN_O\ 2#;.([2#Q+!9D*&#N5!WD\XV
MYR,8[9]JW_$'B*[T;4X[:.VCD6XLYGM=V<RW*8*Q?\"!..Y- $5CX0N--GM'
MLM<N8$CM8;:XC6%")Q$,*>0=IQQD=JV]*T]M-M9(&G\[?<33YV;<>9(SD=3T
M+&N5N]=O=6M=)N[..(QM>VH7$A7,C(QD5N^%RO&.H/X./B<M:Z9J]]8KYD45
M^\H@N6(4P95@H'RR!MIP6Z=J (I/AP9-.N;-M9DQ/"L1D%NH?*S"4,2#RV01
MD^M:]SX7N&U!M1L]5:WO#=O<JS0^8H#1)&4*Y&1B-3G(K.U?4=9>/26FM+>*
M634(#:F.Y8)*6CD)5SMR ,>A!X/7IT/AW5)M9T2*]N($@F9Y8WC1]R@I(R'!
MP,_=S^- $FB:8='TB&Q,YG,98F0J%W%F+=!TZUH444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !5.]U;3=-9%OM0M;5G&4$\RH
M6Z#C)YZC\ZN5QWC/PUJVORLMBUD('L9+8^=(T;J[,K9RJ-N7Y1\N0,G/:@#H
MVUG2TN)+=]2LUGB!,D9G4,@ !)(SD8!!_&E?4[=]+N+^SEANXXD=@8Y058J#
ME=PSCD8]JYN]\*:A=Z3JL"26T-S<74,\#"1BK"..)=DAV@X)BSQZCTK8M]+E
MCT._@6TM+:[N_-=TBE9T:1EQN9RH))P,G;^= "Z?XCL+C2=-NKR[M+2>]MXI
MA#).H.74$ 9P3R<#UJ\^IV$=VUJ]];+<JI=H3*H<*!DG&<XP0:X^3PSJZ6E]
M8K;6<\6IZ=!:2RM+@VSI&4)QM^=>0PZ<@],YJQ-H&K+_ &Q;1V>G7*7$EQ<6
MMW=MO9&E0KLV;. .A.>5XP: -R;Q+HT-O'<#4;>6*2YCM5:&0./,<C )!XX.
M>>W-7$U*QDN9;9+VV:>%=TL2RJ60=,L,Y ^M<%#X0UF,&;[);B1;S3[E8OM6
M=WD+M8$[<+T' &,<"K"^$-3DTW4].DAA67R[H6>HF[=RQF<L5\O&$!!PQ'IG
M!H ZK3==@U75+^UMC%)#:K$PGBE#B3>"<<=,8]><T6FMQ/'.]^UI9[+B2),W
M:.'5<?-GC!YY7J*K:%:ZBNJ:E?7UG%:"Y2%8XHYO,QL# Y( ]16!I_A*\@U=
MIKNR@GMWU>^O2'=6&R1 J<$=_3M0!UFJZQ!IF@W.K@?:(((3,!$P.\#T/2J-
MAXHCN-1%C>VCV4KV?VU':16C:+@$EAT(SSD?C68GA_44^%+:#Y*G4/L30;-X
MP6R>_2LY?".HS_:FAL8[ R:++I[A[C>9I&&$/&0JC!/KSTH [34-3%K:R/;+
M%<SH4S#YZQX#' ))Z<9(]<<57LO$%M=WNJV[CR%TZ989))' 5BR@@^W7%<A>
M^'M;U/2]5+:2MO-<V^GK%"9T8AH9"7Y!Q]T\>WY59FT'5[;7+O58=/-THU=;
MH6WG(//C\C8&7)P&5F)^8CI^8!MZ;K-IXBCTZ^-@/(S/-'++(F86C9H\XSGD
M%N1D#OVK>%Q RNRS1E4^\0PPOU]*\TA\(ZY'H\,#60\U=*U*W8"5.))I"T:Y
MSW!Z]!WIVH:4WAZ"ZD6R@M$G73$MU#Q(DUQ%(692-R@\>I .#STH ]*CECF3
M?&ZNOJIR*PK?Q?9SVFDW7V2\CAU.=K>-W5,1R L 'PQQDJ<8S^%5O TMM+I^
MHO!;-!*U_*]P"(\;VPV 49@0%*CDYJ"'0+N_^',>F7-N;3440O$KLK&*57+1
MG*DCJ!^!YH Z&UU6*[U6^T^.&7=9;!)*=NPEEW!1@YR!UR!U'K4/_"1:<)Y(
MS,%5+D6AE=E5#-M+% 21D@#G'<XZ@X7P_:7%KI,;7JHM]<$W%T$Z"1^2!R>%
MX4>RBLOP3 +?1I["YB'VNSOI_.+( 69I&=7_ !5EP: +!\7V1,0AM[BXWVCW
MF;=HI (U;:WS!\$@XX!/7C/-:^GWUOJ>GV]]:OOM[B,21L1C((STKD?$?A>Z
MU;6WAL ]E!_8\L,<\3>6@E:5&"$+U! ;(P1@^M96IZ1>ZI'H[7_AN[-I%8-;
MM8VC1#[-,&7#+N/"D+@,#D 4 >D1SQ3-*L<BNT3;) ISM; .#Z'!!_&I*\UG
MTC4K234'BTB[+)KUOJ'F1;&:>$;,J#NRS##G!XYZ\U<M]#N-0U72/M^F7"6R
M7.I32K(V-I>=9(B2K''J.>H- '?45Y6/#NL6UO:R:=97,-W-I-PD[!L,7,BL
MJECP&QNQGI5^WLC$+.2+1-872)+F4W%A+$BE#Y:A&6*,@!,[N/[QS0!TEAJ.
MD#2;SQ;!]H^SW<2S3%LL0D8(X7M@ DX^M7M-UZPU2>2W@>1+F-%E:":,QOL;
MHP!ZCW%<I;:5?Q?!AM,>TF%\;)X_L^W+[BQP,?C4FK^&O)T9;VUCO;C5+C[)
M#+-O82I"LB,P&W&T8!SC^E '=45P-II-S:^+WMYH];6V@N(GT^6"0/ (@@#(
M[/D@9+;AG)[=LY>GZ+?G3[-;Z'6&9]$F>Y1I9SOG5E\M3SPP&["_I0!Z4EXC
MZA+9B.8211K(7,9"$,2  W0G@\58KSJYAUB8WRS2:G")M+L465;>64>:')<%
M5Y/</CG!-021:I=7%A'-'K5A"($\@6,$DBK,LT@8Y?E,J4(\P8VG'&,4 >@Z
MEJ5II%B][?2^5;H0&?86QDX' !/4U%;:YIUW<O;PW(,R3R6Y5E9?WB %E&0,
MG!!XZCD9 -<WH:W\OB*[M+^._N[1Q+)'=2B>)4_>@B-D;Y"1@;63^$=,$UH>
M*HHH=/LU@1!=RZI;- 6YS)YJEB>Y^0/^ Q0!M:A<V=A8SWE\52WB7=(Q0M@#
MGH 2>:S+7Q+H5Y=_9XGD\YI!&PDLY4P[+N 8L@ )7'7KQ6M:7<=Y&[QK*H21
MXSYD;(<J2#C(Y''!Z&N<MH[E;KQG<V*RB\>0"W#QE066V0*02.?FR._0>M '
M3M#$RE6C0@@*05'('04K(CXWJK8.1D9P?6O/=.EO);"":/5=5F6ZO[2.6)X)
MXS!@8E4,^3M..<' .<8S6?=ZKJD&FSPK<:QYD4>H&T<^8=Q27]UDJI9V"_WC
MMQR: /4#;PG?F&,^9]_Y1\WU]:C:RLY"K-:P.4;<I,8.&Z9'O7&75S?CQ +B
M"]U%HVUJ"!(02(A ]NKL2I'3=N&>Q_'-[P[((/ MVD=Q/!/;?:5DEF225HG#
M,<X/+8R#@=?K0!T,US86NHV\$IC2[O=R1#9\TFU=S#..P'?TJ:"TMK7/V>WB
MAW=?+0+GKZ?4_G7G%IYFL7FA_:+NYB>&6Z474-PTRR'[,GSQ.PSM(8G'4'<.
MU167B>ZF@TAYM1G^U"'3C(K,P\P/,1(P51A\J0"6QC;QR: .KT.WT+2Y+MX[
MRWN;JXU*:*2<HN\3N=[19 [>E;8TK3EC=!I]J$<891"N&&<\\<\\UYW87;&[
MF+;1O\:R1')/01$#J?\ 9'].U=+K5U?MXQLK&UU&6!%L9+O[.BIBX=)$PA)!
M.""V<8P/QH Z3[#:?:_M?V6#[3C'G>6-_3'WNO2H1I&F!9%&G6@64%9!Y"X<
M$Y(/'.3R:\V'B+5Y?#S7L.ODW1>TBN(!$ ]K,TF),[EP,\C:1QBKT>JZE8W]
MJQ\03WBKKKZ:8)3" Z^63AB%!W[MHZXY' H [N'1],MW5X-.M(F5@ZLD"J0P
M7:",#KMXSZ<4Z+2].@E@EBL+6.2!"D+I"H,:GJ%..!["N)TS5=5U1=/BMM4E
M-WJ5K<&\C.PFPD7[K!=N5P_R8.<_49ILGB?4Y/#MMJC32VD#S6]E<RRA5$;+
MO\Z0$J< OMCR1_"2 .M '<3:7I]Q)-)-86LDDRA)6>%29%!R Q(Y ]#3HTL=
M-CC@B6WM4D?;'&H5 SG)P!W/!/X&N9;6+JS^&USJDNKQ7%Q'#(8[Z",."=Q"
M$# #'H.@!(STK!M=8FU<:7YU^MX;?Q*D<;[XW;8;9F&3& IY+#(&.,<XH [B
MRTS0)(&>PL=-:%D>W8P11E2A;YXS@=,YR/7K4XT32EOTOQIEF+Q %6<0+O4
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M@ HHHH **** "BBB@ HHHH **** "C/.**,<YH **** "BBB@ HHHH ****
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M&"!^( .]FGBMXC+/*D48QEW8*!DX')]ZDKS*\\1RZWX;G-Y?16SQ6]A,8!M
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M4L<2)GMN7TJSI>CWG_"6337T>J1S17DTL-Q"T0MY(&'R(QQN(  79S@C/J0
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MCXC:A>ZD!%!>6426MW(<(NPG?'GH"20W/IQ6-IL&H336UM#J%[IEGJNH7US
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M&PM]3FL9K6]C,<<[K*T0"R^4 7"C.X\'@XP>QJ%?'6F--+&;;4$,?E,Q>V(
MCD8*LG^[D_7V-4Y?A^DFK7=^=5EWW!NCS"I91,FS&[J0N!M!Z8Q5RX\').;M
MEOG1[BTM[8'RP=GE-N#=><^E $S>-=$75Y],^TEKF!92RH-QS&NYQ@<Y SU
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M>%[]* /3**** "BBB@ HHHH **** "BBB@ HHHH *,\XHH[T %%%% !1110
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M8Y_B_NACN QG('..*IQ>! -$&ES:FTD45E+96["$*8UD(+,>?F;"@=N,^IH
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MN-I/OLO&>YXS@9^F)+WPE%J"Z6ES>RO'IXA*?NT#%XSG<' W*6P =I' &,4
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MC7;691HB&5U4L21V7 Z^X]:JW.O&R\575G=2*EC#I\5QD(2V]I73 QR<X4
M=:CT.S^UZ_?Z\UG>68F58EM[M0K%U&&D !(P5$:CO\A[&G:MX7.J:G=7HOC
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M(T<S[RK+Y@RP;HP(^E-N_!5Y/*\,>J01V$EY#?2(;4E_-0(N%(< *0@XP<4
M=G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH *XV[TZY?QN]Q>:7=7T1DMWT^ZAD55LPHQ(&.X$9.20
M=P..W'944 ><6NBZJL:-'93V^HK#=C4;@$ 7A96$>#DECN*L/[H!'>F67A^^
ML-*$::7<M%+9Z<U_ 'R;AE\P3J 6Y.W8".,@8KTJB@#@M"TN^M_LYDTZX@@D
MUV[G:(X 6!XI0NY0>F2OKBJ>DZ3K5KX8T:RLK*XL;V"TO(7+8"K,R?(YP<'+
M=&KTFB@#S#4-/U@Z7,;.QU.")K.U2X@#.9'N!.A=EPQ/"!LL.N1S71:7=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BB@\4 %% .:* "BBB@ I,<TM% "8I:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL
MN_\ $FB:6Y2^U:RMW!QLDG4-^6<T :E%8$/C30[DI]FN+FYWC<OV>QGER/7Y
M4-*/%,3EMFD:TR@D!CI[KGW 8 X_"@#>HK#7Q-&6 ;2=94$\L;%R![\9/Y5>
MT[6+#53,MG/ODA($L3(R/&3G&Y6 9>AZCL: +U%%% !1110 4444 &,4444
M%%%% !1110 44A%** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQG =B?6LVTU4VZ>)O&)4S6[E;?3U!R)5C^08QV>1CSU_K:@I1?*M.G>]TO\
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MA^([6FNB2(R2*K(PP589!%33J.$U/L.4>:+1E>%/^1/T3_KP@_\ 1:UKT
M # '045,GS2;[C2LK!1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHI,\XH 7-%-8\THZ4 +1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M&.<T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .' JH# 2(  A$! Q$!_\0
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MB_O_ *&C[1%_?_0T 2T5%]IB_O\ Z&C[3#_?_0T 2T5%]IA_O_H:/M,/]_\
M0T 2T5%]IA_O_H:/M,/]_P#0T 2T5%]HB_O_ *4?:8?[_P"AH EHJ+[3%_?_
M $-'VF+^_P#H: ):*B^TP_W_ -#1]IA_O_H: ):*B^TP_P!_]#1]HB_O_H:
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M_OD_XT?8KK_GK#_WR?\ &@!O7_\ 51CUI?LEX.C0'CU(H^RWQ_Y]_P#OIO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !29%+10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !117/P>,+&?Q6_AT6UXMRH8B9D41/
MM )"MNR<9QTH Z"BBB@ HHHH **X[_A9OAO_ )^O_(D?_P 778T %%%% !15
M;4+^WTRPFO;IPD$*[G8D#C\<"LA?&N@NTB)?P-)&KL8UF0MA$WDXW=,9_(T
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M69;R51I5+9W\D[%_SUM:+K>N75YI-O?WME/%J4%VN%M=I1H6"[C\Y#9SDC
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MS$=R45%W!OD)/KN/'N>.M %;3]:O(?#NJWNI>7<S:;)<*Q@C,?FK'D\ DX)
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MALKR#3O.O$-QN,>]G4!"N03A">O<"NCO/!OA^_2Z2YTY)$NG1Y5\QP"RC:K
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M3OA9L2*45MWS8QG&XY([UZ!56:^6"]CMW@FV/$\K7&T>5&%QPS9X)SQ]#Z4
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M5?$%_/IFKVE]:Z=>J+"VNHX41\?O7QY;@OR1C(.1U%=DVB:8\JR-80%EMC:
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M'%N+8:1G))[EF))[=3VJY0 4444 %%%% !1110 4444 %%%% !1110 4444
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MYBH!SG .<4NIZ#?36^E3W.BKJ1D$[:C9Q7"QD23!?F#,0&"X*#G."/2NZHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M :M%1SR&&WEE6-Y"B%@B?>; Z#W-<]9>*[F[U*2P;P_?1SPF#[0/-A;R1*2
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MVR*)"[MC.% R3^54--\1:3J\WDV-XDLOEB4)M924./F (&1R.1ZB@#3HHHH
M**HZGK.GZ/&LFH7*P*P)!()X'4\#H,C)Z#-7J "BBB@ HHHH **** "BBB@
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MI.KIJZ&6&%U@,,4BR,>&+KOP/H"O_?5 %RVCEBM88YYO/F5%5Y=H7>P'+8'
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ML:AI4+E 54,2"6P &"GD5,_BN"-4633-36[:1D%IY ,N%"EG&&VLH#KRI/7
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M2U2![F>Y92<RSE2[9)/.T <9QTZ"IZ** "BBB@ HHHH **** "BBB@ HHHH
M***3^*@!:*** "BBB@ HHHH **** "BBB@##@\*V%M+&\<MULCDGD2)I<JIF
M'S@9' Y)'NQJ"R\%Z?IUQ936=U?PM:Q1PL$GP+A4^Z) !SC)Z8Z^G%='10!3
MN=-CNM1L;UI95>S+E$7&U]R[3NR,\=L$5EWO@[2KT79 FMYKBY2[\ZW?:\<R
MC =>, XSG(.<FN@HH R'\.VD\.EK<S7-S)ITPFBFF?=(S $?,<<]>V.@JQH^
MCVFAV)L[,,(C(\GS')RS$X^@S@>P%7Z* ,C3/#UMI>CW&F13SR0SO*[-(5W
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M/Z+X?N-+GTYY;F*1;32TL2%0@LRD?-UZ8%49_"-Y)J5Y.EY ()]4MM052AW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ***3/- "T4#FB@ HHHH **** "BBB@ J&[NHK*RGNYCB*"-I'
M/'"J,GK]*FK'\6_\B9KO_8/N/_1;4 9:^*M;>"*=/!]\\4J!T9+J%L@XP>&]
MZ3_A*]<_Z$O4O^_T7^-7M;=X_A_J,D;,KKI4I5E.""(CR*YRSFU+0'.J+;RB
MSO(+.V@MI[K=YEPY ,G)(08/(SR1[\ &]#XHU!H\S^$M:1\]$\EA^9D'\JD_
MX2:Z_P"A6UW_ +X@_P#CM9Q\3^(?M]GIG]@V\6H3I+(R37@"A$90""@;J&Z'
MG^L6E:[<)8BVTNP@#C[9<LL]RY&U)V3@X)RS9]@/7I0!K?\ "377_0K:[_WQ
M!_\ ':/^$FNO^A6UW_OB#_X[7/W_ (IG\1>'+F:QMUA@B^QO*S3,)%=VC?"X
M'( (YSSD_CZ!0!S_ /PDUU_T*VN_]\0?_':AD\7SQ/M;PIXB)_V;>-A^8DKI
MJ* ,"/Q2'C5FT/6XR1RK69R/R)%/_P"$F3_H#ZS_ . 35N44 8?_  DR?] ?
M6?\ P":C_A)D_P"@/K/_ (!-6Y10!STOBV*$@-HNNG/]S3I&_E3/^$SM_P#H
M">(/_!7+_A7244 <W_PF=O\ ] 3Q!_X*Y?\ "KG_  DUA_S[ZM_X*+K_ .-U
ML44 8D/BS2[B&.:&/4Y(I%#HZ:5=%64C(((CY!I__"36'_/OJW_@HNO_ (W5
M+29GMOAE8SQ,5DCT>-U8=B(00:Y^/QA?P^ +A7D8^(;2-XG;:&P5C,@E.?X3
M& <D?>('>@#HY/'&@PR-')->HZG!5M.N 1^'ET^/QIH,J;ENI@/]JTF4_D4J
MM'XJ2RTB"6X@N+GR+2">^G38!$'7[Q!(R>,D <#\ 9SXNM_[2-B-/O=YN)+6
M.1O+"22HA?:#OSR.A(QSSB@"7_A,-#_Y^Y/_  &E_P#B:/\ A,-#_P"?N3_P
M&E_^)KF8?'%T;ZSU*>TN38R:&]]-:6^QBA$@!?+$<!<]^_3-:$?BT6VM:Y<7
M4DLNEV\=BT(C1?W0F#9<]..A/7 % &M_PF&A_P#/W)_X#2__ !-4O^%C^$?^
M@Y!_WR_^%;+:@)['4)(@\/V8R1B60#!*KDL,9R >.1G*GCUY'P_XIO;B_P##
MEO-J!NFU"T,ERDUIY.QO+#91L ,=W&!G@YZ8H UT^(?A*1PBZY; G^]N4?F1
MBI_^$Z\+?]!ZQ_[^BHE\<:2T%S*5N4%ND,A5T ++*^Q#UXYQPV",\U+=>,--
MLD+7"3ILC268$+F)78JI(W<Y*G[N>.3P10 ?\)UX6_Z#UC_W]%'_  G7A;_H
M/6/_ ']%)XLU:XTJ+2C!=16JW-^D$LTJA@J%'8]?=15'2?&&SPZNHZPR%9;M
M[>SEB3R_M:#.V0*S?+D*3R0./<4 7_\ A.O"W_0>L?\ OZ*/^$Z\+?\ 0>L?
M^_HJI-X^T$Z;'=E+N:VEMQ<,4M6<)&7*$MV&&!!%:6FW%AJ5W?P1Z8J+9RK%
MYK1KMDRBOD=^CC]* (H_&WA>5]JZ_IP/^U<*H_,FIO\ A+?#?_0PZ3_X&Q_X
MUH?8+/\ Y](/^_8H^P6?_/I!_P!^Q0!G_P#"6^&_^AATG_P-C_QH_P"$M\-_
M]##I/_@;'_C69X#M+:7P+H\DEO$[M "69 23D]Z=#JFG77BJ?1)-,@$#1-Y$
MS1+MFD0_O5'KMW*/J&]* -'_ (2WPW_T,.D_^!L?^-2P>(]#NBPM]9TZ8KU$
M=TC8_(UC0ZAX,GN'@CL[4NGFY)TU@I\O.\!BF"1@\ YIL.J^")X9)H[>R\N-
M(I&+:>5^65@J$93D$D#CIWQ0!T7]K:;_ -!"T_[_ "_XT?VMIO\ T$+3_O\
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M>R!W4N)-W( ST'Y5U= !1110 4444 %%%% !1110 4G\1I:* "BBB@ HHHH
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M67;U&,ACSS6)_P (/+:H(M+U4V45O=&ZL%^S[_LS,"'7EL,AW'C QZFNPHH
MY;4_"5QJUO=QW.K%I+G3Q9M(;<##;RQ? ('<#;[=36CI>CW.FZE>3?;EDM+G
M8WD>1@K(L:1[M^>01&.,=^M;%% !1110!R_@02'X=Z2(6593:_(6&0#SC([B
MJZ^!HX(]$GM9TCU/3YUEGNF5F\_((E&,\;R<U<^'_P#R(6C?]>X_F:Z2@#D!
MX.N1!$GV]0RW%[,S;6Y\]7 '7L6!YSG%0R^![AK:-([^)9(](MM/5C&<;HI
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MH,!<DDX_$FK-%% !1110!S>D_P#(^^)/^O>R_E+725S.D.K>/_$P5@2L%D&
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MPR#[4 9'_"6^&_\ H8=)_P# V/\ QH_X2WPW_P!##I/_ (&Q_P"-;%% &/\
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M>7*D@,F0" =@&T;L$YR<8KK?^$2\-_\ 0O:3_P" 4?\ A1_PB7AO_H7M)_\
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M2[CPN+"(L&-JK>4F!DYVG XZU#-#K-Q8V-W:KX6G@MW$EJ^Z1(TX*@JRY'?
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MH Q_^$FL/^??5O\ P477_P ;ILGBK38HVDDBU1$49+-I5T !]?+K:HH YO\
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M@JQK&BJ 1"F1@?\  ?S/O754 %%%% !1110 4444 %%%% !2%<FEHH ****
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MTFYMK>WFT^W>*W!$*E!^[R,''ID=?6K!T^S,]M-]FB$EJK) P4#RE( (7T&
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M\*W** ,/^RM<_P"AED_\ HO\*IG1?%NX[?%\ &> =)0_^SUU%% '.IIGBM5
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M8VSLB"-2T*DJHZ*..![5Q-AK&L7FJV5@FN/(K27I$J10[KE(G0)U7 SEUR
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M#[.KR@)*[JS8 RX783E>#VZ4 :B^"M.2\BN4N;]1%+!,D0N#Y8>% BG;W)4
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M011>:C!+H"+&XLN[!./FX;/?K4&FW2P2Q:7=2R-J+0&[D5MS##.=P5CQA6.
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M,'C!"D5=;1],:!(&TZT,,<AE2,P+M5SG+ 8X/)Y]ZXS5-:O(+^]-G>3#3_\
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MT?"^AF^CO#IL'GQHL8;!QM4;5!'0X''(J*+P?H<$82"TD@ 554PW,J,H4D@
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M5)10!7-A9LA0VD!4C&#&,8SGT]23^-.-K;GRLP1'R?\ 590?)_N^G0=*FHH
M8\,4C(SQHS(<H64$J?4>E1R6=K,)1);0N)L>:&0'?CIN]<>]3T4 59-,L)4D
M22QMG22,1.K1*0R#HIXY ]*9/I&G7+%Y;*V9FD21F,*DLR<*3D<D=O2KM% $
M+6=L]VEVUO$US&I5)B@+JIZ@-U JO+HVES_:?.TVSD^U%3<;X%/G%?NE\CYL
M=L]*O44 9C^'-#DM([1]'T\VT;ETA-LFQ6/4@8QDT]]"TF2)HFTRT,;0"W*>
M2H'E Y"8QT!YQZUH44 9SZ!I$D=Q&^FVI2X$:S#RA\X083/^[V]*6+0]+@6W
M6*PMT%L'$.U -F_[^/\ >[^M:%% &-)X2\/2M&TFC63M$BQH6A!*JIR /I6C
M:V-K9>=]E@2+SI6FDV#&YVZL?<U8HH **** "BBB@ HHHH **** "BBB@ I/
MXC2TT]: '44W%.'2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FGK
M3J;GYJ %!Q2T@%+0 4444 %%%% !1110 4444 %%%% !1110!4U,WHTNZ.FK
M&U[Y;>0)#A=^.,UE>$)I)-*GCN)=0>[@N&BN%OI$=XW"J=H90 5P00<<[JV;
MVV-Y:26XN)K<N!^]@;:Z\YX)!JI'HT4,42QW5VK)<?:9)!+AIVP00_'*]..!
MP/2@#2HHHH *KWU[!IUA<7MRVV"WC:61L9PJC)XJQ6#XJ2^FL;>*STVXOAYZ
M22QPSQ19"$, WF @J2!D#GCK0!B>'_%&L:MH6OPM%"=<T]Y/*C#KM96!:/D<
M''3WVC)R2:;X/\4?;[B<WVM7*M;VZ_:K/4X(H'AD+ ;@RJH*G..>1QZUFW>D
M:K=:C=7L?A#4;1KJV%M)';:E:HF <AL8^\#CFK<<6N'4I;^]\'7E_/);"U;[
M5?697RPV[&% !R>>?2@1HWFN7Q^(6FV=E?I)ILVGR3F%=A25U+ '?@D#IT/\
M/UJCX3\3W>H:Q!IVHZC<PZFJ,;K3KRU5"2!UA95'R]\,2<=SUJM<6&L3ZQ%J
M*^#[Z Q6KVJ00ZA:+$J-G.!C.><]:DL;37DU>RU"_P##NIW,FG1M'9AKRSRH
M9=K%BI7<<# ^I^M &M?:U?ZIXTE\,Z9=BP6UMA<7-T(UDD))&$0-E0,,"20?
M3CK5Z'4KG1[B/3=4N6U"\NYG^Q"*-4>2-(U9B_100=W.1G(QZ#GM435)=;AU
MVT\-ZQ9:B(O(:2&6VD66/.=KIO/Y\'\A4$LFM2SV5Z=#UUM2M3(4N7^SD8=0
M&79N  X!'H?7)H W)?B)H<<4<J"ZFC>R%\6BBSMBW["3D]0W!%0>(/&2K;W4
M>BRNUS9R6IG<P[HPLS !3D@Y(;/'IBN3;P].MNUO;^&]<AB.F?V:!F!CM,OF
ML_WOO$Y]N:?/I&I,U_\ 9M"UNW2^%L9UQ V6AP5()?CD9(H ZO4/&#:5<ZUN
M$EU]ENK:WCMT@V%#(!_%GY\]>W8=\U8C\6P1:WJ5I<S,S1S6T%O:"W*RAY$+
M!2Q.&S@G/  ')KD]0L=6U&YU2=M$UB)[VZMKI&\F!_):' QCS!G('MT[Y-.U
M"TE?7[S61H?B!;V>YM[J#%C%(D30H4PP$V6!#'/*]J .NE\=Z)#%:.[71:Y\
MT)$ML[.&B_UBL ."O<?CTYK>L[N&_L;>\MV+07$2RQL1C*L,@X/L:\G>SNVE
ML9QIGB3[1;_;))';2XR)9;E2&; F&T#(^7GIU[UT_A&[U..[L=/FM]:CL;>P
M6V5;K3XXH]Z=)"X=FR5 &WIWH&:&I:GKMGK^E:>LVG!-1FN%4FV=C&J(77)\
MP;B0!G@59A\7:6+X:;<72_;D5UE,<;>69(T#2*I]@<X]B.H-6K_1S?:]I&I>
M>J+IYF/E&/)<NFW@Y&,<]CG/:L^V\,W=K<ZBD>J(=.O))I_(>V!=))0=V'ST
MR<XQGMF@"6'QIHD]M-<)-/LBBBF^:VD4NLAVH5!7YLMP,=Z)_&NAVMO%+-/.
MK2K*R1?99"_[MBC@J%X(8$<_RK,D\&:BMI#'::LD#QZ9:V#'R21)Y3$G/(.U
M@2"!S[TEMX(NH)K>1K^V/DPWD86.V,:CSV+#"[C@*2>,].* .@L=>M-1U)K.
MV65Q]EBNTF\L^6Z2;MN#C_9_GZ&H9=?M[.^ODN[J,QQ2Q11PPVTC2AV3=MP,
M[R1R-HX .>E1:)H-UI%S:G[5#)!'IEO92KY1W,T._#*<X .\Y!!Z"JNL>%9=
M3FOF9[:2*ZN89=D@=2BI'MX93D/NY!'TQ0!N/J]C%I::E),5M7561C&P9MWW
M0$QN+$D +C.>,55C\3Z/+&KK=GF*:7:8G#!8CB3*D9!4G[IY]JHZAX;O;SPM
M8:?_ &GOU&QDAGCO)D+;Y8R""PSDY^M5M1\-:QJ,]I>R7EC]N%I<6ER1$ZQE
M),8V#<3E<=SSG\* -!_&GAV-@KZI$I,23<JV C+O4DXXRO-31^*M$EBCE2_0
MQO)Y8?:V =Q49./E!8$ G /8FN=A\#WT>FZ[:M>0'^T=/M;2+ 8+$8HMAX_N
MDDD8]:OW_A:>XUNTODBTFX1+:&WD^W6OFM'Y;,VZ(]B=Y_)30!JIXGT66>:"
M+48))HED9XT.YODSN  ZD8Z#FLVW\96MQJ%L=HATZ;23J1FF!5T =5P1TZ,>
MF>GI59/"%[]JLIY+BWS#=WURX7//V@. !QVW<U':: VCQVE]K,L#6MGHG]F7
M"0J[[QN7D #)!5?3.30!UEO?VEU,T4$Z2.L:2D*<_*V=I^AP:R[/Q+9C3WN=
M3OM/@Q+,JF.?<K+&<$@D#) Z@4>$=/N-.\/P)=N[SL,YD7:P0#;&&&,Y"!<Y
M[YK/M?#>I6]PDV^TW+<7\V-S,!Y[90<KSCO_ %H Z.34K&&Q6^DO;9+1PI6=
MI5$9#="&SCG(Q42:YI,EJMTFJ636[/Y:S+<(4+8SM!SC..U<7XDTR;2/AAIN
MF7'E236\UK$^TG8Q$B]R,X_"M=/#VI0Z^=<B6T^T27#/):F9@@4Q+'D/LSNR
MF3\N.<=LD W_ .U],_T?_B8VG^D@&#]^O[T$@#;S\W) X]:1=9TM_.VZE9GR
M.)<3K^[YV_-SQSQSWXKFK?PKJEJMBUM-#!<6Y+&5+ERK;YVD>-HRF'4!OE.0
M<^G6JDGA35WAE$*)%%#=)<PVDEXS*SK*7.UP@9$.<@9.& X&.0#L1K&F,D#C
M4;0I<-LA83KB5LA<+SR<D#CN:KW^N6\-C>R6-Q97-U:J2\+7:QA3G&';G;R"
M.>XQ6 WAO4+:6QETVRMK&=&8NT%R7C :0,RN'3+Y R",$-Z=:@NO#.KRZ3KM
MC;Q)';W4#I!;37 D"R,Y)9&V@JF,':>_IUH [)M1L4O5LFO+=;I\[8#*H<\9
MX7.>A!_&EAO[.XF,,%W!+*HW%$D#,!G&< ^M<M<^'=1N)Y+5U1H7U>/4EO"X
MW(%*G:%QG< NT'TQGN*?HOAVZL;C199+2WC>V^UFX=&!.9&RO..<CD_2@#IY
M;VTAN([>6ZACGD^Y&\@#-]!U-9EGKLFH:U<6EK9"2SMY7@FNA.N4E4 D%.N.
M<9SG/;'-8'B/PSJFJ3:Q:0QH8=3EMIHKSS #:^5L##'7.%8KM[L<X[]%H-G<
MVDFK&XA$?GZA)-$0P.]"J@-QTZ'@^E &C#=VUR\B07$4K1G$@1PQ0^AQTI!>
MVK7/V87,)GR1Y0D&[@9/'7H0?QKD?!^BZKIVHI+?6"VT:V)@(25617$K-A0"
M3M.XD$DGUK$M=%.K>(-8^QZ>JW$6OK,=2S'B)456*==Y)Y&,8^;D\&@#TI;N
MV8RA;B(F(XD <?(??TJM-J]FDLEM#-'/>+"TRVR2+O<+V&2 .>.2/TKS^3PM
MK$_AY;%-$6UN[;3)[2659HR+UR4VD$'/)7?E\8)]S6K_ ,(T^G3>79:#&]O/
MI#VTIB\I=LI#$A@2,[B0N1D<\D"@#LH;Q'@MWFVP2S(K")W&X$CIP<'TXJ;S
M(]X3>NXYP,\\=:\YN] U&6VGLIM#EFGN[&UCMKL218LY(UP0QW9 5OF^7.[)
M JU%X;GC\06^H)I 2X_MV::6Z.W>8#&P4Y!SL)(X]1TYH [QG5-NY@-QP,GJ
M?2LN77HEUE],AL[NYEB\KSGA"%81(6VELL#CY23@'%87BC2)+[4;[S=(DU!+
MK3Q!:21A,VTH9R3EC\N2R'</[GM5GP[I%Y9>*=9N[R+=YMM9Q)<G!\UD1A(0
M>O7'7VH V;K6K.V>-0QF9KM+-Q$0?*D89&[GCJ/?D<5HUP4WA^6:[U.VDTEC
M%<ZY#<M( H62'8N3D'/!5L^[>YK'/AO48[6VM+[1KVZTI/MD4=K:M&6@9I@8
MW <X'RY 8'(R>G< ]#UC6[/0H(;B_+QVTDJQ-, "D9/0MSP/?\ZL?;XO[36Q
M"N9&@,X<#Y-H(&,^O-9GB/3OMUCI]H\+7,7VR(3!EW[D&=V[VQU^M<O?>'?$
M&GVFI:?IK/-:16BI8.KA9!&95+PDGN%# 'T(H ]%HK@X-+F@TRRO])TS4HRF
MHNQL;MEB(BF'ER +'PJ G>/0@GI6KX3TN_LMZZCYA:R0V5O(S9,\8;=YI';(
M*CURI]: .GHHHH **** "BBB@ HHHH **** "BBB@ HHHH *:>M.IIZT *.E
M+2"@?>H 6BBB@ HHHH **** "LCQ6S)X/UMT9E=;"=E93@@B-L'-:]175M#>
MVLMK<QB2"52DB'HRG@@T <*]QJ_AU7U6-/\ 0;A;.WBM;BX9P9&8!Y!UVC!Q
M[D9(K7T[7=<O-0:W.G6TBVMTMI>&&7[A\M7:12Q!*@MC;C)ZY[5M7.EV%_8I
M83Q"2WA9"J!R"K(0R\@YR, U _AO2)-8_M8V:B^[RH[+DXQD@'!..Y&: .7@
M\<:K+I*7O]G67SZ5+J2CSV'$94,I^7J=V1_DU:;Q$\4^IW]II<T\HM+&9@DC
MO\DA?)\OH-@!/RC)_4;B^&-'6W6W%H?*6R>P"F5SB!L;DSGV'/48ZTC^%])?
M<?(F0E(H]T5U*A BSLP58$8R>1ZT 8]MXMU+4E']DZ;!J#1P0SRF*;8KK([
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MS-V]L _RDOE 0P^4 \9X&*5_!DTEV&DM+:6(:]]L_>$.3;B$)@YZ_,!P?3-
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MSTU[2>Y$-\$AMEN\-:L#)$?XU!Z@=ZIW'A.2V>\NX;R26/==7$=J(1G?,AW
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MP!NQQTJA%XEUR:.]GN+_ .R365OITKVHCC(WS'#JV06 /!QD$;AS7HTD,4P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445E>'KB2ZTR6260R,+V[0,3GY5N)%4?0  ?A0!JT444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %-/6G4S^*@!:,44X=* "B
MBB@ HHHH **** "BBB@ HHHH **** "BH;N[M[&TENKJ9(8(E+/(YP% HM;J
M.\MUGB$H1NGFQ-&?R8 _I0!-1110 4451U35[#1;476HW"V\!8)YC D GIG
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MZNC#(93D'\:=0 4F*6B@!#0*6B@ HHHH **** "BBB@ HHHH **** "BBB@
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M[H)VD8QV!->E4QH8F*EHT)52H)4< ]1].!0!YK%XOOUE%E-K:):/=I&VJRB
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M73;-T>-865H%(9%.54\?=!Z#H*(]&TN)D:/3;-&C=I$*P*-KL,,PXX)'4]Z
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M?MXO+ATJWC3*G"@CE6+*?P))H RD\4:E%KMOIUREBQ^UQVD_D"0@,\329#$
M9^4#;R><DC(%5QXOUDV4UZMC;/ MA<WA^5U\HQ,0(V;H2<>W0]JZ*7PQHLVI
M'4GTZ'[:9%E\\#YMZ_=;ZBN=T/P +"ZF:]-D\,T#PS):K/'Y^Y=I+@RE>1GH
MH.><B@"U)XBUFSU*.TO8=-#AH#(D#R.=DLZQ+R0 I&[/.=V#CH33/^$IU)M3
MBBGL+0Z=/J<NF;XYF,NX;L,1MP!A>>>*VKSPQHU_<_:+FR5Y?+2(MO895&#*
M#@\X(!SUJKI7A:"SO+B\O";BY:[N)X&\URL2R,3PI. P!QN SCO0!E>#/$%W
M)+I6@W=O$,Z%!?1S)*6)7Y4PV0.3UX_7K5R_T61?%&G75A=7K7371GNS)<L8
MUM]C#9LSM&6VA>,\$YX-;%GH&F:?=V]U;6VR>WM!91/YC,5A!!"<GGD#D\U7
M/A/1CJ[:H;>4WC2B8O\ :I=I<8P=N[;Q@=NPH R-,MKJR\?7)U,2/+>12RVD
MD-R[0^6K*"K1GA7 *<C(Y-6]5\47&FSWDPLXY;"QNH;:X;S2)09 AW*N,$#S
M$XR,\^E:NG:'8:7/+/;)*99,@O+,\A4$[BJ[B=HR<X&*BN/#>F7.IMJ$D<OG
M.T;R*LSJDC1\H64'#;>,9]!Z4 97AVRFO-8U34KV:5Y(-1GCM]MP^T1[0FUD
MX7 QD=>23UK @\1ZS>W'AK4'CC::5=29K=9FCBD$; +G@XP <<'\,G'?V&FV
M^F_:?L_F?Z3</<2;W+?.V,XST''0<5FV_A#2;9X6B2XS#Y_E!IW8()0 X4$\
M#CH.GXT 4;3QC/J$UHMEH\TZ20VTLY63F(3*6X^7!VC!))7KQG%2^(3<?\)5
MX6CANYX8Y+B82I'(560"(OA@#@\KWZ9-2P>"]&M[NSN8DN%EM8HXD(N7 =(S
ME XSA@"!C/H/2K^IZ':ZK=6=S.]PDUF7:%X9F3:6&">.O''XGUH I:]XDETJ
M[2RLM.DO[QK=[GRE+#Y%('!"MEB6  P!ZD<57_X2YAKJV#Z<?*=GC1DG5YMZ
MQ>:0T8'R\!@/FR2.F.:DG\%Z;<F&62>_^U1.S?:TNF29PV 59EQE<*HQV XQ
MS3I/!NG27C7*SWT3&629%BN658W="C% /NY!S['I0!5L/&8O+..0VL+3S.ZQ
MQ6T[3XVQ^8P?:FY7 !&W:3G&,YJWJNIB;P7+J,D&HVF^%6:*,B&XC)(& 3T-
M)-X.L+C,DES??;/,647J3;)E*IL&&4#C:2#QSGG-:$VBVL^AMI,CSFW9-A8R
M$N><YW'OF@"M:^(4N_$-SI*0 -;DARTRA\;00VP\E3G&1D<5F2Z[-I7B'6'N
M$NI[);BSA&'39!Y@VY )R?F9<_7/8UK_ /"/VK:Q!JDTT\\]LTK0"5@1%Y@P
MV.,XQP 20*BO?#%G?S74DTUQ_I,\$[*K* K18VXXS@X&<Y]L4 9\OCNU2WN[
MI-.O7M(89Y$G$>$D,3;6&3TR>GX]#Q3SXVB5H5?2-1#N8RZ(J2&-)"P1CL8C
M)VY(SD#GZR?\(78BTU&S6]U!;*^216MA*OEQ;VW,4!7@Y]<]35A_"]N=0BO(
MKZ^MW6&."5;>18UN%0Y7?A<YY(RI'!QTXH QO#GBJ?[/Y>HV]Y*T]_<PP7/[
MO8[*SE8Q\P(.$(&0!VS70Z7KMMJZV[6T,X6:V%SF10/+!. K<\-D-ZCY3S5.
M'PW!I2FXM&NKDV\TUW;VCR(J^<ZL#@[0>=[ ;B0,U/X<TE=,M+B5K5;:YO;A
M[F>-7WA&8\*#[#TXR3CK0!LT444 %%%% !1110 4444 %%%% !1110 4444
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MBBC(H **,T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*G+,I7Z@H<_EVH TJ*** "BBB@ P#1110 4444 %%%% !1110 4444 %%%%
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MR>9QA@=P./:NVHH \L:VN-'US[!!9+)-'%91+&UM<(MXUNH97$B;EX/=NFP
MYP:U7\$:TXN6_M2S\Z6UGMA)Y+'B259-Q4G:#P1@ #G/-=]10!Q^G>%-1L]5
M@O);FU<)J$EZX7?D[[<1%06)/!R<D\^W2ELO#&JV^K:8\MW:/9:=<W$T1"MY
MLBRA^&[9!<\]ZZ^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I#TI:0]*  =*6D!I: "BBB@ HHHH ****
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M!C(1UC8J3GIC@T :%%007MM<V\%Q#/&\5PH:)@W#@C(Q^%3T %%%% !1110
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M,,9B1GVJ#ER-QP >W&>E7[SQ*+7PC;ZS%LN6G\E5*(54L[!<X8Y !/0GMC-
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M HHHH **** "BBB@ HHHH *3^(TM)_$: %XHI#S2CI0 4444 %%%% !1110
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MVZU8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "FY^:G4P]: ' XHS2"E H 6BBB@ HHHH **** "BBB@
MHHHH **** ,[5==TS1%1M1NU@#YQD$\#J3@' &1R>*DO-6L+ PK<W**\YQ%&
MN6>3_=49)^H'%9GBZYA;1;K3/M,D-S=P.D06W,N_(P5P 1STQP>>*Y>^_M.V
MUF\OU^T0:T+.UCLH4A5HI ?]9$N5;'S YP1@8/2@#TBBH8+J&Y:98F),,AB?
M*D8; ..1SP1R.*FH *RM3\2:/H\_DZA?Q6\@C$A5\\*20">.F016K7$_%0(O
M@+4=JIY\YACX7YG"RA@!CTY/XGUH ZO3M4L=6MVGL+E)XT<QLR?PL,'!]#@C
M\ZM9]JX3QMJ=WIFIV"6MW_9MG>I,\EVD7#7 11%O(4D]!QCD#';AUG>:UJ?C
M*\TZ77)+>"QM[6X>.&!!O)7+@[EW $^O(S0!W50"\M3>FR%S";L1^:8/,'F!
M,XW;>N,\9KQVU\9^)9=*M9WUR7S9M*N;QOW$'RO'(ZKCY.A"C.??&*UKCQ-?
M1ZUJ$PNX8W3PL+N.401;A-\I'S;<D$G[IXYZ4 >IT5Y7#XTU.VM=>>;6DN%M
M!I[P2M!&21*H,@&W QD]3G%1-K]UK6F6K7VL^7#;>*!;&=/+ :)1OC9CM ^\
MHP< 'N* /5(;F"X,@@FCE\IS')L8-L8=5..AY'%2UYA9>([Y-5ELS<0:?:S:
M_?6\]['#$A CC4H&R,%F/\1&3BJMWXY\0?V/IDXGCMIY=)FO)085)9D8A3@]
M P&?QH ]5GN(;6%IKB6.*)?O/(P51VY)J*#4;&YCDDM[VWE2,9=HY58*/<@\
M5R'CJ\:X^$MS<S>5YMQ;0,0P&"S,A. 3UZD?2N;6]\C6M;N[I;:TN5\, 6<(
M/F+=Q[-V\L0-Q!7:1CH.X&: /68I8YXEEBD62-AE70Y!'L:2.>*5G6.5':-M
MKA6!*GT/H:\IMO$GB#^R+"STB2WAF.G6K6L,21[7D=]K!L_=  ..G3O4MOK%
MYHWC'4F@EC,-YXA@LI863DAT(+!O; XQ0!ZK17F">(M8TZVU>XCU!+YTU>Y6
M6#Y#-%%&I7*(6&X#:K%1C@'IG-=]I.L66K0XMKN*:>..-IT0C*%ER,C)QGGB
M@"\)HFC,@D0H,Y8,,#'7FG*RNH92"I&00>"*\QN/M>BV/B'4((6DTB\GNX+N
MV09^SN"R+,H_NG^,8XX/(%;!US4=.AOHK<0"+1'M;5K7R\M<!E3)!R-N=WR\
M'I[X !V](S*BEG8*HY))P!7"6OB+4K"QN]0N[E+BUAUV6TN/W9S%#N\M".>@
M;8<8R0?Q,5]K^I7?A;6(]3L;-[G3[:7[=;R1-Y3.6!AQ\V<&,%B,]2O(Z4 >
M@,RJ,L0!D#D]STI:\[\3W%W>G6+2=EGAM]6L(;6(+M*EO*8\C.<[B.F?Y5?N
M/$VN6VGRRRQV:FUNYH;JYCMY)(XXT4$.4#A@.>6!;&.G/ !VM%<8FNZMYVI1
M0W%J\CZQ]DM?,A9PD8@63A5(+_F ,DDXXJM?>,]7@TBWU"&WL2G]DP:E.KA\
MDLV&5<'C@\$Y_&@#O**\Z\2W]UJVJ:08_+2TM/$L%LJB-O-+(K%F)SC:<GC'
M0 YP:6P\475K965II6FV<8G2_N-LDC[5,<SYQU/S<GVSQP,4 >B45R:^*-0N
M+B-;73T<$V@:,[MS+,,EPPX 4 YX/W3TXJWXIU^[T* 2VMO#-MMYKF0.S9VQ
M[<@!03SN^\>!WZB@#H:*XY_&=TNI(@L(?L9O;6S+&8^9F>-7!QMQ@%QWYQ4K
M^*+YX=2@CM((]0L&N#/&\A(2-4+1..A(;*>G\7IP =917F__  D]]:7\6L2(
MMT5\,PWD\7G&-"2Y)91M/)^@[#-;<VN+8:K?S6]FTTD]Q8PYDNV"D2_*I"[2
M$QGD#KUH ZVBN/E\<20V/F2:?"MPLEY%(C7>(PUN"6 <ID[L9'RCC/I5[5]?
MO+3P=#K,%JL5Q*+<F&<G,?F.BD'CJ-WYT =%17.GQ2!/N%H&LO[0&G&9)<NL
MI;;DIC[N[ SG/?%,\0ZQ/;WTVG(Z10G2;JZEG$A62+;M 9>,?Q'O[\8&0#I:
M*X;1_&,EMH^FVEY;2RW\EE8O"QD+FX\T;2[$ D8*L3U./6N@&OB'P[<:O?V4
M]I]G#EX7!W':<#;P,AN,9 Z\XH V:*Y^3Q#>0W<%A-I7EZA<2.L$9N%\N1$0
M,SA\9P,@8VYS[9(S9?'\8MUDM])N9B+&6]F0R*AB6*39(#GJ00>G7% '945R
MMUXNELM2U2WDL3,EM=VUI L+@/(\R@C.XA1]X#J*?_PF0CU6UTZYTJY@N+AQ
M&(VEB+AC&7'RAN5X*[NF0: .GHKF+#QDEW#I]U-I5Y9V5](D<5S,T>W+*2N=
MK$\D;1QU(SC-3:MK4Q\&MJ]EOA9_+>+&UB5,B@$=0=RG\C0!T-%<O%XUAE\V
M!=-N_MZ7;6OV3Y"Q94WDY!(QM]^OYTD7CNPD<#^S]25%M%O)Y&B4"",ACE_F
MSQL/0'\: .IHKESXLM;V)#$;VS9+^WMVW0HWF>81@ Y*[3D@D'(P?;-C3?%U
MKJ=];VR6-_$+@S+%--&HC9HF(9<AB<_*3TQ^/% '045C^*K^YTOPKJ=]:.$N
M+>!I(V*[@"/:KE_?KIEB)Y8IKA]RQK' F6D=B   2 ,D]20!ZT 7**YS_A-M
M,^R6UQY-Z1<0S2JBP%BHB;;(#@X!4^^/0G(S6U;QA =,D?2'DEG5;:5I%BW+
M$LK*5W9Z$J3],@T =917*:;XHD;4M9M[L-*8+\V]K#!'EV41ACQWQR<__6K0
M7Q9I,K6JP23W#7*&1!#;2,0HD$;%AC*X8\YQC!H VZ*Y:#Q-+?\ BW3K2PS)
MIMQ:33-(8B-VTJ%=6_N\X_'W%=30 4444 %%%% !1110 4444 %%%% !3/XJ
M?31]XT %.'2D/6E'2@ HHHH **** "BBB@ HHHH **** "BBB@ JGIVI0ZG#
M-+ ' BGDMV#C!W(Q5OPR*YCQC#=OJUC-9V\]S)&G%N;5WBD^=3Q*O^JD&.&.
M!_*J%MIMQ:SB_BL;[[6VK:@6*B09A*3LO!X 9O+(..I'K0!W%_?Q:=#%+,KE
M))XX 4&<,[A%)]LL*9I^JVVIO>K;[\V=RUM+N&/G4 G'J/F%<#I*:K*EPDME
MJ"PO-I+Q1R6TBA"DP,GWB22 H+-WZD"NG\)6UQ;3>(C/!+$)=8FDCWH5WH4C
MPPSU'!Y]J -C2M2M]8TNVU&T+&"X0.FX8./<51U'PU#J5XURVIZO;LP *6U_
M)$@P,<*#@5Y]IUAJ>DZ/;*EAK/[W1=MQ%$)<B7ST48'.U@FX[1@D ^N:V(H]
M:72A>:?!>O>66K2F*WG22)989<J  _\  "X;OMVF@#>_X0R#_H->(?\ P:2_
MXTR3PK9VREWUW7P40R;?[4E)(7J<9YZC\ZS)K":#Q-;6-Y/K;10I:BPGM$8I
M\F0XE;D<GEMV,@CTK1\1K&GB/39Y(KEP;&\C1H4D8"0^45#;/4!^O'Z4 %IX
M=AU+3K.\M/$7B".":))H_P#3,EE89&=P)Z&E_P"$,E_Z&SQ)_P"!:?\ QNN2
MM8=3TS2X(+=-3^QR:3I\UX@,CNN'*RK&#]T[,948X'':NNTM98_ UVUM=:C.
MQBG:![F-HY5X. H/S  ],\],<8H K3^%56Z@LY?%/B=GN Q7]^I7"XSD^7@=
M1C/7\*AU+PQ:Z99_:;[Q7XC2#S4!;SD;#LP53Q&>Y'-0Z6E]I]EH$SWVJ/)/
M837%T;J220(_DQ_>!Z8;) /<FN6@OI-6\/31KJ%])<O;6.^UFDFE=IA<(995
M#C &"GW>.OX@CNE\"(JLG_"1:VR.Y=E>2%@S'J2#'@GWJ27P:\I4MXCU=BJ%
M!N\@_*>W^JZ=*P$69-?L5OIKYX+37KB**2220G8UME>1R1N.!VP2.F:O^*3>
MVOBI;NR\\W)T:Y2S"LQ5IPRL!M'!.,G!'.!Z# !:D\&7\T(AE\5:B\0QA&AA
M*C'3C937\$7<@0/XGOV"+L7,$!VKC&!\G QVJ3PM*S:G,MM?W5[8M9PRR-<2
MM)Y<Y+9 +<C(&2O\/' S7*_;+ZPBO+<:C=6$3:W=K/=20RS%%Q^ZR P.",X/
M3@9H T;_ .$UGJ<WG7FLWLLFP1AO)B&%&<#A?>M#_A 92ZN?$-Z7603!VMH"
MPD P'SLSN  &>M9[SZO)8ZW.=;U FPTJ*:W98EA\Z1HI.60@D$D*<<<U$U_K
M%M<ZD%UF]D2UETV2%7"$2&=@) ?ER1C. , =: +5KX,L]3:\\K7WN_*NG2X$
MNGVT@$^!N)#1X+8(R?UKH]%T&[TO4;FZFU8W:SJ Z&SAB+,,89F106( QSZU
MS[ZA?W&IV]BFHSPK/K=U;R&,H&$:Q,0H)!QV/KSQVK*N_&-[:Z/I\IUH+<BV
M@E;>(U$@-P8V;D$ME0<@8"XSG)% 'I2V-HD,\*VL"Q3LS3((P%D+?>+#N3WS
MUJ"?1M-N=2BU">PMY+R+ 2=HP6&#D<^QY'H:X*77[[3;F\MFU>.U:35[E)9[
MAE80J4S"&RIVJ0.,C^'&>M;VO7-Q_P *Y%S-J0,I2W9[R$>6'!D3+#(X!!],
M8/I0,VK.TT1IM1CLX+-I'FS>K&JG=)U^?WYSSZU*(=*U:UNT5+6Y@G<QW.T!
M@[+\I#8ZD8 Y]!7&-J,UKXFU2\LM2!BEUBPMVA 1DE62*)2<XSG!)&"/N]Z+
MGQ#?VNGRW1O?*M4O[U)3;B$3!%G"JRJRD. "0V/F.X'/J ==-H^BK<&XGLK1
M9IGB!D=0&D9/N#)ZD8&/I[4L_A[2+DDS6$+;FD9N/O%\;\^H; R#P<52\4O%
M&=$:9D51JD6"Y &=K^M4_$WB*6WELK;3;VTA$[RQR7<LRK'%(L>Y$9BK %MP
M/3H#B@#6N/#&B7=S)<3Z;!)-+(LKNPY9@" ?R)'OWH'AG15M6MET^(0-;_93
M&,@&+<6VXSZDG/7FN4C\3ZK'K5K:S:G9SD3V<$JVP7RV\V/+'+?,Q)(*E>,'
MGG-)_P )5J5O&D=W=B*>>>)3(YB$*1,9<21RJ&!5MBKA@2#UZT =9-X8T6XU
M,:E+I\378E2;S,G[Z_=;&<9'K2KX;T=0@%C& D<L:\GA923(.O<DUF#5=1L_
M <VH7^HZ8]['&P^UVQ+P,V[:#VYSQZ9K#LM>U*^\1Z7;S7\B0PZQ=VK;2@\]
M%@WQ[]ORG[V./8\$"@#4NO!CS:U]IB:VB@!C\MT:=)8E1%4 ;9 K8V\$COT.
M.=_4]#T[63&;^W\TQI)&N)&7Y7 #CY2,@@#\JY[Q)XDO],UEX;:YM1%"MJ6A
M:,ESYDVP[B2.-O3;D\'.!C+(_$&KKXAA@ENK5K.;4[BQ"+;D.H6,NAW;L$@X
M!XH WT\-:0@4"T)VS13@M*['S(E"HW)[  >^.<U#8Z.4:_NM8:TENKX+!(T"
M-&AB'RJG+$Y.X\YY)'H*K>'-5U/4KAH;N2'S+$/#>JD>,S;_ )2IS]W8,_\
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M3-?QW<Q:/RVCD*E6+%M[9"D'( &1@#FH[;0)[KPW%YZ->-'-'902V\22HUM
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MB%L?[89Q_NU1\1ZK<P:KK%M)?36DR64<NCI&Y7[1,-Y8 =)"6"*5.>#P!G-
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M#]G8MYF&+%B2JXYZ*!QD\GL 76UC29)+JUDO;;,"$SI(X 5>ASG@@'@^AX-
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M^Z=Q).&.X#!'>FZ[H6J7&L:S/:6(ECN8;-U(D1?.\F0EX23R"P(Y(QP >.*
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MBB@ JCJ6D6.KQI'?0F5$S@"1EZ]>A&:O44 <_HO@K0O#VJS:CI=H;>:6+RF
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MWQ=:7VHZG&T\*VMO)#' ^UE9V=-Q4@C.>#T'3\:NQ^)M)EO?LL=T&(L_MQE
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MY5.-K_UL<GK/B:^LY]9DM$M_(T:.*2XCFC8O.&&XA&# +A>Y5N?I3M*L#?\
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M'7<@B4JK+\OWN><Y!]*H-X!TTK"4O;^&:/SMTL+1HT@E^^" FT#C^$"@!_\
MPF]H9=-4V=PL=^ELT;N57_7_ '0!G+8XW8SC(JJOCY9+"XNET>\B1;>YEA>5
MDVRF#.]>&)'3J1V-6V\#V32VK+J&HHELELJQK(FUC <QLV5))_(<GC-*O@FQ
M&F16#7EZ\,<-U%EF3<1<??)PH&1DXX[]Z %U;Q+=:7X$&O-9)]J,,3&!Y %5
MW*J,MGH"P/7IW%3W'BB*VOEBDLK@6HG2VEO R&.*9@,(1NW=64$@8!/7@X6]
M\,1ZCX1_X1^ZO9Y(]B*;@JF\[&#+D8V_P@=.GYU&WA5)+AS+J%S);2SQ7,UN
M0@625,?,<#C)56(&!D=LF@"UJOB"'2]0L[$VMQ<W%T&95AV<*I4$_,PSRPX&
M3C)QQ6</'FE"YFB>*Y2.,3$3D(4<QMM8 !BP)/3<!GM5W7O#D>OM"MQ=21PQ
MD,$1%W!@P.Y7(W(W;((ZU1;P1"]K?6+:K?G3KEG=+4E-L+L^_<IVYX;D9/YT
M 3/XKD6^L;7^P[]9;F[>U=)3&K)MB\S<,,588/9NS=2,&&'Q9#:Z<AECO[^X
M)NI&2.W1)$BBE9&8KN PO"C'S'TSG%K_ (1RY=M.EGUJZGN;*Y,ZS21QY8%"
MA3 4 #:3SC.2356+P:;0P2V.J3074<=Q"TQC#%XYI#(1VPP8Y# ]N<T 22^.
M-,CO%@%O?21E[=3<QP@Q*)@"C%L].0/QJWXE?58=.DNM.U"ULDMXGFF>>'S-
MVT A?O *#ALGGM5%O!D(MIK6&]ECMW>T*)L!V+;[<+GOG:*T=<TF[U7[*+?4
M?LL<+^8\9@6592,%<Y_ND9^N/2@#G=1\3ZO;VFA2W*MI4=W KW=S)9&:.*1M
MH5&^9?+[\G.,@>M:GBO7Y]!N=%,89H;F\\J9$A,CLNQCA0.<YQTJ>^\/WFIV
MD5E?:N\UH8D2Y06Z*TY#9)R/NAN 0!TINK>';K4[FWN1JFV6TNQ<VHDMPR1C
M9MV$ J6&23G.>: +MKK^G76BR:LLQCM(@YF,JE6BV9W!EZ@C!XK'U+QM;0Z!
MJ%Y;0W$=U;>6!!=V[QO^\8(K[#@E<D\^Q%:#>&XI?#E_I,UP[M?>:TTX7!WR
M$DD#L!D #T'XUGZGX0N-7LKI;S4HC>SPV\ N$M2H"Q2>9RN\Y+-[X'&!UR 7
M)M9ET2RM&U-WNWO+Q;>%H+5D(#=-R\G( /UXXJ+2_%5K+J5QIM_=1I>?:YXX
M5$3!2B9(!;E=P49.2#WQ5W7]&DUF.P,-TMO-97B7<;/%YBL5##! 9>/F]:R+
M_P #+J15;F^S%]LN;AD6'&Y9D*[,[N" ?O=_04 ;NF:]INKRRQ64[/)$%9T>
M)XVVM]U@& )4]B.#57P]JUUJLNLK<K"HLM1DM(O+4C**JD%LDY/S=L4SPUH$
M^B1LMS/9SL(HX$>"S$+%4W<N<DL3GV QP.35:QT/6=-GU'[+>V0BO]0DNF9H
M6+QJP48'."<+WX^O2@"^_BK1([F>WDOUC>!'D=I$94*H<,5<C:V#P=I.#Q3#
MXMT7[''="ZD,<DCQA5MI3(&3EP4"[EP!DD@ <>M8:^"+N"WO[>VN=,3<'^RW
M1L0;D!GWE'DS]WEEX /.<@CETG@[4FLIX?M5GYTEQ+<1W$8ECD@=U4;E8.2<
M$'(/#<9]* .E&MZ8=3&G?;(_M;,56//+,!D@'H2!R15NYN8+.W>XN94BA099
MW. *Y6V\*W&G:Q=ZB/[*GW-)<)<2Z?ON1(5QC<I'RYYX&>W>M#4],O\ 7O"L
M4%PT$&H_NI_EW>7YB,' (/.TD8/<9[XH 74O$]K!I\4]C+#*\MY'9@R$A8W8
M_P 8ZC Y[9X]<U*-;_LX:5::R\(U&_D,2?90QB9@"<@MT&,<'/)QSUK,_P"$
M>U2>X^WW#6:7<VH6]Q/''([1K'$,84E02Q]P/3MFKWB#1KO4M0T6]LY(0^GW
M1E9)B0&4J5." >1G@=_44 &A>*;#5K)&EN[2.]6$S3VZS F)02"3GL,<^F1G
MJ*U;34+*_CDDM+N"X2-BKM%(&"GK@XZ<<UQ,W@?5+FSLK9[BRB2"PN+=BI+8
MD=PP(^49'RC.<=\5TWAS2YM-M)C=6FGVUS,^YQ8[BK8& 26P2?PH LV^O:/=
MEQ;:M8S&-/,?R[E&VI_>.#P/>J;^(?#VEV-N8+NS%M+=):QK:LI42.>GR\#K
MN/M7*S?#_4[C0;73&NK6)H])>R>6-V),AE20<;1E/DP>_P QX]9]3\,ZYJEQ
M'K#6UI#>IJ-I<_8A<DJ5@WC)DV=6\S^Z<!1U/  .KBUF&-+Z74+FPMH+>Y,(
MD^U*1@*#\Y.-K<_=JT^IV$<L,3WULLD^WR4:509,YQM&><X.,>E<=<>'-=@U
M&75;..UEGAU:6[AMGD*I-&\*Q9)QPPP3^?XK-X9U-=:@"Z=83:;(EMYD8N9(
MTM6CX.Q!@,!U7(!SZ4 =G<WMI9*K7=U# K'"F60*"?;-95]X@>#78M)L[6.Z
MN&B2=U-PL9$;/MRH(^8@ L1D<"H-=T^_DUBWOK6SAOX?LDUI+;RR[-H<J=P)
M!Z[<$<<8]*J^'?#]_H^LVQGVR00:-!9&8/UD1V) '7&&X)]* .E>_LXIV@DN
MX$F52YC:0!@H&2<>F.].:ZMU+AIXAL4.^7'RJ>A/H.#7'7VBZO>>(=1,-H\5
MI=)*)&FDBDAD)@\M74?ZQ'X4'C&T&LK_ (1_Q),]SJ#:3&DHM[';927*,)S"
MYW1E@<#@ @G(Z>^ #M)O$5K#K=GIY*&.ZMGN$N1(-F%*C'X[NN:V*\]NO"T]
M['%))X:MHE.EW@^R+,DBPW,CJR $X&XX/(& 3U[UW&FQR0Z59Q2H4D2!%=20
M=I"C(XXH M4444 %%%% !1110 4444 %%%% !1110 444F>: %HI,T9H K7N
MI6.FQA[V\@MU)P#+(%W'T&>I]JQO^$EO;_<NBZ#>SX.!<7J_98?K\WSD?1:H
MKX$DL]2N-4TWQ#?Q:A<<//=QQ7) YPH++N"^P(R /059^R>-[7'E:KHU^ 1G
M[3:O"2._*,0#VZ&@ O\ 3=5N;-Y]:\1_V=:QJ6D331Y(4#GF5\MT]-OTK,2\
M\+V"0IX:TVWUC5+D;HC$1,P[;I96R47ZG.<\=:I?$/4O$T?@R[MKC18-DJ*)
MKNTNO,2-<Y.59%89 QW SUS46AW/A#1;V.YT?6KJ.Z(+WZ3V\TCW:'G+*0-K
M G(91W(P<T".ST30WLI9-1U&=;O6+A0)I]N%0#I'&/X4'YD\GFMJL-O$]ONQ
M%INL2@#EAITJ#Z?.JFJY\7,D1FF\-Z[% N2TC6Z':!U)4.6Q^% SI*Y'QY#&
M8] O).!:ZS;.7Q]U2V#GVZ?E7365[;:E90WEG*);>90\;CHP/UK(\9:3<ZUX
M=DM;.>""998YA).2$78P8DX!]*UH-*HFR*BO%GE.R)=1UB501]CO?L=NP3)8
M22W.-I'J<#CC\J[^-8=:^%EQ96XD:&'31#%*Z%?-=(@<@$9QN&/J#BLCPMX?
MU"YO=(U%K9183-_:,MQOPQ?=.8T"GG&)@<].O/2O3&4,I5@"I&""."*Z\562
M:2W7Z?\ #,QI0=FWU,WPY=B_\,Z7==Y;6-B/0[1D?GFM.L[0=(CT'1;;3(9I
M)H[<$*\F-Q!8GG''?%:-<,[<SY=CHC>RN<-JNOWNEZ[XE?[8I2WM[(0128"Q
M!W97?Z+G<3@]L\ 5-%JVO2M86*:CI#375S<(+F-3.OEJFY> RC=S@]NA^N[J
M-]H-E>,VI36$-PT(5GGV@^46. Q/12P.,\$@U=BTZQA%N(K*WC%L"(-L2CR@
M1@[>/ER/2I&<##XE\1W-K;2_VC81-=1WK*/L9/E_9Y,9^_SD<<].#SS3]4\8
M7=GH[ZS%#8)>-H=K=[W@8D-))C9D')7YC@=CR:[D:5IRQK&MA:A%#@*(5P _
MW^W\7?U[U4BL?#^H">WCL]-N!;J+26,0HP15(81D8X ."!T!H Q+SQ!J5FEU
M:/=VANX[]X$D\@KO3[,)^%+8R"P&2P&!W8C.+>>(KNYLM0O9Y+2>-_#MM>"Q
MF3?")&+%@5)YZ=_]GTY[ZXTC3+L$7.G6DP,OG'S(%;,F -_(^]@ 9ZX%5+_3
M_#FGV37%_9:7!:QQ" O-#&JK'G(3D=,\[?6@#";Q5J37UU/''$MM:ZNFF-9M
M$?-=6V#S0V[U8D#&"!^(=X>\4:KJ%Q9M?BR6VN7ND CB9&3R6QNW%R"",]AC
M'6MZ6+0+0KKDL>F0D(NV_<1K\I&%Q)Z$$ <]ZE@TC2%MHEM]/LE@".(Q%"H4
M*_WMN!P&XSCK0!>1UD171@R,,JRG((]17G4INO#/]LZ@@\W0;FYG2[MT3FU;
M[JR(!U4D_,.W7GFO0X((K:WCMX(UCAB0(B*,!5 P !Z8J&'3;.""XABMHUBN
M7>29,<.S_>)^M '&P^)[C3=*O8K*U@^SZ%9VA>%@=TP= QVG.%PO R#D@]*G
MD\2ZAIDFJWEY+#)I]OK*6DA,1!MX62/YL[N@9QGCN3Z ;S:5H-WJ7^HM);VS
M2-64,"\:CE P!Z<$C/X5,= TIGOW:QB8Z@5^U[AD3;>!D&@#F/\ A*9-4\/:
MPMQ:P.]I9W37EO\ ,OR@'RAUR Z9.>O''K5"YU'4-4BU6W=86M[6YTI;6$!D
MPSO$Q&_)(^]C.,XKO)M,LKB*]BDMT*WJE+G'!E!7;@D<_=XJG)X7T62ZDN6L
M$\V01!V5F7=Y1!CR <9&!S[ =* .<E\::G#IUW++:6\;6=[-:7%P$D>!-BJ5
M+!?F4-N S@@8/M5@^)M2C;5=@MY7356LK:-D;*JL(?.U 6<Y[ 9 ).<#C2N/
M"GAWSBTUN(WNKB5R!<R)YLDH'F# 8;@P097H0O2GWOA'0;^YDGN=.5Y9)EG=
MA(ZY<+MS@$#IP1T/?- &#)XXU5M'.IVNE6;00Z;#?SB2Y96 <R#:N$.?]6>N
M*GU'5;G5-1T]X4B6QM]<%MN\QA(S(KJV0.,;LC'/ !^FJGA#0H[&2R6R?[/)
M;K:LAN)#F(,6"YW9X+'WYQTIP\+Z#+JJ:NEMONEE\P2+</M\Q1MW%0VTM@8)
M(SZT <W%XKO=-TF*+3])MBL6G7%^ZRWCG8L4I5E!*$MUXSC].=:]\57T>HFV
ML=+2?#6R;99C&S^=G##"M\BX.3CLWI5\>%-&^R&U2T9(_LDED,3/D0NVYER3
MW/.3S6!>^"M3F\23W]M>1VT<KIMFBN9DDB1550H0':W"GJ><]* -K7=6O+36
MK'3H4B,%W:W3NQ)#J8U7&,?[W_ZJYWP_XON]/\*6YO[(RM'I\$L$@N"[3EW\
ML;OEROS$=-W'KTKL=3T*RU:YM;BY\X2VN[RVBF:,X;&X':1D':.#QQ5*3P=H
M\MG]DEBE>#[$MCL:9B/*5MR]^H/?VH ?9:U?W&B7UY=Z2UC<VPD*Q2R$I)M7
M(8-M!P?=0:Q;3QQ?265D6T8W5V]I;W=S'9,[;4E/!0;.6QEBI( '&XUTNGZ)
M9Z9ITMC!YS12DF1I9F=V) 'WB<] !^%9L'@G2[=K%HIM04VD8B4B[<>9&&++
M&_/S*"3@?ATH KS^+KR*6YVZ(SV\=ZMC'-]I4>9(9%0?+C('S'GV]ZET[Q5<
M7M_!;3:2UNKW<MD\GVA7"RHC/@ =050\\8/&*NGPU9M%)&9;@J]^-0^^.)0P
M8 <?=R!Q3H?#EG!*DD<EP&6_DU ?/_RT=64CI]W#$8H YG3?&<=EX=LC!9ZA
M?@:=+?M)<W"M*(XWPVYCC<>>U;0\6))JL-E#92,LY"Q2O(%#,T)F4$=0" 1G
MU^E+!X+TFWLEM$^T>4MA+IXS)SY4C;F[=<]Z6#P?86FI)?PW-Z)%F6?89LH7
M$?EY(([J2#]>,4 9=CXF:]M="UK4#/:K+:W5P\4$@\DJH!RX/)( R/0YJ_-X
MRBM+22:[TZXC=8H)TC5E8O'+((U(.0 P)Y!_,TZR\&Z;:6EK:F6[GAM8IX8T
MFD!_=R@!E. . !@?4]:=_P (=92636UQ>7MP"L,:R2NF](XG#J@(49&1R3EC
MZT 7+'78[G3+V]N8)+3[$\B7".0Q78,DY4D$8P:QM4\820Z+J+I9RVEZNG/?
M6OF,CADX 8X)P067*GCGJ><;UMHMM;VVH6Y>66.^FDEE$C#C>,%00!@8Z=_>
MLIO!UG+8S6MS>WUQYEG]A661H]\<.02 0@R>!RV3P* *<NJ7GAKP>NIL]UJ$
MUS)#LBNI%RA?:I&X=NI'U[5/%XD?3]9O[:]@OI89-4BM89@(RD)DAB*H<,#]
MYCR >O)YK3U'P];:IH,6D33W"Q1>44F0J) 8R"#RI7/'/&*CN/#%O<N7DO+O
M+7\-^V"G,D:JJC[OW3L4D>HZCI0 :9XIL=6O(K>VCGVS1O)#,0I20*<'E22.
MN1N R*-/O[N?QAK5C)-FUM8+9HH]HX+[]QSU_A%.T3P^="=XH-2N9-/ (M[.
M0)M@!.3A@-Q]LG@>O6FRZ#<KK%_J5EJ;6TE[''&ZF!7V[ P!&?\ >/7- "3>
M+-,AU9M-+2/,LAB9HP& <)OQ@'=T.,XQGC.>*AA\9Z=-;/+Y-RC(\,?E2*JL
M3*,IU; XZY(QWI3X7F62^6WUN^@M;U6,L*A"?,:/87#E=P/ ; QR.W2J%IX&
MEL=.FM(=3AD$R0QR)<6"/$ZQAAAD!'4$<Y!RN<\T :%SXRTRTG2*X6XC;; T
MH= #!YQP@<$YSQS@''>K.L^)+31)[>WG@O)Y[A'>..UMVE8A,;NG^\*H:;X2
MGTBXMGL=:N8XQ#%%=1O&LGG^6,*06SLXX.,\ >F:/$-AJ=WXHT2?39%@,4%V
MKW#P>:D981XR-R\G!QSV[]* )T\9Z-+:R74<LKPQI;NS",\"=BJ?J.?2F_\
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M?11R#["T.^$LH:W9C\PW D'=V(^M:.M:'<:G>:-=Q7,4<^GW/FMNC)60%2K
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M\GG QD$BNU&G62I,BV=N$G.95$2XD/\ M<<_C2O86<D#0/:0-"Q!:,Q@J2,
M$C&.P_*@#SI]5O[#6-8U:UO+.5EATK[1Y<64N/,8KE3N^48;(Z]OQZ[6[BXB
M\0^'XHKXVT$LTHE3 Q-A.%.??^=:[6%FS2,UI 6DV[R8QEMN-N>.<8&/3%/F
MM;>Y:)IX(I3$XDC+H&V,.C#/0^] ' 1>*]<?P[/K"WVCNLL=NT4(<NUN\DRH
MP< #"@,1R205I[:]XE36-7T\:A8N=-N;"$.;,CSOM#*IR-_&-V>.N.U=F-%T
MH)*@TRRVRL'D'D+AV'()XY/O4KZ=8R/,[V=NS3%&E+1*3(4Y0MQSMP,9Z=J
M.)M=?NKV2U6]CM+J:U\2R:<LS08^58G.X#/#=L^U5='\:ZW<Z%;:E=SZ=_I=
ME--&GV=P(GCN$B&<,2V[S.@QRH'J:[]=,L$8LMC;!C,;@D1+DRD8+]/O8)&>
MN#40T/21 (!I=D(1&8A']G3:$)W%<8^Z2 <=,\T <A;>(=6OO$FG6LMPD$<6
ML7=G*J1X$RI#O7/)QU(Z^AZBH=%\2WLLTVFZ?:6%FRI>W>XQ,R.4FV!<;P03
MDDG)]A7:)H.CQJBII-BJI*)E MD 60<!AQPW YZTY]$TJ5%233+)T5F95:W4
M@%CEB..I/7UH Y2R\6ZQ?SRW"0V4-E'/I\9B>-S*1<K'N^;< "IDXX.<?GK^
M+-;O]$@AGM8XQ;;9&N+AX6F$.,;245@VWDY89Q@<<UK/I.FR22R/I]JSRLCR
M,85RY3[A)QSM[9Z4S4=$TW5GC>_LXYVC5E4O_=;&0?4' X- ''66L7&C:C.\
M*VDEE?ZY-$RL6$F3$&#@YQC*G(QW'K5'6_$5]K7@7Q$EU%$B+8VUS#)%&Z!T
ME)_O') *'#8&<]!7>G0M*:0.;&$L)S<\C_EJ1M+?4CBH(O"NA0VDUK'I=LL,
M\:Q2J%^^JDD GJ<$_P O04 4- 9CXU\6J6)"RVN 3T_<+6/+X^OK M/?65L]
MJ9+V*-;9V+%K<,<DGC!"XZ>_M7;PV5M;W5S=10JD]R5,SCJY4;1GZ#BJ4?AO
M1XEB1;&/9$\SHK$L 9<^9D$\@Y/!XH Y;6/%VM65C)"$M4O)+:WNX)HU8HJR
M3)&RL#W&\8/<9X&*Z;7]3OM,MK/[#;07-Q<W*VX6:0QJ-P8YR >X'%1IX0T-
M-/FL!9L;:941E:>1B%0[E56+94 C("D 5H7.EV=Y%:1SQ,ZVDJ30_O&!5T^Z
M<@Y/T.0>] '.)X@UJ]M;IO['\NW07,,MQ%<J?)>,%=PY#$;U8?=!Q@]ZR+?Q
M,=(M-(FE@FN9_P#A'8)0QN&P[M)%& 5/&2S@ENN,UUP\+:*NI7&HK8J+FX#>
M:PD8!BPPQVYVAB"1N SR>>:&\+:*\:1O8JR)9?8%5G8@09!"]?50=W7CK0!G
MW'B34-*^R2:SIL=I;2WAMI)UF#A5*91\#. 6&TYZ?C20>(M7N)8D@T579$@>
MZC\X!XQ*3PN>"57!/KR.,9K2C\,Z3'H[Z4ULTMF[B1TFE=RS @@EB<\;1W[4
MZZ\.Z;>:S!JTL<HNX@HW1S,@<*<KN .&P2>M &9X[CDM_#&I:G!>7D%Q;VQ$
M7DW#1JIR/FPI&3]<^U+J>JR^'[O[#IUC>:I<SHUT8GN&;8HV)A20QY/.#P#G
MD9 K:U;2[;6M+GTZ\#FWG #A'*D@$'&1]*K:KX<T_6'MI+H7 FMU*I-#.\3[
M3C<I92"0<"@#(7QC<#6!:2Z0(K<7<-I),]TNY))8U=1LQ@D%MI^;Z9Z55'Q"
MV1ZHUQIT8:RM/M:K!=B4.N\IM+!0%;(&<%L9QU!%;X\,Z:)FE5)59KJ.[.)2
M/WB*%7\, #'2J$/@'0H(;B%4NFCGMOLK+)<N^(MV[:N3P,^GJ?6@"H_C*^;4
M+C3H]+ABO+74+:VE26X++Y4P+*^0OWL#&.<>IK;U?6I;&\M;"RLQ>7URKR+$
M9A& B8W$L0>?F  QSSR,5#<>$].N+Z^O2]RES>RP3221R8*M$,)MXXXS5W4-
M(@O[JVNS)-!=6V\13PD!@&&&&"""#@=1V&* .;369O%=]IJZ;/<6UC<6)NA-
M!*%DC<2!3D8(;&"NTY'S'T&)?$WB5]!N=7FA6:6>UTV*=()& @.Z5EW<?-N]
M>>0.W6MK3_#]AI<]O)9J\26]K]ECB!RH3=NSSR3GOFHM6\,6&LO>/<M.KW=J
MMH[1N 0BN7!''7)H 6VU];G7YM(6!1- %\_,Z[DR@<$+U9?F R.^:K7WBZVL
MKR[C^S2O;6$D<=[=;E"0E\8XSEL;AGCCWYQ9C\.0+JMMJ,UY=7$UL28O.$9P
M2FP_,$#8P2<9QDYQP,,N/"MC<:A>71EN%2]:)[JW5E\J9H\;2002.@!VD9QS
M0!G:7XDEM]3EL;^&[>*?4Y[:WNSL*!LEECP#N' .#C'3FH-'\1^3:VLVHWMW
M*\>DSWDPV(498Y "QQ@[\< #C!/M6Y%X<M8K[[2T\\JBZ:\2!]FQ)64J6&%S
MT8X!)P3[#&;=>$H[329OL#W-Q=QZ9-80K)*B;UD.XG.W ;(X/3U]: +*>+[5
MY+J+[#?"6UEABD0JAQYB;PV0V H7DDD8JG_PF,5](L5M#<103Z3+J N%V%XP
MK;>F2"1^()QVS46E^'+R[MF2^>]L(XIXI[=-MJ) Z*RG=Y:;&7!7 (R-H]!5
MRW\%6EJ(A'?7A"64MC\_EDM&Y+<G:.A/&,=!G/< 2W\764&D6\\GVRYACM+>
M:YNS&H$8D4;6< ]3U(0'&?3%6(_%ME+JOV%;:[_X_6L3.47RQ,J;]OWL\C/.
M.U5E\$VT<*VT5]<+:/:PVEW 54BX2)=JDG&5)'!(ZC'3%3Q^$X8KKSUNY,_V
MLVJ8VC&XQ^7L^F#UH +[Q7#IWB6;2KBW98(-,;49;G>.%#[<;?S_ !QQWJ]I
MVMP:A>W%B8+BVN[=5=X9U .QL[6!4D$'![Y&.<5GZQX0M=:U>6_FN94\[3WT
M^6)0"&C)+ Y/0AB#^ J]INCR6E_+?W=Z]Y>20I 9#&(QL4L1\H[Y9B3^@H S
MHO'&G3S+%!9ZE*[R2Q)LMB0SQGYE!SC/?TQ4H\::4T=M*@N7BGCBE+B(XB61
M_+3?GU8$<9Z>E-TWPG'IES:2Q7CLL%U<7)5D'SF4'C/;&:RY/ $SVT,(UHXC
MBB3+6JMAHY3(&7+?+DG!'?'7M0!I:'XBDNI;N"\61VCOKN,2I'B.**)R%WMT
M''3UP?2KVD^)=,UJYEMK.8M+%&DI4C&4<95A_AU!Z@5CP>!A;W]Y<1ZB1#J$
MEP;^ 0C;<1REB%//#+N(#=P<8 K5\.Z)<:);/#<7ZW@ 5(B+5(2B*, ';RQ]
M2?3H.<@%9?'.A&Z:"2>XAVM*AEFMI$CW1@EUW%<9 4G']>*?!XST:>%9!+,@
M,\-OAX64JTH#1D\< @CFL'3/#VH:Q:WGVB[EL8%U*]GMHS:-',CN9%20LS<@
M"0L  .<<\5%<^&KC1M"U.&\AFUF35%A@2.PM=ABD1&"R,2_ !53N/0XZYH Z
M.^\::)IT[0W$\WF*)"5CMW? 0@-]T'@$]?8TZU\9:)>I<O#<RE;=8V;-M("X
MD.$* KE]QX& <G&.HJC)X-=IK>2.\4&+2YK)BZ%B\DG)D)SSDY)]2:@OO!=W
M?C?)?6PF2SM88C]G+*)(6+992W*L688]#[4 7W\>>&X[:*=[]E60R +]GE+@
MH0'!4+D$9&01[]*OV/B"QU'5IM.M?.=XK>.Y\X1GRG23E=K]#Q^?.,X.,@>%
M;UC;-)<V,;Q6MU"WV6U\I=TP4!@ >VP?6K&@^'+O1+V)Q>026_\ 9UM:2KY1
MWEH58!E.[ !W'J#VH FE\36=A>ZHNH7MO';VDL$0VQR;T:100'XP<D\;> .M
M:.E:O8ZU9?:]/G\Z'>R$E&0A@<$%6 (/U%8T_AFX?5-4NX[J(+?7ME<[60Y4
M0%"5SGJ2@Y]^E7] T>31X]06259/M5_/=KM&-HD;(!]Q0!KT444 %%%% !11
M10 4444 %%%% !1128YS0 M%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%<W"6EI
M-<2!BD2-(P49) &>*RM*\4Z;JUU%:PF:*>:W%U"D\17S(CC#*>A'/3.?:K^J
MJ[Z1>I&C.[02!549+':>!7$'PW)9>#;?46BU*ZU5--M[;R%<AH4_=^8B*HSV
M.>K$9&>: /0J*\NO/[2M;.&V^Q:M)!]OO52(1RDQQ'_5/A,DJI88_'H15VWB
MN;K5-+#3:[-;F*V^RW<*'"LI83><7Y0D]<]1QS@"@#NC?*-3%CY;[S#YV_\
MA W 8^O/Z54_X232_P"U$TTSR"YDD:),P2!'=1DJ)-NPD=P#[5)C/B'/?[)_
M[/6/>WRW_BFRMI;+4Q!93[HR+&3RWFVLN\R8VA%#'OR3[#(!U-%%% !1110
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MR3]31K4GD:7)<[&86[+.0HR=JL&./P!I+^]8Z#-?:?(CMY!FA8C(<;=P_/\
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;"BBBLR@HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .+ JH# 2(  A$! Q$!_\0
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M#CT/J*F%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(1FEHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT/A,W<[3Q$B0*Z.PPK<,< 9Z=>.F.C_X2?5G\2W447]F?V;;3M;O'-,(Y<A
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MSGS%4H9#$5//4?(P_&N37P;JMM8PBULH4D32K"*2%95C$\\,V]U9AZ@?>]Z
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M<>6-X&-O7Z<?2M"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *C,$+3+,8D,JC"N5&X#T!J2B@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***.]
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MEVNTG!6/R0">1QW.>>,5C2^'=6>^UAOL,!L)8Y%CM/MS 3.9%8.IVYA.U3D
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M3Y5Q)%)O9E((V8XPI[]_:K2^&-&1+M%L(_+NX([:>/<VUHT!5%VYP, \8P:
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MM!JT-\UVFF+>M*RH?M"[@F5PV<EF ^8+Z].:ZO2=6CUFVGDB@N;?RI6A(G0
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M26LD5TA3SL2-'A7\I=SX&=V .AQ@]B:JMX\TI-/6]>&\2)HFG4/$$9H0J$R
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MS+?=G>IZJV[ZBH;GP9K!\R2UN-)B:[TV6PNX([5HX1N=V#H 2<C>0<]>3WX
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METVQFN1<RV5O).,8E>)2PQTYQGBFQZ7I\2(D=A:HJ!U4+"H"A_O <<9P,^M
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M3Z-8&UCD\Q(?LZ!%;U QC/KZ]*L2Z3I\VEG3'LH/L.T+]G" ( #D8 Z8//%
M'+6GB/7KYK2VB6PBN9;V\M7DDA<KB'=M8*'XR1@C<>^*YWQ%XIO/$O@/4U6.
MWMTCTRWN;D%2S.TK' 3YAM V\DYSG&!C)]%M_#^D6DB26^G6\3([R*50##.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3'.:6C/.* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHK.BU[3)M3;3H[Q&NE8KL ."P!)
M4-C!88.0#D8YH T:*** "BBB@ HK-D\1:)#+)%+K&GI)&_ENC7* J_\ =(SP
M>.E:0((R.10 44A( ))P!U)K+_X2;0#")1KFF^47\L/]KCP6Z[<YZ^U &K14
M5M=6][;K<6L\4\+YVR1.&4X.#@CCJ#4M !1139)$BC:21U2- 69F. H'4DT
M.HI%974,I#*1D$'((I: "BBHWGAC=4>5%=ONJS $_2@"2B@D#K32Z!PA9=Y&
M0N>2* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTM%-3=L7?@OCYMO3/M3J "BBB@ HHHH **** "BBB@ HHHH *;CYC3J3^(T
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MSS#)]H2RB@VG;M^14 "\9YZG)R:V!IE@MS/<K8VPN)UV32B)=TB^C'&2/8T
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M#U$QF[T]93'"D"EG;(13E1G/.#SD\T 8,7C35)M5D@&GV:VGVV\LHY#,Q??
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MAM#1^4^])!@?>#8_ ?C6KH>A2:1+?3SZC/?W%[(LDLDR(O*H$X"@#HH_3W)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH[T %%%% !1110
M4444 %%%% !1110 4444 %%%% !117/CQ*8;GQ&+J!%AT:-928G+,ZF,R'((
M&#@=/UH Z"BL'1-<N[S49M-U.UCMKQ+:*Z58V)!C?(QR <JRD'\*WJ "BBB@
M HK@6^)1BAUF.?2!%J.G;G2V:Y.VZB5]A>-]G."#QC\>N.Q35+/[3'937EI'
MJ#*-UJ)U+@XS@#@G\NG- %VBN<\0^)I]&UO1M+M]/2ZEU1I51GN/*"% IY^5
MLYW?I2Z/XRTS4K6_EN773I-/N#;7:74BJL;@XX?.",@X/MTH Z*BN:OO&-M!
MKEKI-E$M[--;B[9UN$1%AW %@Q.&(&YL#LM;*ZOIKV[W"ZC:&%" T@F7:I/0
M$YP* +E%8NM>);31[2*X %T'O4LF$+@['8XY]".XZU;T_6=/U6:[BLKJ.9[2
M7R9@ISM; /Y<XSZ@CM0!?HJGJFI6VCZ7<ZA=L1!;H7;:,D^@ [DG  ]33K74
MK2[TZ#4(IT^S3HLB.S  @C(H M44TRQB+S2Z^7C=OSQCUS6;JNN6VEVD$W$[
MW,H@MTC=1YCG.!DD #@Y/M0!J45FR:U;VUG%+>*UM<RPM,MH[+YIVKE@ #@D
M?7%3:9J<&J:7;7\)VI/ D^QB-R!U# -CH<&@"Y134=9$#HP93T*G(-54U&.3
M6)],$4OFPP1SLY V;79U !SG.4;M0!<HJ-KB%+A(&FC$S@LD98!F ZD#J<9'
MYU)0 445DZ7X@M=61Y8(;A+81B5+F5,12)DC*MG'\).#@@$<<T :U%4(-7M;
MG5I=-B+F:*!+@MM^1D<D*5/?[IJ_0 4444 %%%% !156;4;:%H1N:3S9_LX\
MI2^U\$X;'W<8/)JU0 4444 %%9FF>(=,UB29+&X:3R1N9C"Z*1DC*LP 894\
MJ2.*M17]K/?3V44H:X@1))$ /RJ^[:<]#G:W3TH LT5!;7MO=O<)!)O:WE\F
M48(VO@-CGKPPZ>M3T %%107,%U%YEO-'-'N*[HV##(.",CN""*EH **** "B
MH+:\MKPS"VGCE,$IAEV-G8XQE3Z$9''O4] !1110 45#<W=M91"6ZN(H(R<;
MY7"C/IDU':ZE87KLEI>VUPRC)6*57('KP: +5%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1CG-%% !1110 4444 %%%% !1110 4
M444 %%<*GC>XN)[&Z6TN8[;[7>6TUO"JRM*(U.UO;&.>?Q-:2>/M"DDLD25S
M]K6!E/RC9YI(0,"<]0<X!QQGJ* .HHKGAXQL#O\ ]&O5 G:V1I8Q&DDBEPRJ
M[D*<>6QZ_KQ2W?B.SNO!,VO6-\T%LUN9$N1#YC1\X^X>I!R,>HH Z"N;;PS)
M-<^*FEG00ZW&D:;0<Q@0^6<_SK0M]>MKK5I]/AAN7:"0Q23"/,:N%5MI/4<,
M,$@ \@$FJM[XOTNPU273YUO!+"\22.MK(T:&3 3+@8 )..O7B@"K9Z1KD-W<
MZM*U@^JO;P6D>7=HQ&C$NQ.T'+;B<= 0.3745CQ^)M-EU9=.5I=[R/"DIC(B
M>5,[XPW]X8/Y'N*=J'B/3M,NC;W,D@9?*,C+&66(2.43<1TRP(H UJAN[N"Q
MLYKNZD$<$*&21ST50,DUFVOB73]0F-O:O*;C=,A0P/F,Q8#;AC(Y9<=,YXJK
MI7BFVN+32TFF:YN[N!)2]M;N$"L=JLP.=@)! R>QH \[O[SPEJ7AW3(9=>T^
M/5["X,J3)YA4H92S)NV D%3Z=1Z9HO\ 4O#UYJ;%/$6FQVS:['JQN 9!-M6/
M;Y>W9C.<X.[OG':O1+/Q1#J7]DS0,;>*]FGC\FYMY!+)Y:L?EQP#\N><\9 Y
MI]EXV\/:@EP]MJ =+> 7$C&)U_=GH1D#=SQ@9.>.O% CAO%'B_0]0\5>&]3L
M-6L98M-:=Y1([H2750!]P^E8+WFC6L$NH1^(-/N=0FUH:G-:*\B1,N6^0/LS
MD;R<X ]C@5[3IVKV6JFX%G*[FVE,,RO$Z%''8A@/;\Q7.3>+["X\30682.33
M_L,\TMQ-;2#A2H^1F #H1G[N0>.: .$6[T.UU&8V5[HBVIT"6PCMVO7>,2-*
MT@4L^&9<'&>.?3MF+#:R^&_$-I/KNC?:K^"P6#_2U(#0 !APH"C XP.F!D\F
MO2;W6]#=+%-*T^TEEN[YK(F:Q9?(=4+-N0J&S]T8XZY[58@U;PU#92-J2:7'
M<VL/F71AMR8QAS&Q0E?F <%>.AZT >?R7U@VBWB'5M+^T3^)?[4$2WBG$)*Y
MY.!D<_E6KX;\4Z?H-]JT:7.DO%?ZY)/YYO47%L_1@.ORX^Z<=?QKL-8N-*L?
M*2TL--FE74+:SN4:)<Q"5E&< =<,".U6](?0-:CEFL;&W/D3M$V^U"%71B,C
M(]1D?T- ":[IUYK&H6%DGG6UE$WVJ2\B,982H1Y:!7#=R6SM_A'-<K-X5U*W
M\-'1%L[V>.PU%IM.N(9+<L$*L59D<JI 9V4KQU!'%=G#XET6X@N9XM3MVBME
MWS/OP%7)&[)[9!&?:I8M=TJ;2_[3CU"W:QW;/M <;,[MN,_[W'XT#,>[T_47
M\&:7 ]E%)=6IMI+BQ@VJCA"I:-<G;QC('3@"LFV\,W<D5BYTWR(/[?:_^RN(
M\V\!B9<$!BO+X.%)^]TXKKI]=TBU,@N-4LX3&YC?S9U7#!0Q')ZA2#]*R=6\
M6QP7-A::4UE<SWMO)=1M-<^7&8U QS@\MDX[?*?2@"'Q5I5U>ZYI5S;V!NDC
MM[N!RNS,;.J[&.XCC*GI7+7/@_5(-,2"PTE0K:18I=0H4B-U+')F5&(.-Q7N
M>O3)KNM;\26VF:%>7]I+;7<T-I]L2$3C]Y&>CC&3M/8XP?6LO4/&5PEU=6NF
M6VGS3V=K'<7"75^("JN"<C*D;5&TDDC[P]J 'Z7I$UMX(U*TTRQN-,NKI)WA
MAGF4LDCJ0#E>%&<$ =*YR/2IEL=02T\&SVMO/;V,<MN8X?G>.1V=@H<"3@I]
MXC./FXX/1:GXU?36UE3IRR?V8+,G%QCS//;;Q\IQM/Y^U=*M_9M>&S6[@-TH
MW&$2#>!Z[>N* /+++PSK-NVFE=*F2>*RU"UAF98R;>1Y':)S@X48; (Z<CI7
M4^!=+CLGO)TTG4=-:2*&.5;KRE61UW995CZGD98_>R/>MO3=?@U36]1L+?RI
M([..&03QS!P_F;^,#IC9ZG.:T&NHO,DACDCDN47<80XW>V1VZC\Z .'T;3+V
MWUFTGFL)EO8WNO[6N1$0EXGS>7@D_."2I4<E0,<5;T[1[E/A$VEBQ*7KZ7)&
M8&C"L92A R#WSCD_I5X^,8/^$'?Q&MNK.EHMP]H)@64L,A2<<?7'X5KVFHO<
MSSB2!88(XHY4E,RDL&!)RO5<8ZGK^% 'GJZ+?M/<SPZ=>0K%8:>EH%1D*.CX
M8 #T!.?8UL>'+&\3Q-+-J4>M"^CFN=TS%/LDL;-\G(Y("[<#L0> *[1[JWBC
M622>)$<[59G #'T!JI-JL9-S%8(+ZZMG1)K>*10R;B.I8@# R<=>* .8GM9Y
MO'LLETNM)Y,\<UI+;QYMS"(@&1F R/G+DKGG(P*RXX=8M]-U:VL;/5$EDLFG
MTN5A('AA=\M Q/248R,Y."!GC%>ET4 >8BWGCL[7_1O$=QH,UW,;BUE@=)XR
M8QY>U5PWE[MQ/;=@X[FWOU6UU&[MO^)ZT$PTHV[2":1MJR*)]S*-J-M^^ 1G
MD\\UZ'10!YMHMOJEK%;Q1V^I02GQ+*]TNR55,#"4@Y/!0G;R,C.,\XIL=QK;
M:'.Z2:H-4BTR]%^K&7:LV,Q&,-P&SRNS^$_2O2ZR[;7[*\UA=-MR\CO9)?),
MN#&T3,5&#G.>,].G>@#-\++>17^I17$EZT>RV<"Y=VVR-'EPI;MG' X!]*P]
M(O+Z74+!V?4VN5-VFKP2R2;54!MA4$[5^;;M*8R#]<>A44 >>Z;;30? YXDA
MN3<'39?W99PX8ANF>1]!Q^=8^JW6H1:1J.I:0^H0SV&FZ8D&S?\ OCYDF[<"
M,M@.1C\:]:IAFB6=8#(@E=2ZQEAN900"0/0%ES]1ZT >=ZGJM_;_ -H/<:BT
M*1:S,L4$UP]O]HB$"XC20#@[F+ ="1CUKI-0U::#PI9FU9H=2U"*."S6[/SB
M5U&"^ >5&6;C^$UT=8__  DEDVM_V5''<R2B7R7ECB+1QR;-^UF'0[3GT]^#
M0!QL+7'A"T\4:,KK;L^G2ZGIXCF,IC(C*R#<54Y#J&''\7KFJUQJ6KV#Z@PU
M^^DDM4TV?R9?+P6FD"R X0$+C' Q]ZO19]7LX+ZRLVDW37DKQ1;.1N12S GM
M@*:O4 >:7GB#45N]?D37E@N;&"^)TYXLL H/DN,C &-C9YSN]Z@;Q'JFG17,
M-QK<LT;C37FN)/*#6B3,PF92J@8 V@9!QN![\^C7FJ6EA=6=K<2,)KR0QP(L
M;-N8#)Z X  SD\5:>..165T5@Z[6!&=P]#[<F@#RO3+MOMT5II.OR1VNH:OJ
M!N;R-HW+!(0RD,01T"G([<TL'B;Q!::1!>G5'OIKG0S>NC1Q 0$2QJ9 $7HJ
M.['.<E>0,8'J/D0[HV\J/,>=AVCY<]<>E4KJ]TW3KNRM9E5)KE7BMU6(GY47
M>RY X&%Z=\4 <7::MJ5Q=:7:V_B=)K:_OKE%FMPDK)$L!<*79 "58#G'?G.*
M9X8\1-+>:7J6MZV(C+HOF-'))&J2,)&W-C'7:N3CIBNXTJ;3=1TVSOM.CB:U
M92]NPBV[0>N 0",\U)/I=C/;- UM$$:,Q?*@!"'J!QP* )'%I=017,@BEB3]
M]'(0& ^4_,#]">?0UYYIM\NC?#?PO<P2P6[W)CM);]@H^SQL69OF*L!\RA?F
M!&3DUW]C/92QS6EH04LG%M)&%("$(IV\]?E9>GK45D=*U71@EK%!-IKAHO*\
MK$9"L59=I'3((Z4 <!>^(/$7V:6*V\0VCM!H]U?_ &NUBCF68Q2X7!( !(^4
MX&,@X]K4?C6[DUVTQ?Q?9I_W+0D1A4?[*)1@_?+^8<?W<$ ?-FNY.C:68UC.
MFV9C6$P*OD+@1'J@&/NG XZ5&= T9IQ.=)L#,"I$AMDW?*-J\X[#@>@H \XN
M/%&OMX0U"XNM4&^YT9+V!K:$1/;L7"%0<Y.<]>H[8XKM_$NH:A8:%;3Z9()Y
M&==[J$:1XPC,S1J2JNV%S@$<9(Z5I_V+I6S9_9EEM\C[-M\A<>5G/E]/NYYV
M]*=<Z5IUW9Q6ES8VTMM%CRXGB4JF!@;1C X)''8XH X6#Q'J!FO[E-;AD22R
MT[[-YD&$,DS%69%ZY."<'N1D@+FG:9XEUNYU/3Q=2A?*_M%)[<1J#,8&0+G:
MQ ;#=B1D'K72:S9^%+8Q+J]KID9N56UC\Z-064$80<?=!V^PX]JDFTKPSHD,
M-Y+8Z;91VTI>*3REC$<CX4D<<$X4?@/2@#G[3Q)XEGTB6^BCT^]61;>6(6P\
MR1%=<R+Y0<%B "1\P/7KBNNT6^_M/1+*^\V*4SPK(7B1E5B1U ;D#V-5H_"V
MA0P201:3:1QR2"5U2,+EQG!X],G\S6G;V\-K;QV]O$D4,2A$C0855'0 >E $
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 <M8>"X[&;<NH3/$L]S.L;1K\IF&",CTR:-$\&?V!-;O8:K<(BPQ0W$?E
MH1.(RQ4G(X.&(..WI5.U\<W36$3S:/)/>2O=,EO9L7)BAD*$XQ][. !W//'2
MK=]XT^QW%ZHT6_EALTC9Y1L7)D"E5VL00?FQ@@8Q0!)/X4F:R@%KJKV]_;7D
M]W;W0@#!3,SEU*$X8?O".QZ8Q5S5=!?5?"=QHDEZ0\\/EM<F)>O7.U<#\*S$
M\< :DMG=Z+?6I%ZEE))(\3"-Y%!CSM<D[@1TR!GK6AH'B9-?NKV.&SDBBMG,
M?F-(A)8,5*LH.Y#QG!'0T 0IX8D_X2Y==DO(1L+X2"V\J2167:%E<-B11U&5
M!SCGC%)J?A>74)=4<7Z1B]DM)%!@W>7Y#AL?>&[<1[8]ZDN/%D-G)>BZTZ]B
M2VM[BY5F5,RQPL%<JN[(Y8%<X##FH(?&]G*MRO\ 9VHI<0O BVSQH))C-G9M
M^?'.TGDC '- #+/P:;2]A7[:K:9;7SW]O;"$B196###2;CE1O8@;0>1D\<V+
MWPY<R^)!JEG>PPQS+&EU%+;"4L$)*E&)^4X..X[XI/#VKS2Z?K%YJ330I;7L
M^5N FZ&-0#M.S(('/0GCN:='XMA>U69]+U.%Y7C2VBDC0-<EU++L.[;T4D[B
M,8YQ0!6L?#.IV/B(ZPFIP&6Z5UU!/(.V;!/E%1N^4JI"^_/4G-5;7P5=VPT)
M!=VH.F1PH;A(G69@CDLN0V"C# VL"!R>]:#>-M.\F%H[:^FFD$^;>.(&2-H2
MHD1N< @L.^#Z],U-:\8POI3-HS7#S&.VG,Z0@K$DK*5#;NA92>QQWQQ0!+8^
M%KRVETAI;Z!QIES<2Q[82NY)$90#\QY!<DGCCCWK$UGPS=:7H)D:5[D1Z/!I
M.R"&1BNV09FPIW8 P2!S\M;B>)?L^L262FZU!I=3-H0(D06W[DR;0>-P^4G)
M[9] #-8^((HK>4/<7>I3M=7*HD=J%=5C?:PVCJ%)5<]3D>M %;P>)[_2M2-Y
M'$#=3LSSP030>:S* 2%E&X8  R../8UD/X U6\MK:VOM0LO+L;$V=H\4+9(5
MHVC9P3@_ZL!AT()]>.BD\::,GELCW,T3QPR^;%;2,BQRDJC%L8 R"/7\CB[8
M:]::EJ%S:6J7#_9W>.2?RB(@Z$!DW?W@3T[X)&0* ,=/#.H2RZ1<7)TR*>TO
MFNYULH&B1\QE. <DMTY-8LWP_P!9NQ?&[U*TDEN;":T\P!^2\JR!MN<(.,87
M@>_6NQ?Q%IT>HBR:20,9A;B7RF,?G$;O+W8QNQ^';.>*HZ%?ZGJ=W?WL\X2Q
MAN;BW2U^S'+"-R@</G)^ZV1@\F@"K)X<U:Y$\EQ+8B:;5;74&\O?@+$L8*\C
M_IEQ]36A;:+<G0M5TFYECCCNY;HQ30,2P29W?)! PPW]B>E8L?CV*34-,N)%
MDM]*N=,EO'!MI)) 5=1GY03M R<XQCFNA/B;1Q?QV7VT&:218DQ&Q0NR[U7?
MC;N*\XSF@#F;WP?J^H6,2RFP6>VTW[!&JS.4FRZ$LQV9483[N&Y;KQD[_B?0
MY-9\+7.EV7D02R-&Z!N$RDBO@X'&=N,X[]*EO-4N(/%>EZ7'Y!@N;>>67()<
M%-@&.< '>>H/2I=3\0Z5H\@2_NQ$V%9OD9@BLVU2Q (4%N 3@$T <]#X9U:2
M_BN;M-/7_B=?VFZI,[[5\@1A1E!DYYSQTIFB^$=3L(-)BN)+3%G;7T3F.1FR
MT\@9<94<  9Z?2NB/B71Q+<1M?1JUNDKR;@0 L9VR$$C!VG@XS1-XCTJWMS/
M-<-&@+[@T+AEV %B5VY  ())&!D4 <>/!&N3:?/!.VGQO_8$>D1F.=W#,A)W
MG,8P#GH,X]ZT=8\-:C>:=XEMH(H0;ZUMX;;][G)12#NX&.3^/M791R1S1)+$
MZO&ZAE=3D,#T(/<5CMXNT%(IY7U*)(X%#N[!@-N_9N!(^8;OER,C- '-ZKX1
MU.ZM]>6%(2]Z-/6(F7 (@8%^,<=^_/MW@NO!.H7UUJRRVL'G2&Z-EJ1U"8%%
MFW?+Y/*]&VD\< <'%=A'XFT:6T%U'J$30FX^S C.3+C.P#&2<<X].>E5]"\1
M1:CX676[UHK:$--O;/RJJ2,F<GV7/XT 5O#FGZE#K>IZA?Z?;V*W-O;1)'#*
M'&8_,!Z 8'S#'L!618>&=6M[^UB\B(265]/>#5&DS]H60280J#NSEUSGC"\$
MUU$/B;0[FSENX-5M)+>*01/(DH(#'H/J<\>M7;2_M+^S%W:7,4UN<XD1@5X.
M#S[$&@#S > ]4?PTT46G1VE[#I+V+QJZ#[7(7!#9!QC"Y!;!RW;%6O$6GWFF
MKK,T\<82^.EPVH,R)YSQ,6=<L<# !/S8!'>NZ@\1:-<HKPZG:NK3) I$@YD8
M951[D<CU[5'J.J: UFZZE=6+VK.\3B<JR;E.U@<\<$X.>E 'GU[I%SKFCW4.
ME:%ES+?+< RV_P"[GD6-EVD,5VD'&1\P(QD G.I<^'M78ZT!I.]KJXT^YAD$
MD628_*\T<L#D;'//![=:[&#4=$LIX=)M[NP@E#&*.TBD12"!DJ$'3@@XQWJ,
M>(+2[\-W.LZ7+%=Q10R.F&P&* \$]1T],\]* .7MM#U(:V!)ITGG6^I37<NH
M@IBYMW5\0@YW$_,HVD;0$Z]*S;+PI?:?IMM')HT\0.B-!>?8WB,DDWG1D#&2
MKD*&(SP02.*[ZRU[3KRQ^T?;K0&-4^T*)U/DLV,*W/!R<8-2-K>DI';2-JED
MJ71Q;L;A )CT^0Y^;\* .?L=,UA_AU=Z?'#%8ZC+'.L/EQK#G<S;6*J<(S @
MG!X)]JP[O0KO4+X7-CHMQIVF3W%CYUF0L99EE8ROM4\ (0">]>AWE_9Z=")K
MZ[@MHBP4//($7)Z#)[TYKRV26.)[B%9)1F-"X!<>P[T <QX=TRZA\.:WIKVD
MENIO+N.UCEQM,3$[-O)^7!Q^!KD(_#=]=:<6DT2\AD@\,I:PK]QOM:,X!&UO
M7#<]CDUZHVH62-*K7<"M%CS 9 "F3@9YXYI[W,$>?,GC3#;3N<##8SCZXY^E
M '%V&GW4GC1Y[[3M4$@NY)X+U'00^2T8VH_1CC&W;@@'GN:R/%-LVH>-=8ME
MBOYKD:9#]A%LT@6*X+-L9MIP #SEN, _0^DF]M1NS<PC:N\_O!POK].16=?2
M:;I<%[XACCADN#;'YQ* 9@BLP0$G'8T <'JHUAM1U7RM*U59I(]1A\^.!R)/
MW \H[@3D$I\H P"V.N36AX:T4Z3KOAJY?3[\RW.CLMS-)YDGE7!$3'>6)\OA
M7&..3C%=[!=1S6$5VQ$<;Q"4[CC:",\FI4=9$5T8,C#*LIR"/44 >?>)(-2E
MUC68XXM3^V.ML=)N+=9O*3LP9E^08;<3NZ@CKQ6WX7L&@USQ-=26\L1FU#]V
MTB,N]/+3D9X(SGD>AKJ** /)='T9YKRQM;FSU"-(]8U W+*LT956B?:0XQUX
MZ'G..]1V$NLW(T./4I?$$;/:6_V:2VB8XE$C"02$D $@)DMD;<^N:]>K)?7X
MEU*]L([*\FFM/(W^6BD$2D@,.>@VG=Z8XS0!E^)YA:^)?"]U(DOD0W$YD=(F
M<(#"RC.T'') K)\9:T][:Q"P;5HH]MR$FMDG16D6-2N1&-Y&6.,D+E23D 5V
MDFI1!HQ!'+=;KC[.Y@ 80M@DE^> ,8/N15R@#RZ"ZU:YUF^O9[S5HX()](-L
MF9$C<2;!."F.1C=D'H:6PNY;GQ=HTU]_:)U*"_O?MD;K,T4*>7((]@(V@;=N
M"HRW).:]0HH \ATJ>\A\.Z?;W5W?V,46C":P%LSIYER&?*G ^=ON80Y'/3DU
MJ->ZX(-?U&\O=0CELIX83;VV&2.-UB\UE7'S%07(/M7H-]>+8VQG:&XF&Y5V
M6\1D8Y..@[=R>PJ:::*W@DGGD2**-2[R.P554#)))Z "@#FO!CVSG6S:7$]Q
M;F^5HY9RS,Z_9X1RS<GD$<\\5S:ZGK-SIVEH^I7EN9(-4>>1-H;]W+^ZR2#C
M ''MFO3** .&FUV\'PXT6^N;N2"ZNVM(YK@83&YU#%F(P@(SEL<9Z5D6>L:E
MJ.F0H=;NXYHK#4I7,3(2S0SJ(\DIDX4^V0!ZG/HEQJ=K;:G9Z=*Y%S>+(T*[
M20P0 MSV^\*>+Z$ZDU@!)YRPB8GRSMVDD#YNF<@\=: .(MM7UJ:318WN+EAX
M@TZWD2>-%VVLRJ&E(&. R-D9S\P].FOXGU:XL=4MK;^T3IMK)9W$HN=L?S3+
MMVIEP0."QQU.*NF/3=-\3QR3WMT]_J8=+:&5W>- JAG"#&U,A03GKCBMR@#A
M-!EO-4\3Z9<ZFS17;Z$DL]MM7;DR<$J1D9//7((QQCG,\<3.Y\3V\NH[!LTX
M0P2E2JCSURX4C) /7G!R<]!CTZJ<EQ8R:C_9T@1[EX?.\MHR<HK8!SC'#'IU
MH XBX\1ZE;-<V4^L);HNJSVBZA<>5&$46ZR(&.PI]YNX!.,=:[?2)9I]'LIK
MB>*XFDA1VFA4JCD@'< >QIJSZ=>7EW8#R99X#')<1%,X+#Y"<CDX7]*NLP1&
M=CA5&2?:@!:*BM;F&]M(;JWD$D$T:R1N.C*1D'\C4M !1110 4444 %%%% !
M1110 4444 %(1SFEI#TH  :6D S2T %%%% !1110 4444 %%%% '*GP%8@QO
M#J>JP2Q3S2PRPSJK1"4Y>,?+C83SSDY[U;O/"L%U%JB"^O(_[0,!8[E;RO*Q
MC;N4GG:,[L_A61;>/9Y;*WO9=(CCM;E+LPL+S+%H Y(;* *"$/S$\=ZGN?&M
MQ:6<TTVFPKY-W]FD<W#B%,PK*K%_*R =X7E0.^: +USX1MKJ\EN7NI]TFHP:
MB1QPT2J%7I]W"CWJ73/#46GZW/J\EW-<W<L MRSJBY0,6!.T#<W;<>P%9\OB
MHW&H7NERVPME%L\B2"Y*2RKY8;?%\FUADD;@V05SBJZ>+YK+3@L&E23QV=C9
MSS-+=C>%ER.NWYF&TGMG!Z'&0"0^ 5,<L1UW43"\5U"(RL6 EP<N"=FXG(!R
M3V'3O;N_!MM=2W,ZWMS!<2_93'+'MS$T&[:PR"#G<<@T+XM$FM1Z?'9%P]])
M9%A*"Z%$WERH'"_CZ'O5C4_$365S?0VUE]J_L^U%U=8E"E5.["J,'<Q",<'
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MGNX9+V6.:5HIBOS(H48]L  @\&N;O_&NJ:7,]W<V-K+IB:A/9;8&<SG8C,K
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M7 &&ZJ!VY]=K0]=U'4?%<L9U>P\A+BZ@FTQW7SXQ&Y6-D4*#R%!8LS#YN,=
M ;YT?09)HK4VEFTMO,;Q(B 6C=B27 [9)^F:L66BZ;IS0-9V<<)@A,$14?=C
M+!BH]L@&N=M&C3XL:LSE5(TJ$Y)Q@;SG\.E06_B6_P!5\5-!9ZGIL%E#<1 6
M\KX>Y@>(,'3*G<6+<8( V\YSF@#J)-#TN:.^CEL872_(-TK+D2D# )]^!^54
MQX.\/+#!"NE0+%"&"(N0I#$,0P!PPR <-GI7+1>+-:NK:7[!=6=Y/-917-N
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M =,XX%=A10 4444 %%%% !1110 4444 %%%% !111WH **** "BBB@ HHHH
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MT>&'WSM;"G'3@9P:EFT_5&^TW#6^I>?##I'V<J)>&#XFP!U(4G=Z9YH W!X
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M\J\C*88'/<[1G !KI]"U&_N;O6-.O'BEFT^9(DNDBVK(&C5QE<GD;N<$=NE
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MAE=ESOC&?E.>HY/%<5IWBK5-3U^*)K_3K$K) OV">4;[B*2)7+J-NYFRW&&
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ME@1]TDC@'IQQ3KOPYKE[IB%[/1K751*T@N=/N)8-KB,*CYV$MR6!5AC;@<T
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M #G#?> .<G'09P0 =+/=6]K;FXGN(XX0I8N[ +@ L3GZ GZ"H+?4OM=Y&EO
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M-O 8ED8L")'&X@N ,;@!G))Z\ #-=\1RZ1JVF6T=H9;::95O;@]+=')2,_\
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M9OM*8C!.T;CGCGCGO5F:[BCCN2CH\ENF]XPPR.,C/IG%<"GAV32H)[KQ9=6
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MJ1ENX4\8!.>>*RK'PQKW]C7%C<Z7"C1Z'=:=#)YZ$R2%\H0!]T-P>O&.<<4
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MS%%)@?Y-&T>_YT +12;1[_G1M'O^= "T4FT>_P"=! - "T4W:/?\Z7:/?\Z
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M;N4N3M,PD8[MK;AC '! ;G@XK,D\=7D$MTSQVCPK:S3Q,H=5!2X$7+,?F7#
MD[1]T]1BNFN;'0=3UJ,W-O8W.IV2B10X5I8@2=IQU SR/?FDC\*Z!%)*\>CV
M:M,)%D(B'S"3&\'ZXH PKJ34+GQ'HIDDTV6XBGN4AGA!*[3!G)7)*G=P1NZ<
MYJ^/$TB>"8-<FMXUGD$:%%;**[R"/.3@[03GUQ6C9>'-'T[[+]CT^"#[*SM#
MY8QM+C#'W)''-6!I5@NE'2Q:Q_83&8C 1\I4]1^M '(:QK%_=A]*D$:SVNMV
M5O+)%&2DT;E)!\I.1U&X9/ /.#6UJ%W!X1LM,C@BAATLS^1*6)Q#O#%6!)X7
M?@'/0-QTJW%X9T>"S@M$LQY,%PMU&&=F(E7HY8G)/ ZDUH75I;WUN8+J%)H2
M58HXR"000?P(!_"@#SS4O$U_KWA*55L_)O[>6V6ZA4LK17!NT01@\]0K'N<,
MO'-;4&L7&H:A:07UA;&YMM:>S#Q7#A5Q;-*'''/RDC:>,_@1NW6DZ7<++;3Q
M*/M4ZW+HLA0R2)LPW!!XV)^0J-=#TA;UG6+%S]J_M @3/GS=ICWXSW7(QT/I
M0!R'B/7M1U+P-/>FV@BLKJ*WGMI8+KYP3<1C8PQZ$9(]Q77:#JUSJ;:E%=V\
M4,ME>-;'RI"ZN BN#R 1PXXQ5>/P3X=B@O($TU5BO'6291*_)#[QCYOE&X X
M7 HD\-:7)JD-W YBG%Z;Z3;,[&1U4QG +8 Y /&,<<9H ;KOB"YTC4H[5;6*
M1;BTF>V9Y"OF7"8Q%TXW \=R01BN:U?Q%=:O<^&;S2PGDS7B>7_I+*LK-"69
M'P#PIVCH><\<5W]S96UW);/<0K(UM+YT.[^%]I7/Y,?SK.3PMH\0L5BM!$EC
M</<P(CL LC9))YY^\>.@Z=.* ,6/QEJ5U9QFQT'[7=K:BXN(5N0NW,K1[5)'
MS$^7(>W0=<\7;3Q->7&KI:RZ7'%;O?RV(E%UN<,D;2!BFS&"JG^+@^O6GOX(
MT-WM7,,X>V5D1EN9%+(7+E6(/S+N.<&KT>@6,4BR()=ZWKWP)D)/FLK*?PVL
M1CI0!GZMXANM.UJ[MA;V\EO!IAO%#3;&=]^T D\*OOS^E<Y=^-8WU+2+V\+V
M$%EJ5U:7B),S1.5@)4Y(7<N67!91@^W-=;J7AG3=6NI+JZ2;SI+?[,S1RLF4
M#;QT/4-R#45MX1TFV?>J7$F99)G$T[2>8TD?EONW$D@KC\J *=UXJO+2Y6U_
ML1KBZB@CGNXK65Y3&'8@!"(\.V%)YVCT)J2V\6F?7K?3CIKI%-=7-HMQYRG]
MY""WW?0J#[@\8[T__A"M,#6;QSZC"]K"MN'ANW0R1*<JCD'YE&35J/PQ8QWM
MO=K)<>;!=S7B9?(WR@A@>.F"0!0!0U#Q=_9GB#4K2ZAC%E96,=SO5OWCN[[5
M49P.3@?4CGTF_P"$ICBO);&[LVAODF@B$7FA@PE)"MN],AL\9X]Q4^H>%=.U
M'4KF^G-P)+FU^RS(DNU64$D'Z@G(/L*S]9\.71A$MA)/<W4D\3W,CW(AE>.-
M6V*I"[?E9@W(]>^" !)?&JK"GEZ-?3W6)F>W@'F$+%)Y;$;<YRP.W@ X/([U
M-<\0Z@Z%8(IK9+;6[.V!B8;YD<1NR$'H2) ,?@>]7K;PI)=1VUU?WVH07T*O
M&CPW*AUB;'[MF55##*YSC/N<9J]<>%K2YN)96N;L"2[@O-@=2%EB"A2,J3R$
M4').<=J *,GC2.*U1_[)O7N0UQYUM$-[1B%E#D$<-]]<= <]15_2_$<6K:I<
MV=M8782V.V6XDV!%8JK!<;MV<-W P00:AG\(6TLRSQ:CJ-K.L\TWFV\JJQ$I
M4NA^7!7*+VSP.:4^&?L=OJ?]F7]W!<W]PD[2F1<HPVC@E#Q@<@YSTR,YH MZ
MUKUMH9M!<1R.UW*8HPC(HW!2W+.R@<*0.>N*Q;/Q%-;:_J\-W%>36OVZV@C<
M;"ML98HMJMALX+OC*ANO/K6]K&D1ZU9/9W$\J6\B,DD:*A#@CON4\CJ",<UF
MQ^#--A4(DUT$%S:W*J74X:!55!DC)!"+G)R?44 4-2\:13Z?K-I9Q7EGJ-OI
M4]]"TT:?=0LF[&3@[EZ, <'I6GIE[=R^,==L9;AI+>V@M&A0@#:6$FX\ 9SM
M'6LZ/X?V\<,T8U2\;S+"XT_+I'D1RONZA021SR>N<\5N66D+9ZYJ&I_:)9'O
M8X8V1@ %\L, 1@=]Q- %,>,-/\F>Z:"[6PACF<WWE PMY3;6 (.<Y!QD#=VS
M37\8V4$CP7-G>P7:30PFV=$+YE)$9!#%2"01UR.X%0+X)M_L%_I<NHW;Z1=;
M]ED%C"PEV+$AMNX_,20"<#T-++X.6YN8KNZU"26\6YMIGF\I1O6 EE3';)))
M/>@"P/%]@PM%2"Z:>Z\[9;[560&)]CC!89(;L,DX)QQ5?_A)'OHXVB%Q8A-8
M^P9,2R^=M8AAU^4':?F[>],OO!<5[8W%A)>#[+//-<,K6Z%E>23?N5NH89(!
M]/H*GA\+M$[8U"1HO[4.I1H8E^0L69DSW!+'GL,?6@"31_%4.JVUK(]I/ ]U
M)<K"AVME87*DG!ZG'3USU&"8HO&NER6\MVZ316264-Y]H<#!65F55QG.[*X_
MSS#;^$+FRCLDL]7>(V=S<21LUNK'RYB2R=<;@3D-^E5H_ 3#3%T]M6?R/L$%
MHQ2W 8O#*TD<@))  +'*X.?6@#HK#6[*_L[NY1FB6SD>*Y$@P8F0 L#C(/!!
MR"1S5(^+])6QGNYOM4*0QQS,DELX<QN=JLJXR1GCCIWJU%I=S/H-QIVKW_VY
M[F.2.6981$-K C 4$XX/J:QY/!]W<:?+'<:I ]W]GAM8;@69 2.-P_S+YGS$
MD#)!4<#CU +G_"9Z/]CEG+72&*4PO#);.DJL$WG*$ XV\YJ\=;T[^Q8=62<R
MV<X0PM&C,TA<@* H&<DD#&,COC!K&F\(W@U2ZU2TUD17TEX;F-I+8.J*8A&8
MR-PSP!SD8Q6GJFC3W^CV<"W48OK.2*>*=XOD,B=R@(X(R, \9XZ4 5Y_&>AV
M<*R3W$R$O)&8A:RLZO'@LK*%)! 8'GJ#D<<U)!XAM?)GFN;E9%%Z]M$(+67=
MD*6V%<%BP4,20,<55L_"TMMKD.JO=0F9KB:XN56,@,6C$:A<MP !SG.<]NE8
MNMZ5J>FB$07$KO+JMQJ N8K*:<0!D*JA$1W?=<C."..<=P#?3Q7I[O'=I?PG
M3#I\EZ28)1(45@"XX^Z,GC&>F.*EA\8:%/!++%=R,(I$B91;2[RS_<"IMW-G
M!P0".#Z5@VWA*[O]%B^>&Q9M%FTL1")\*'<8;#'</E7H><GK5Z?PMJ*W\UY9
MW\,;S-9;E8,!M@W;AE2#SN'ITP>": -.SU^+4M5T];"6"XTZ\LY[A)DSG=&\
M:X^G[P\8SD57\2^*H-%MY4@(FOHVA!B*.54/(J?,P&%.&) )!-5/"OA2[\/K
MID4UQ;/#8VUU"!$K DRS)(#R3P F/7W-0:IX1U2ZN=6CMKNT^Q:G=6]T_FJW
MFQF,H2!C@@^6,=,9_&@#HTU_29+UK1;^ SC?\N[@[/O@'H2O< \8.>AIEMXC
MT>\9EM]0AD972,@'G<^=G_?6#@]#6!_PAEU)I::/-=J+*"XN9X;B-V$Q\U91
MM8>WG-D[N<#@9-2#0=??2K:.:32C>6DML\?EHZK((B<[VY/(/&!Q@]<\ &U<
M>)=%M%)N-2MXL/)'AVP2T>-X ZG&1G'K3[?Q#H]VLK6^IVDJPQB20I*"%0]&
M^GO6!9^%]3A\16FJ32VA$%Q>S>6C-R)PFT9(Z@J<GZ<=JSIO >IW%G%$\]FK
MQ:+:V(^9F4S02B3)^4?(=H&>O)XH ZW_ (2;0Q;+</J]DD3;P#),JDE,;A@\
MY&1D=LCUJ>WUBPN]1DL;>X62=($N"%Y!C?.U@>AZ=O45S-IX1N8M7T;46L],
MMVM6NY+F&WD<J[RHJJ067)X7!Z>V:MZ1HNKZ+'%Y*6,[IH]K9?/.Z#SH=_HA
MRA\SKP>.G/ !U-<BOB;Q"^JG3?\ A&[47*VBW;1G4^51F*A?]5MW94]\>]==
M6(FF7:^.)M5*Q_8WTY+8'?\ -O61FZ8Z8;KGM0!%I'BFVU2QG826B7\9N"+,
MW*AML<C(&/=0=HYQ@9J_:ZS:RPV*W5S9P7EW$LB6XN5<MD9^0\;QUY YQ7)V
MGA75(/[-S;VV86U)YOWF<F8GR\''0@\X]!3M*\-ZOIU]HLD$ @:&UM;>_D^T
M*\<RQQD$;"N0P/"LI[GWH [NBBB@ I#2T4 )DT9-+10 F*3-.IM !3A2"EH
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MR0H;'KZU6UB35FT[2[R]?5K.WU26:XNUL5D9X&*(L*D(P8#:I)'3=U%>HT4
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M[L>Y*@DU=J"SM4LK&WM(RS)!&L:ENI"C S^53T %%%% !1110 4444 %%%%
M!1110 4444 %%%)WH 6BBB@ HHHH **** "BBB@ K&\4:?)J>DQVT=I'=?Z7
M;R/'(5P4257;KQRJD8]ZV:* //#X+FB\77,YT:&ZL'GCN+69=0> 6VR,#;Y*
M8!Y! /H>>XK%ET6\TF^T.VN]+::P^W*+:SE,,DYQ#)N0OD*Z@XV%B#CKCBO7
M:BEM;>>2&2:"*1X6WQ,Z E&QC*D]#@D<4 >8S^"-0,R&71VO+&6.<)8QW_V8
M69:=Y$7Y3M*X8 XW8(X'%:D'A_44;6+.XT.&9Y7O'M]3:=&9TE5@JD'YMW(4
MYXP.M=_10!P$.@WXU71KN+1IK>2-+:*Z$QMY(52/=DK\Q9'!)P4X(;D9SCM[
M*>>XLXY;FT>TF8'= [JQ3GU4D'U_&K%% !1110 4444 %%%% !1110 4444
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MG MV$3&:-U).T'@MRW!'/UJU110 4444 %%%% !1110 4444 %%%% !1110
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M!]U1@D#!]<\U+X0U*[N-5@M-4O=3MM5CM6-WI]\@VSM\@\V)@,;,AN!Z^V2
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MB>334U%M0:V2<0N8M@@2;.PN"6P^,;AZ]L$ Z'4=)L]7>RDN-[&RN1<Q;'(
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MOVKR_P!TK;=W**I8G:.3G^M10>)9Y-<GTA[2);N.]$03SCDVYCWB;&/^ XZ
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MP\H@N6=6W#GC[H_STZBC- !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDR>4Z3Q&-@=JL.#ST93SZU?-+X]?4FR^$QK1/&K<7%SX?@0'"B.UF<[?<>8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>#T]"FUR[K?7T\OQVZA)._Y'444?A17,:A1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:@!]%-S2CI0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%&1ZT %%&110 4449'K0 4449'K0 445 ;RU6X^SFYA$^0/+,@
MW>O3K0!/129]Z ?>@!:*** "BBB@ IF#NI]% #=N:<!@444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O!K>KZOJE_;Z1;
M6B65G)Y)O+EF;S9!]X*JXX'3)-;^HS&WTR[G!P8X7<?@I-5-!LHM.\/6%M G
M"6Z9VC&YL9)^I.3^-:1LHN35R7=NQG0>(;ZSU2*PUW3EM1,=L%Y#)YD$C8^Z
M20"A.. >O-=&#UJIBTUC3%9HUGM+F-7"R)D,K#(R#6-H5PFD7%YH%W<,[V:&
MX@>0Y+6Q/'/4E3E3^![X#DE)72LUN*]GJ6O$7B.#P_' #!-=WET^RWM( #)(
M>Y [ =SVIK:\]WI^E2:;"KW&IHLL22G CBP&9VQ_=# 8'4D#O6"NK21:+JWB
MRXCV37""+38B-SK'TB&.Q=FW$#MCKCA="N[?26\0:E,Q>UTN*&QC &2HAC^9
M5],N?Y9Z5JJ*4=M5^+[?)OYF?.V]]&:MU8:7HLAU+5-7O!<R2[U+7<NTG.?+
M2$-@K_LX)Y[\4_0-;U#Q!I5I>P6"6\,JG?+.^"2&*Y5!DX.#U(Q[UF^,_L^J
MMI6F10XUNX.ZV=9&5K-2,O+E2,X"\ ]2/:J^G^%_&.@VJ6VG>(K:Z@C55CBN
M;?8%4#H,;JRE?E][?IZ&L;7T.FO?#UMJCHVHRSS!?^64<SQQ$^I4-S^)KBO'
MUG8>&M.T\:1X?TQGEN LC26B2';D<$D$X)8#/;(P0<5T27OC2!5$VEZ==$ ;
MO)G*$^_S<5PGQ#\2_P!HM86DUE=Z=>1J[%;A,+DO&5*MW&4/..U9,T6YW_AD
M1Q:GKVGVSL;.TNT$*F1G"%HU+*,G@!L\#IDUTH6LKP]I T328[5I/.N&)DN)
MSR996Y9B?\\ 5K4D2]PQBBBBF 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$ND6<VM6NK/'B[MXVB1P>JMC(/KTX^IK1' Q17,FUL:V"BBB@ HHHH ****
M"BBC(]: "BBB@ K-G53,_P JY!]*TJSY?]=)_O4 0^6O=1GZ4OEKZ#\J=10
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M_&IJ0T 1>2GJ_P#WVW^-'D1_[?\ WVW^-244 1?9U'.7_P"_C?XT"W7IE_\
MOMO\:G/2D'6@"+[,G]Z3_OLT?9D_O/\ ]]G_ !J:B@"#[.G]Z3_OL_XTI@&/
MOR_]]G_&I>]*>E $!@4DDM(?K(W^-+Y [/)_W\-24HZ4 ,$; 8$TW_?QO\:3
M:_\ SVF_[^-_C4M-H 9M?_GM-_W\;_&C8W_/>;_OXW^-/HH ;Y;?\]Y_^_K?
MXT>6_P#SWF_[^-_C3QTI: &>6W_/>?\ [^M_C2;&'2:?_OZU24AZ4 -42?\
M/:;_ +^$_P Z0A\_ZZ;_ +^&GB@]: &[&_Y[3?\ ?UO\:;L/_/:?_OZW^-2]
MJ;0 T(0?]=/_ -_6_P :7+C.)9>1W<FEHH -TO\ SVD_[ZI#O/6:7\'(I:*
M&[#_ ,]I_P#OZW^-+Y;?\]Y_^_K?XTX=:6@!GEM_SVF_[^-_C1L;_GM-_P!_
M&_QI]% #,-_SVF_[^-_C2;'[S3?]_&_QIW>G4 ,\ML@^=-Q_TT/^-.._!Q+*
/..N\TM!Z&@#3HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2R XX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *44E**
M$I:2B@#"GT[5;BZ1FND$,<V_",P)7/IR#QTK=HHH :Z;UP>GM3NPHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124HH 2BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5F:_K,
M>@:-/J,D+S^6558H_O.S,% 'XFM.L'Q?8S7FA&:VP;BQF2]B0YPYC.[;QSR,
MXQWQ0!F:;H=QX@O[7Q'K$TBH<36VF\F.,8^1F#?Q@$Y( YZ>_8 !0   !P .
MU8_AC7$U[18[G;Y<Z$Q3Q$Y*2+PP]??GG!%;- '.^,/$C>&=/M+B-(G:>[C@
M;S6P%4Y+-^2G\Z9XDNEO? S3A4=;Q(% !RO[QT'XCYJPOC"V?"EK$H5I'OD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I124HH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG*')P)6/R]CSGN.*S=/FCU7XN37UDZS6L6FA3,A#(6RIP&&1GYAQ0!W]%%%
M&/XHTJYUOPY=Z=9W MYYPH60D@ !@3TYY (_&D\+Z3=Z+H4-E?7INYT_CR2%
M   49YQ@#\2:V:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "E%)2B@!**** "BBB@ HHHH **** "BBB@ HHHH
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MK_K-V[/3U_&H)O"VDSZT-6>UC^U]=WEIR<8W=,Y]\]A0!A)J5_'XT&@3SO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%<_>>*H;+QE:>'I;9R;FV-
MPLX;A<;S@K]$//N.*DA\3037D48M+A;6:X:UBNSMV-*I8%=N=PY5N2,<4 ;E
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !15>_OK;3+&:]O)/+MX5W2/M)P/H.:=:W4-[9P7=N^^">-9(VP1N
M5AD'!YZ&@":BBB@ HHKF7\?^&X]3_L]K]A/D#'D/C)&1SB@#IJ*** "BBB@
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M1B)HF\L%F(4#&0,=35VPU*6/5+CPO)>3R:BNH^>KF1R1:Y67[Q[8^3;GOZ4
M=O15"QL)K2ZO)9;V6=)Y=\<;DXB7:HVC)/=2>WWC5^@"GJLE[#I5S)I\*S7:
MH?*1G" GZD$>_/7IQUKA+*X\7:W?216_B:VLI(\K+:FU61HW&,C<4 /7L:]'
MK)UC0K?4XWFB"6^IJFV"^1<21'G'S#!*\GY<X.>10!Y7X@TW5['Q5'#J_BN5
M))K1V%TL)V@'?\FU3D9PW('&:L>$=7\*:5 /[9UF6>ZMKJ1HE=;AH\ACMD"\
MKD\GD9R?6M'Q!H^JS:KH<%W=127P4P)<,H8/(%F,;E2,8^[G/0YZ]3)X02>T
M\8W^A:Y:VTER\9N ZQ1['XC4$  8R 3^?UH Y_6?$>BW_B76-0BUBZA9H4^P
M7$*RC:P$? 7*]2).O'.>3BNG\/?$F.72XHYK&]N3:Q[9[H,GS!1R^"P/(P2.
MO/>D^(NC):(=<BAC\A+1[.2- %(#)(%/I@.R'UXK<\!16UM\/=/(5?+:%Y)<
M#[Q));/KZ?A0!OV>J6M]I,>IQ.PM7B\W+*00.^1[<UY[X5\0:A?_ !/U*![Z
M:73Y%F,,+.2JA7"@A3T^Z?S^M:&FW,EMX'\6W"R@1K=WYM<#[B\X&,?WLG\:
MXOP3J":7XQM;K4I6>.:V$0<+Q')+B0# Y();TX+>@H ]MNH3<6DT ?89$9-P
M&<9&,UR7@*:6$ZUID\DDKV^IS[&;IL^7&.>,DDX]ZZBYO4@LQ-'M9I%/DJQ*
MAVVE@"0#@<=<5XO!J-^OC*XN;N^N+*QN]0D@F%K(2 ^2H *E6(^5?FP#Q0!Z
MAXTUE]%T,/'<+:R7,GD+<N"1"=C-NP%8G[N,8[]JXW1+/4]<N+2[LK^]N'$Z
MO/J;W#1Q,%(W*L6[)R.,%5')Z=^R@\(>';FU6673XKQIDR9[@M([YYSN<EAZ
M]>*YKQ18W'A& W^E>(YM.LT"K%I[QO,FXYX!8MM!QTQ@4 >BQJR1(K-O8* 6
M]3ZTZL#P;J=_J_AJWO-1B"RN3MD#*1,O9\ #;GD8QGBM^@ JAK.LV6@Z;)?W
M\C)"G'RJ6+'L !Z_E5^N%U/2-0M/',WB.XT]=4T^.%?*03*'MMH&657PI((8
M]1]_U% %U=6U[Q-IXDT2U73K2<9AO[B96<KZB(!OU(Z=J=I>AZKI$TFJ:MXA
MN=1:*)V,(#1ITS]T-M/?J._M4<_Q&TFSA2:\M;ZV1GV9=$;!_P" N?0U=T?Q
MMX?\0W0LK&[,EPRD^4\+KD#KR1C]: .7M(M0AN$\8+J%S+;/J,J36A<X2 RO
M&.K8./E. .W6O1H)DN;>*>/.R1 ZYZX(R*\QU+PGK]MK>IQ1ZC+'HNH?:'C6
M&8A4=E9\,FX?W2.,@Y'N _1](U2X\'F>+Q5>6;6#RQR-M9P%B+# &[&,!>@]
MJ /3ZB:XB0R!GP8UW-P>!C->;Z!\1FLM/9-92>[MH+E[<ZHNWY^?E)CX8<$>
MI^IK+UJX@\0_$FT70YU4:GI;Q2R;"H;=')RP(YPH3\AZ4 =G=_$GPY9WTMFT
M\[RQ9W[(3@8&3UQZ59TCQ[X>UNZCM;.\<W+_ '8GA<'\\8_6LOPM::]X0MFT
MW4;:*YTN(R2"]MY%'E)][E" QY!)QD\X&<5D>,_&/A?4]*O[.VLEU"]$; 2-
M%L\HX(W[F&?EST'7Z4 =GK'BJPTB^ATXI-<ZA-CR[:)0"0<\[F(4?=/?-;-O
M*9K:*5HVB9T#&-B"5)&<'!(R/8UYKX8\,WT7PZEOM.*?V]=Q;H+C=AUC^7$8
M8]/E7CH!G\:SM.\4ZKH7B/3[/4=1O[R1\17-@Z(6\Q@5^5RQ!P^.Z]^E 'K]
M<UJ7B?2[I]1T.TO"VK+!*OE!'0J0IR=^,<=>#7)>*]8U_6-2ET>!CI%I]E^T
M7&^16?R<D%FV ]25&U6/Y$XCT'P!XBT^*.]TGQ%;PB=1(LGV?+,&P>=P)P<#
MB@#M?!5\U[X<19-YFMII+>4NV[+*QYR>O&*Z&O(#IWBWP]XD2QD\0+;P:M<;
MFNH(%<&:3/5"!@DIU''3WKK3X8V6<W_"2:W=:I @,KIF2$?+R#A'[8H ;\1M
M?TZS\,ZAITTW^ESQ!8XO+8Y)/KC X!/7M5S2-2^S_#"VU"'.ZVTK</\ >CC_
M ,5KSZQ^';^(KZYU/2[R.STU[J6*-9%:5P@RI;#'G)[$]\YJ-D\3:!KH\%PZ
MW"MK,N(/.A!CE63^'[K%<DL/0?0YH ZWPOX;M?$NFIKVO;[Z:\=Y$CED<K&F
MXA5P#M. #V[^U4));#3O'EAIOA:>XCE2X5+VR0L(0G/F'YVQG&W@#MP<U7@N
MO$?@"T*:[;QW>A/(Z;;:1,*7). " W][C@<ULZ"-<L]^H:/IUM=Z-?9N8+<S
MK#)&7PQW$H<D'=_$1R/3% '?5P?@?0(;6SUG1-4M8+AXKE6?S '#*\2$#GZ5
M>UG_ (277-*NM+30X+1;J$QM<2WX(0GK\JH2:X'3=>E\.^(M$@U<R07%JDB:
MA*Y$ID0[VC.1DG <].>/I0!U]VK> -6CFM4(\.7!42P)(3]G?.TL V202RG@
MCH>/7LM-U&VU;3XKZS<O!+G:Q4@G!(/!]P:X#4]0F^)$R:?H0_XE,+K]NFG.
MP/DA@ N-W&P],<GTYKN- TB/0M$M]-BQLAW8P21RQ;OSWH TJ*** "BBB@ H
MHHH **** "BBB@ HHHH **** "E%)2B@!**** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!BZOXJTS1-1L[&[:4SW3HB*B9 W$@
M$GTR#[^U;".LBAUY4C(->,_$VY@A\?0R3$_NK6$KQG!$NXX_#-=UX.\:Z7K_
M )>EVBW(N;:V#.9$ 4A=JD@@GN: .NHHHH *A>TMG8L]O$S'J2@)-344 0?8
M;3_GU@_[]BE2UMXW#QV\2,.A5 "*FHH *@O;R#3[*>\N7V00(9)&P3A0,G@5
M*[K'&TCG"J"2?0"N ;[?XY\331I*R^%[*;R9XF('VB6/!((&&P=PZG'R^O%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHQUQ[T =E6%XTM8[SP5K$4@!5;5Y1GU0;Q^JBMVH;N W-E/ &VF6-DSZ9&*
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M7M(&DE79(YC!+KQP3W' _*@#RO3DFTZ+0;NRFN/M5QITCOON'8.P@F*C#$@
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M!'7VJ;0(-5M]&A36KM;F_P"3(ZJ% R>@P ./7%6[&V^QZ?;6I;>88ECW8QG
M S^E6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *44E** $I'I:*  =!1110 4444 %%%% !1110 4444 %%%% !1110
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M444 %%%% !1110 4444 %%%% !2BDI10 E%%% !1110 4444 %%%% !1110
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M "4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO2T4 8MQX:LGUB/5K4&UOA(K2R1LP$J_Q*R@A3GU()X%;5%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 )1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNG:(@^WR.Q__ %4 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E%)2B@!**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124HH 2E;I
M24C4 +VHH'044 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %**2E% "4-10>:  =**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **:9$7=D_=ZTJL&4,#P>E "T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%*1Q24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !2BDI10 E%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ( 03ELY-+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %**2E% "4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2BDI10
ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MHI*44 )2MTI** #M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4HI*44 )0U%*W2@!**.U% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !2BDI10 E*W2DI6Z4 )VHH[44 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %**2E% "4K=*2E;I0 W-+3:7- "
MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 )2MTI
M*&- #:*** %'2EI!2T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4HI*44 )2-2TK=* &=J*=VIO>@!1UIQIE** %HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "E%)2B@!*5NE)2MTH 3M3>].[44 ,[T^FG[U.H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BFTZ@ I124HH 2E;I24K=*
M $[4O:D[4IZ4 1]Z?3:4'- "T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !2BDI10 E*W2DI6Z4 )VHS1VI,T &*7%)F@'- "T444 %%%% !1110
M 4444 %!('4^PHK+UJZ^R)9R&41H;I [$X&WG.?:@#4]**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH
MKJ=;6TFN'("11L[$]  ,U'I]XFH:?%=QD%) 2I'0\T 6:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E%)2B@!*5NE)2MTH ;
MFDHI<4 )2BC% &* %HHHH **** "BBB@ HHHH *YGQF28M$C_@FU:".0?WE.
M[(KIJY_Q5;/<_P!B;"H\K5H)&SZ#=0!T'.!G'X4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8OBZ7R_!N
MN-NVD:?/@GCGRVQ53X?N\O@'1G<Y8P#/YFIO&RM)X(UU1C=]AE/X!23_ %J'
MX><?#_1?^O<?S- '2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%!H 3-+2 4M "9I:3%+0 4HI*44 )0W-%!XH 3!I:,BB@ HHHH **** "BBB
M@ HHHH **** "J>H6S7'V7:N[R[A)#ST SS5RB@!32444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9/BI/,
M\):TH7.;"<8_[9M57P-$T'@C2(W4J1;CY36])&DL;1RHKQN"K(PR&!Z@CO21
MQI#&L<4:QQH JJH "CT [4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *44E** $I6Z4E#=* &TZCM10 44AH% "T444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !2BDI10 E(U+2/0 G:G4WM3NU
M !12&@4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%%  >E-IQZ4WO0 ZBBB@ I1
M24HH 2D>EH//6@!O:G=J3 I: #%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!
MZ44'I0 W-'>BCO0 ZBBB@ I124HH 2@\44,: $S1FDI<4 ***!10 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1^5%&!0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 F*,4M)F@ S2TVG4 %**2E% "4C"EH;I0
M VES248H =12"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #28I:.U #:=3
M:=0 4HI*44 )0W(&*** $Q1FEIM #J*04M !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 F#2T44 %**2E% "444-0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %**2E% "4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !2BDI10 E%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 )110>* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124HH 2AN:*
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124
MHH 2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *44E** $HHI&H 6FTX=!3>] "BEI!TI: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *44E** $H844K=* &9I<4E&: '44@I: "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *44E** $I6Z4E*W2@!E+BC%+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 )2MTI*
M&YH .U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
MBDI10 E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4HI*44 )110U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4HI*44 )1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %**2E% "4444 )FEI,49H 6B@44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4HI*44 )1110 4F*6B@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124HH 2BB@\4 %)FEI,4 +
M12"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124HH 2E;I
M24K=* $[44=J;0 ZBD%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2BDI10 E*W2DHH .U%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !2BDI10 E%%(W'2@!:*;DTN30 M%(*6@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "E%)2B@!*",T44 )BC%+10 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 )110>* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124HH 2AN:*
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I124
MHH 2BBE;I0 E%':B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %**2E% "444'
MB@ I.O0XI:, ]:  =**9%$D,:QIG &.:?0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !2BDI10 E*W2DH;F@!NXTF33\"C H 1>E+110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4F32TO% "4444 %**2E% "4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6793807680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Nov. 10, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ZYNEX INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000846475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZYXI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6796188336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">3,981<span></span>
</td>
<td class="nump">2,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,196<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,812<span></span>
</td>
<td class="nump">3,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit</a></td>
<td class="nump">3,027<span></span>
</td>
<td class="nump">4,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital leases</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,090<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and payroll taxes</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Deferred insurance reimbursement</a></td>
<td class="nump">880<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,660<span></span>
</td>
<td class="nump">7,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Capitalized leases, less current portion</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualNoncurrent', window );">Warranty liability</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">8,837<span></span>
</td>
<td class="nump">7,767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; $.001 par value, 10,000,000 shares authorized, no shares issued or outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.001 par value, 100,000,000 shares authorized, 31,271,234 shares issued and outstanding</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Paid-in capital</a></td>
<td class="nump">6,018<span></span>
</td>
<td class="nump">5,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(9,985)<span></span>
</td>
<td class="num">(9,845)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Zynex, Inc. stockholders&#8217; deficit</a></td>
<td class="num">(3,936)<span></span>
</td>
<td class="num">(3,982)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(4,025)<span></span>
</td>
<td class="num">(4,071)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; deficit</a></td>
<td class="nump">$ 4,812<span></span>
</td>
<td class="nump">$ 3,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45023-112735<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14764-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Line-of-Credit Arrangement<br> -URI http://asc.fasb.org/extlink&amp;oid=6517033<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid after one year or beyond the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6796212864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6794345136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNetAbstract', window );"><strong>Net revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue', window );">Rental</a></td>
<td class="nump">$ 1,324<span></span>
</td>
<td class="nump">$ 924<span></span>
</td>
<td class="nump">$ 3,226<span></span>
</td>
<td class="nump">$ 1,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Sales</a></td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">1,743<span></span>
</td>
<td class="nump">7,164<span></span>
</td>
<td class="nump">7,155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenue</a></td>
<td class="nump">3,627<span></span>
</td>
<td class="nump">2,667<span></span>
</td>
<td class="nump">10,390<span></span>
</td>
<td class="nump">8,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue - rental, product &amp; supply</a></td>
<td class="nump">880<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="nump">2,803<span></span>
</td>
<td class="nump">3,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expense</a></td>
<td class="nump">2,125<span></span>
</td>
<td class="nump">1,943<span></span>
</td>
<td class="nump">7,465<span></span>
</td>
<td class="nump">6,923<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">622<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="num">(1,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
<td class="num">(368)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">532<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="num">(1,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">532<span></span>
</td>
<td class="num">(324)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="num">(1,729)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Plus: Net loss - noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) - attributable to Zynex, Inc.</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="num">$ (322)<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="num">$ (1,711)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share - attributable to Zynex, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.05)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted - average number of common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">31,440,526<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesIncomeStatementLeaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39896-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesIncomeStatementLeaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6776931616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - 9 months ended Sep. 30, 2016 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Paid-in Capital</div></th>
<th class="th"><div>Retained Deficit</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2015</a></td>
<td class="num">$ (4,071)<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 5,832<span></span>
</td>
<td class="num">$ (9,845)<span></span>
</td>
<td class="num">$ (89)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Employee stock-based compensation expense</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Service provider warrant expense</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 30, 2016</a></td>
<td class="num">$ (4,025)<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 6,018<span></span>
</td>
<td class="num">$ (9,985)<span></span>
</td>
<td class="num">$ (89)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,271,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of recognized equity-based compensation related to stock options during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28183637&amp;loc=d3e4724-112606<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Warrant<br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4590271-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568740-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6776807184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 1,183<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Change in inventory used for rental</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Net repayments on line of credit</a></td>
<td class="num">(976)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments on capital leases and other obligations</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,027)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash</a></td>
<td class="nump">83<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at the beginning of the period</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash at the end of the period</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">262<span></span>
</td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid (including interest and penalties)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6786494256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">(1)&#160;<u>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</u></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt">Organization</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Zynex, Inc. (a Nevada corporation) has its headquarters in Lone Tree, Colorado. The Company operates in one primary business segment, Electrotherapy and Pain Management Products. As of December 31, 2015, the Company&#8217;s only active subsidiary is Zynex Medical, Inc. (&#8220;ZMI,&#8221; a wholly-owned Colorado corporation) through which the Company conducts most of its operations. One other subsidiary, Zynex Europe, ApS (&#8220;ZEU,&#8221; a wholly-owned Denmark corporation), produced minimal revenues during 2015 and 2016 from international sales and marketing. Zynex Monitoring Solutions, Inc. (&#8220;ZMS,&#8221; a wholly-owned Colorado corporation) is developing a blood volume monitoring device, but it is not yet developed or ready for market and, as a result, ZMS has achieved no revenues to date. Its inactive subsidiaries include Zynex NeuroDiagnostics, Inc. (&#8220;ZND,&#8221; a wholly-owned Colorado corporation), Zynex Billing and Consulting, LLC (&#8220;ZBC,&#8221; an <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 80</font>% owned Colorado limited liability company) and Pharmazy, Inc. (&#8220;Pharmazy&#8221;), which was incorporated in June 2015 as a wholly-owned Colorado corporation. The Company&#8217;s compound pharmacy operated as a division of ZMI dba as Pharmazy through January 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The term &#8220;the Company&#8221; refers to Zynex, Inc. and its active and inactive subsidiaries.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">&#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt">Nature of Business</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">ZMI designs, manufactures and markets U.S. Food and Drug Administration (FDA) cleared medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. ZEU was formed in 2012 to conduct international sales and marketing for Company products. ZEU produced minimal revenues during 2016 and 2015. In addition, ZMI dba Pharmazy, which sold compound transdermal pain cream, began operations in early 2014 and was closed in January 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">ZMS was formed to develop and market medical devices for non-invasive cardiac monitoring, the products of which are under development. The Company is currently developing a blood volume monitoring device (Blood Volume Monitor). ZMS produced no revenues during 2016 or 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">ZND was formed in 2011 to market electromyography (&#8220;EMG&#8221;), electroencephalography (&#8220;EEG&#8221;), sleep pattern, auditory and nerve conductivity neurological diagnosis devices to hospitals and clinics worldwide. In 2014, the Company decided to no longer focus on selling this product line. ZBC was formed in 2012 to provide medical billing and consulting services. The Company stopped offering billing and consulting services in April 2015. No significant revenue was generated from ZND or ZBC in 2015.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In 2016 and 2015, the Company generated substantially all of its revenue in North America from sales and rentals of its products to patients, dealers and health care providers.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">&#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Unaudited Condensed Consolidated Financial Statements</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make the information presented not misleading. A description of the Company&#8217;s accounting policies and other financial information is included in the audited consolidated financial statements as filed with the SEC in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2015. Amounts as of December&#160;31, 2015, are derived from those audited consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with the annual audited financial statements, accounting policies and notes thereto, included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2015, which has previously been filed with the SEC.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as of September 30, 2016 and the results of its operations and its cash flows for the periods presented.&#160; The results of operations for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be achieved for a full fiscal year and cannot be used to indicate financial performance for the entire year.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="BACKGROUND: transparent; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Reclassifications</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="BACKGROUND: transparent; FONT-SIZE: 10pt">Certain reclassifications have been made to the prior years&#8217; condensed consolidated financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or cash flows.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Recent Accounting Pronouncements</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In July 2015, the <font style="BACKGROUND: transparent">Financial Accounting Standards Board (</font>FASB) issued <font style="BACKGROUND: transparent"> Accounting Standards Update (</font>ASU) No. 2015-11, &#8220;Inventory (Topic 330) Simplifying the Measurement of Inventory&#8221;, which changes the measurement from lower of cost or market to lower of cost and net realizable value. The guidance requires prospective application for reporting periods beginning after December 15, 2016 and permits adoption in an earlier period. The Company is evaluating the impact of this guidance on the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="BACKGROUND: transparent; FONT-SIZE: 10pt">In August 2014, the FASB issued ASU 2014-15 &#8220;Presentation of Financial Statements&#151;Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity&#8217;s Ability to continue as a Going Concern&#8221;. The amendments in this update provide guidance in GAAP about management&#8217;s responsibility to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are effective for the annual period ending after December 15, 2016 and for interim periods thereafter. Early application is permitted. The Company is evaluating the effect of this updated guidance on the disclosures in the footnotes to the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="BACKGROUND: transparent; FONT-SIZE: 10pt">In May 2014, the FASB issued ASU No. 2014-09&#151;&#8220;Revenue from Contracts with Customers (Topic 606)&#8221; which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018, using one of two prescribed retrospective methods. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is evaluating the impact of the amended revenue recognition guidance on the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Management has evaluated other recently issued accounting pronouncements and does not believe that any of these pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779310960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BACKGROUND AND MANAGEMENT'S PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_BackGroundAndManagementsPlansAbstract', window );"><strong>Back Ground And Managements Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_BackGroundAndManagementPlansTextBlock', window );">BACKGROUND AND MANAGEMENT&#8217;S PLANS</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">(2) <u>BACKGROUND AND MANAGEMENT&#8217;S PLANS</u></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt">Background</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">&#160;</font></b></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> For the years ended December 31, 2015 and 2014, the Company reported net losses of $2,911 and $6,199, respectively. As of September 30, 2016, the Company had no available borrowing under its line of credit although, based on an interim agreement with the Company&#8217;s senior secured lender, Triumph Healthcare Finance, a division of TBK Bank, SSB, formerly known as Triumph Community Bank, (the &#8220;Lender&#8221;), continues to make additional loans to the Company based on the Company&#8217;s cash collections. The Company&#8217;s working capital deficit at September 30, 2016 totaled ($4,464) as compared to ($4,773) at December 31, 2015. In addition, the Company remains in default of its secured line of credit and as a result, if its lender insists upon immediate repayment, the Company will be unable to do so and may be forced to seek protection from its creditors. The Company has not been in compliance with the financial covenants under the agreement with its primary lender since July 2014. The Company&#8217;s assets, both at December 31, 2015 and at September 30, 2016, are significantly less than the Company&#8217;s liabilities, and the Company is dependent on its banking relationship to be able to pay its obligations as they become due.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company&#8217;s losses, lack of liquidity, and substantial working capital deficit raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Although the Company&#8217;s revenues increased during the three months and nine months ended September 30, 2016 as compared to the same periods in the prior year, the Company has not recovered from the significant revenue decreases in total net revenue for the years ended December 31, 2015 and 2014 (approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.6</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.1</font> million, respectively) as compared to 2013 and 2012 (approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">21.7</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">39.7</font> million, respectively). The primary reasons for the decline in revenue from 2012-2013 to 2014-2015&#160;were (i) the impact of Medicare and healthcare reform, (ii) a loss of Zynex&#8217;s independent sales force to sell transdermal compounded pain cream from competing pharmacies rather than focusing on selling the Company&#8217;s Electrotherapy products and (iii) in the latter part of 2012, the elimination of Medicare reimbursement for transcutaneous electrical nerve stimulation (TENS) Electrotherapy products for low-back pain while still covering TENS for other indications. Medicare also continued increasing the requirements for paperwork and documentation in connection with reimbursement requests. As a result, late in 2013 Zynex began declining orders for Medicare and Medicaid patients. Commercial and workers&#8217; compensation insurance plans continue to reimburse at similar levels as in previous years and have not adopted Medicare&#8217;s limited coverage.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During 2015 and throughout 2014, in an effort to minimize the impact of the challenges discussed above, the Company restructured its internal operations, including manufacturing, billing and customer service; and made reductions in its fixed expenses by cutting its administrative costs by approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.2</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9.7</font> million, respectively, principally through reductions in headcount and facilities rent. In addition, the Company during the second quarter of 2014 narrowed its focus to the NexWave, InWave and NeuroMove electrotherapy products and continued to build the sales representative group for its electrotherapy solutions. The Company continued to narrow this focus by closing its billing consulting services in April 2015 and closing its compound pain cream operations in January 2016. The Company is continuing to address cost of revenues and overhead expenses in 2016 and as a result has improved the Company&#8217;s operating performance for the three and nine months ended September 30, 2016 (being net income of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">532</font> and net loss of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">(140)</font> respectively) as compared to the same periods of the prior year (being net losses of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">(322)</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">(1,711)</font> respectively).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the fourth quarter of 2015, the electrotherapy industry experienced a significant development when the Company&#8217;s largest competitor (DJO/Empi) announced the closure of their Empi electrotherapy division. Empi previously held a large share of the electrotherapy market. Management believes this presents a significant growth opportunity for the Company. The Company has recruited many former Empi sales representatives, including those in areas where it had no previous representation. In addition, during 2016,&#160;the Company&#8217;s orders have been steadily increasing as compared to 2015. To focus on growth and the potential for future positive cash flow, the Company has committed its limited resources to the new salesforce, including the supporting product production and supporting administrative (customer service and billing) personnel.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company is not in compliance with the financial covenants under the terms of its line of credit with the Lender. See Note 7 to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report for further discussion.</div> <font style="FONT-SIZE: 10pt">&#160;</font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt">Management&#8217;s Plans</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company&#8217;s business plan for the remainder of 2016 and into 2017 focuses on the Company&#8217;s effort to attain external financing, retaining the Lender&#8217;s continued support, maintaining the continued support of the Company&#8217;s vendors on the slow payment of past due invoices, and pursuing organic growth in our electrotherapy and pain management products with a goal of attaining positive cash flow. The accomplishment of organic growth in revenues and cash flows is dependent on taking advantage of the Empi opportunity, increasing the number of sales representatives, promoting the EZ Rx Prescribe program (described further below) and continuing improvements to the Company&#8217;s billing organization and processes. The Company&#8217;s long-term business plan contemplates organic growth in revenues through an increase in the electrotherapy market share and the addition of new products such as the ZMS Blood Volume Monitor, which is currently under development.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company is actively seeking additional financing through the issuance of debt or sale of equity. The additional capital is to refinance or replace the line of credit and to provide the additional working capital necessary to continue the Company&#8217;s business operations. The Company&#8217;s history of net losses and negative working capital may make it difficult to raise any new capital and any such capital raised (if any) may result in significant dilution to existing stockholders. The Company is not certain whether any such financing would be available to the Company on acceptable terms, or at all. Any additional debt would require the approval of the Lender. A significant component of our negative working capital at September 30, 2016 is the amount due under our line of credit and past due accounts payable, all of which is considered a current liability.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In addition to seeking external financing, the Company has and will continue to monitor and control its sales growth, product production needs and administrative costs going forward. The Company&#8217;s efforts to reduce costs and increase revenues have led to net income (loss) from operations for the three- and nine-month periods in 2016 ($532 and ($140), respectively) as compared to losses for the same periods in 2015 (($322)and ($1,711), respectively). If the Company continues to increase its revenue while controlling its administrative costs and the Lender permits it to continue to operate, the Company believes that it may continue its 2016 return to profitability in future periods. The Company believes that as a result of potential growth opportunities coupled with reduced administrative expenses, the securing of additional capital (if available), the continued support of its Lender (which cannot be assured), and the continued support of vendors to work with the Company on the slow payment of past due bills (which cannot be assured); that the Company&#8217;s cash flows from operating activities will be sufficient to fund the Company&#8217;s cash requirements through the next twelve months. Management believes that its cash flow projections for 2016 are achievable and that sufficient cash will be generated to meet the Company&#8217;s currently restrained operating requirements. Such cash is projected to be generated by securing external financing, retaining the continued support of the Lender and vendors, and increasing cash flow from operations generated from organic growth. There is no guarantee that the Company will be able to meet the requirements of its 2016 cash flow projections or that it will be able to address its working capital shortages; the principal component of which is the negative working capital.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">There can be no assurance that the Company will be able to secure additional external financing, the Lender will continue to make loan advances, the vendors will continue to work with slow repayment terms, and the sales and cash flow growth are attainable and sustainable. The Company&#8217;s dependence on operating cash flows means that risks involved in the Company&#8217;s business can significantly affect the Company&#8217;s liquidity. Contingencies such as unanticipated shortfalls in revenues or increases in expenses could affect the Company&#8217;s projected revenues, and cash flows from operations and liquidity, which may force the Company to curtail its operating plan or impede the Company&#8217; growth.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_BackGroundAndManagementPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to back ground and management plans of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_BackGroundAndManagementPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_BackGroundAndManagementsPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_BackGroundAndManagementsPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6786490704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">(3)&#160;<u>PROPERTY AND EQUIPMENT</u></font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Property and equipment as of September 30, 2016 and December&#160;31, 2015, consist of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Useful</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>lives</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>(UNAUDITED)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Office furniture and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>913</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3-7&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Rental inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,201</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Vehicles</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>76</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>76</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Leasehold improvements</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>104</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>104</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2-6&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Assembly equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,419</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,432</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Less accumulated depreciation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,902)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,631)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>517</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>801</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2921-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779316320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNING (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNING (LOSS) PER SHARE</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">(4) <u>EARNING (LOSS) PER SHARE&#160;</u> &#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">&#160;</font></b></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net loss by the weighted-average number of common shares outstanding and the number of dilutive potential common share equivalents during the period, calculated using the treasury-stock method. For the nine months ended September 30, 2016 and 2015, the potential common stock equivalents&#160;<font style="BACKGROUND-COLOR: transparent"><font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"> totaled <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,160,250</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,507,750</font>, respectively</font>, and were</font> excluded from the dilutive loss per share calculation as their impacts were antidilutive<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6786456176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION PLANS</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">(5)&#160;<u>STOCK-BASED COMPENSATION PLANS</u></font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company previously reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,000,000</font> shares of common stock for issuance under its 2005 Stock Option Plan (the &#8220;Option Plan&#8221;). The Option Plan expired as of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">December 31, 2014</font>. Vesting provisions are determined by the Board of Directors. All stock options under the Option Plan expire no later than ten years from the date of grant. Since the Option Plan expired, the options granted in 2015 and 2016 have not been approved by the Company&#8217;s shareholders and were issued as non-qualified stock options.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In the nine months ended September 30, 2016 and 2015, the Company recorded compensation expense related to stock options of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">171</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">67</font>, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the nine months ended September 30, 2016, the Company granted options to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 804,000</font> shares of common stock to employees at a weighted average exercise of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.27</font> per <font style="BACKGROUND-COLOR: transparent">share<font style="BACKGROUND-IMAGE: none; BACKGROUND-ATTACHMENT: scroll; BACKGROUND-REPEAT: repeat; BACKGROUND-POSITION: 0% 0%"> . The 2016 grants were issued as non-qualified</font> stock</font> options.</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions during the&#160;nine months ended September 30, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Weighted average expected term</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>6.25 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Weighted average volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>122.73%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Weighted average risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>1.51%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>0%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of stock option activity under all equity compensation plans for the nine months ended September 30, 2016, is presented below:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Remaining</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Aggregate</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Under</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Exercise</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Contractual</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Intrinsic</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Option</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Life</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Outstanding at January&#160;1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,685,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.46</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>804,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(329,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,160,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.40</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.91 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Exercisable at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,537,048</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.45</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.23 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of status of the Company&#8217;s non-vested share awards as of and for the nine months ended September 30, 2016, is presented below:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Non-vested&#160;Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted&#160;Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Under&#160;Option</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Grant&#160;Date&#160;Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Non-vested at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>672,155</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.31</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>804,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(523,953)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.26</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(329,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Non-vested at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>623,202</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">As of September 30, 2016, the Company had approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">252</font> of unrecognized compensation expense related to stock options that will be recognized over a weighted average period of approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> years.</font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65895303&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779102896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">(6)&#160;<u>INCOME TAXES</u></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The provision for income taxes is recorded at the end of each interim period based on the Company&#8217;s best estimate of its effective income tax rate expected to be applicable for the full fiscal year.&#160;The Company&#8217;s effective income tax rate was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font>% for both the three and nine months ended September 30, 2016 and 2015, respectively, as the realization of any deferred tax assets is not more likely than not. The Company paid no income taxes during the three and nine months ended September 30, 2016 and 2015.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6602947312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LINE OF CREDIT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">LINE OF CREDIT</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">(7)&#160;<u>LINE OF CREDIT</u></font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">&#160;</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company has an asset-backed revolving credit facility under a Loan and Security Agreement as amended, (the &#8220;Triumph Agreement&#8221;) with Triumph Healthcare Finance, a division of TBK Bank, SSB, formerly known as Triumph Community Bank, (the &#8220;Lender&#8221;). The Triumph Agreement contains certain customary restrictive and financial covenants for asset-backed credit facilities. The Company has not been in compliance with the financial covenants under the Triumph Agreement since July 2014.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> On July 14, 2014, the Company received notice from the Lender of an event of default under the Triumph Agreement. The notice relates to the Company&#8217;s default under the minimum debt service coverage ratio requirement for the quarter ended March 31, 2014 and certain other alleged defaults. The Lender notified the Company that it was exercising its default remedies under the Triumph Agreement, including, among others, accelerating the repayment of all outstanding obligations under the Triumph Agreement (outstanding principal and accrued interest) and collecting the Company&#8217;s bank deposits to apply towards the outstanding obligations. The Company and the Lender have been discussing the terms of an accelerated repayment of the amounts outstanding under the Triumph Agreement and the Lender has (pursuant to a forbearance agreement which has been extended through December 31, 2016) continued to make additional loans to the Company based on cash collections. As a result of the Company&#8217;s increased revenues and cash flow, the Company was able to make a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">976</font> payment to the Lender against the principal amount of the debt during the first nine months of 2016 as compared to only a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">120</font> payment against principal during the same period in 2015. This payment during 2016 resulted from increased accounts receivable collections, principally from a single insurance carrier which (as described in Note 8 to the unaudited financial statements below) we may be obligated to refund to the insurance carrier.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Notwithstanding the Company&#8217;s improved performance in 2016 and expectations for the future, no assurance can be given that the Lender will continue to make such additional loans or that the parties will agree on a repayment plan acceptable to the Company. If the Lender insists upon immediate repayment, the Company may be forced to seek protection from creditors.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">As of September 30, 2016, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,027</font> was outstanding under the Triumph Agreement and zero was available for borrowing based on the default status. Borrowings under the Triumph Agreement bear interest at the default interest rate. As of September 30, 2016, the effective interest rate under the Triumph Agreement was approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11.0</font>% (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6.75</font>% interest rate plus <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font>% additional default interest rate and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1.25</font>% fees). The Triumph Agreement requires monthly interest payments in arrears on the first day of each month. The Triumph Agreement matured on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">December 19, 2014</font>. Triumph has agreed to forbear from the exercise of its rights and remedies under the terms of the Triumph Agreement through December 31, 2016, pursuant to the terms of the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> September 29, 2016</font> forbearance agreement. The Triumph Agreement requires a lockbox arrangement whereby all receipts are swept daily to reduce borrowings outstanding. The Company is obligated to reduce the loan balance by $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">85</font> each month. In connection with the agreement entered into on March 28, 2016, the Lender suspended this monthly payment requirement for February, March and April of 2016 up to an aggregate cap of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250</font>, in exchange for the issuance of a warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50,000</font> shares of the Company&#8217;s common stock.</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The Company used the Black Scholes option pricing model to determine the fair value of the stock warrant, using the following assumptions:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Contractual term</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.0 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>122.44</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.44</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the nine months ended September 30, 2016, the Company recorded bank fee expense related to this stock warrant of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font>.&#160;</font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779315488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFERRED INSURANCE REIMBURSEMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceDisclosureTextBlock', window );">DEFERRED INSURANCE REIMBURSEMENT</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">8)&#160;<u>DEFERRED INSURANCE REIMBURSEMENT</u></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the first quarter of 2016, the Company collected $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">880</font> from a single insurance company for accounts receivable. The accounts receivable had been previously reduced to zero by the allowance for contractual adjustments. Subsequent to March 31, 2016, the insurance company verbally communicated to the Company that this payment was made in error and requested it be refunded to the insurance company. The Company recorded this $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">880</font> insurance reimbursement as a deferred insurance liability. However, the Company is disputing the refund request and has initiated an internal audit of the reimbursement to determine that the original sales arrangement was properly executed, the products had been shipped and title was transferred (or rental services were rendered), the price of the products or services and the reimbursement rate is fixed and determinable, and the Company&#8217;s ultimate claim to the reimbursement is reasonably assured. The Company will record the appropriate amount as net revenue when such internal audit is complete and the Company&#8217;s claim to the amount is reasonably assured.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6480747&amp;loc=d3e6772-158386<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6480747&amp;loc=d3e6764-158386<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6796241328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL LEASES AND OTHER OBLIGATIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesCapitalAbstract', window );"><strong>Leases, Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock', window );">CAPITAL LEASES AND OTHER OBLIGATIONS</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>(9) <u>CAPITAL LEASES AND OTHER OBLIGATIONS</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> The Company had previously entered into a Lease Termination Agreement (&#8220;LTA&#8221;) and new Lease Agreement (&#8220;LA&#8221;) with its landlord relating to the Company&#8217;s headquarters location in Lone Tree, Colorado, under which the Company reduced the amount of space leased at its headquarters. Subsequently, on August 12, 2016, the Company entered into an amended Lease Agreement to extend and amend the terms and conditions of the LA.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following is a summary of the key terms of the LA, as amended:</div> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt">&#160;</font></font> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt"> &#183;</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">The&#160;original term of the LA term was extended by two years and as amended is to end, unless sooner terminated, on December 31, 2018;</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -24.5pt; MARGIN: 0in 0in 0pt 49pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt"> &#183;</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">Fixed rental payments were decreased from $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">49</font> to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">38</font> per month; and</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -24.5pt; MARGIN: 0in 0in 0pt 49pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 24.75pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="33"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt"> &#183;</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">The Company and landlord shall each have the right to terminate the lease at any time, without liability to the other, with ninety days (originally six months) prior written notice to the Company and ninety days written notice to the Landlord.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company also leases certain equipment under capital leases which expire on various dates through 2018. Imputed interest rates on the leases range from approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>%. At September 30, 2016, the total recorded cost of assets under capital leases was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">461</font>. Accumulated depreciation related to these assets totals approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">264<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for capital leasing arrangements including, but not limited to, the following: a) the basis on which contingent rental payments are determined; (b) the existence and terms of renewal or purchase options and escalation clauses; (c) restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455398&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6452660&amp;loc=d3e36991-112694<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesInFinancialStatementsOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6733337408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">(10)&#160; <u> CONCENTRATIONS</u></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company sourced approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 40</font>% of components for its electrotherapy products from one vendor during the nine months ended September 30, 2016 and 2015, respectively. Management believes that its relationships with suppliers are good; however, the Company has delayed and extended payments to many of its vendors for cash flow reasons, which has caused many of its vendors to require pre-payment for products or services. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company had receivables from a private health insurance carrier at September 30, 2016 and December 31, 2015, that made up approximately<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5</font>%, respectively, of the net accounts receivable balance.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6327-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6442-108592<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779110672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LITIGATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">LITIGATION</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">(11)&#160; <u> LITIGATION</u></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">From time to time, the Company may become party to litigation and other claims in the ordinary course of business. To the extent that such claims and litigation arise, management would provide for them if losses are determined to be both probable and estimable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company is currently not a party to any material pending legal proceedings.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6761673216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Unaudited Condensed Consolidated Financial Statements</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt">Unaudited Condensed Consolidated Financial Statements</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included herein are adequate to make the information presented not misleading. A description of the Company&#8217;s accounting policies and other financial information is included in the audited consolidated financial statements as filed with the SEC in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2015. Amounts as of December&#160;31, 2015, are derived from those audited consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with the annual audited financial statements, accounting policies and notes thereto, included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2015, which has previously been filed with the SEC.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of the Company as of September 30, 2016 and the results of its operations and its cash flows for the periods presented.&#160; The results of operations for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be achieved for a full fiscal year and cannot be used to indicate financial performance for the entire year.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="BACKGROUND: transparent; FONT-SIZE: 10pt">Reclassifications</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="BACKGROUND: transparent; FONT-SIZE: 10pt">Certain reclassifications have been made to the prior years&#8217; condensed consolidated financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or cash flows.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><u><font style="FONT-SIZE: 10pt">Recent Accounting Pronouncements</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In July 2015, the <font style="BACKGROUND: transparent">Financial Accounting Standards Board (</font>FASB) issued <font style="BACKGROUND: transparent"> Accounting Standards Update (</font>ASU) No. 2015-11, &#8220;Inventory (Topic 330) Simplifying the Measurement of Inventory&#8221;, which changes the measurement from lower of cost or market to lower of cost and net realizable value. The guidance requires prospective application for reporting periods beginning after December 15, 2016 and permits adoption in an earlier period. The Company is evaluating the impact of this guidance on the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="BACKGROUND: transparent; FONT-SIZE: 10pt">In August 2014, the FASB issued ASU 2014-15 &#8220;Presentation of Financial Statements&#151;Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entity&#8217;s Ability to continue as a Going Concern&#8221;. The amendments in this update provide guidance in GAAP about management&#8217;s responsibility to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are effective for the annual period ending after December 15, 2016 and for interim periods thereafter. Early application is permitted. The Company is evaluating the effect of this updated guidance on the disclosures in the footnotes to the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="BACKGROUND: transparent; FONT-SIZE: 10pt">In May 2014, the FASB issued ASU No. 2014-09&#151;&#8220;Revenue from Contracts with Customers (Topic 606)&#8221; which amended revenue recognition guidance to clarify the principles for recognizing revenue from contracts with customers. The guidance requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The guidance also requires expanded disclosures relating to the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Additionally, qualitative and quantitative disclosures are required about customer contracts, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This accounting guidance is effective for the Company beginning in the first quarter of fiscal year 2018, using one of two prescribed retrospective methods. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016. The Company is evaluating the impact of the amended revenue recognition guidance on the Company&#8217;s consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Management has evaluated other recently issued accounting pronouncements and does not believe that any of these pronouncements will have a material impact on the Company&#8217;s consolidated financial statements.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6786577312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Property and equipment as of September 30, 2016 and December&#160;31, 2015, consist of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>September&#160;30,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Useful</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>lives</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>(UNAUDITED)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Office furniture and equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>913</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3-7&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Rental inventory</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,201</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Vehicles</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>76</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>76</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Leasehold improvements</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>104</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>104</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2-6&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Assembly equipment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7&#160;years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,419</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,432</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Less accumulated depreciation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,902)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,631)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>517</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>801</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6767161168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Stock Options Grants</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company used the Black Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions during the&#160;nine months ended September 30, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Weighted average expected term</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%"> <div>6.25 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Weighted average volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>122.73%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Weighted average risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>1.51%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="53%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="14%"> <div>0%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity Under the Option Plan</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A summary of stock option activity under all equity compensation plans for the nine months ended September 30, 2016, is presented below:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Remaining</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Aggregate</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Under</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Exercise</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Contractual</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Intrinsic</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Option</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="10%"> <div>Life</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Outstanding at January&#160;1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,685,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.46</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>804,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(329,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Outstanding at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,160,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.40</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.91 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="42%"> <div>Exercisable at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,537,048</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.45</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.23 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Status of the Company's Non-Vested Shares Under Option</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A summary of status of the Company&#8217;s non-vested share awards as of and for the nine months ended September 30, 2016, is presented below:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Non-vested&#160;Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted&#160;Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Under&#160;Option</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Grant&#160;Date&#160;Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Non-vested at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>672,155</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.31</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>804,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(523,953)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.26</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(329,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Non-vested at September 30, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>623,202</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>0.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779329840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LINE OF CREDIT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock', window );">LINE OF CREDIT</a></td>
<td class="text"><div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Company used the Black Scholes option pricing model to determine the fair value of the stock warrant, using the following assumptions:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Contractual term</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.0 years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>122.44</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.44</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of warrants, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_ScheduleOfShareBasedPaymentAwardWarrantsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6764195552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=zyxi_ZbcMember', window );">ZBC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling Interest, Ownership Percentage by Parent</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=zyxi_ZbcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=zyxi_ZbcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6794356384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BACKGROUND AND MANAGEMENT'S PLANS (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>BACKGROUND AND MANAGEMENT&#8217;S PLANS [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (loss)</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="num">$ (322)<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="num">$ (1,711)<span></span>
</td>
<td class="num">$ (2,911)<span></span>
</td>
<td class="num">$ (6,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total net revenue</a></td>
<td class="nump">$ 3,627<span></span>
</td>
<td class="nump">$ 2,667<span></span>
</td>
<td class="nump">10,390<span></span>
</td>
<td class="nump">$ 8,923<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="nump">$ 21,700<span></span>
</td>
<td class="nump">$ 39,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_IncreaseDecreaseInWorkingCapital', window );">Increase (decrease) in working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,773)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts', window );">Fixed expenses reduced by cutting administrative costs through cutting headcount and facilities rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 9,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effect of headcount reductions and facilities rent on administrative costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_EffectOfHeadcountReductionsAndFacilitiesRentOnAdministrativeCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_IncreaseDecreaseInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_IncreaseDecreaseInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6794307104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 2,419<span></span>
</td>
<td class="nump">$ 2,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(1,902)<span></span>
</td>
<td class="num">(1,631)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 913<span></span>
</td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Office furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zyxi_RentalInventoryMember', window );">Rental inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 1,201<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Assembly equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and Equipment, Gross</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and Equipment, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=zyxi_RentalInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=zyxi_RentalInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6782854864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNING (LOSS) PER SHARE (Details Textual) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from</a></td>
<td class="nump">2,160,250<span></span>
</td>
<td class="nump">1,507,750<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779097808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Fair value of stock option grants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average expected term</a></td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">122.73%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">1.51%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6780846144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Details 1)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Summary of stock option activity under the option Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Under Option, Outstanding beginning balance</a></td>
<td class="nump">1,685,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares under option, granted</a></td>
<td class="nump">804,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares under option, Exercised</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares Under Option, Forfeited</a></td>
<td class="num">(329,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Under Option, Outstanding ending balance</a></td>
<td class="nump">2,160,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares Under Option, Exercisable ending balance</a></td>
<td class="nump">1,537,048<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding beginning balance | $ / shares</a></td>
<td class="nump">$ 0.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted | $ / shares</a></td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited | $ / shares</a></td>
<td class="nump">0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding ending balance | $ / shares</a></td>
<td class="nump">0.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable ending balance | $ / shares</a></td>
<td class="nump">$ 0.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life, Outstanding</a></td>
<td class="text">6 years 10 months 28 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable</a></td>
<td class="text">6 years 2 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6785518144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Details 2)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2016 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Summary of status of the Company's non-vested share awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Non-vested Shares Under Option at January 1, 2016 | shares</a></td>
<td class="nump">672,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Non-vested Shares Under Option, granted | shares</a></td>
<td class="nump">804,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Non-vested Shares Under Option, Vested | shares</a></td>
<td class="num">(523,953)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Non-vested Shares Under Option, Forfeited | shares</a></td>
<td class="num">(329,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Non-vested Under Option at September 30, 2016 | shares</a></td>
<td class="nump">623,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value at January 1, 2016 | $ / shares</a></td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted | $ / shares</a></td>
<td class="nump">0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Vested | $ / shares</a></td>
<td class="nump">0.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Forfeited | $ / shares</a></td>
<td class="nump">0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value at September 30, 2016 | $ / shares</a></td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6785685680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION PLANS (Details Textual) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Employee stock-based compensation expense</a></td>
<td class="nump">$ 171<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares under option, granted</a></td>
<td class="nump">804,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted</a></td>
<td class="nump">$ 0.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to stock options</a></td>
<td class="nump">$ 252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of unrecognized compensation expense related to stock options</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</a></td>
<td class="text">Dec. 31,  2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=zyxi_TwoThousandAndFiveStockOptionPlanMember', window );">Two Thousand And Five Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=zyxi_TwoThousandAndFiveStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=zyxi_TwoThousandAndFiveStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6734302096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid (including interest and penalties)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6785756496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LINE OF CREDIT (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Contractual term</a></td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">122.73%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.51%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Contractual term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">122.44%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">1.44%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6785254768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LINE OF CREDIT (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Date of Maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 19,  2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPayment', window );">Obligation to reduce loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate', window );">Extended date of forbearance</a></td>
<td class="text">Sep. 29,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost', window );">Class Of Stock Warrants Or Rights Warrants Issuance Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">976<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate under the Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate', window );">Additional default interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Fees include in effective interest rate under the credit agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAbstract', window );"><strong>Line of Credit Facility [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended', window );">Aggregate periodic cap payment suspended</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments of both interest and principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Line-of-Credit Arrangement<br> -URI http://asc.fasb.org/extlink&amp;oid=6517033<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of cost incurred in issuance of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_ClassOfStockWarrantsOrRightsWarrantsIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility extended expiration maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_LineOfCreditFacilityExtendedExpirationMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility periodic interest payment, suspended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_LineOfCreditFacilityPeriodicInterestPaymentSuspended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of additional default interest rate in effective interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_PortionOfAdditionalDefaultInterestRateInEffectiveInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6786500416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFERRED INSURANCE REIMBURSEMENT (Details Textual) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities', window );">Proceeds from Insurance Settlement, Operating Activities</a></td>
<td class="nump">$ 880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Liability for Claims and Claims Adjustment Expense, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 880<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14764-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670824&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the amounts received by the insured under the terms of an insurance contract settlement. This element pertains only to insurance proceeds related to operating activities. It excludes insurance settlements classified as investing cash flows, for example, insurance settlements related to fixed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInsuranceSettlementOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6785491056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CAPITAL LEASES AND OTHER OBLIGATIONS (Details Textual)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember', window );">Lease Termination Agreement And New Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease termination date</a></td>
<td class="text">Dec. 31,  2018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_ImputedInterestRateOnCapitalLease', window );">Imputed interest rate on lease</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum | Lease Termination Agreement And New Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_FixedRentalPaymentsForEachMonth', window );">Fixed rental payments for each month</a></td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_ImputedInterestRateOnCapitalLease', window );">Imputed interest rate on lease</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum | Lease Termination Agreement And New Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_zyxi_FixedRentalPaymentsForEachMonth', window );">Fixed rental payments for each month</a></td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Assembly Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsGross', window );">Cost of assets under capital lease</a></td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation', window );">Accumulated depreciation</a></td>
<td class="nump">$ 264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasedAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45014-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasedAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total charge for the use of long-lived depreciable assets subject to a lease meeting the criteria for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6455314&amp;loc=d3e45014-112735<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_FixedRentalPaymentsForEachMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed rental payments for each month.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_FixedRentalPaymentsForEachMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_zyxi_ImputedInterestRateOnCapitalLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Imputed interest rate on capital lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">zyxi_ImputedInterestRateOnCapitalLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>zyxi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=zyxi_LeaseTerminationAgreementAndNewLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6779463392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS (Details Textual)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember', window );">Raw materials | Electrotherapy products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Net Accounts Receivable | Credit Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration Risk, Percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_CostOfGoodsProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>58
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M H6L H6L H6L H6L!0I9"Q2R%BAD+5#(6J"0M?@@*^O^#!^] E!+ P04
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M5D[&=)Y3FM/K%9VPV0VCL_?C9!?^>L.Z'>+?.CX;3-M%A14,W&W2R+3<])E
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M_,(N7$+@.#YG$0Q65] [G73N^\>)S>(!^>J5Y+_B/J"^-M1>7Z XS 4?Z[2
M#HC#^AEL$=7^@7%/!142*'T06H-%.&+8>=PA2A))#)@C1FCGX(4![-GU?HQP
M(6UNE^$PS]P?,\DBB:#?_TY/EXSL=C#;(Y3N;T\#<5@AI;#D:ST!O;WI*KTY
M+CAV(JW?"]Z%1%VPN)H$V$'G383,L!PR!W 'Q2'%N=(!DA2E&96HC'2AE&#:
MR @J!$?44.XB>D/3IIC2!_.E/.9[W&T.G(\Y8Q\"HV)GZD+TYG@-;%&]*9OC
MGM*^C1>T^9! 1Z.JHMTG2@K.L!/KH+7H9R_1!T?HXQ#M6$$I)'G6_N8BI!K
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M-)80RX 7@IEZ.Y<;XZ2=+*[3P@_=-IUJ!_TE24>;W1",AF V^-&F(1P-X<(
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MHNK(JPCA2(3S=F(SUN)RFP<855QV4]&G^KS7 T[ZZ?::K]#\'U!+ P04
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MZ9_=\"9V1YE9 $8!F 3)0]X?>7_B/?^A (X">!>$#P7!* CN@NBA(!P%X20
ML-_[8:_ZG=XBCK*4DLYB+9+MYZT$3F40$=EB?30Z?$"QUTRL?F:)FSJ?,LZ(
M@![9:(AG0G(- 29DJR&^"=EI"#0A>PT))L01E1K+!;=RX5 N4/6AGB(:RAV0
MID>^03?R3%2N4KX1V:I($/O !.VT;$D, Q.UUZ@X>5ZW/ZO;5^N.]!R#(O>U
MBD#D 1\^3P1GB:":*#8EVD ED3??WH'9+C&+/H*9CT#UD1A]!&J.P&AC 5ET
M$<Y<A(H+SW6--D+UVWK0".T6H44KT<Q*I%DQ=NPFTEL?&)LQCYZWOHJ$KA<;
M6U_+EB2QN?6C_VW]>%9XK!4.C+T?/^]]1SE76W3!OQ"]E VS#H2+([H_3\^$
M<"S"N2^B;PIQET^3"I^Y'$9B3(?K;9APTMXNZ^D?0_8/4$L#!!0    ( $QG
M;DGD1:AYO (  '8*   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULE9;!
M;J,P$(9?!7%O80P!4A&DAM5J][!2U</NV4F<!!5PUG::[MNOC0FQ+5>AEX#-
M/[^_(68\Y86R-WXD1 0?7=OS57@4XO0417Q[)!WFC_1$>OED3UF'A1RR0\1/
MC.#=$-2U$8KC+.IPTX=5.<R]L*JD9]$V/7EA 3]W'6;_UJ2EEU4(X77BM3D<
MA9J(JC*:XG9-1WK>T#Y@9+\*G^&IAEQ)!L7OAERX<1\H^ VE;VKP<[<*8\5
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MD="Z$-[ZV*0KE1*'P_Q EE=:?0!02P,$%     @ 3&=N29;Q6^NB 0  L0,
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M2&A="#_[V*0KE1*'P_) UE=:_0502P,$%     @ 3&=N2<OL*^VA 0  L0,
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MB836A?#.QR9=J90X')8'LK[2ZA]02P,$%     @ 3&=N2?-5^3NC 0  L0,
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MG!2&+"!.$;2' D$.[9F65A(1DJN0E)7^??F0%#L(FHNXNYJ9G>6CG-"\V![
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M7595&HF"T.[#2H@'>':326)A>X+M-/#WZTL26H1V>8EG)N><.>-+,:)YL1V
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M&<XY<\:7;$#]9AH 2SZ4;,V1-M9V!\9,T8#BY@H[:-V?"K7BUJ6Z9J;3P,M
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M[V(=KU1,+';3 YE?:?X?4$L#!!0    ( $QG;DF B _,Q0$  )8$   9
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M*6RS8I$2JJI]J!3EH7WVPG!1?*&V6=*_KR] V JI+W@\G'/F#!Y3S%*]Z1[
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MJL:F=%X8DU2% 38JGPOUZ(V#BEZD[B:JS^TS8 >2M<.K-CZM^7]02P,$%
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M?&[%"[U\)V,-F2+<TI8/W\'VS 7MKB%AT.$/_6SZX7G1OQ3%&.8/@&, G )
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M&;J*/:6"R.SB!UG:4;:HTZ E>Z%>"U6S;MKT0-#3M0>=&N'Z'U!+ P04
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MONJO4#\PLKD]"..KE/X#4$L#!!0    ( $QG;DD!S)D=7P(  /@(   9
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M/@[4HT?@88A\KD0N0QD_!=-$]D0JB^:X<?H$*P/ 6S_]D,M%$$="OH"84;X
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M@["G.&D&1AK>I0:\R>;  R1$<+0D6Y T%-,DRR+Q!,N"<)A7&\&@&+4R6)0
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M(RF^%(?@CA9&,+,5B!94, "/GT<4C2 M9$_@@+9"$.:!YG&!%W#AJDJ0CZV
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M -H4BPDG9ST.=*) ^)AFSRGROED*8UIEBKJ(AV_C44#Q7]&6'.XUMINR89?
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M19)9'Y#7KNTU75:$MMZQZ'05-('A)36Q]%QYR%K)@*LI]!K%YG53DEB0BX#
MV9^!KP9*4$J/8BP<C7ZV(*QA7#,$8:@=@20=67HTEP0VS-%,PA6:RE8] CB
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M;VYT96YT7U1Y<&5S72YX;6Q02P$"% ,4    " !,9VY)2'4%[L4    K @
M"P              @ 'G 0  7W)E;',O+G)E;'-02P$"% ,4    " !,9VY)
MXPZ8X8H!   6%@  &@              @ '5 @  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " !,9VY)K(E91LH"   /"@  $
M        @ &7!   9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $QG;DG.
M//'V/@$  &D#   1              "  8\'  !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( $QG;DF97)PC$ 8  )PG   3              "  ?P(
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 3&=N2<XXE?5& @
M>@H   T              ( !/0\  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" !,9VY)A@KQ$[(#   \#   #P              @ &N$0  >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ 3&=N2;%I],]3 @  \P<  !@
M ( !C14  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $QG
M;DG5]JM3]@,  $T3   8              "  188  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " !,9VY)LFFT\!8"  !.!P  &
M        @ %"'   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ 3&=N2=*&.CT0!   M1,  !@              ( !CAX  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( $QG;DF4^[/Y6P(  #T(   8
M              "  =0B  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " !,9VY)Y$6H>;P"  !V"@  &               @ %E)0  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 3&=N20J/<7.@ 0
ML0,  !@              ( !5R@  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( $QG;DGL2XN3HP$  +$#   8              "  2TJ
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !,9VY)EO%;
MZZ(!  "Q P  &               @ $&+   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ 3&=N2?TT\X>B 0  L0,  !D
M ( !WBT  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !,
M9VY)R^PK[:$!  "Q P  &0              @ &W+P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( $QG;DE7#2%MH@$  +$#   9
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M970Q-BYX;6Q02P$"% ,4    " !,9VY)Y%L-E:$!  "Q P  &0
M    @ '+.@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M $QG;DEGB=1UO $  'L$   9              "  :,\  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ 3&=N2:>04_:D 0  L0,  !D
M             ( !ECX  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " !,9VY)5K(C9[\!  ![!   &0              @ %Q0   >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( $QG;DG-!K(4I0$
M +$#   9              "  6="  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ 3&=N28"(#\S% 0  E@0  !D              ( !
M0T0  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " !,9VY)
M>--<T[ "  #0"0  &0              @ $_1@  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( $QG;DG.V*(@, ,  (D/   9
M      "  29)  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ 3&=N23@G)[>] 0  $P0  !D              ( !C4P  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !,9VY) GBWL\P!  #@!
M&0              @ &!3@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( $QG;DD<6S)AC (  &D)   9              "  810  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 3&=N28%S5GM#
M @  9@<  !D              ( !1U,  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " !,9VY)<B2MSD8"   O!P  &0
M@ '!50  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $QG
M;DF^'[BU[ $  %X%   9              "  3Y8  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ 3&=N25,E,F7] 0  >P8  !D
M         ( !85H  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " !,9VY)73KG?,P"   4"P  &0              @ &57   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $QG;DGK^SQ8SP$  *$$
M   9              "  9A?  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ 3&=N20',F1U? @  ^ @  !D              ( !GF$
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !,9VY)096%
M*^T!  "-!0  &0              @ $T9   >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( $QG;DFUAGG/Q"D  %.J   4
M  "  5AF  !X;"]S:&%R9613=')I;F=S+GAM;%!+!08     +  L .8+  !.
%D      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>58</ContextCount>
  <ElementCount>152</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>20</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>101 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>105 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CondensedConsolidatedStatementOfStockholdersDeficit</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>107 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatements</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>108 - Disclosure - BACKGROUND AND MANAGEMENT'S PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/BackgroundAndManagementsPlans</Role>
      <ShortName>BACKGROUND AND MANAGEMENT'S PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>109 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>110 - Disclosure - EARNING (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/EarningLossPerShare</Role>
      <ShortName>EARNING (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>111 - Disclosure - STOCK-BASED COMPENSATION PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/StockbasedCompensationPlans</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>112 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>113 - Disclosure - LINE OF CREDIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/LineOfCredit</Role>
      <ShortName>LINE OF CREDIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>114 - Disclosure - DEFERRED INSURANCE REIMBURSEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/DeferredInsuranceReimbursement</Role>
      <ShortName>DEFERRED INSURANCE REIMBURSEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>115 - Disclosure - CAPITAL LEASES AND OTHER OBLIGATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CapitalLeasesAndOtherObligations</Role>
      <ShortName>CAPITAL LEASES AND OTHER OBLIGATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>116 - Disclosure - CONCENTRATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/Concentrations</Role>
      <ShortName>CONCENTRATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>117 - Disclosure - LITIGATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/Litigation</Role>
      <ShortName>LITIGATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>118 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>119 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/PropertyAndEquipment</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>120 - Disclosure - STOCK-BASED COMPENSATION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/StockbasedCompensationPlansTables</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/StockbasedCompensationPlans</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>121 - Disclosure - LINE OF CREDIT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/LineOfCreditTables</Role>
      <ShortName>LINE OF CREDIT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/LineOfCredit</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>122 - Disclosure - ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsDetailsTextual</Role>
      <ShortName>ORGANIZATION, NATURE OF BUSINESS AND UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/OrganizationNatureOfBusinessAndUnauditedCondensedConsolidatedFinancialStatementsPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>123 - Disclosure - BACKGROUND AND MANAGEMENT'S PLANS (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/BackgroundAndManagementsPlansDetailsTextual</Role>
      <ShortName>BACKGROUND AND MANAGEMENT'S PLANS (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/BackgroundAndManagementsPlans</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>124 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>125 - Disclosure - EARNING (LOSS) PER SHARE (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/EarningLossPerShareDetailsTextual</Role>
      <ShortName>EARNING (LOSS) PER SHARE (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/EarningLossPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>126 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/StockbasedCompensationPlansDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/StockbasedCompensationPlansTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>127 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/StockbasedCompensationPlansDetails1</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/StockbasedCompensationPlansTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>128 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/StockbasedCompensationPlansDetails2</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/StockbasedCompensationPlansTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>129 - Disclosure - STOCK-BASED COMPENSATION PLANS (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/StockbasedCompensationPlansDetailsTextual</Role>
      <ShortName>STOCK-BASED COMPENSATION PLANS (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/StockbasedCompensationPlansTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>130 - Disclosure - INCOME TAXES (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/IncomeTaxesDetailsTextual</Role>
      <ShortName>INCOME TAXES (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>131 - Disclosure - LINE OF CREDIT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/LineOfCreditDetails</Role>
      <ShortName>LINE OF CREDIT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/LineOfCreditTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>132 - Disclosure - LINE OF CREDIT (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/LineOfCreditDetailsTextual</Role>
      <ShortName>LINE OF CREDIT (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/LineOfCreditTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>133 - Disclosure - DEFERRED INSURANCE REIMBURSEMENT (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/DeferredInsuranceReimbursementDetailsTextual</Role>
      <ShortName>DEFERRED INSURANCE REIMBURSEMENT (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/DeferredInsuranceReimbursement</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>134 - Disclosure - CAPITAL LEASES AND OTHER OBLIGATIONS (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/CapitalLeasesAndOtherObligationsDetailsTextual</Role>
      <ShortName>CAPITAL LEASES AND OTHER OBLIGATIONS (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/CapitalLeasesAndOtherObligations</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="zyxi-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>135 - Disclosure - CONCENTRATIONS (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/ConcentrationsDetailsTextual</Role>
      <ShortName>CONCENTRATIONS (Details Textual)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.zynexmed.com/role/Concentrations</ParentRole>
      <Position>35</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>zyxi-20160930.xml</File>
    <File>zyxi-20160930.xsd</File>
    <File>zyxi-20160930_cal.xml</File>
    <File>zyxi-20160930_def.xml</File>
    <File>zyxi-20160930_lab.xml</File>
    <File>zyxi-20160930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0001144204-16-133951-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001144204-16-133951-xbrl.zip
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M?R!-\O+RLJ_#""X?85^SQZ39#.8Y41G, >/\X^3NBK3W%?^WUT?'-([QWP3
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M1NM@$OBAZ+ZL0/*\*KIS+KKB;"M LHAFN85$LO/6LB$)TS56),L*>?%BKM5
M6427XI4^<D!)URJZ>;&HPT;&!!A- X93G^C)]%;-*\'X[5^/FG!A=6I<T2?5
M/.>]GF:]UD3%*]Y,)P:[@ID5A_,K*2V ;E$Z^<+2$W,; RS2CSWT47E!TSFY
MY#D)[O,AZL8@ZB8A6E@0BT.D; *B3@RB3@JB19JGAXG7_4U U(Y!U$Y!M$A=
M]+ A4$&(>(>T\^&0:N[-\#>JZKQ0^!W%:INH!4$TPYQ^T:([8, ;*YF&C5GQ
M"Y3Y/+9;6+8*2=KVX2\'P*V@NXBG%^D:0#=<KG+1C7D7V3U0?G5F(GDIB7?A
M.0 W"#"<V7C%OQ)1O"+=T).DR.O,I'32GM$"V-?%--9PMGQ,<S3ID5*P4TTI
MF":BLJ!3S+#GU'I(YA<BWA&6O].1H9GKKF%>.?R9&,1VF+4<Y(I4TM_!RG%/
M&T^G+L<3<-[X(<%ZF.;5_E):,\GQVUG'#:":V_1EFZC&5C5\=#WT\MK%I.[
M;6TE2T(OQWU>#[U$D=^) R/S6 ?\;5)^Z&OI@S&>__[%OY\[>.%BDTI>B3/E
M*-4>J2P0MX?ZW(9AN?T/.C--.S>"^AI,7::ED%^$35E'WPS $]<Q51F,X'NJ
M>0XWD<]?,:V!ZN*.RWCBN9QV-\/T)0&@K)=>W2))MXD:;G.2P! QV+>QE2X#
MUFT0H$"0)E$O;@X!P*?O]S=/ -.T-35(59_)*UPY'SBO!-U,ZF,A.$J%?L'Z
MY-6L2P7-5P,^^^%83_:3:?2(?Y0\>%$=W<_S_!4S3MBE)>*^&7*IR#KU"]Q/
M.4Q9/QL O#3:)*_*##QW9#O&7^D4HY25]?!B/XQLCZF@+-"/A?T5Y=.B)$W(
M</A\K8XSA'6_2&YK*QUC*AO3TD@);&N(<YTSX.T56 O/ UI*MZFTFQVE!(R3
M )6]G6+9Q8*TQ:V6?H%J0R#S>PE]5CJ\91/DPG:&E =WPKVZ A/T"NR)5$&^
M#0"^ V:92Y&#%8R?RC-+;(+4E;CS5^IH!J.WCJ$5+UBO+%'DL'NP$4(MPF-I
M\K&E=&)Q$A;:@\6O+K?[2Y"R/)Q*)V>&""B9IL6+1W:68<^2$:O,-I]'Q\+E
M+6&;;T8>+DV^Q_QI'Y>>]HZ.50/]-4RK<8 XGFIB'E5[>=8\5/9^N3WXI]+Z
MTCX\2Y%LN["733Y_;?!Z14$0E!7(U^;D:W]I=TJDW@J@;W#O7L),AL4,;;GV
M@LIA3J1U,SLT">T&F2HYD;($78K?OM\<N)EWL<2-E#//P5M*7%T(?S%^8300
M>2N8]X<%S/OT%:JE0"I[$\S?AZLJL.(%=KJ]\K9'03PV2+YE_9[# D%?I=?I
MM[J'&R'3 K]GC>WX.V5 ^F0L9H5M5" >W&MWCGJ=\@1)%N1E4^?:YM<C:,IZ
M+8%@1RN&%3:/S&8X++7)N6N%4; +U7 RE'@1&J8+XBYR"],NS.;QV1HK;H*R
MRNK.X4Y0W!BQ%^WS1=&?HP*A](-^6^FE56KY0&^,-DLRWD)R=8HS7#H2OQ54
M=L9@<[=H@9#]0;O3CM?R>P<,-I=<O=5#B+MCL-+.*#>A(XK[#4L%9<O%:Z9.
MY7ABVE,:E!;*AB9<-3XQ>[!%!_KP=TRWOK;=?U+7+TKT%]7CSM\2;)F32-ON
M)1.EM@+^UF@FUA"T?*RVTPH!KZ/#O5]N>__< I4R 4Z3*W%[]]1S<N\7W=%G
MVWS& !I_Q4_U3^1=)7^9/;G/JSO>2=\*S0(RC<@9?70O+>8Z'F["X)[2'6PO
M<5?!>*;17:4-8]A.5#-/WZW""-6^HL3P6PKVK!4,:!- %!]BX I&.+<6IV64
M@;:R .TN+]9[T.\EU[4@Z(GK,7X!H)MA5!_FC Y5STS0[M(*J1?_>N-$:"\@
M@JA8W/%OT:R%1Q$^P"IJ!B^F<T'GLO_<PCCKDZ*3RP]*.X<?YJ!0!'O!/(;F
M*^:E974[K[)[JLA7 1AF;CJ+PD)^0:,;YPXMA-!@#=,.3U73Q.OA_G/,?S!+
M=W>^M0^S4"D0.DYWDUD/ML2.742:Z*XP)]&]QT"MZ3/Q\4YLO4(DOWU17XVQ
M-XYSY1T:9\B,I;!P3DIPNQ>[%;<*ED48.9F*M;S1T6[UH^0PY6@QQZ8F*\W4
M#ZW< 6/>. @83T"P4?UWVX1A</99"3U'//GLEEC++(;-6-)%%Y]!*BG[[78W
M70YSLQAOE,AW!OM^X= %2K!\$A_EZL R4A2+8KL5'CXSL(:'I6^!O,HB\]+7
MJQOGX#B^"5D?+Y:75@K!9SR55"V-WP5>7IPI>1?(>I%,7A::1>67P$;W''SP
MGKJNR2F740MN 3X=/Z"8QB>OM$JJ&=WR,"46Z,)XI;JX-Q.KF7:N:J,O /FH
M$//R6X&8.&%8@IF>8,]QOK'T:_K"?PZ_B[.X^"5BO> FSD)-GB)73EY$]RA:
M_AQ<$W2YQ/L<6'\GDAPW5KRT4B'*?#&LHGAT<Z5DST<C%[1-(%)\07H+$.&E
M1)1E\0B-T-AO.D@AZK(MW>-LYS4KZ!XD+]7, W412NR*PH,@>$V^A4>4NN+-
MD^D7]=^VPZ77S*T[ON.V08&\@-]!=RX%UL!LMJ.FA5Z?,$I1OT=N8"%;^%NL
M+R;0  M5H.&;4+SI*4ZF)]321F/5X05?O]U[DXEI4&?FP9Q1YA!VD0DJ#HYB
M;O$B_$N@5>)F5@5IM<B6Y,*ENS52I6HD:[ST";NC&C6>,>ME*3+YX<Q2B-1>
M9!%RAE)VQ5!5HM*B^&2H<)>ADDZ-XS-;\P)+9GE;MMW&@@?-__GI4WJL^!P#
M^%+G03!37;[I?+L-PGH(6%(Q2V*T+%3"L.M*=]' ?>;AAH-FZZC9:24Q2PR=
M-?>%P335_"=5G0OX9OELI7:[)V9/SIL:=O[,P;'):G,?[/WR/YVLF6/#QN<^
MY]79[N@3+X]DN7C7<85I^WN__.N?U^?_()?7IV+VK(%G)S[E#&Y>6CI]_3N=
MKC#S(6P;^-]A]Z"+H?VY0\?G]H]PHB59G=..]GYI!E<>%PT]B_J%88**@I^>
M;&<%Q#NMO5_NQQC[=,@=G6 DWWHBZ%^KUC1.A\0\<3 >'!7SK>^GXT?;7 $
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MO5=NI'VG_*4X72;B@)K;T. 3&&!@\0SD?3) 5UQS#'Y=.."$K(AD?&F!3;6
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M%$##<5XHP(Y,(!;(LJWFGYYJ&D.#ZDGT]RN^\VLBH2XMOC@6L!^!K>B.&*'
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MQ(/](Z4:_=&KN9Y2+NY8+G97E(N5N'/3E)NJ<D[>=H^Z_ 0YWE6O4DY>%<,
MNQ6[:S-&EN2(0UPEBE7HK&!ULF66/.AU^HU6]U#N*[FOJFC/U&L[@:/7DSMI
MNY<X-N7HM3N[=?2JO9Y2,NY:,B[KZ>V0>E5R]:JXK>*NWB?>4CSZF'@G_D%_
M/TW?UX,SZYF 5WY,3?UCXT=&'6/XXPQ#A&.%F X(\\9CU9D2>PB#JZ['\"]W
M1,FI/9ZHEE]H[["M]#\#0]I6\YDREP)O8^\DHKZHCLZ(RM]2+9T,;8>_;1D6
M)6.89<0(M71X8=8/;A"#D8E#&19GU,DC->V7XXTO!-^-E]=GY]? ^ZW]'C:Z
MKPL3B?=0FHWVB&H:3];/>Z*TY5Z9TY DC9!"?UR>/?R&/\?E(-_FP60Q&H:/
M'[9^"&4N"*NKP>T]S*'9IJE.&,BA&Q!0%U<W?QR39X,9,-@>T:B)U3\UPWKZ
M>:\E/D]47?<_KQE.JE(=T%Y/%AQ?B%N=NP-<AY(R0ENVFWL#"QNVUPV1?N\-
MZ-Y6&P@IE5?8O&^GP+AHCQ721':%>!>KSJOC130YPUZ&X:<+U8AQA*Q 7X$#
MW<UE[6:)_\B6BQ6@)[+N?"W0K4(Z[CM(#SSHMQM*;V<'1W(W[&PW5*M<XXYS
M9#M*[5A"IG^5:RW(2LNU0+=*!5PJ?55;5EJN!;JRTK*LM%Q#W;Q=3_YW<2(C
M3;1*HULEU;Q)UV,I^?6AU^XTCGJ=G94/DMS[7A3Q9AD9%+$,FE9/$6_729;E
M !>B*ZL$K460.B3GRW* [WH'R'* J<"YO!5;/9M@E\?LU;DV746C45:KJ/^M
MZ=V>U[<[C7:K+?>4W%,5O!=8JZVTRY.%*NXC>1-PPS<!0^@J =& W_W+NMT7
MNT5(1BI8=9.)8[\:8]6EYI3\+7/P%2\UMGOM)&4 ),]RJ&8_6<9?8%%J  >U
MF(KIW(2^XM^4.-14T=QT;8#!UKX3FZ=[,X <+- 7PS3)(SX5CF(_ X(J>?'O
M@!!57/T@$P#-UOD=R 2.9:+82R+([_7O+V;6_ ]<//%;?(^VHU.'7[D+4KY1
M$!SCC;_/A#_3--6I[;G'0^.5ZI\+7=43#DSXEQZ"&?_3B?X,I,5/GSS6?%+5
MR?&9P3339IY#;X:GL46\$VMW:C.7\8M5)RJC^JTZ'5/+90_TU3TQ84E_^<__
M^,__(.2G8+A[;41USX3!9EX:X%W6>^0#D?7/,-6;SS5@S!N+[QX0PG!T8"O+
MA0]W=/CSWFU+^0;_1]Y_L%M'WSHM_O<>,718>55S#?U;NZ_L_9+:M>'NF[CP
MCZ_XQ,*3%(LTQ!<-V&[ **342Y\+A4"E9.!#3*YX#/<O?'%BJK >L+RV"3.+
MC4PFCH'<2<:V3DW<YCIUJ3/&N\GXSE U'/*,"?WB^G,D L@39G$!H3V&[_.'
M;=.T7WCEYH@=B.XY_@.1!BER]UG><Z[ />>8.19<SUA\\WD>+-D7H2>OQZKG
MVN$0_=)O0\^%I_[7\#KR&EZ)@>%M7[Y*8-M;?/EJQ=C>3E&2D=UE-NX?:7L9
M#7"-6]Z@C6OG.V\]/ZD:H8*JW*!:?>/O*&;4S2S-UJM&#6XI##>9^E)$&#[;
MX,D:IN%.:W<$6D])6,43WXV*NA(/[S-DF=)N[_<[/^QZ-:4@V[55YQCL>W/H
M4$H,9%O*7.)@)86Z&3SUE&I5/ JJE@&WG%3;[RD[DVG2.-N1<79F/!LZM70R
M-:A9O^3D>DHN:8^5*KE:TA0+_RZ8?5"?X]!RSR^+G([&#UWCHP\T%X2E.UW[
M1+0M3T37SL%(EG&.G6.J_BH1#PO;$=4T"?W3PR\2&1$34[58#8HWRP/,I& M
MJU#SD2S4/%\9937YDF>1%<5MF;*/M494+N(;0/1=5=;.R)T.JVG+I:L2;G+_
M;3E45B4Z2'.G1KC)G?H6-671'A1R&2N]C!D&SWMO%E)-W*04E?:.7.1:RMB<
MW2I[;KV!191*LQ:KF&'NW-&Q:EB&]237KMIKE[<#GYX<^K1:,M_;6$=I\]0&
MN?>^644/.[F&=5[#\U?J: 9[O_*V)LN88?.<VI;KJ)KKJ:9<O6JO7LXFO(2%
M-"QF:.]V':754QOD9)?7O.TLF_F^BV6^=0Q-VDVU7^4,R^K*&,J%K?W"YFQ?
MV6![/8.KXG=GLVRP&\]EKFKIO+A:V&$[HIALM5T+=*M0W?L=U!M6&@>'O4:[
MM[.6G'(_[&P_U+Q16+EEM[M2(VRYM>'VMT#&PM=8(D@!6%6#H!;DD)NA7E[4
MYNIX9'E1OV+):ME1L>KH5JF[<:6;PAVVNM@@L78++/FY9F[,IGL;[JX]D.3A
MLGBXDJ:77-[ZJ=QJX"O9N5Z>Q';/8X+DPYWY$E7T*:N(;DT%6XGE32LIR"3[
M2O:5["O95RYOG=&MN722[/SNO8;MGC]<V,Z0&O($8@ZZRV5H5GS]MT^0<D,J
MFQ&&'SKM(SRR^"AWP'O< 45/-4IC_(J?>W1VEI]5[7U0'71K:O)5>WG?NIBK
ME:*76^+=>T$[O<LRVSA#^LE+R(@.R C=]AYQ_NI0I IYK4L2[(U> F@W@&3R
M+HS<51OQR-[99FKM=^4^>A-GB ?[1THUVLM7<SVE7-RQ7.RN*!<K<>>F*3=5
MY9R\[1YU^0ERO*M>I9R\*H8!=BMVUV:,+,D1A[A*%*O06<'J9,LL>=#K]!NM
M[J'<5W)?5=&>J==V D>O)W?2=B]Q;,K1:W=VZ^A5>SVE9-RU9%S6T]LA]:KD
MZE5Q6\5=O4^\I7CT,?%.U@=.+^XP/=J.3AW>,SPH:(B0'6/+\L^$/],TU:GM
MN<=#XY7JGPOU&A?^9_B7'OSU*?ZG$_T9@/_3)X\UGU1U<GROC:CNF?1FR)L&
MG:B,ZJ?V>$(MIF+AV'O7UKZ+&K)LH+G&L^%.'W"8!_KJGICPXR__^1__^1^$
M_#0[XK5M/5/F4IT/G?TVT6S+A0]W=/CSWFU+^0;_1U_RP6X=?>NT^-][Q-!_
MWKM080#]6[O?V?O%7\: E&%S]XD+__A;3_ *>> <=TW];O(-\44#W%?'&)($
M5P3#K=J8/M9C7OPS<?>R^6/3DPV!J,$$J1?Y0P/"O/%8=:;$'L)SJNLQ_,L=
M48*+KUI^'<+#MM+_#/O5MIIB)0G#I23JB^KHC*C\+=72R=!V^-N685$RAME'
MC%!+AQ=FPP0-8C R<2C#VI4Z>:2F_7+,281@A\Q:,KVXL+J\/CM'SFCM]PP0
M/FO1,"4_-@F[> ^%_6B/J*;Q9/V\)RI_ELJ_)$DCI- ?EV</O^'/<34A)%IZ
M[\4>/T29YJLDD.57@]M[F$.S35.=,!#3-R"_+ZYN_C@FSP8S8+!"PFZ-:%N5
MRJ3V>K(>^T+<ZMP\X3J4E!':LAO?&UC8L/MPB/1[[\_WMKID2*F\PN9]._77
M1?>PD":R:<:[6'5>/#"BR1FV>@P_7:A&C"-D@?[U9'TULDF6$O^1+1>KST]D
M6?Y:H%N%;.5WD#UYT&\WE-[.SM7D;MC9;JA6-<L=IQ!WE-JQA,R.*]=:D(6H
M:X%NE>K;5/HFNRQ$70MT92%J68BZAKIYNY[\[^)$1IIHE4:W2JIYDZ['4O+K
M0Z_=:1SU.CNKKB2Y][THXLTR,BAB&32MGB+>KI,LJR4N1%<645J+('6XNR"K
M);[K'2"K):8"Y_+2</5L@ET>LU?G5GD5C499S*/^E\IW>U[?[C3:K;;<4W)/
M5?#:9*VVTBY/%JJXC][-1<DBUQIG+D7BHX_IRY4#QU&M)SJFEGLRC1ZY5:?X
MU0 OV6$6*L\]'3#FC<4]S//7"=5@_@?JC)45+E!V]WZY/?AGYTL,N8V!ETF(
MF5NFLS.=+#/3[[8)PYBP"G>J2U>@2&^/>)8AWIAX#MTC.M4,V)7LYSV@EK+?
M;O<[*7)M%HF-TNW.8-\O'$HO,3<96'E%JATLIEIKOZ7TE U1+0N%K?#:&>QV
MG5KZBC3K+Z!9"VBV82:+0Y\FUZ6EV6/ZH+Z>&4PS;0;0K7--^["JU[29\1<]
M)H=X!9@HRG[+L+9W"_PQ4#%YMXL_''Q,ZET/O[V\/KWY<DX>!O\XO^>*R@M5
M5N+^<3A-I6Z=%[TQG3M._.U*8/8PHF3BV'B;V;;X97B#;R:P5UYA5H,1AVIH
MV/ 8!UZ4ASV(=^>IJHW@69!AQIA,X-^V3KB2)3#.O.OXCR#O"/P#8@-D$(QB
MN(R /4C1%*&QJ8F##U!_[Q/7AE>).IF8AL9MK>#6_M S33*$7:^:O*[.?K12
M#W-@F#_=B\JR:1:8MC^FEN+'QH\,=_F/,_8KIVTKL=P_<*!Q>3GD[@AT *]
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MCZBJ^R6A&5:=$D "LE?8X.X!YFW >S"<JML-OSB7*'^:S/KV&PY';4CM(<%
M("6F7X!5M+&+SQ=O-<P;4@%UO"</?'>EG95;GJ2M%93.GR$2_"H*#8OBS?A4
MK R8*-ULB1!36+KH:K")FJJ)U,UM<NQJDN AD8MK8"$R<(YXR7Z?3-_I-%E-
M[6K0B'4Q.)Y!:J5$YB52;1,W)Q*9J7X"ZLG-P\/-%R3)*V&V:>AA:NK5^<5#
MXGOLNM$,#Q.5W@^)!-C4(<.I:AJ/CM%@JL6:/+TZ>82@X!&"/]/#S6T6 '=B
MIO"'O7C$/2>2'IVN)%)S8\>CX0G*[>#L[/+ZUX@2F*H;?.D3(9:]V^[N]WL(
M?/!( &;\-8&18>UAAC=/2';M20A4IY.GWS)$:XJ^:7;-('%[$_G:V:=0[Y2&
MP4#WT_&C;<Z<D25$VF%GHY1=GI*[)]]L+YF("\/6Z[QO:2A-Q4?1.\&OE?\(
M(O?%%LFY0J.%\A9E-&H[2T?=;(*Q"Y($%+=#_-[GO&<[Z-5TD<S#)=9JHZ>4
MR;:F3=@X?-]D+ [I'FUBOTN=(76&U!E29U149_#8$G%X<"FJ$\V[8NLT:&[!
M"RR7>GVV>Y2TKD')E%L4_C Y_@14$[]G_!DUG-1-4C=)W21UD]1-E=9-Z0YE
M8>"1C;!&/2_JSEN5\1YM>*+/(Y&!9R+*S//8G>KR=KZB<30&,FW/)::A/HI6
MFG[\DO=_$[_SRA3PBZY.&?D0^%+FE##CU2]8\1$OJ-L.>7$,%SRIH-E>JG<8
M#[3&QLI^^LK'+*^;\-8T4UVNKI?6>U4UF2V8)6HHBM7[)SSB*^+2FI\*X#\F
MPM044R!X?Z5GU<$@/:PS;[;HMX] 9WB?7(XGGAOK\,=O#H5-./P!'5%]GS<'
MVUBKEG1+$># ,H>'OY(3[).!.[>JBVLC/<.:+IK-1(M%[,O*YE!]II%-N8;I
M@9* '\#7-&_LB=HR.IT L.*T.EEPAJ*4$6!SI#8*9/N@6^9P\Z/>!;N;5S>E
MNY2SW)E<"S\']I8Z//EKG4/?7E4/?7?9XCP\Z,WM;MZ-G2@#(-=@W9 /5S?W
M]Q_)[?D=N?]M<'>>4D=>UCE9@L5W<,Z\#-++@UZ_&F$G*C,TL/#$1B,?8$>B
MP84M=W#'85P:NXERG?HXY:W(>5XR&%K8E-,>T^ =C&Z#IGFA:!]2O:GZ'8PM
MC^LCT#9!!QF_U4PLRSG6)50T"-TG9X;))PU!*P83PK(6*$&#W.A9'2'!)G 3
M&PQ*5W0=CU[GU@N8]SR>,X-( ]2JJ?E:+2J4Y&+ QW.F35%*:4S!4@:D+_R&
M0$7*M7%(,4M':/A9X/C(,>"2[!QGC.A:5=._3.6"B<2PAZR5?;H;>^/RR^!7
M?H'+HO$+6LW!P\/@]+<O/.3"-$Q\3_Q\=WY[/H"?'#JAJIOXZ?;F_A+34H"E
M?R!!%($K>UIRY[=V \C12#=IVD"'N4:OU6_T9YI! ?--1+:>.4W]A#!@=# )
M&7W%2P9!I) W-@RXDW-^M$D"MD,#2N4=J@T'^ZF"/O3#CBJP2_#VQJR<@H9-
MS:R<N88)MV!^^E_-YH5MN]?81OC>[W\&IDJS&1@XIF%]/Q["(^"=TBOX0%[Y
M5[!+ ,>1ZTZ./WUZ>7G9?WUTS'W;>?K4;K4ZG_#G3_C@GO^\.YW \\$!X]XO
M?/!/,Z/#]S]]PJ&,8_PWA^+_!U!+ P04    " !,9VY)TZY9W^T*  "<8@
M$0   'IY>&DM,C Q-C Y,S N>'-D[5S_;^+(%?_]I/L?7"I5>U()(>QN+^GF
M3@Z8K'4$4W"ZVZNJTV /,%HSYCSC!+;J_]XW8QL,M@<#V12I_B6Q9]Y[\][[
MS-?GX7WX>3GWM"<<,.+3VUKSXK*F8>KX+J'3V]JCW:W_6--^_NG[[S[\H5[7
M[C'% >+8U<8KK8,XL@/D?&$)O]:\:%Y<:^+A;;WO/]6O+IOOM7\VFS>M]S?-
MZW]I_]8?_J,9(UNK:\_/SQ<N2.!2PH7CS[5Z7;3#G!F>(XVC8(IY'\TQ6R '
MW]9FG"]N&@W!]W5%\7*.7<'5$&U<7K>$WAZ>8\J[?C#OX D*/7Y;^SU$'ID0
M[-8T,)2RFZ^K)2DC3%)O$3ZW+OQ@"B27S<;GA]Y(ZIF(]0C]LD6]' =>0M]J
MB.HQ8C@A%[4N7S.DB=\UHLHUJ:>0^[D'@M-"B8*84,81=39*9)2.36Q>7U\W
M9&U"&K+Z%*'%FGB"V%B2QA72<?7+9KW53%@</Z0\6&W;R+!S,?6?&G%E'EL8
M!- !B_CBVAQ&%Y-\'J@0Y&^WR?'2F>73BYH<^80^8<;S6:(ZP=3:9J*(."R?
M1U8)EN8V"R-./@-4Y) # 'RUP"P7&EF38POCBZ"@$:C):<7%BP [8N07]J_K
M!@J<P/<P:.#P.EXN/$01]X-5%][7#O$I#>?Y0EP>-(3&#2"J Q4.B+/FV\\4
M,\ <HFD?$*4^3"XP*<EW4;)8$#KQXU<H$/W[1BAL [LF'AZ'9O'4($WK^$XH
MYAB=N@;EA*],$!G,94,UC8!WE!3KQI/F73PAE$@UFY=-F!83]O0CB-(B65I*
MV(?&KH3OO]L5'S+L6O0G^0P ,I F><6L$?/')&K>32.'<CK(<T*OL-&8K;&%
M14KD42"U?>IB"DW  _,]XHI^>X<\,?>-9AAS%D%5@DX-V!6@- */XABQMM7O
M&/V1T1%/(ZMG=G0;7N[TGMYO&]KHHV'8HPJWXW$;()C]^0QS OJ5!7&;28UH
MZQA$M3=;3?Q0(7P0PFM_,VMB+<3^$E12#=$"!C6R;\LA.[+AWX/1!U2MKF8-
MC*%NFT!087H<IM9DQ'WGR\SW7#@CP+:<.(27P3:?48WQNP,Q%A"/;*O]RT>K
MUS&&HS_]L77]5ZUC=,VV:5>('SV*VXC-NI[_7'80;^C5^+X_9@RW]=%'K=NS
M/E5CN!!1*Y@B2K[*1ON(AP&V)G<A(Q0S!KO/1XI"EW )8!;)+J&PV!+D;2"-
M<']QJ>K>\1>Q9R;,\7P&3<&+-;S7^^:O<@+_L];7[<>A(7K$W>/([!NCD:;W
M.]IC7W_LF';4A_)Z4]?LPUIOZKU4OZIZ4E%/ND/.EVD IWL7$'Z  ^ TPFX
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MG3.E0=*B]+0[@0!IBYY-38 @RESA7XZ_39D <2^V5BR4>/^NX-UL*)0[ 6I
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MSW1479R#=STU+/:C^_1.L5KDO+G36Q+WG=A^O"PX3*[YT+-Y9K2B#^-HK*_
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M[NZMK=DJ>6:\LY5D=I-S2K;EB6X\DJ\D[YYDZE2*%B&9&8I4^.*Q]M3Y[Q<
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M?__^#?DK:AI[/\6$_BY<.PE1E9 OP&R!_W51-+O O[JX_.'BW>7KE]C]!ND
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MRLI:/W5>!M>NK4%L[_@I\ E_#)"O&:W3IT-UBP_CV?1OX]5T/AN!V7CUL)B
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MZ##U0<VN\!<:;.X$I],L*CX-?@VCSUZPS1.X6$Y$3*?7*4C(T7(;)RLF7]"
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MC\X_PNC:1R.!II=TEY(2LC=P'\%UZX$%J];+*5\P6Z_H)-WP*Q>-BOI$>>^
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M6Z>HK=A3IV62WDLO2(NB8?9MH8N%FS_ZWC:;3Y,P?S@/^*$3@,>LY*1YNU1
MHLR..!>&IUPSX7RK.#3+O[E,XST,7-B6$7-"7YHOFG23M]6ZYG3&<FE<Y>E[
MWADH>S-X%-^3\./M-H);?#2U+\1=._NBPAV(!Y94ZB2^SW%&7C0_>=L4XUP*
M7A[5Y=*/CN*;/G8_Q;3K-VQ.MNN>'=3D)2$?.28!%WG.-YPTHBX]F7=.0EEE
M75/1436]O>C*8)Y[?X*7 KIY\OLFC!ZA$['C 7.NJ-NHMC@B6 @-CZ.Z*T;5
MM2#YI[O]"GV0BO&>4D@\6(<[N')>8+S"#]2P_ O=3G.9<)K/EL?B41- VH!/
MI)7!HP&N=ILOP7-4JV]Y6?(Q3I.G,!)?XF01:%]$,CEG0P243:VYT<G7?W,=
M):-\D]@1GDBR22S #_,LLAU!UAQ$BL9!C**>*SU4G-L=)_>!T];8/'/'R72H
MSS5W-N0X"-7-FG08NM98>O68R)PSA3.9%Q +C&*AK/!!<@M=&#G^$L6C*6+D
M4&O,\3.]]*Z_Q&LO.F'?VZOX,7*[HM[S"%]]RCL'9>]-HO)A=<.U90=1U5%J
M]KT+K;5=^S,2JAYLWQ:B\11^_03=U$>KI^63$\$K_)3;=;C;PR#.V#Z6,8JO
M#L<V^8[.^(L3N:QUSP#?T'^RWZ-^* O)^R8GBICRXI&\<%CMOUH:BSR?5FU8
M[!Z3KYA?L0V&*>I@?AA ::S<CW P<W;"!V-KS?37XJ]S25T_0_\"^._6+ #;
MU$I5T&?J5/_PB]]H:#0T!@'VRPM'$%BSAFM7+PL(/:_75E_"U5.8QD[@C@/W
M%@4%RR1<?Y[OL6/"W^17XY,FU[NJDY>J"1!$"0I24FL.$P-"#3)R\F:'X:0W
M/4(:7MLJ0K.VW.V$2]W;9SBT)K/^79@]%RJU_\J@,K2)QI*!L8%2-@=%>VMF
M8XDQ:=]-DQ@0X\B2W)UETMF"+M$^;1N^K)GHI<9&$F-F;XX(US&L90QO3[C/
MSO4OO/O0"+7BEEAE"Q;95FQ5]P\;:HG=,V;.P)3*_&7\US@_S_FM-:%QP&^=
MCZ%Q]-6[W=62[\GWP/&#9VR'(LSU9I9R@--GI6.?= [==HDF+_A'WJ:R; ?:
M[4E:,BIQMB!D;P;GQ&:/BSH+.-GM_?  (8CQTC&7;UV5#_+DTVG0:O!L6FD7
M;)[!!)DM]N,/Y"[/-,B2?#]$83Q(\,G[VOE,DER=#3!-YM\;@>R+N')4]DW\
M&_15PW=*]:DQSBMCA?OL/'Z+20>[=2#U)JH>Z6=A</$,XW(>B<$#4<1<BR+V
MB*A(>?Z0>BY.KS:N$G5 G$7P*/;'O86/LL[8HEF,>?+;*LNO$-],A>X8>3)G
M"R<O,%I[,;R//!J_*F/7)Q?VS7J]ZKC+;,A/B>!.AP4W(&<'%/P PI#E$^6@
MFB]5X^2J@85J]ICBG'QG_UY V:<.Y0(TYI?F"[<EC)X1&^T2H[@C"SN(;/$J
M3!R_^O?K,$YF8?)7F.#$N&V =Q\J9XB\-82F[^O/4=6D5^9"//\P<\-A!,JO
M9QXU'M5=,?HP., $'#\]JAU[&UYOF%+P0Q"535MW.$ $?;+5DX39;D@>EEI0
M,D2KL5.9M/HM_2MPH]G,<1M&^:]P.]X[7;H9^7H<*TO3PWE8S$6KF\T?5MG@
M:D-'9KY2?RNK]R)ZNB@BUZP4 SXV2O^_3U;T'-J<LX3;T'@R%22>Z_DIOL]Q
M+&4U>2&5^-U;-#98G#3;XIIO)DX4>,$V1C(0A8QW8<HM(]53__K/M7K2"W7L
M5>FW6EBMZ!E@<P"5OK$Q%[UC+YCYUA'(OF#X;$R'DN*CDF!52>;]5*^V0YVJ
M]6\X%FU7LC8);ATO^L7Q4SB.XW2734CCP/T(DZ?0#?UP*_, L):OV[<]V8M.
M!SBDP]\'A %0X0#@Y/$*#\('CJW9C!Q$ST1)ST1)R.%7 [)L^]&"L$RC4?=V
MDM/5HC6[RD>Q:(\RHN%<BS6*1E<PVO&6Q$-^U(QC'$J#VOPA>6J;?!K@;UO@
M W6IM.7\)5=$,IPBY%,8=*GA.@R((TH=GR.X=H<_J&MJ]?,:_-*91L*%1+^$
M/NH&EWT3%#/1\O7SCH29.C7A^8],&'RIUJR:J=G@N:0P/A5H5\8O MG/-OSG
M>[)!PW\9-W:F\P-^K>,V@J*'Q#5^^[SG!H8^-<X,Y(4<S((-3YB;U#$U+42(
M[F*#-:/CQ7/]<X2D7A8J:CC;Z8+GV :=+,1>[4RGBF(6O/&>/1<&KHF%1/W;
MYSU5,/1I8A%1L/"US122*B[%/WC0/\\;, -+?[;3 ,]I:5DSL#V6B1J6]U&X
MAU%RP 6)DG'@3OZ9>GLLAWR)2E$7!BM0"J6CBK/E!"-2?2HA!XPED8WU(N7&
MCUT.4F7P].'S-HT"+TDC2"IGO>"?8N$CISPB[1CD2D =W!:-"=Z*YI:\:JHD
MR7RSP;F;FYI L,"4><,1 ZMI*K*H.J$ X@)?__2GP3/Z;Q@=^.4.&8WU%C=D
M<4RM+$D[4#:TH6:A(N]>T=!P*4(N2&J%!R40HL^3_P*?O+4OX;V;#;5[;(I3
M:B,];V")7Y;FU[S7;0=!T]/R$*#QQ5N(@OFGT'>GNWT4/F?W$87HY5+I?^&6
M*P/U%%K1&E2;6X+RKJ)XE>;F#4 "5-2CM;*(TEB$F[56N),HJ2A#K+]8MXQ$
MBFO$.YO*'<H/&57L6W&\+("AJ+"2B- >^+'*LG"AE]<K&@%R@\BLV^XL6:M(
M%ML1MWB,"N T7M=:K]-=2B[NW<!]!-?9<SOH9Q^2_<W '>_"*/%^([]G"L&Q
MM/X^H?_25G_:H:XD';L&U;Y'H.R=P+_:/[+TNLV/ZA;2MYF_S[04D/?(79&9
M#ZBL.QC'P*EHS*U\P+Q#Z-N(J*M;@UB0/B=3/3!99+>$\3W66.+JE9A4NU.0
MD(9.Q:Z<S.8TY&IZ++REI!/'LN/4Q*?:(%D0'#[$<)/Z=]Z&=Z@E16U/F%B3
M23%6S&@!)K8T5)223EDL*Z)&&HS2H2,+B6=PVRPO)E/6.ZA7V!9E#@WQQ?.Y
M9R;4W9"5<<NOTD7E1^ *;KT WQL'5XZ/BY<.52>5E+Q8)DZ4B%R*/BWS2\?B
M)VW_CQ.D3G0 ER. [6E0Y4P"8<1N1#5-G2R1[R0[F>#=6YY:SN*BFIQ7Z^V6
MFHI+.Y\YX1>]$T+[Y\YN-F!H;<BIX!?&/&!V'T*3(D6%PK-NSM^7\:RQ;T<F
M-L7S\6*E4\[_?1M&&^@9B71%')R=KY/7K99(N/@5*/GXVGQB=X6+W&39T_E[
M2D6+'RP*5#'W,_2GC1+?I/[W#3*",L]>ATN58.)\O:J,AC5M,0B>&?BZ=QRZ
MC .E,$(%,%GUIM=7O!DQK-:^ZNT*:=<ZV-REZ%?/X+*LS#,5ZG.83D[.YR)M
M9UWK?4I.SMN<Z4W;WL9 3DNY?JU9/^AW$<.^4F:W0SYYK\GD8D*:@[-;2<CK
M5L?V]-FX6R,:EW6S7]=^MK%(MY/1GX]796Y"6;%KTX&IL_.])XV L>WR?P4?
MW>O(R+KM?X7]=?/;%B<ZEO/9QLBF+YR#6!1##O&OAGQ$0_;+9[=-(=;E\-%Q
MEC);UD</R:^'?SI#RX/O'?2;[G9X2[SY8@9J[3WC(LK9&^C)$RS^@E-R+?&L
MPUMUWSL-2B9]/CYRGB9Q@NS*"[;9T>N 7K'E6V?G!]OT-:3GJWROR-.P]QQ1
MAUZ;.1D50O!8ZN51@UYDSPE-:P7FRN&IY)PF *;+ZMOE"_R51B>/Y_=I'*?0
MO4DCQ$ZVW9V-?/6YXR+AP.5Y\0Z=Z7?3720>T@\7WZF<C1E>X/>FH3B/%,/<
M=Y0$%KB*SL"G?,&)J#^?B"Y?U^-R?\6YV( Q7>O7SBZJ:]?9D/ZD\L7A/$J'
MO%L]2K0]L788\^L[/A':WODXK=SKXM*]@R]#6[YU=@ZK35\:PA_\O6(9>LZ[
M;=+J:SJJ"N%7MZYBVF#??DM@@.?CM2H+Q,8A2A%%DL1O/5MJ? [.SL/)ZU;;
M]MO9YO<;&0:AMOY5=NZ&U-O7-@<I>M0!=_SDW:E%\U6LOF(8:N+JG17[9K#^
MM=UE*HM/VG(0SFH6I#&9'0.A/SZGS8N!'(2R'Q[4.VBM2!NF08*WDT/?6WM0
MIDPDC\A$U5BV!"UU8//&H&AM54U(\7"T5"N5&@N+YGCYQ;6A-:DT!_;-Z+WI
M5MM>W'G/WH/I6SAI_XMLY)E81'6R__.Y-<)>(R[@SO'P)L9U&) Y)'7\%8QV
M/PQX7:03-V=W3Z2;SLUM#)9<@0I; /-E_-3$^"A(*@L7"JZIV1*_;,9S]'T9
MY&2WH<]?HVG&B^>;1J1^R/Y_!5^2*_3QSQP7*]N!=J\H+5G3A @A3OP_DHZR
M%=D!?,K_B^D!Z<#P0VB=I7P(G-3%^RK8+[@(X]E/,2)TR:,$MUZ  C8/.8ME
M@GY!]A7,>PDUO#8-NPM8=3Y2X(51MAVS@&O?B6-OXZTSW^/^(XT3/ 8W,%Y'
M'O$S'*M4[\K \P7*TM)OL=;I[#73 82UP!B[ I9^U> 4M)[/XH:]=F/%!9<#
M+FXZ<7-VBYMN.C>WPZ1]<:/IRGL_XZ"TO*E\TKRO-.@[^E[>G.PXSF>_O[*2
MFR*)O"#VUD-7Y>-\\^SV]'GZT[:!5'YYT-(A6E)K5?0YWFXC<C>AJ0 ;-WZ&
MM-$!\YAX!GJ6<6E=($WA)_71<XXR:0UJ"R9M<W2Z%,KQ=%]K#,BPTP%#/:Z1
MGD%$-WG9>Q%IC,LO#1&_-;]P/M$:I9L!7-;Q&Z0TF276V!^2>HLR>##2:&?K
M)^BF/IQORM)FA-UQ7@!IA7V"S &1:D?ZK4954LHX\@[PF=&QM"'I Q2=@$^D
M&PT[TG+3\\DR'^MCX>.AE!R8X6I8&.Q.</CNVW?O?XZQ.BY^8;[Y8X$/Z(1R
MRM1/@+C&M]?QQOI\\ZN#75 RCQ9XZV;\XO$>'N/0Z']MG<,_]<PZ;HLAF;<&
M801(>_ )4UB032L<#>II=;FA,(RGFQ#O *HBJJ"R U.E# JHRFALQ55]5*20
MU38D^K"5\_(1"JH5--IIQT^33^J\(@?*IZR%!?AHU6P3$1RURF#@M\.+1T;V
M[?MW;\FXXM]4ILGVP#?_:HP7F%FP',?I+EN("L/-WK^@#4O]ZX89H,[S-RC!
M%;U"*YQ:#,IO@,I'] 6P@@/)X=5U-YU-P/P67"\F-]/50%*ZX3K%[#IMF3Q:
MQ$0-4M^)@.O%:S^,TP@6,7SL;0.2@8&PX50@D&+0N*3 %VEW@(@\"0&*>+T=
MWG[#O]S@DN//Y)$TU-V7G,,1\(*UGV8',H]I H(P ;ZW\[)BPS^!5\[W );5
MAV&T&X%7CY5?/8<^DM#'2ZF<2Z0$]*]\H1&3U06B65=H7!1]NS!P\>_=[T'D
MQ9\O-A&$ "VOX:OX^Q&I>?P*?D]T@%/"P 9-Z?LP3LA+I5A.U&L2>6NB@-?F
MW/= #K1P_(-ZSQ.FC#PT(27DBL_G 4I<_!O7G<-72Z[1L+$F!O5^]+K_#G*V
M!Z?8PY-ZU:4WG^<Q:GS\5=$3P%V9]&\]B+V >\0>N:F-G8*S(V:,7,0:M<=.
M)XTBY J\ 'B%U!6W9-B@N\*[9K:G85M?3#\-T!R#F9"XQ=O25GMLW\9O$WUE
M&ZMNZC(UW8SS!6HV@(V;,AB1V5OFDYE#3+L4;/ <VZ,PVW2 W5&:F\GM9($B
M9C"=+1\6X]GU!"PFTX]7#XOEY.-DQHBCC9@%!V1,"Q$B3.<]@7 -H1O?(@E+
M_I8P27QRKC3?0WQ\%&SS[6</\G9XNW1FX*Y !XF; "TZ 1@9X&A\QWYP7D7>
M$SAV91ZXW0><SK0_;;3U@?S.<Q[Q<H^/WEHK[;"L\TAM(QS_.@*K,''\H4[\
M<-\B;\[GE;"'UN-E&_.@;P% $\W,T3]AQ7GEK#]_B- B K]&\]$)G+RD#G[>
MAU=_1H58[]I25B+Z'B1:1F:$ %&""BEY[,B.ZC3J@U9;/'48L?[!13XFW-R6
M)+8"7)1$\N JL&4\#CY-OO'U7SXLY@^S&S!&__LXGHT_D##XNV__\,/E[W]>
M@ON[\6QI<O.EJVBK?.\5+58J6\<1])W\X;A'/+;;;&SQ!NON.+9[,K:U#5S3
MFZI*-BGC.W@&>8+OF$=;)_!^(T,Z<W#QMOGF*HV] ,8Q^GYYG[N\SEV]S5U>
MYC[>Y28[MBQ?,]#']/JFH336-(CYXL-X-OW;>#6=ST9@-EX]+,CYT=7#<CJ;
M+)?$ SS,Q@\WTQ5:'U_/9S>3V3+[:3F_F]Z,\:]OIS.T:)Z.[\!RA7Z!?<4R
M/W0S/;T."KV:26G G;XES$<O""/DX:9! O$QTOQ+ */XR=O?0P1SY)VW\.IP
M[T3H1\X21ZD7[4L@-1F;EC-#X,,W!4/?QVONHA.T#B^Z <=^<'YQUI/YQ4F'
MH6TN7CJ/JSX 9^\'S#?EML 2;HE9<>#*H=$.3A[_%!1)6QR:'/> BN;F\28<
MB2:Z)(?AA'CD;X]K9GI6LX'>>;_*67.8_W9U;4$R5KL":S,A0WL:C1]^J=3)
MB<( _;C.%\>*-:+4N]+O*M2EI3P(_ *J-7QKG=A;FJ8'R1=P3=+(6,);X#\[
M@IERJR<A6=5X8[A^O0V?W[C0PW;[(_X!F^N/%7-%O_K[3;[<7Z%N6\R0;J+-
MO%JXH\X-\S\#_'=S2&'IL4  7XE#C>P8?<[%G[SUG2UC:!MMM(YMDS_J9F[Q
M=X ;F!W=5EU6AY>CR*$M][YX.8=Q-Y73UH@M-_EE&G76$*"6AF]]"K7=9N@<
M50^-B%LO7CO^7Z$3W:+?M*VXN*V-H(+FF8F+K"G ;0%I; <R&%IOPP97Y7K0
MD<%3'A^U]@814N=;A)'<A5B'DA;MLW'"5/U02)F0PY4%W'KX##-(9LZ.-;&T
M-]6*#P:W36ADS<"Q'< -S8*"I^@J'L1:'A8*UQ"79/.G@0M?_@(/7"Q0;0V
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M#A0^AT<[P.$%30,__$_B)Q?PBVJ1JY0&\+W=Y9$+AL_DEYUA<JZ<^ER6RH,
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M97L'*&RX6],O+7D(-,?<WEO1G.TFD<X6=QTN4IBQ$PG-YLGS(Y9=+0.:2!2
MV(TR2QNUX_4.G671U>JH7I)!DX8 ,@KS60V>Q/804_@=2$0X2J9^1'\6[5W[
M6?&*Q&F>,N?S>19''^;"XAD)3L)"3H+4&_@W)C,78W_A3%M,W?->Z*2R$5;R
MAOO'KD;UJ9_2=#2I=.YU_K\ZHUFO =A:HSAGJDC@#UD3C*VET'9Q\T'C9/ZR
M]BT)6)XX.J'!G+*5\]@928.$%GBEUR)F37E#'*F[ZNE+/;26\BABT)QK\J,D
MN22.X,^@-&\;S"^F38$L49PGZVE./;26DC6Z3=O/>T:T2'GH9(EO^3'10V<+
MOK!SC9X0+>U7CU!<.&AR()J_]6!V8%LN>?'0W>!#^^[AD;-G2.^"1S+.0^CW
MQA-[)S_\9&[G&16JF+)K]OEX2]-\-O^M(%/KF2BK'P*1H;B_MD&\P)S;@KQ:
MFE=P:&U9_&7AG 09?:;9:R---6O<ZWU!L5AM5SOKR,C2V0231E['T3-)0;SS
M%Y#K:Y].0]X0QZ,IV] T?7E8.K=@><G2X8;)TGN6P^,:#XS]?'VA1<?VCP?[
M1;?8+\J%<1&04&^W8OD+ !R%>5)&R_JP:T4 G7C^S_9%PQGS* N+=ZQSD(J#
MT5U&]-991F<TOBE)K_1@SUOW-28#*^U[![T:C\(+Y@[;'(H>8FKO8R .% 9L
MB]QR)J 618?GT:B4!)^F\?/G,:%LS [9'TQGAZ6A"C]Y5V3JA^=1QA*L\1^&
MXI0"L$[-U6W3N*XT0@'@>4-*E^TY N%;4=4B -.I(40H^4V"-KOM]C$HP1KQ
M7P_!-S)[((EH7E\5\ [</L_%%RIG.JWTV.W+31I+L_&"\K:WO9(\R=7*=T#H
M3N.NMCO1MBA"2Z]169BJ[3G)CWY$)$D?Z=,-2=C;L/Z4G+[>^(HL @:M@.B<
M>J&VJ ]\<Y"Q;"P]A>54K:YS-GF/)J,GPEX7CJ9W9%H(3^;?(*H#8G%J,MRZ
MRB@D8>GUK="-5>+4#[Y/DSB/QB"Y;WX$^C_WZF WK>\F!KUC:._+P-F]0>TW
MG5%$'UB4O\#\SX&-YPC?@/?\(27_S '8.7M3[!Z^IWKUF5\#1(+B!HA'E(!2
M&1 \!W:KW"K??A;6 ;'@2/TB8TV;Z#(F/$]!MVN)ZWU!DIA#-4"%G<?SU'-;
M5K3>%W16M$+R"BM:T6VW!^>NF7-Z.&YLU:.U1?@=>C[ZFF3S+.97<2H]+I?+
M@10Z:%4IJ!4<D3?16SH68]"!.S\DZ>+A OD;>I62( FG>Z^MZP$7/XJGJ@7+
M#&AMPO+3GI'Y?R^CO\?)=QI-%_F=1,N&JAX@=QH=O#7F#:1AZ;'K)KZ: BTX
MGTQ(D(TF_T'\<1'D=$M8:MK"^30:7_C!(F_!+0AF%)V,9S2BS/20T6=2N":*
MU*1QPQ[@_G7TR)*XVGMT>YN66>Y=VZD?@H#)W2,A[,TD1MTCR6C@QCJ[8KG$
M_ U[9)?IADZ*6W5U[\!98HFZIM4#%'DAM(6K93<]L)?LP:UI;0GK*XM^'DV*
M. .5X514QSO :)AA5"DXY0+I@N6T#$QI,MTL[!V@" J3\\3G5@ &CXW4PIB5
M&7/$A;U#%+%4YJ-T'0$>&ZJME.6P?1DE!=IQD8#YAB1%N("$7;T&O$-<)KAU
M(OFL&R#K@J/3.MP"6WJ29X]Q0G^^[9*5&E"MZ!VB<&YOP#P741=\D'@P+],T
M-V9[7LD[1)%-I3'3)33V'8EPL#S*LY2]^4.CJ2'5I9K>(0I_E<9\5R%9,HZZ
MW76_)<&OL:9KU/9P!"D;D:\+RY)5%(L"&"SEDEK>(0Z?E9J$<^'8LDKB8EJY
MA MJ>#BRIS9CN 1%P.YN6<<V .HMW;)JWB$N&UDMGJMX!&0WL96YSFBW</7N
M7DJ[P8$[W^Q5&@1QXC;5U8)F$P 3Q19)DP^!Y<L(;!>N(X0X3U\U/+HU:H.H
M<.RDC*@5':<TX7;A)D,L)AUO<(W:("H4.S!M5@V5HHJT"S<A%WD241:=R[PA
MZ O[*Q7&FJLK@6!0;,ZT.>2K@ J@I9N35OS/F">+'UY&++XA3E[EB0.XA0$C
MBDO+FB2J@%FZ[,#@1OH7>:1!J#%BUPMZ QP7F U'*0]4A_S$KYC?(WO/Z'+V
ME,3/<]\W)=.26B A%+>8#6E7(NR0G_A*-$K>*R5!$BCN+1MRS45EZ8+#?8;6
M6S^:JDYDJS* '<?]I(5S5P54%RXL"DC*45HJ!=!1W#]6N) 05NYW)ZX>OODO
M=);/E*RME0/\*.P?&Y3PF>/TW=;% H8%\AN-]"@LEP,QH#!MZE*XV7=;UP48
M*!0N(U<:SIGJRB P%%:I5NV5%;0"]=@MTY00[!^)/'!67A$DA-M$5>'24!-*
M& 5:L&4SE1UE. F"?)87F?O/"'0_H 5?\'=(%G%C)S/VN/ \IDPH'HG:V/H$
M"!^W^4Q+P>Q*0Z"*^D:WX[DJ1F3*>H1SO9('<LNJ>8,CW):99G/2"J% #8S-
M<^Y?<1=B_3,EDSR\HA-YT(&R-@@,Q3&C)96H A5HA@6CW3;=8,[])*+1E*6L
M6'IDND]XN.C4JD<:/C"B*MZ@[^Y9N)JQLX,^BM58+E*!]PH'21=\5.R&S X&
M*"ZS>&0I:.5#Z8*O2=.HV<$ Q7Y(P12?7A&<+KB+- V<'0Q0W$K5&*L5#%V(
MG3V),CJF8<YRG=R1($^*3"CG+T&8P[;G J3&WLW+EYE8-E:P&<NG(CM0VV@?
MQ(WCVDN@"(+3LSWHK;FK;'-C+'E[V:&;.-;'EP?#H?,)WG27/41QHV)#\'I[
M\6%'_,4M[\6'*(P6/+*,]^+#COA]-]Z+#W'<G\F9TM^+#SOBNMUX+SY$<0]6
M8ZQ6,'1A+\Y_L_R$/6H[?S[E])7_\.V%3Y,B!+STX"U[=X5DC_$X#N/IJT[:
MO/:_#E2AL,.)E$B@<ML23(><TM_V5W*9/>C([/SEB02P<[LGR:RGTN!6/NH-
M#G#8%[>EBI*1T** .^2X;Y6II:C^BN$$PY+5OM["!+:MN9S_=6 ,AWD6P9#8
MAJ0[%-!@56:W-/U^D1"R?'EQFR.#]VU@"X=YNT/C0BQG%(\ (!P5RYGDC#[3
M,8G&+M:+\K>!+12!#ET:%6(Y6XJEP7Y=T'N_+RB9K;_LGE>.V]?-; I>[[Y
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M*[$F$F-9 Q&*YQ^1"%L).*[?&V_8_^5ON%U)73",?LD[\M)<= FRHE%*@R)
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M99U <U26O#XQG'8N(]COD3<?1_8E1I!\AI;4 @FA.$]L9<)6RL&2*Z?3^5L
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M(661XKP*5;VRR^IY_4,4!A@E@P+BU=BZY'%VES\]A90DYDJ@J FBPCG^]=1
M"UV7GFW9 'JEX: BK@2R13$+-%CF*U@Z\9S+!LBWI,"RNRE9-9 IBH@I%7^:
MK&\@:^%9ERW?4XU9BH,Q_)'&(1TS[XC5J%A8+!_C$%"E9V1" YJYN+X2](B%
M-FD].*15W]N]!&8X\I?I2U?K3@M71C,L5UH]E+G/--(R\9&\WVA%( @45DX%
M4]HW6KVNI%!C[R+$40%-PXQ=*0MBP&&_%! DVNAP85BZJ,)P@GE[-^7&I^/+
MI;>@VDXMJP=20A$?9T:V!B1+%U,8B+]ESE<1&9_[242C::H./.96 +F@.+*:
M42W#8NG^R7WHS#6<TF(XI<4A-#U=.@4K>995 PGAL$\9L:U&9.GNR3WG3=.<
M]I!Y$VEOIRL0NG"[M'EHO(R",!^##B^>/3O)LH0^Y!D3TGW,5W,I_S8^  +'
MY8U44061XMC#;NE6ZZEX\P5@))G;.>01Y)V.\BS-_(@)1*9"U;(@$12&34-M
MX,.P=6>%A=FW%*[I?2S8[A:B./4+V^>,Y7DMF"N&RZB01'I+8+RD-"-W)'FF
M 9F_571+@G@:445\WI9Z /3A,@%J:>%6A6/K&L[]GD=';(O7<MAC.=R7QVJW
MY?5Z*,X_]C6- ]/6;9Y[G;E)X@G-KN2QYF^% #Z*<X\9R]7^=R<KQ,YLC7$X
M;;K9&HN=.LW35#PMG_C>Y9UQ#X51M/'.N"?.'V9L">7QBN>BG[VSYJ>/%V'\
M(W5\O[_JA]FU_D8UH._(N7'*\#J_ARRON%"L6O?X/7%:\5_Z(A]E"O&"+..;
M?''B\%_L)A]'3B8%4_HW^>)\3+MUD]_XE@!'=J0:8[6"H0L1I]<D8\L1'/:>
M*6Q^3E__3%D*(,Y[7K#'@1]R^&WQC[#GT=A.V/D "!SM6:@OOCJTB+U#S@/-
MQ-*:KH&<41RQ;&I-&WHYEU-W'!WXPKB,GDG:Y@QH^ &0.EI3L?$,6 M[AT)\
M2]G8R@]K%N\'<F0CLS*;M0221.&B85,O!.;K.H)IZOAQ/%>QB$R9)6B'I[76
MIC.0,PI_C_85T(:<+/F&9#%+X8E0&R]HY$=!BXNLX0= ZKB,A4T6V5K8NQ1H
M79[W;\G38D$839A0F7&^"#N7W^"JZX/84)@>;2J!\$)85QQ=BM)>@QI'4_:B
M0CDK<NF]9ZG_NW8K7@_',S+M:Y2Q4!J[D.#?H&F*M[6E$ 2-PCS;OO;9D),U
MIQCG.S0FBI-HS/[#W#:>_9"-R[G[WV44)&P\GI'Y?V7W. ;-@ AWT*AKCM"6
M&PL.)5&0#Y!16%'-29WWW*YOBGNO;3W*=M"T^-9S6^^,('$38VF0"C'XX=)3
MY#*:Q,ELSH>&!X]>"R \M&ZI8MJ-P.%XJ\2.7BQ=(YF;M83\<C$0 @IKKQ%G
M?-HW8=EZM\3]#13L&N(9N?=?2*HD=ZTD" *%,=4*OQQDMIXMJ5*\31_143+U
M(_JS:._:S_*$C":G><IL)O.W*OQ\3+/"A733EW1Q%O'#-Z=2%YZD90QOW6/,
M1N.;DKQ&$TZ'-18L*^V#RAR[&L&- )S1- CC%#2#O65S"MW\WI:L.)_R>D,4
MUB:+.L"?8=H1G"577)<SU*D??)\F<1Z-01+?_,B?OS";WH1^9#C="%YE8U_X
M0_0%R?R@7]D[V*_AF&[6W>*#LB&J7QFZZ_2>R52PZR/*%*>E,:+]^-C?/K/N
M/O@I*03\_P%02P$"% ,4    " !,9VY)1.W\/N9F  #+1P4 $0
M    @ $     >GEX:2TR,#$V,#DS,"YX;6Q02P$"% ,4    " !,9VY)TZY9
MW^T*  "<8@  $0              @ $59P  >GEX:2TR,#$V,#DS,"YX<V10
M2P$"% ,4    " !,9VY)K(^K1ZX'   '80  %0              @ $Q<@
M>GEX:2TR,#$V,#DS,%]C86PN>&UL4$L! A0#%     @ 3&=N2>_)F(J>)0
M8W8" !4              ( !$GH  'IY>&DM,C Q-C Y,S!?9&5F+GAM;%!+
M 0(4 Q0    ( $QG;DEH2^=>>CD  .U* P 5              "  >.?  !Z
M>7AI+3(P,38P.3,P7VQA8BYX;6Q02P$"% ,4    " !,9VY)FG4UVM4K  !C
M^ ( %0              @ &0V0  >GEX:2TR,#$V,#DS,%]P<F4N>&UL4$L%
3!@     &  8 B@$  )@% 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
